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A-001
THE EFFECTS OF SEGMENTAL 
CHOLANGITIS ON HEPATIC 
REGENERATION CAPACITY 
FOLLOWING PARTIAL HEPATECTOMY
Y. Yokoyama, K. Watanabe, T. Kokuryo, K. Kawai, 
T. Kitagawa and M. Nagino
Nagoya University Graduate School of Medicine, 
Department of Surgery, Division of Surgical Oncology, 
Nagoya, Japan
Introduction: In patients with hilar cholangiocarcinoma 
partitioned hepatic ducts often develop segmental cholangitis 
(SC). Although these patients need to undergo major hepa-
tectomy, the effects of SC on the liver function after major 
hepatectomy have not been elucidated.
Methods: Rats were subjected to segmental bile duct liga-
tion (SBDL; correspond with 70% liver volume) and lipo-
polysacchride (LPS) infusion into the bile duct of the ligated 
lobes (SC group). The rats were sacrifi ced and blood and 
liver tissue samples were harvested. For another experiment, 
the rats with SBDL were subjected to partial hepatectomy 
(PHx) for the lobes of the SBDL. Rats with saline infusion 
into the bile duct were used as control (Sham group). Hepatic 
regeneration rates, survival rates, and the expression of 
hepatic regeneration-associated genes in the liver were 
evaluated.
Results: In the rats at 3 h after the SBDL, both the hepatic 
regeneration rate and the survival rate after PHx in the SC 
group were signifi cantly lower than in the Sham group. The 
expression of HGF mRNA in the future remnant liver of 
the rats in the SC group was also signifi cantly lower than in 
the Sham group. Serum HGF levels after the SBDL were 
signifi cantly lower in the Sham group.
Conclusion: These results clearly demonstrate that segmen-
tal cholangitis impairs the regeneration capacity of the 
remnant liver. Therefore, hepatectomy should be avoided for 
patients with acute segmental cholangitis even if it occurs in 
the resection side of the liver.
A-002
THE PROTECTIVE EFFECT OF 
PURIFIED MICRONIZED FLAVONOID 
FRACTION ON ISCHEMIA/
REPERFUSION INJURY OF THE RAT 
LIVER
S. Coban1, F. Yildiz2, A. Terzi2, N. Aksoy2, M. Bitiren2, 
H. Celik2 and A. Taskin2
1Gaziantep University, Gaziantep, Turkey; 2Harran 
University, Sanliurfa, Turkey
Background: Flavonoids have been subjected to consider-
able investigations due to their antioxidant and anti-infl am-
matory properties. But there is no previously reported study 
about its effect on hepatic I/R. We investigated the effects of 
micronized purifi ed fl avonoid fraction (MPFF) on hepatic 
Ischemia/reperfusion injury I/R injury in rats.
Materials and Methods: Thirty rats were recruited in the 
study as follows: group A: sham operation (n = 10), group 
B: I/R (n = 10), and group C: I/R + MPFF (n = 10). In group 
C, rats received (80 mg/kg/day) MPFF by gavage for 3 days 
before surgery, 30 minutes prior to ischemia and just before 
the reperfusion. In group B and C, all rats were subjected to 
60 minutes of hepatic ischemia followed by 60 minutes 
reperfusion period. After reperfusion period all rats were 
sacrifi ced.
Results: The present data showed a decrease in serum 
aspartate aminotransferase (AST), alanine aminotransferase 
(ALT), lactate dehydrogenase (LDH) levels in the MPFF 
treated rats when compared with I/R group rats (p < 0.001 
for all). In the MPFF treated rats tissue levels of total oxidant 
status (TOS), oxidative stress index (OSI) and myeloperoxi-
dase (MPO) were signifi cantly lower than those in I/R group 
(p < 0.01, p < 0.001, and p < 0.05, respectively). Increases 
in total antioxidant capacity (TAC) and catalase (CAT) levels 
were statistically signifi cant in the MPFF treated rats com-
pared to I/R group (p = 0.01 for both). On the other hand, 
MPFF attenuated histological alterations that were induced 
by I/R.
Conclusion: The present study demonstrates that MPFF 
ameliorates I/R-induced liver damage probably by antioxi-
dant and anti-infl ammatory properties.
A-003
NATURAL MUTANTS OF HEPATITIS B 
VIRUS X PROTEIN INCREASE THE 
LEVEL OF HYPOXIA-INDUCIBLE 
FACTOR-1A BY INTERFERING WITH 
VON-HIPPEL-LINDAU IN HUMAN 
HEPATOCELLULAR CARCINOMA
P. B. Lai, L. P. Liu and G. G. Chen
Department of Surgery, Prince of Wales Hospital, 
The Chinese University of Hong Kong, Hong Kong SAR, 
China
Introduction: Mutations in the hepatitis B virus X (HBx) 
gene are frequently found in HBV-associated hepatocellular 
carcinoma (HCC). Activation of hypoxia-inducible factor-1α 
(HIF-1α) in response to both hypoxic stress and oncogenic 
signals has important implications for the development and 
progression of cancer.
Objective: In this study, we explore the relationship between 
HIF-1α and naturally occurring HBx mutants derived from 
human HCC.
Methodology: Forty mutation hotspots of HBx were identi-
fi ed from 101 HCC tissue samples. Four frequently detected 
mutants (A257G, G348A, A389T, and G391A) are located 
in the HBx transactivation domain. The DNA of these 
mutants was then isolated and cloned for functional studies 
on HepG2 and MIHA cells.
Results: The natural HBx mutants were found to retain a 
similar ability to wild-type HBx to increase the expression 
and transcriptional activity of HIF-1α in HepG2 and MIHA 
cells. Immunoprecipitation analysis further revealed that 
these natural HBx mutants inhibited the binding between 
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HIF-1α and von-Hippel-Lindau protein (pVHL), which may 
prevent HIF-1α degradation. The positive association 
between the HBx mutants and HIF-1α was confi rmed in the 
HCC tissue samples.
Conclusion: We have identifi ed 40 HBx mutation hotspots 
and revealed a potential association between the four most 
frequently occurring mutants and HIF-1α. Analysis of these 
mutants demonstrated that they function in the same way as 
wild-type HBx in inhibiting the binding between HIF-1α and 
its degrading molecule, pVHL, thus suggesting a novel 
mechanism by which mutant HBx may stabilize HIF-1α 
protein.
A-004
 ANALYSIS OF HEPATIC 
MITOCHONDRIAL FUNCTION USING 
A NEEDLE BIOPSY SAMPLE
M. J. J. Chu1, A. Hickey2, A. Bartlett1,3, A. Dare1 and 
A. Phillips1,2,3
1Department of Surgery, Faculty of Medical and Health 
Sciences, University of Auckland, Auckland, New Zealand; 
2School of Biological Sciences, Faculty of Science, 
University of Auckland, Auckland, New Zealand; 3New 
Zealand Liver Transplant Unit, Auckland City Hospital, 
Auckland, New Zealand
Background: Marginal liver quality and function is assessed 
using histology and peripheral blood markers. Mitochondrial 
function assessment allows direct measurement of cellular 
metabolic function and may provide additional index of 
hepatic health. Hepatic mitochondrial function measurement 
currently requires large tissue amounts (>100 mg) from open 
surgery. Here we report a method to assess mitochondrial 
function using <5 mg of tissue from a needle biopsy.
Aim: To determine if mitochondrial function assays can be 
performed on tissue obtained from a standard needle biopsy.
Methods: An 18G biopsy needle was used to collect all liver 
samples. Six biopsies were taken each from three normal 
Wistar rat livers to confi rm reproducibility. Samples were 
obtained from six resected human livers and compared to 
matched remnant liver to investigate the ability to detect a 
difference in mitochondrial function. Mitochondrial function 
was measured using high resolution respirometry oxygraph.
Results: The mass of rat liver tissue obtained by a single 
needle biopsy was 4.12 ± 0.19 mg (mean; SEM). Analysis 
was undertaken using only 2.44 ± 0.09 mg of tissue. State 3 
respiration were shown to be similar between the three rats 
16.8 ± 0.7 pmol O2.(s.mg)-1 (Mean ± SEM, CV = 0.08). 
Ischemic human liver samples consistently showed lower 
state 3 respiration compared to normal.
Conclusion: Consistent measurement of liver mitochon-
drial function and detection of derangement in a disease state 
was successfully demonstrated using half the tissue from a 
single needle biopsy. These data suggest that outpatient 
assessment of liver mitochondrial function is feasible, 
thereby providing another potential means to assess hepatic 
status in patients pre-operatively.
A-005
INDUCTION OF TUMOR GROWTH 
AFTER PORTAL VEIN EMBOLIZATION 
IN A RABBIT VX2 TUMOR MODEL
L. T. Hoekstra, K. P. van Lienden, J. W. van den Esschert 
and T. M. van Gulik
Academic Medical Center, Amsterdam, The Netherlands
Introduction: Preoperative portal vein embolization (PVE) 
is an option to increase future remnant liver (FRL) volume 
through induction of hepatocellular regeneration. This inter-
vention however, may also increase tumor size because of 
growth factors and cytokines released in the regenerating 
liver. The aim of this study was to reproduce possible 
enhancement of tumor growth after PVE in a rabbit tumor 
model.
Methods: New Zealand White rabbits were allocated to 
PVE (n = 5) or a control group (sham, n = 5). Two weeks 
after implantation of a VX2 carcinoma, PVE was performed 
with particles and coils or the liver was mobilized (sham). 
CT volumetry was performed at day 0, 3, 7, 10 and 14. Liver 
damage parameters were assessed before the procedure, and 
at 3 hours, day 1, 3, 7, 10 and 14.
Results: Portograms performed directly after embolization 
and at day 14 showed complete portal occlusion in all PVE-
rabbits. TGR was increased in both groups, with a larger 
increase in the PVE-group over time (day 14: mean 34.4 ± 
4.3 mL/day vs sham: 24.1 ± 7.2 mL/day). The hypertrophy 
response and regeneration rate in the non-embolized liver 
lobe were signifi cantly higher in the PVE group, which was 
confi rmed by liver to body-weight index assessment. There 
was transient, minimal increase of liver damage parameters 
after PVE, which returned to baseline values within 7 days.
Conclusions: TGR was signifi cantly increased in the PVE 
rabbit tumor model over time, compared to the control group. 
This fi nding supports the notion that PVE potentially 
enhances tumor growth.
A-006
WHOLE EXOME SEQUENCING – AN 
INTRODUCTION TO A PROMISING NEW 
APPROACH WITH APPLICATIONS IN 
HPB SURGERY
D. J. Cavallucci and S. Gallinger
University Health Network, University of Toronto, Toronto, 
Canada
Introduction: Whole exome sequencing is a relatively new 
approach to genomic analysis focusing on protein coding 
sequences to identify variants responsible for genetic dis-
eases. This technology is attracting increasing attention for 
providing many of the benefi ts of genome wide interrogation 
at reduced cost and with fewer signifi cant statistical and 
bioinformatics challenges. Exome sequencing has been used 
to identify the gene responsible for the monogenic disorder 
Miller syndrome, among others, and more recently, to iden-
tify novel somatic oncogenes involved in some melanomas, 
including GRIN2A, that appears to be involved in up to one-
third of metastatic melanomas.
Methods: We will describe the principles behind whole 
exome sequencing, including a review of the approaches 
taken in the few published studies in this area. In particular, 
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we are currently focusing on the approach used in our lab to 
attempt to identify candidate gene(s) responsible for familial 
pancreatic cancer.
Conclusions: Whole exome sequencing represents a new 
and powerful tool for rapid analysis of the germline and 
somatic genomes responsible for a variety of cancers. We 
believe it has a particularly powerful application in the 
understanding of familial cancers as these groups likely have 
a single or few causative mutations. Although familial pan-
creatic cancer represents a relatively small percentage of the 
overall burden of disease, an understanding of the genes 
responsible for this high risk syndrome should aid in our 
understanding of carcinogenesis in this poor prognosis 
malignancy.
A-007
CANDIDATE GENE APPROACH TO 
RISK STRATIFICATION OF 
CHEMOTHERAPY-INDUCED 
HEPATIC INJURY
C. H. C. Pilgrim1,2,3, K. Brettingham-Moore1, A. Pham4, 
W. Murray5, E. Link1, M. Smith3, V. Usatoff3, P. M. Evans3, 
S. Banting1,2, B. N. Thomson1, M. Michael6,7 and 
W. A. Phillips1,2
1Division of Cancer Surgery, Peter MacCallum Cancer 
Centre, Melbourne, Australia; 2University of Melbourne 
Department of Surgery, St. Vincent’s Hospital, Melbourne, 
Australia; 3Hepatopancreaticobiliary Service, Upper 
Gastrointestinal Surgery, The Alfred Hospital, Melbourne, 
Australia; 4Department of Pathology, The Alfred Hospital, 
Melbourne, Australia; 5Department of Pathology, Peter 
MacCallum Cancer Centre, Melbourne, Australia; 
6Division of Cancer Medicine, Peter MacCallum Cancer 
Centre, Melbourne, Australia; 7University of Melbourne 
Department of Medicine, St. Vincent’s Hospital, Melbourne, 
Australia
Introduction: Chemotherapy-induced hepatic injuries 
(CIHI) are unpredictable and put patients at risk of increased 
perioperative morbidity following hepatectomy for colorec-
tal metastases. Risk stratifi cation of patients based on genetic 
parameters may help in determining treatment strategy if 
groups of patients are found to be at higher risk based on 
genetic profi le.
Methods: CIHI were histologically scored on H&E and 
Masson trichrome stained slides of 233 non-tumorous liver 
samples collected at hepatic resection. Candidate genes 
involved in oxaliplatin metabolism (nucleotide excision 
repair enzymes ERCC1 and ERCC2, and glutathione-S-
transferase enzymes GSTM1, GSTT1 and GSTP1), and 
metabolism of 5FU [thymidylate synthase (TS), thymidine 
phosphorylase (TP) and dihydropyrimidine dehydrogenase 
(DPD)] were chosen for study. Expression levels were 
assessed by reverse-transcriptase real time quantitative PCR 
(ERCC1, ERCC2, TS, DPD and TP). Multiplex PCR was 
used to assess for null variants of GSTM1 and GSTT1. DNA 
sequencing was carried out to identify ERCC2 Lys751Gln 
and GSTP1 Ile105Val polymorphisms.
Results: Low-level DPD mRNA expression was associated 
with steatosis (OR = 4.48, 95%CI = 1.31–15.30 p = 0.02). 
Expression of ERCC1 and ERCC2 may be associated with 
sinusoidal injury. GSTT1 null variant was associated with 
decreased risk of sinusoidal injury independent of chemo-
therapy administration (OR = 5.74, 95%CI 1.32–24.88 p = 
0.02), while GSTM1 null variant was associated with less 
steatosis in the setting of chemotherapy administration (OR 
= 4.83 95%CI = 1.00–23.28 p = 0.07). Neither ERCC2 
Lys751Gln nor GSTP1 Ile105Val were associated with dif-
fering rates of CIHI.
Conclusions: Genetic parameters may be useful for identi-
fying patients at higher risk of CIHI, and therefore may be 
useful in determining preoperative neoadjuvant chemother-
apy treatment plans.
A-008
IMPROVEMENT OF CLASSICAL LIVER 
FUNCTIONS FOLLOWING REGRESSION 
OF HEPATOCYTE APOPTOSIS AND BILE 
LAKES AFTER BILIARY DRAINAGE FOR 
SEVERE OBSTRUCTIVE JAUNDICE
A. Nugroho and T. Lalisang
Digestive Surgery Division, Cipto Mangunkusumo 
Hospital, Faculty of Medicine, University of Indonesia, 
Jakarta, Indonesia
Introduction: The regenerative capacity of the liver is an 
important factor following biliary drainage for severe obstruc-
tive jaundice. Regression of hepatocyte apoptosis and bile 
lakes by means of inbition of bile acid accumulation through 
biliary drainage may lead to improvement in hepatocyte 
regeneration. This study aims to assess the impact of biliary 
drainage on hepatocyte apoptosis and bile lakes, as well as 
classical liver functions in obstructive jaundice patients.
Methods: Twenty-one obstructive jaundice patients were 
included in this study. Specimen from liver biopsies were 
taken before and after biliary drainage and stained by TUNEL 
to identify hepatocyte apoptosis and HE to identify bile 
lakes. Serum bile acid and liver functions marker were also 
measured serially.
Results: Excessive hepatocyte apoptosis and bile lakes as 
well as liver functions impairment were seen in all patients. 
After decompression, the bile acid serum was signifi cantly 
reduced from 96.4 ± 53.9 to 13.0 ± 12.6 (p < 0.05), followed 
by signifi cant decrement of the hepatocyte apoptosis index 
and bile lakes. Consequently, the liver functions were also 
signifi cantly improved.
Conclusion: Classical liver functions improvement were 
seen, as a result of hepatic regeneration following regression 
of hepatocyte apoptosis and bile lakes after biliary drainage 
in obstructive jaundice patients.
A-009
IS THERE ANY BENEFIT OF ANTIBIOTIC 
PROPHYLAXIS IN ACUTE SURGERY 
FOR GALLSTONES?
G. Jaafar1, G. Persson2, J. Österberg3 and G. Sandblom1
1CLINTEC, Karolinska Institute, Stockholm Sweden; 2Dept 
of Surgery, Jönköping Hospital, Sweden; 3Dept of Surgery, 
Mora Hospital, Sweden
Background: The aim of this study was to see whether 
prophylactic antibiotic in acute cholecystectomy has any 
effect on reducing postoperative infections.
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Methods: The study included all acute cholecystectomy 
procedures registered in the Swedish register for gallstone 
surgery 2006–2010. Data on age, operation time, indication, 
method of approach (laparoscopic vs open) and ASA clas-
sifi cation were retrieved from the register. The outcome mea-
sures were postoperative infection requiring antibiotic 
treatment and/or abscess necessitating drainage. Univariable 
and multivariable logistic regression analysis were per-
formed to assess the benefi ts of antibiotic treatment, adjust-
ing for other confounding factors.
Results: A total of 13911 operations were registered during 
the period. Antibiotics were given in 5283 (69%) of the 
procedures. Antibiotic requiring postoperative infectious 
complications were noted after 1070 (7.7%) procedures, 
abscesses after 273 (2%) procedures. In univariate analysis 
a paradoxical increase both in the risk of antibiotic require 
infections (Odds Ratio [OR] 1.42, 95% confi dence interval 
[CI] 1.23 to 1.64) and abscess (OR 1.47, CI 1.11–1.95) were 
seen. In multivariate analysis, adjusting for gender, age, sur-
gical indication, ASA, surgical procedure, operating time and 
perforation of the gallbladder decreased OR < 1 for both 
antibiotic requiring infections (OR 0.94, CI 0.80 to 1.11) and 
abscess (OR 0.88, CI 0.64 to 1.22), albeit not reaching sig-
nifi cant levels.
Conclusion: Although prophylactic antibiotics could hypo-
thetically reduce the risk of postoperative complications in 
high-risk surgery, the benefi ts are minor.
A-010
PERIHEPATIC NODAL STATUS DURING 
LIVER RESECTION FOR COLORECTAL 
METASTASIS IS NOT A CONTRA-
INDICATION FOR SURGERY: A REVIEW 
IN PUBLISHED SERIES
M. V. Perini, D. Yeo, V. Muralidharan and C. Christophi
Department of Surgery, Austin Hospital, Melbourne 
University, Melbourne, Australia
Background: Hepatic lymph node involvement is consid-
ered a contraindication for liver resection by some surgeons; 
however, nowadays, with improvement in treatment of stage 
IV colorectal cancer, patients with metastatic periportal 
nodal disease can achieve reasonable survival.
Aim: The aim of this study is to review the data regarding 
outcome in patients with positive and negative lymph node 
status during liver resection for metastatic colorectal cancer.
Material and Methods: Medline, Embase and Central 
databases were searched using a formal search strategy. 
Articles with survival data were considered for inclusion. 
Only papers regarding liver resection for metastatic colorec-
tal cancer submitted to lymphadenectomy were enrolled. 
Review articles and papers without clear data were excluded.
Results: A total of 24 articles were found. From these arti-
cles, only 19 had data regarding survival in patients with 
positive and negative lymph node patients. Mean survival in 
patients with compromised lymph node were lower than 
patients without lymphatic disease (3 y survival in positive 
and negative nodal status of 24.5 m and 52.7 m, respectively 
and 5 y survival of 11.3 m and 34.8 m, respectively).
Conclusions: Articles available showed that patients with 
hilar lymph nodal disease can achieve good survival and 
should not be preclude from surgical treatment.
A-011
COMPARISON OF CLINICAL OUTCOME 
AND COST-EFFECTIVENESS AFTER 
VARIOUS PREOPERATIVE BILIARY 
DRAINAGE IN PERIAMPULLARY 
CANCER WITH OBSTRUCTIVE 
JAUNDICE
S. K. Hong, J-Y. Jang, M. J. Kang, I. W. Han and 
S-W. Kim
Department of Surgery, Seoul National University College 
of Medicine, Seoul, Korea
Introduction: The clinical benefi t of preoperative biliary 
drainage (BD) in periampullary cancer with obstructive jaun-
dice is not well established yet, which includes PTBD, 
ERBD, or ENBD. There are few comparative study compar-
ing these BD methods, and therefore, selection of preopera-
tive BD method depends on clinicians’ preference or hospital 
facility without strong evidence.
Methods: Between 2004 and 2010, 211 patients underwent 
pancreatoduodenectomy after preoperative BD due to peri-
ampullary cancer with obstructive jaundice in Seoul National 
University Hospital, Korea. Clinical outcome and cost-effec-
tiveness of each preoperative BD methods were compared 
according to its’ fi nal drainage method or by following the 
intention-to-treat analysis.
Results: There was no difference in drainage duration 
between PTBD and endoscopic BD groups (14.2 vs. 16.6 
days, p = 0.121) but daily diminution of serum bilirubin level 
was higher in PTBD group (0.7 vs. 0.6 [mg/dl]/day, p = 
0.041). Concerning procedure related complications, pancre-
atitis occurred more frequently in endoscopic BD than PTBD 
group (16.3% vs. 2.8%; p = 0.001). Thirty-nine patients who 
were initially subjected to endoscopic BD switched to PTBD. 
With intention-to-treat analysis, drainage duration was 
shorter (13.2 vs. 16.5 days; p = 0.049), daily diminution of 
serum bilirubin level was higher (0.7 vs. 0.6 mg/dL; p = 
0.041), and admission cost was lower (14.2 vs. 15.7 × 103$; 
p = 0.040) in PTBD group than endoscopic BD group.
Conclusions: Although the role of preoperative BD is still 
controversial, preoperative BD is needed in some situation. 
When selecting the method of BD, PTBD is more cost-
effective and safe method compared to endoscopic BD.
A-013
TRANSDUODENAL AMPULLECTOMY 
FOR AMPULLARY ADENOMA
V. Powle, R. C. Shah and P. Jagannath
Lilavati Hospital and Research Centre, Mumbai, India
Background: Villous adenomas of ampulla are rare neo-
plasms with incidence of 0.04–0.12%. Due to the high risk 
of association of invasive carcinoma, the surgical procedure 
of choice is still controversial. Transduodenal ampullectomy 
is a challenging procedure for villous adenomas of the 
ampulla and involves extirpation of the ampulla of Vater and 
reinsertion of the common bile duct and the pancreatic main 
duct into the duodenal wall.
Aim: To highlight the technical aspects of a transduodenal 
ampullectomy.
Methods: A 50 y old male presented with abdominal pain 
and was diagnosed with a periampullary lesion on a CT scan. 
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A side viewing duodenoscopy showed a bulky papilla with 
villous appearance. The biopsy was suggestive of a villous 
adenoma with mild dysplasia. A transduodenal ampullec-
tomy with pancreatico-duodenostomy (pancreatic duct – 
2 mm end-to-side duct to mucosa anastomosis with no.5/0 
PDS) and choledocho-duodenostomy (CBD – 4 mm end-to-
side duct to mucosa anastomosis with no.5/0 PDS) and 
feeding jejunostomy was done. The patient had an uneventful 
recovery. Histopathology reported a tubulo-villous adenoma 
with mild dysplasia.
The video demonstrates the technique of a ‘Transduodenal 
Ampullectomy’ as our adopted method of ensuring an ade-
quate excision of ampullary adenomas.
A-014
CHOLEDOCHAL CYST – INTERESTING 
CASES
A. Javed
GB Pant Hospital & MAM College, New Delhi, India
We have a cumulative experience of managing about 550 
cases of Choledochal cysts. Some of the interesting and 
unusual cases, some of which also do not fi t into the of 
Todani’s modifi cation of Alonso-lej classifi cation are 
selected. These unusual cases together with some of the 
complicated choledochal cysts are included in this video 
presentation of interesting cases of Choledochal Cysts.
A-015
EARLY EXPERIENCE OF 
LAPAROSCOPIC MANAGEMENT FOR 
CHOLEDOCHAL CYSTS
D. W. Hwang, J. H. Lee, S. Y. Lee, K-M. Park and 
Y-J. Lee
Division of Hepatobiliary & Pancreatic Surgery, 
Department of Surgery, University of Ulsan College of 
Medicine, Asan Medical Center, Seoul, Korea
Introduction: Choledochal cyst is a rare benign disease and 
total excision with hepaticojejunostomy is known as the treat-
ment of choice because of the risk for biliary cancer. This 
study presents our early experience of laparoscopic excision 
for choledochal cysts with Roux-en-Y biliary reconstruction.
Methods: Between July 2009 and January 2011, 15 patients 
had been tried to undergo laparoscopic excision for chole-
dochal cyst at Division of Hepatobiliary and Pancreatic 
Surgery, Asan Medical Center. Clinical, radiological and sur-
gical data were analyzed retrospectively.
Results: The male to female ratio was 1 : 2.75 (4:11), and 
the mean age was 36.1 years (17–55). According to Todani 
classifi cation, there were type Ia(n = 2), type Ic(n = 6), type 
IVa(n = 6) and type IVb(n = 1). The mean operation time 
was 424 min (288–524 min). No operative-related transfu-
sion was required. All the patients underwent this laparo-
scopic procedure using a four-hole method. Conversion to 
laparotomy was required for six patients (40%), and their 
causes were bleeding near liver hilum (n = 1), venous con-
gestion of Roux jejunal limb (n = 1) and severe fi brosis and 
infl ammation around cyst (n = 4), respectively. The mean 
postoperative hospital stay was 11.9 (8–36) days. There was 
no major complication including anastomotic leakage, post-
operative bleeding, obstruction, or abnormal fl uid collection. 
The mortality rate and the incidence of carcinoma was 0%.
Conclusions: Morbidity and mortality rates are comparable 
with previously reported results. On the other hand, conver-
sion rate, mean operation time and hospital stay reveals not 
so favorable results. However, with acceptable experience 
both in complex biliary-pancreatic operation and advanced 
laparoscopic surgery, laparoscopic management for chole-
dochal cysts using a four-hole method is one of technically 
challenging and advantageous treatment option.
A-016
VIDEO OF FIRST-EVER LAPAROSCOPIC 
CHOLECYSTECTOMY IN A PATIENT 
WITH SITUS INVERSUS TOTALIS WITH 
ABERRANT CYSTIC DUCT AND ARTERY 
ANATOMY IN SINGAPORE GENERAL 
HOSPITAL
T. H-N. Justin, C. S. Claramae, L. Albert, C. K. H. Pierce
Singapore General Hospital, Singapore
Introduction: Laparoscopic cholecystectomy (LC) is a 
technical challenge when required in patients with situs 
inversus totalis (SIT). We present a case of symptomatic 
cholelithiasis in a 37 year old patient with SIT and aberrant 
cystic duct and artery anatomy successfully treated with LC.
Methods: The characteristics and surgical approaches in 28 
previously reported English language cases assessed via 
Pubmed and Google Scholar were reviewed.
Results: Most surgeons used a mirror image opposite to 
conventional LC. There was no signifi cant increase in post-
operative stay or operative time.
Conclusions: Laparoscopic cholecystectomy can be safely 
performed by a right-handed surgeon.
A-017
SINGLE INCISION LAPAROSCOPIC 
SPLENECTOMY: OPERATIVE VIDEO
G. Shenoy, G. Srikanth and N. Shetty
BGS Global Hospitals, Institute of Gastroenterology, 
Bangalore, India
Introduction: Laparoscopic splenectomy is now the gold 
standard for patients with idiopathic thrombocytopenic 
purpura (ITP) undergoing splenectomy. There are a few 
reports in literature on SIL Splenectomy. We describe herein 
a patient undergoing single incision laparoscopic splenec-
tomy for ITP.
Case Report: A 20 years old unmarried female patient with 
steroid refractory ITP was referred for splenectomy. Her 
platelet count was 14,000/cmm preoperatively. She received 
pneumococcal and meningococcal vaccine 2 weeks prior to 
surgery. A single incision laparoscopic splenectomy (SIL 
Splenectomy) was performed through a circum-umbilical 
incision using regular laparoscopic ports and instruments. 
Dissection was facilitated by use of single articulating 
grasper and splenic vessels were secured at hilum with endo-
GIA stapler. The technique is described. She made an 
uneventful postoperative recovery and was discharged on the 
second postoperative day. She was doing well with no visible 
scar at eight month follow-up.
Conclusions: The video demonstrates the feasibility of SIL 
splenectomy without the use of single port device.
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A-018
ROBOTIC EXCISION OF A TYPE 1 
ADULT CHOLEDOCHAL CYST WITH 
TOTAL INTRA-CORPOREAL 
RECONSTRUCTION (WITH VIDEO)
C. N. Chong Charing, K. F. Lee, J. Wong, K. W. Fong 
Anthony, Y. S. Cheung and B. S. Lai Paul
Department of Surgery, Prince of Wales Hospital, the 
Chinese University of Hong Kong, Hong Kong SAR
Introduction: Complete excision with a Roux-en-Y 
hepatico-jejunostomy reconstruction is the standard treat-
ment for Type 1 choledochal cyst. With the advancement of 
laparoscopic and robotic techniques, increasing number of 
reports on performing this complex operation by minimal 
access surgery has been published. However, the reconstruc-
tion was mostly extra-corporeal and was reported mainly in 
pediatric patients. Only one adult case had been reported and 
the reconstruction was performed extra-corporeally.
Methods: Robotic excision of choledochal cyst was per-
formed in a young adult using da Vinci® S Surgical System. 
Reconstruction in the form of end-to-side antecolic hepato-
jejunostomy and side-to-side jejuno-jejunostomy was done 
intra-corporeally.
Results: The total operation time was 568 minutes with total 
blood loss of 280 ml. No intra-operative complication 
encountered. The patient enjoyed an uneventful post-opera-
tive recovery. He resumed normal diet on day 3 and was 
discharged on day 5 after operation. No unplanned emer-
gency re-admission or recurrent cholangitis occurred 6 
months after operation.
Conclusions: Robotic excision of choledochal cyst is safe 
and feasible and should be an ideal case to start with in the 
initial phase of performing robotic approach hepato-biliary 
surgery. It requires substantial amount of dissection and 
suturing skills for the two anastomoses. The specimen is 
small and extension of port site is not necessary if the recon-
struction could be accomplished intra-corporeally. Moreover, 
it is a benign disease and therefore, the oncological clearance 
is not a problem. As a result, the advantages of the robotic 
system can be fully utilized.
A-019
MULTI-MODALITY THERAPY FOR 
PANCREATIC ADENOCARCINOMA 
WITH ARTERIAL INVOLVEMENT. 
ARCAP: ARTERIAL RESECTION FOR 
CANCER OF THE PANCREAS
A. M. Fox1, P. W. Kim2, T. W. Small2, S. Serra2, J. Kim2, 
M. Krzyzanowska2, D. Renouf2, G. Zogopoulos2, 
S. Gallinger2 and I. D. McGilvray2
1Department of Hepatobiliary Surgery, St Vincent’s 
Hospital Melbourne, Australia; 2Department of 
Hepatobiliary Surgical Oncology, University Health 
Network, Toronto, Canada
Introduction: The purpose of this studyis to evaluate our 
initial experience of pancreatectomy with major vessel arte-
rial resection/reconstruction for adenocarcinoma of the 
pancreas.
Methods: From February 2008 to March 2011, 22 patients 
with pancreas adenocarcinoma, major vessel arterial involve-
ment, and no metastases were assessed, and where possible 
treated with neoadjuvant chemo/radiotherapy. Outcomes 
were collected on a prospective protocol.
Results: Of the 22 patients, 6 progressed and dropped off 
protocol. Seven are currently undergoing neoadjuvant 
therapy. The remaining 9 were submitted to operation. Of 
these, 7 underwent resection with arterial reconstruction, one 
required arterial resection but no reconstruction, one was 
bypassed due to metastases. Arterial resections performed 
were SMA (n = 2), CHA (n = 2), RHA (n = 1), RRHA (n = 
1), RLHA (n = 1), Jejeunal arteries (n = 1). Concomitant 
venous resections were required in 6 patients, 3 requiring 
interposition grafting. Median estimated blood loss was 
1000 mls (range 400 to 2500 mls). Median operative time 
was 12 hrs 13 mins (range 9 hrs 30 mins to 15 hrs). There 
was no perioperative mortality, 3 patients had major morbid-
ity, median length of stay was 11 days (range 6 to 47 days). 
All surgical resection margins were negative. Four resected 
patients have recurred and 3 have died of disease (at 4, 14 
and 18 months). One patient died at 4 months of a perforated 
stomal ulcer. 3 patients are alive and disease-free (at 4, 5 and 
13 months).
Conclusions: Arterial resection for pancreas cancer can be 
performed safely and for negative margins. However, most 
patients progress therefore patient selection is critical and 
alternative neoadjuvant therapies should be sought.
A-020
VALIDITY OF SURGICAL BYPASS IN 
UN-RESECTABLE PANCREATIC CANCER
A. M. Malik, K. A. H. Talpur, S. Q. Bughio and H. A. Ali
Department of Surgery, Liaquat University of Medical and 
Health Sciences, Jamshoro, Sind, Pakistan
Background: A large number of patients with pancreatic 
cancer present late in the course of their disease when it is 
already beyond surgical cure. Palliation of the distressing 
symptoms like obstructive jaundice and gastric outlet 
obstruction becomes mandatory in most of the unresectable 
pancreatic tumors. This study is done to evaluate the effi cacy 
of surgical bypass as a palliative procedure.
Methods: It’s a descriptive analytical study conducted at a 
teaching hospital during the period from January 2005 to 
December 2010. All patients with obstructed jaundice and 
gastric outlet obstruction, later on diagnosed as pancreatic 
cancer are included in this study. Preliminary investigations 
included LFT’S, Blood CP, Ultrasound abdomen, CT scan 
abdomen, and x-ray chest. Surgical treatment was planned 
after assessing the resectability of the tumor. Surgical bypass 
was done in patients with un-resectable tumors. The vari-
ables studied included demographic details, presentation, 
procedure performed, post operative complications, follow 
up after discharge from the hospital. The details of individual 
patients were collected on a proforma sheet and statistically 
analyzed on SPSS version 17.
Results: Forty three patients with a mean age of 62.09, Std 
6.782, range 29, with advance carcinoma of head of pancreas 
were operated and bypass surgical palliation was done. The 
morbidity, mortality and effi cacy of various surgical bypass 
operations are evaluated.
Conclusion: Bilio-gastric bypass still offers a reasonably 
safe and effective method of billiary decompression and duo-
denal obstruction caused by inoperable pancreatic cancer.
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A-021
A MOLECULAR PROGNOSTIC 
NOMOGRAM FOR RESECTABLE 
PANCREATIC CANCER
D. Chang1,2,3, E. Colvin1, M. Pinese1, C. Scarlett1, M. 
Pajic1, A. Gill1,4, E. Musgrove1, R. Sutherland1, J. Kench1,5 
and A. Biankin1,2,3 for the New South Wales Pancreatic 
Cancer Network (NSWPCN)
1Cancer Research Program, Garvan Institute of Medical 
Research, Sydney, Australia; 2Department of Surgery, 
Bankstown Hospital, Sydney, Australia; 3South Western 
Sydney Clinical School, Faculty of Medicine, University of 
NSW, Sydney, Australia; 4Department of Anatomical 
Pathology, Royal North Shore Hospital, Sydney, Australia; 
5Department of Anatomical Pathology, Royal Prince Alfred 
Hospital, Sydney, Australia
Introduction: Defi ning clinically and biologically relevant 
phenotypes has lead to substantial improvements in the 
overall outcomes in some cancer types. About 80% of 
patients with pancreatic cancer (PC) succumb to the disease 
despite curative resection. However, relevant molecular phe-
notypes in PC have not been defi ned. This study aimed to 
evaluate the potential clinical utility of biologically relevant 
molecules as prognostic factors in resected PC.
Method: We assessed the relationship of aberrant S100A4 
calcium-binding protein expression with survival in a cohort 
of 372 patients who underwent surgical resection for PC and 
derived a nomogram using clinico-pathological variables and 
aberrant expression of S100A4 and S100A2.
Results: High S100A4 expression was an independent poor 
prognostic factor in both the training (n = 76; HR = 5.00, 
95%CI = 2.29–10.9; P < 0.0001) and validation sets (n = 
296; HR = 1.78, 95%CI = 1.29–2.46; P = 0.0004). 
Incorporating previously published data on S100A2, demon-
strated that high expression of S100A4 was still an indepen-
dent prognostic factor. Aberrant expression of these proteins 
stratifi ed the cohort into 3 distinct prognostic groups. A pre-
operative nomogram using only variables that could be mea-
sured preoperatively (tumor size and molecular biomarkers), 
predicted survival better than nomograms derived from using 
clinico-pathological variables, which are only determined 
after examination of the resected specimen.
Conclusion: Aberrant expression of S100A4 and S100A2 
stratifi es PC into distinct prognostic groups and improves the 
accuracy of prognostic nomograms using variables that can 
be determined preoperatively. The development and applica-
tion of such nomograms in routine clinical practice has the 
potential to improve patient selection and as a consequence 
overall outcomes for PC.
A-022
NEOADJUVANT CHEMORADIOTHEPAPY 
AND DISTAL PANCREATECTOMY WITH 
EN BLOC CELIAC AXIS RESECTION 
(DP-CAR) FOR LOCALLY ADVANCED 
PANCREATIC BODY CANCER DERIVED 
FROM IPMN
H. Ishikawa, H. Kinoshita, T. Hisaka, H. Horiuchi and 
K. Shirouzu
Department of Surgery, Kurume University School of 
Medicine
We report a case of resected locally advanced pancreatic 
body cancer derived from IPMN. A 63 year-old man was 
diagnosed as locally advanced pancreatic body cancer 
derived from IPMN with extrapancreatic nerve plexus and 
splenic artery invasion by abdominal CT scan, ERCP and 
angiography. We found no distant metastasis. Based on these 
fi ndings, we conducted chemoradiotherapy (CRT) with a 
total 50.4 Gy and systemic administration of S-1 (80 mg/
body). Combined chemotherapy of gemcitabine (GEM) 
(800 mg/m2) and S-1 was continued 2 courses after CRT. 
Reevaluation CT after CRT showed no changes around the 
lesion (SD) and no distant metastasis. Transcatheter arterial 
embolization of common hepatic artery was performed prior 
to surgery, and 1 week later, DP-CAR, the concomitant 
lateral segmentectomy of the liver were performed. The his-
topathological examination showed invasive ductal carci-
noma derived from branch duct type IPMN, stage IVa with 
nerve plexus invasion and without splenic artery invasion. 
No metastasis was observed in lymph nodes. The postopera-
tive course was uneventful, and the patient remains well 
without local recurrence in the 12 months since surgery. In 
conclusion, combined strategy of CRT and DP-CAR was 
effective for locally advanced pancreatic body cancer.
A-023
CLINICAL FEATURES AND 
MANAGEMENT OF 
PSEUDOANEURYSMAL BLEEDING 
AFTER PANCREATODUODENECTOMY
J. H. Lee, S. Y. Lee, D. W. Hwang, K. M. Park and Y. J. Lee
Division of Hepatobiliary & Pancreatic Surgery, Asan 
Medical Center, Seoul, Republic of Korea
Introduction: A ruptured pseudoaneurysm is the most 
serious and life-threatening cause of post pancreatoduode-
nectomy (PD) hemorrhage. The aim of this study is to evalu-
ate the clinical course and to assess the management of 
pseudoaneuryms following PD.
Methods: Between March 2003 and April 2011, 576 patients 
underwent PD (5 whipple’s and 23 pylorus-preserving) for 
periampullary tumors in single division, Asan Medical 
Center. We reviewed the clinical course, managements, and 
outcomes of 28 patients with pseudoaneurysmal bleeding.
Results: Bleeding developed at median 21 days (range 
8–70) after operation. In particular, 10 patients (35.7%) pre-
sented the bleeding after postoperative 4 weeks. Before 
development of bleeding, 26 patients (92.9%) showed pan-
creatic fi stula (ISGPF grade A,9; B,16; C,1). Fourteen 
patients (50.0%) experienced bleeding from the gastroduo-
denal artery stump, 8 (28.6%) from common hepatic artery, 
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and 5 (17.9%) from proper hepatic artery, and 1 from left 
hepatic artery. Nineteen patients were performed with micro-
coil embolization, 4 patients with stent insertion, and 2 
patients with glue injection. Of 25 patients with angiographic 
procedure, hemostasis was achieved in 23 patients except 
two patients required re-laparotomy for hemodynamic insta-
bility. The mortality rate was 17.9% (5 patients, due to sepsis 
and disseminated intravascular coagulopathy).
Conclusions: A delayed hemorrhage following PD is 
closely associated with pancreatic fi stula and carried a sig-
nifi cantly higher mortality. The patients with pancreatic 
fi stula are needed to do careful attention more than 4 weeks 
after operation. Selective micro-coil embolization or stent 
graft is recognized as an effective treatment for pseudoaneu-
rysmal bleeding of the hepatic artery.
A-024
LONG-TERM SURGICAL OUTCOME OF 
AMPULLA OF VATER CANCER AND 
PREDICTORS OF LYMPH NODE 
METASTASIS IN EARLY LESIONS
M. J. Kang, J-Y. Jang, I. W. Han and S-W. Kim
Department of Surgery, Seoul National University College 
of Medicine, Seoul, Korea
Introduction: Ampulla of Vater (AoV) cancers are known 
to have most favorable prognosis among periampullary 
cancers, but few studies offered adequate pathologic details 
and long term outcome. The authors investigated long-term 
outcome of AoV cancer, and explored predictive factors of 
lymph node metastasis in early AoV cancers.
Methods: From 1990 to 2010, clinicopathologic character-
istics of 391 patients with surgical biopsy proven AoV cancer 
were analyzed.
Results: Curative intended resection was performed in 
95.7% and 95.1% of all 391 patients achieved R0 resection. 
Overall 5-year survival rate 5YSR) was 73.1% in stage I, 
46.4% in stage II, 36.0% in stage III and 7.3% in stage IV. 
Curative resection signifi cantly increased overall survival 
rate than palliative operation (5YSR 59.3% vs. 6.4%, p < 
0.001). After curative resection, eleveated serum CEA (p = 
0.009) or CA 19–9 (p = 0.031), poor histologic differentia-
tion (p = 0.007), and microscopic venous invasion (p = 
0.001) were independent prognostic factors. Of 235 patients 
with T1 or T2 cancer, jaundice (p = 0.002), elevated serum 
CA19–9 (p < 0.001), advanced T stage (p < 0.001), endo-
lymphatic invasion (p < 0.001), and poor histologic differ-
entiation (p = 0.002) were signifi cant factors related with 
lymph node metastasis. Of these, elevated serum CA19–9 (p 
= 0.009), and stage T2 (p = 0.045) were preoperative assess-
able independent predictors of lymph node metastasis in 
early AoV cancer.
Conclusions: AoV cancer has curative resection rate of 
95.7% overall 5-year survival rate is 59.3% after curative 
resection. Besides in cases with suspected local extension, 
T2 AoV cancer or early AoV cancer with elevated serum CA 
19–9 have higher risk of lymph node metastasis. Preoperative 
endoscopic ampullectomy should be avoided in these cases.
A-025
DISTAL DUODENECTOMY WITH OR 
WITHOUT PANCREATIC 
UNCINECTOMY: A VALID OPTION FOR 
LOW-GRADE MALIGNANT AND BENIGN 
PATHOLOGIES
K-Y. Lee1,2, W. Y. Shin1 and S-I. Ahn1
1Department of Surgery, Inha University School of 
Medicine, Incheon, Republic of Korea; 2Department of 
Trauma Surgery, Inha University Hospital, Incheon, 
Republic of Korea
Introduction: Pancreaticoduodenectomy is a standard sur-
gical procedure for various duodenal and pancreatic diseases 
including trauma. In spite of recent advances in surgical tech-
niques and outcomes, the procedure still carries signifi cant 
morbidity and mortality. Most of the serious complications are 
thought to originate from the failure of the unique anastomo-
sis, i.e. pancreaticoenterostomy. For low-grade malignant and 
benign pathologies of duodenal third and fourth portions and 
pancreatic uncinate process, ampulla of Vater can be saved 
provided that suffi cient surgical margin could be obtained.
Methods: We have experienced fi ve cases of patients 
managed by distal duodenectomy. There were two cases of 
duodenal stromal tumors, one of whom pancreatic uncinec-
tomy was combined. Two cases of traumatic duodenal per-
forations were managed by distal duodenectomy. Another 
case with pancreatic islet cell tumor was managed by distal 
duodenectomy and pancreatic uncinectomy.
Results: Two of the 5 cased were complicated with pancre-
atic fi stula, which was self-limited. One patient has died of 
unrelated cause. The remaining 4 patients were without evi-
dence of disease at the median follow-up of 8 months (range, 
4–24 months).
Conclusions: Distal duodenectomy with or without pancre-
atic uncinectomy is technically feasible, and can be per-
formed safely in selected patients.
A-026
RESULTS OF 
PANCREATICODUODENECTOMY WITH 
PORTAL OR SUPRA MESENTERIC VEIN 
RESECTION FOR LOCALLY ADVANCED 
PANCREATIC HEAD CANCER
M. Shimoda, M. Kato, S. Mori, J. Kita, T. Sawada and 
K. Kubota
Second Department of Surgery, Dokkyo Medical University, 
Mibu, Tochigi, Japan
Background: It is known that portal vein (PV) or superior 
mesenteric vein (SMV) was easily invaded by locally 
advanced pancreatic head cancer due to anatomical charac-
teristics. Few studies have investigated the results of pancre-
aticoduodenectomy (PD) with PV or SMV resection (PVR) 
for pancreatic head cancer.
Methods: From Apr. 2000 to Dec.2010, a total of 217 PD 
were performed at our department. We retrospectively 
reviewed a database of 81 patients who had undergone PD 
for pancreatic head cancer (PC). We divided them into two 
groups, Group A: a group with PD with PV/SMV-R, Group 
B: a group with PD without PV/SMV-R. The clinicopatho-
logical fi ndings and mortality were analyzed.
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Results: In group A, 29 of the 81 patients (%) needed PD 
with PVR because of local invasion of PV or SMV. There 
were 13 female and 16 men, with an average age of 68 ± 10 
years. Median survival and disease free survival were 20.4 
months and 8.6 months, respectively. Nine patients had PV 
resection, two patients had PV + SMV resection, and 18 
patients had SMV resection, respectively. In 21 patients, the 
vein was reconstructed by side to side anastomosis, 5 patients 
required partial resection, and in 3 patients, a graft was used 
for reconstruction. The 3 year-over all survival raye was 
36.8% in group A and 22.7% in group B, respectively. There 
was no difference between the two groups (p = 0.091, HR: 
1.576; 95% CI: 0.9299–2.670). The 3 year-disease free sur-
vival rate was 28.6% in group A and 12.1% in group B, 
respectively. Also there was no difference between the two 
groups (p = 0.206, HR: 1.414; 95% CI: 0.8264–2.420). There 
were no differences in postoperative complications and post-
operative death between the two groups.
Conclusions: The procedure of PVR by itself was not a risk 
of any postoperative factors and PVR can be performed 
safely.
A-027
EFFICACY OF PALLIATIVE 
GASTROJEJUNOSTOMY FOR 
DUODENAL OBSTRUCTION CAUSED BY 
PANCREATIC HEAD CARCINOMA
S. Motokazu, G. Naoto, K. Yuichiro, K. Takahiro, 
T. Shinichiro, K. Masaru and K. Taira
National Cancer Center East
Introduction: Pancreatic cancer is one of the most severely 
aggressive tumor and still diffi cult to cure the advanced 
disease. Once it causes gastrointestinal obstruction, bypass 
surgery is to be proposed in order to improve oral intake and 
quality of life (QOL). We discuss here about the effi cacy of 
palliative bypass surgery for advanced pancreatic head 
cancer obstruction.
Methods: Data on 285 patients received treatment for unre-
sectable pancreatic head cancer between April 2001 and 
March 2010 were collected retrospectively and survival, 
food intake time, and QOL were evaluated. 35 patients 
underwent palliative bypass surgery by the method of stom-
ach-partitioning gastrojejunostomy for cancer obstruction. 
QOL about food intake was evaluated using Gastric Outlet 
Obstruction Scoring Scale (GOOSS).
Results: There were no signifi cant difference about age, 
sex, and physical status at the time of cancer diagnosis 
between bypass cohort (group A) and non-bypass cohort 
(group B). Overall survival was 262 days in group A and 251 
days in group B (p = 0.62). Overall food intake time was 217 
days in group A and 156 days in group B (p = 0.19). GOOSS 
showed remarkable increase from 0.4 to 2.7 points after 
bypass surgery in group A. Patients in group A showed 127 
days of postoperative survival time, 78 days of food intake 
time after surgery, and no operative mortality. 17 patients in 
20 who survived more than four months after surgery in 
group A were able to have chemotherapy.
Conclusions: Bypass surgery yields signifi cant increase of 
oral intake and favorably comparing survival time.
A-028
THE ROLE OF ENDOSCOPIC STENTING 
VS. SPHINCTEROTOMY ALONE IN THE 
MANAGEMENT OF BILE LEAKS AFTER 
BILIARY AND LIVER SURGERY
J. Chang, T. Yong, P. Evans and V. Usatoff
The Alfred Hospital, Melbourne, Australia
Introduction: Bile leak is a serious and well recognized 
complication of hepatobiliary surgery, including cholecys-
tectomies and hepatic resections.
Management usually includes endoscopic retrograde cholan-
giopancreatography (ERCP). However there is controversy 
as to whether biliary stents provide an advantage over endo-
scopic sphincterotomy alone.
Methods: This is a retrospective review of all cases of bile 
leaks over a 20 year period (between 1991 and 2011) in a 
major tertiary referral hospital in Melbourne, Australia.
Results: Outcomes of spincterotomy alone versus stenting 
were analyzed. This included the duration of bile leaks, the 
need for further procedures, and complications associated 
with the two arms of management.
Conclusions: Conclusions regarding the most effective 
treatment will be drawn from the above review.
A-029
OUR EXPERIENCE OF PRIMARY AND 
METASTATIC SOLID-
PSEUDOPAPILLARY PANCREATIC 
TUMORS TREATMENT
V. Egorov1, H. Dubova2, A. Schegolev2, V. Vishnevsky1, 
O. Melekhina1 and T. Shevchenko1
1Vishnevsky Institute of Surgery, Moscow, Russia; 2Kulakov 
Federal Research Center of Obstetrics, Gynecology and 
Perinatology, Moscow, Russia
Background: Solid-pseudopapillary tumor (SPT) of the 
pancreas is a rare pancreatic tumor with positive prognosis 
but uncertain malignant potential.
Method: The clinical, demographic, imaging, and patho-
logic fi ndings of 22 patients operated for SPT (2005–2011) 
were analyzed. Positive immunohistochemical staining for 
vimentin, nuclear β-cathenin and e-cadherin, α -1-antitrypsin 
and α -1-antichemotrypsin with negative reaction for sinap-
tophisin and chromogranin were the diagnostic signs.
Results: The mean age was 37.5 (15–70) years, 21 were 
female. Mean follow-up after the fi rst tumor detection was 
4.1 (0.5–17) years. The main symptoms were nausea, vomit-
ing and vague abdominal pain. Tumor markers were normal 
in all cases. On B-US, CT and MRI tumor were solid in 7 
cases. Tumors with the mean diameter of 7.2 cm (3–15 cm) 
were located at the head (11), body (10), and tail (1) of the 
pancreas. Surgical procedures included pancreaticoduode-
nectomy (10), distal (including combined and extended) pan-
createctomy (8), segmental resection (3) and debulking (1). 
Two (9%) had had at presentation and 2 (9%) patients devel-
oped liver and retroperitoneal metastases in 14 and 60 months 
after the initial operation, which required staged hepatecto-
mies, removal of tumor nodules, debulking and repeated 
arterial liver chemoembolization. All patients are alive.
Conclusion: In spite of strong believe in low grade 
malignant potential of SPT 18% of patient developed distal 
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metastases. Aggressive surgery for initial and metastatic 
SPTs prolongs survival even in disseminated tumors.
A-031
SEQUENTIAL TACE AND PVE BEFORE 
RESECTION OF HCC IN CIRRHOTIC 
LIVER
T. P. Fung, K. L. Loke*, T. Lau, D. Tam, W. Chu and 
S. H. Lam
Hepatobiliary and Pancreatic Division, Department of 
Surgery, Department of Diagnostic and Intervention 
Radiology*, United Christian Hospital, Hong Kong, China
Introduction: This study evaluate the effi cacy of Pre-
operative TACE/PVE Combo for cirrhotic liver before major 
resection.
Method: Between March 2009 to April 2011, 10 cirrhotic 
HCC cases with insuffi cient future liver remnant undergoing 
pre-operative TACE and portal vein embolization were 
reviewed. Pre-operative TACE is performed, followed by 
portal vein embolization 2 weeks afterward. Ipsilateral 
approach is preferred. Histoacryl/lipiodol mixture is used. 
HBP surgeon performed CT volumetry on the day of PVE 
and 4 weeks after PVE. Additional 2 weeks will be waited 
for insuffi cient FLR.
Results: 10 cirrhotic HCC patients underwent TACE/PVE 
combo.8 were Childs A. 2 were Childs B. Anesthetic risk 
ranged from ASA I (2 case), ASA II (6 cases), ASAIII (2 
cases). No morbidity and mortality was noted. The future 
liver remnant ranged from 18% to 79% with mean FLR 
35.7%. 5 cases need 4 weeks and 5 cases need additional 2 
weeks to achieve adequate FLR. There was no signifi cant 
change in the ICG before and after TACE/PVE combo. 5 
underwent Extended right hepatectomy, 2 underwent right 
trisegmentectomy, 2 underwent right hepatectomy. 1 got 
metastasis in omentum and no major liver resection was 
done. Operation time ranged from 118–546 minutes, mean 
operative time at 304.5 minutes. Blood loss ranged from 
100–700 ml, mean blood loss 339 ml. 8 cases got satisfac-
tory recovery. One died of cardiac event and the other died 
for de-conditioning.
Conclusion: Pre-operative TACE/PVE combo successfully 
increase the FLR and improve the safety for major resection 
in cirrhotic HCC patients.
A-032
LONG-TERM RESULTS OF 
LAPAROSCOPIC TRANSCYSTIC 
COMMON BILE DUCT EXPLORATION
N. O’Rourke1 and C. O’Rourke2
1Royal Brisbane Hospital, Brisbane Australia; 2University 
of Queensland, Brisbane Australia
Introduction: The aim of this paper was to evaluate the 
long-term results of Laparoscopic Transcystic Common Bile 
Duct Exploration (LTCBDE).
Methods: 124 consecutive private patients of one surgeon 
(NO’R) undergoing this procedure over 14 years were 
enrolled in this study. The presenting author (CO’R) 
attempted to contact all patients.
Results: 109 patients were able to be contacted. Of these 
109, 73 were females with an age range of 16–88, with a 
mean of 49. Mean follow up was 5 years. Of these 109 
patients, 13 underwent a planned ERCP within 5 days of 
LTCBDE. Of the remaining 96 who underwent LTCBDE 
alone, the length of hospital stay ranged from 0 to 28 days, 
with a median of one day. After discharge, one patient devel-
oped transient pancreatitis on day three and no intervention 
was required. Two patients of the 93 had had documented 
episodes of pain requiring ERCP, sphincterotomy and 
common bile duct stone clearance, one at 6 months and one 
at 12 months following the initial LTCBDE. 5 patients had 
occasional non-specifi c abdominal pains with no abnormal-
ity detected on imaging or need for intervention. Therefore, 
of the 93 patients who underwent LTCBDE alone and who 
were felt to have successful duct clearance, only two devel-
oped symptomatic duct stones with a mean follow up of fi ve 
years.
Conclusion: When deemed successful at time of surgery, 
LTCBDE alone has excellent long-term results with apparent 
successful stone clearance of 98% (94 from 96) in this group.
A-033
IS HEPATIC RESECTION FOR PATIENTS 
WITH RECURRENT COLORECTAL 
LIVER METASTASES WORTHWHILE?
H. C. Rolff, D. Calatayud, P. N. Larsen and A. Wettergren
Department of Surgical Gastroenterology and 
Transplantation, Rigshospitalet, University of Copenhagen, 
Copenhagen
Introduction: The aim of this study was to evaluate the 
peri- and postoperative events and long-term survival after 
repeated liver resection due to recurrent colorectal liver 
metastases (CLM).
Methods: A retrospective review of charts from patients 
having undergone their second liver resection due to CLM 
was compared to at a matched control group with identical 
demographics, primary tumor and hepatic involvement. To 
avoid time bias, the control group was identifi ed by selecting 
the fi rst coming primary liver resection due to CLM after a 
secondary resection due to CLM. Hereby 24 patients were 
included in each group (primary resection group (PRG) and 
secondary resection group (SRG)).
Results: Perioperatively no signifi cant differences between 
the groups was noted, although there was a trend towards 
that the resections in the PRG involved more liver segments 
2.6 vs. 1.9 (p = 0.08). The rate of postoperative surgical 
complications was 17.4% in the PRG and 4% in the SRG (p 
= 0.18). The admission time was 10.6 days in the PRG and 
8.4 days in the SRG (p = 0.71). 30-day mortality was 4% in 
the PRG and 0% in the SRG (p = 0.41). The estimated 5-year 
survival was 36% in the PRG and 42% in the SRG (p = 0.17).
Conclusion: This study shows that a second hepatic resec-
tion due to recurrent CLM is safe and feasible. It also shows 
that patients undergoing second liver resection due to CLM 
do not have an inferior 5-year survival compared to patients 
that has only undergone one hepatic resection due to CLM.
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A-034
INTRODUCTION OF FAST TRACK 
PRINCIPLES FOR LIVER RESECTIONS
N. A. Schultz, P. N. Larsen, B. Klarskov, L. M. Plum, 
J. G. Hillingsø and H. Kehlet
Rigshospitalet, University of Copenhagen, Copenhagen, 
Denmark
Introduction: In a national Danish study the median LOS 
(length of stay) after liver resections was 9 days [Jensen et 
al. Ugeskr Laeger 2009]. In January 2011 fast track princi-
ples for liver resections were introduced at Rigshospitalet.
Methods: The only exclusion criteria was Klatskin tumor. 
New SOPs (standard operating procedure) for laparoscopic 
and open resections were introduced for all clinical settings 
including KAD, drains, analgetics, laxantive (including 
chewing gum), eating/drinking and mobilization from POD 
0 (post-operative day). Pre-operative information, informa-
tion about physical home-training and follow-up and was 
done by project nurse also according to a SOP.
Results: At the end of April 60 patients have undergone fast 
track liver resection. Median LOS was 5 days, 3 days in the 
laparoscopic group and 5 days for open resections (P < 0.01). 
Median VAS-score in activity at POD 1 in the laparoscopic 
and in the open resection group was 0 and 1 respectively (P 
> 0.05). Median VAS-score in activity at POD 3 was 0 in 
both groups. Median time to passage of stool was 2 and 3 
POD respectively (P = 0.04). No differences in LOS, VAS-
scores or time to passage of stool were observed between 
minor open (≤3 segments) and major open (>3 segments) 
resections. Four patients required readmission. No 30-days 
mortality was observed.
Conclusions: Fast track principles have been introduced 
with a median LOS of 5 days even after major resections. 
These principles are safe for the patients. The future perspec-
tives are median LOS of 2 and 4 days for laparoscopic and 
open resections respectively.
A-035
AGGRESSIVE SURGICAL 
MANAGEMENT OF ACINAR CELL 
CARCINOMA OF THE PANCREAS
K. Tan, R. J. Rinch, L. K. Nathanson and N. O’Rourke
Royal Brisbane & Women’s Hospital, Brisbane, Australia
Introduction: Acinar cell carcinoma (ACC) is a rare cancer 
of the pancreas accounting for approximately 1% of pancre-
atic tumors. Surgical resection is known to benefi t these 
patients. The aim of this study is to analyze the clinicopatho-
logical characteristics and presentation of ACC.
Methods: Retrospective review of prospectively collected 
data from 2008 to 2011 included all patients who underwent 
pancreatic resections for histologically proven ACCs. All 
specimens of ACC were reviewed by an expert pathologist. 
Patient demographic factors, outcomes and tumor character-
istics have been examined.
Results: Six patients were identifi ed between 2008 and 
2011. Two were female and four were male, with the average 
age at diagnosis being 66.5 years (51–75 years). Tumor size 
ranged between 2 to 12 cm (median 5 cm). After thorough 
staging, all patients were determined to have local disease 
only. Two patients underwent open pancreaticoduodenec-
tomy and one patient required reconstruction of the portal 
vein. Four patients were treated with distal pancreatectomy. 
Two patients had a laparoscopic approach and one had a 
spleen-preserving procedure (Warshaw). Two patients under-
went open distal pancreatectomy because of tumor rupture 
in one case and the need for en-bloc total gastrectomy and 
adrenalectomy in the other. Clear margins were obtained in 
all cases. Only one case had histologically proven lymph 
node metastasis. One of the six patients has completed a 
course of adjuvant chemotherapy. One patient died at 18 
months postoperatively, but their presentation was with a 
ruptured 12 cm lesion of the pancreas. The remaining fi ve 
patients are alive and disease free with follow up ranging 
from 1 month to 3 years. Alpha-fetoprotein was found to be 
elevated in a single patient. This has not been reported previ-
ously and the signifi cance remains unclear.
Conclusion: The outcomes of resection for ACC of the pan-
creas are more favorable compared to the more common 
ductal adenocarcinoma. R0 resection can be achieved even 
in the presence of large tumor size at time of presentation 
and nodal metastases are less common. Aggressive surgical 
management is indicated. There is no consensus regarding 
the optimal management of these patients. All patients 
should be discussed in a multidisciplinary forum including 
pathologists as the histological diagnosis is often challeng-
ing. The potential for alpha-fetoprotein as a marker for these 
tumors requires further investigation.
A-036
LAPAROSCOPIC OR OPEN 
CHOLECYSTECTOMY IN CIRRHOISIS: 
A SYSTEMATIC REVIEW OF OUTCOMES 
AND META-ANALYSIS OF RANDOMIZED 
TRIALS
J. M. Laurence1,2, M. M. Devadas1, G. D. Eslick3, 
E. Johnston1, M. J. Hollands1, A. J. Richardson1, 
H. Pleass1,2 and V. W. T. Lam1,2
1Department of Surgery, Westmead Hospital, Sydney, 
Australia; 2Discipline of Surgery, University of Sydney, 
Sydney, Australia; 3The Whiteley-Martin Research Centre, 
Discipline of Surgery, The University of Sydney, Nepean 
Hospital, Sydney, Australia
Introduction: Cholecystectomy is associated with increased 
risks in patients with cirrhosis. The well-established advan-
tages of laparoscopic surgery may be offset by the increased 
risk of complications relating particularly to portal hyperten-
sion and coagulopathy.
Methods: A systematic literature search identifi ed studies 
comparing open cholecystectomy (OC) and laparoscopic 
cholecystectomy (LC) in patients with cirrhosis. Meta-
analysis was performed of randomized controlled trials 
(RCT).
Results: Forty-four studies were analyzed, including 2005 
patients with cirrhosis undergoing cholecystectomy, 1756 
laparoscopic and 249 open, with mortality rates of 0.74 and 
2.0 percent respectively. Child-Pugh C patients constituted 
1.6 and 4 percent of the patients undergoing LC and OC 
respectively. The laparoscopic conversion rate was 5.7 
percent. For LC the overall complication rate, infectious 
complication rate and rate of post-operative hepatic insuffi -
ciency were 17.7, 5.8 and 7.7 percent respectively. The rates 
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of these complications in OC were 47.7, 20 and 18.1 percent 
respectively. Meta-analysis of three RCT including 220 
patients was conducted. There was a reduction in the overall 
incidence of post-operative complications (OR: 0.25, 
95%CI: 0.07–0.88), of infectious complications (OR: 0.23, 
95%CI: 0.1–0.56) and a shorter length of hospital stay (MD: 
−3.31, 95%CI: –4.46 to −2.16) for LC. However the fre-
quency of post-operative hepatic insuffi ciency was not sig-
nifi cantly different between LC and OC (OR: 0.53, 95%CI: 
0.12–2.32).
Conclusion: There are few RCT comparing OC and LC in 
cirrhotic patients. These studies are small, heterogeneous in 
design and include almost exclusively Child A and B patients. 
However, laparoscopic cholecystectomy appears to be asso-
ciated with shorter operative time, reduced complication 
rates and reduced length of hospital stay.
A-037
SINISTROPOSITION OF SYMPTOMATIC 
CHOLELITHIASIS
K. Khandelwal
Bhatia Hospital, Mumbai
Aims & Objectives: Sinistroposition (True Left Sided Gall 
Bladder) without situs inversus viscerum is a rare clinical 
entity. We report our experience of two such cases within a 
span of 3 months, managed safely by laparoscopic cholecys-
tectomy. Routine preoperative USG may not always 
detect this anomaly and it can confound the surgeon 
intraoperatively.
Material & Method: Two consecutive cases of symptom-
atic cholelithiasis, a male aged 59 years and a female aged 
28 years were admitted in a span of three months. 
Sinistroposition of gallbladder was detected on laparoscopy 
and with alteration in port placement a safe laparoscopic 
cholecystectomy was carried out.
Conclusion: A Left sided Gall Bladder without situs inver-
sus viscerum is a rare clinical entry and a surgeon can be 
foxed during laparoscopic cholecystectomy. A carefully per-
formed USG, selectively use of CT scan, MRCP or ERCP, 
modifi cation in technique and selective use of intra-operative 
cholangiogram can aid in safe management of this rare 
anomaly.
KeyWords: Laparoscopic Cholecystectomy, Sinistroposi-
tion, Left Sided Gall Bladder.
A-038a
10-YEAR RETROSPECTIVE STUDY IN 
THE USE OF PERCUTANEOUS 
TRANSHEPATIC BILIARY DRAINAGE
E. J. Harnaen, S. Mackay, S. Safari and S. Hassen
Box Hill Hospital, Box Hill, Victoria, Australia
Introduction: Percutaneous transhepatic biliary drainage 
(PTBD) is often used as a second line therapy for obstructive 
jaundice when initial endoscopic biliary drainage (EBD) is 
unsuccessful. Although PTBD is considered an invasive 
technique associated with major complications, in a selected 
group of patients, PTBD may be more benefi cial as the initial 
therapy. The study aims to assess the indication, outcome and 
complication of this procedure.
Methods: Clinical records of patient who had PTBD from 
January 2000 to July 2011 were recalled and analyzed. Pre 
and post-procedural factors were correlated with clinical 
success and adverse events.
Results: Majority of PTBD are used in malignant disease 
(>82%) as a palliative option. Clinical success in relieving 
obstructive jaundice exceeds 85% although some patients 
may require a second attempt. Procedure-related complica-
tion rate is <18% which includes sepsis, bile leak, bleeding 
and pleural effusion. Those who have had unsuccessful treat-
ments have much worse prognosis associated with high 
mortality.
Conclusions: PTBD has evolved into a safe and effective 
procedure in relieving obstructive jaundice. PTBD provides 
a useful alternative or adjunct to EBD in a wide range of 
biliary disease. However patients who had unsuccessful 
PTBD are associated with high morbidity and mortality.
A-038b
SINGLE INCISION LAPAROSCOPIC 
SUTURED EXOGASTRIC 
CYSTOGASTROSTOMY – OPERATIVE 
TECHNIQUE
G. Srikanth and N. Shetty
BGS Global Hospitals, Institute of Gastroenterology, 
Bangalore, India
Introduction: Feasiblity of single incision laparoscopic 
(SIL) surgery has been demonstrated with variety of abdomi-
nal procedures, viz cholecystectomy, appendectomy, sple-
nectomy etc. We herein report a patient who underwent SIL 
cystogastrostomy.
Case Report: A 48 years old female patient presented with 
pain abdomen following an episode of acute pancreatitis 
(idiopathic). CT of the abdomen showed a pseudocyst in 
relation to the tail of pancreas, abutting the body of stomach 
with splenic artery running along the cranial border of the 
cyst. A SIL exogastric sutured cystogastrostomy was per-
formed. No disposable port device was used. A single inci-
sion multiple port technique was used for access. Regular 
laparoscopic instruments were used during the procedure. 
She was discharged from the hospital on third postoperative 
day. She had no visible scar at 5 months of follow-up. 
Operative video of the procedure is presented.
Conclusions: We have demonstrated the feasibility of SILS 
approach for sutured cystogastrostomy for pancreatic 
pseudocyst.
A-039
SINGLE INCISION LAPAROSCOPIC 
LATERALPANCREATICOJEJUNOSTOMY 
FOR CHRONIC PANCREATITIS
C. Palanivelu, P. Senthilnathan, P. S. Rajan, S. Rajapandian, 
J. Singh, A. P. Manoj Kumar and P. Das Gupta
GEM Hospital, Coimbatore, India
Introduction: Laparoscopic single-site surgery for chole-
cystectomy and appendectomy are described in the literature. 
The benefi ts of these procedures compared with traditional 
laparoscopic approaches have yet to be determined. To date, 
no series of Single incision lateral pancreaticojejunostomy 
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has been published or documented. This study isaimed to 
determine the safety and feasibility of SILS surgery for 
chronic pancreatitis.
Methods: This study describes the technique and results of 
Single incision lateral pancreatico-jejunostomy in our series 
of 2 patients
Technique
Incision and fl ap rising
Placement of ports
Opening of gastro colic omentum and exposure of pancreas 
with suture retraction of stomach
Identifi cation of the duct and laying opening of the duct, 
extraction of the stone, uncinate duct opening
Creation of roux limb and pancreatico jejunal anastomosis
Results: The average duct diameter was 1.1 cm. The 
average time taken was 210 minutes and the average blood 
loss was 60 ml. Both the cases were completed without any 
need for additional ports. The immediate (24 and 36 hrs.) 
post-operative pain score is comparable to our laparoscopic 
series. The scar score at 7 days is better in single incision 
surgery compared to laparoscopic group.
Conclusion: In our experience, this technique is both fea-
sibleand safe for selected patients. Although technical limi-
tationsexist that will be improved upon, further studies are 
needed to compare single incision laparoscopic surgery with 
traditional laparoscopic technique.
A-040
RIGHT TRISECTIONECTOMY PLUS 
CAUDATE LOBE RESECTION FOR 
HILAR CHOLANGIOCARCINOMA IN 
A PATIENT WITH GBWR <0.8
M. Lucas, G. Nicolás, K. C. Javier, S. R. Alejandro and 
M. Patricio
Liver Surgery & Trasplantation Unit, Hospital Alemán of 
Buenos Aires, Argentina
Introduction: The Hilar Cholangiocarcinoma or Klatskin 
tumor is a very rare entity that accounts for 60% of all chol-
angiocarcinomas. To date, the only potentially curative treat-
ment described in literature is the complete surgical resection 
with negative histological margins. This implies the resec-
tion of the supraduodenal extrahepatic bile duct, cholecistec-
tomy, periportal linfadenectomy and, in most cases, parcial 
hepatectomy. This is followed by a bilioenteric reconstruc-
tion. The objective of this presentation is to show the surgical 
resolution of a Klatskin Tumor.
Methods: Video presentation of a patient with Hilar 
cholangiocarcinoma.
Results: Case description: We present a case of a 56-years-
old male patient. He consulted with a 45-day history of 
obstructive jaundice and imagenological diagnosis of 
Klatskin tumor. He was initially treated at another institu-
tion with a percutaneus biliary drainage. At our center CT 
scan showed absence of extrahepatic disease and an esti-
mated future liver remanent (FLR) of segments 2 and 3 
of only 400 cc (Graft to Body Weight Radio (GBWR) = 
0.57). Laboratory tests showed total bilirrubin = 3 mg/dl 
and Ca19–9 = 134 UI/mL (<35 UI/mL). Portal emboliza-
tion of the right hemiliver was performed to achieve a 
hypertrophy of the FLR. Three weeks after portal embo-
lization and with a FLR of 480 cc (GBWR = 0.68) he 
underwent surgical resection (right trisectionectomy + 
caudate lobe resection).
Conclusion: Even in the presence of reduced FLR, the 
aggressive surgical approach is recommended in selected 
patients with good performance status.
A-041
TORSION OF PEDUNCULATED 
ACCESSORY LIVER LOBE WITH ACUTE 
ACALCULOUS CHOLECYSTITIS
K. Khandelwal
Bhatia Hospital, Mumbai
Aims & Objectives: Accessory lobe of the liver is an 
uncommon anatomical anomaly usually asymptomatic and 
found incidentally at surgery or autopsy. It presents as pro-
jection from the surface of the liver in the vicinity of the 
gallbladder fossa or, very rarely, as an isolated lobe. A case 
of torsion with infarction of a pedenculated accessory liver 
lobe associated with acute acalculous cholecystitis is 
presented.
Material & Method: A 32 year old female presented with 
four days duration of right hypochondriac region pain, 
anorexia, nausea, and fever with localized tenderness and 
guarding. Her WBC count was 9200/uL with 70% neutro-
phills, LFT was normal. Ultrasound showed distended, thick 
walled gall bladder with intramural air, no sludge or calculus 
noted. EUS showed the same fi ndings with enlarged cystic 
lymph node. Laparoscopy showed congested edematous 
gallbladder with duodenum adherent to Hartmann’s area. 
Torsion of pedenculated accessory lobe of 2 cm. diameter 
noted at the undersurface of left lobe of liver. The pedicle 
seems to consist of hepatic blood vessels and bile duct with 
an extra hepatic connection. Pedicle was clipped, divided and 
the lobe excised. Laparoscopic cholecystectomy was 
completed.
Result & Discussion: Microscopy of pedenculated lobe 
revealed necrosis, trabecular pattern in the central area, 
edematous tissue with few biliary canaliculi at the periphery. 
Gallbladder showed features of acute cholecystitis. The 
patient made an uneventful recovery.
We report a case of acute acalculous cholecystitis with 
torsion of pedenculated accessory liver lobe. Two coexistent 
pathologies made this unusual. Considering the position & 
torsion of accessory lobe with subsequent ischemia and 
edema compressing the cystic duct leading to acute chole-
cystitis, as no intraluminal pathology of calculus or sludge 
was found. Pre-operative diagnosis of a small size pedencu-
lated accessory lobe is diffi cult.
Conclusion: Accessory lobe of liver is an incidental fi nding 
may also be a possible rare cause of acute acalculous 
cholecystitis.
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A-042
SINGLE INCISION LAPAROSCOPIC 
SPLEEN PRESERVING DISTAL 
PANCREATECTOMY – IS IT FEASIBLE
C. Palanivelu, P. Senthilnathan, P. S. Rajan, 
S. Rajapandian, P. Praveen Raj, V. Vaithiswaran and 
A. Ramanujam
GEM Hospital & Research Centre, Coimbatore, 
Tamilnadu, India
Introduction: As innovation continues to move 21st century 
surgery forward, one of the emerging concepts is single-port 
or single-incision laparoscopic surgery. The fundamental 
idea is to have all of the laparoscopic working ports entering 
the abdominal wall through the same incision. The major 
drawback to such a surgical approach is that the concept of 
‘‘triangulation’’ to which laparoscopic surgeons have grown 
accustomed in terms of both the instruments and scope is 
lacking. This, however, seems to be overshadowed by the 
increasing acceptability of in-line viewing, with the re-
emphasis on surgeons performing fl exible endoscopy and on 
newer ideas such as natural orifi ce translumenal endoscopic 
surgery.
Methods: This video describes the step by step approach of 
single incision mullti port technique using conventional lapa-
roscopic instruments for distal pancreatectomy.
Step 1.
Incision and fl ap rising
Step 2
Placement of ports
Step 3
Opening of gastro colic omentum and exposure of pancreas 
with Suture retraction of stomach
Step 4
Mobilization of the pancreas, attempt to preserve the splenic 
artery and vein was made by clipligation of the pancreatic 
branches of the splenic vessels, then the transection of pan-
creaswas done using harmonic and stump closed with 2–0 
PDS sutures
Step 5
Specimen extraction done inendobag through the same 
incision
Conclusion: Single port spleen preserving distal pancre-
atectomy is safe and feasible in experienced hands and can 
be done with conventional instruments.
A-043
NEOADJUVANT CHEMOTHERAPY FOR 
LIVER RESECTION IN THE ELDERLY
M. Farraj, R. Eshkenazy, Z. Rivkin, Z. Assi, Z. Bramnik 
and A. Arish
Rambam Health Care Campus, Haifa, Israel
Background: Hepatic resection is the treatment of choice 
for colorectal and neuroendocrine liver metastases. The neo-
adjuvant chemotherapy in non resectable colorectal liver 
metastasis (CLM) is indicated; nevertheless its indication is 
debated for resectable tumors.
Aim: To compare the outcome of hepatic resection in the 
elderly regarding neoadjuvant chemotherapy.
Methods: Between March 2003 and Feb 2011, 124 patients 
had 133 liver resections in our institution. These comprised 
40 patients (43 resections) aged 70 years old and older 
(70–87) and 84 patients (90 resections) aged less than 70 
years. Data was analyzed according to demographic status, 
morbidity and mortality of the surgical treatment, extent of 
liver resection (minor resections at least 3 segments and 
major above of 3 segments), blood transfusions, length of 
hospitalization and neoadjuvant chemotherapy. The surgical 
technique was not change according age of the patients. In 
the elderly group we analyze the morbidity into two sub 
groups, older than 70 who received neoadjuvancy and those 
who have not.
The t-student test was used to compare the results.
Results: No statistical difference was found between the 
two groups regarding demographical status, morbidity, mor-
tality, extension of the resection, blood transfusions, length 
of hospitalization and the use of neoadjuvant chemotherapy. 
In regard of the neoadjuvant chemotherapy, 36 (40%) 
patients in the young group received and 16 (37%) in the 
older group, p = 0.156.
In the elderly group, 16 (37%) of the patients received 
neoadjuvant chemotherapy and the morbidity was 25%. 
Twenty seven (63%) have not received chemotherapy before 
the liver resection and the morbidity in this group was 19%, 
p = 0.667.
Conclusion: Chronologic age doesn’t seem to be a contra-
indication for hepatic resections. Liver resections in patients 
70 years or older is safe. Chemotherapy in the elderly doesn’t 
affect the outcome.
A-044
STRATIFYING RISKS AND IMPROVING 
THE EFFECTIVENESS OF BLOOD 
TRANSFUSION IN PATIENTS 
UNDERGOING LIVER RESECTIONS: 
A PROSPECTIVE STUDY
C. C. Cheung, W. M. Wong and C. F. Mak
Department of Surgery, Tuen Mun Hospital, Hospital 
Authority, HKSAR
Introduction: Liver resections are regarded as major sur-
geries which commonly require peri-operative blood transfu-
sions. In the past, most patients were cross-matched with 
standby blood products prepared before the operations for 
timely use but resulted in excessive procedures, overuse of 
resources and risk of critical incidences.
Methods: A pilot study was done in June 2009 in a regional 
hospital in Hong Kong to identify the risk factors for blood 
transfusion in liver resections, followed by a prospective 
study between June 2009 and Dec 2010. Patients underwent 
elective hepatic resections were divided into either high or 
low risk group. Only high risk patients had stand-by blood 
products prepared pre-operatively. The physical conditions 
of all patients were closely monitored during the in-hospital 
period and they were managed accordingly.
Results: Two risk factors were identifi ed in the pilot study, 
they were: undergoing major hepatectomy and additional 
operative procedures.
A total of 154 patients were recruited. 38 cases (25%) were 
regarded as high risk and ten of them (26%) received blood 
transfusions peri-operatively. While for the low risk group 
(116 patients), only 13 patients (11%) eventually required 
blood transfusions during hospitalization. (sig with P < 0.05). 
The median blood loss was 599 ml.
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Conclusions: Risk factors for blood transfusion in elective 
liver resections were identifi ed. The number of stand-by 
blood products were markedly reduced and hence minimiz-
ing unnecessary procedures and wisely use of resources 
without jeopardizing the patient safety.
A-045
MICROWAVE ABLATION OF LIVER 
TUMORS
B. Knowles, S. Banting and B. Thomson
Department Surgical Oncology, Peter MacCallum Cancer 
Centre, East Melbourne, Victoria, Australia
Introduction: The aim of our study was to evaluate the 
effi cacy and safety of microwave (MW) ablation of liver 
tumors guided by intra-operative ultrasound (US).
Methods: Between February 2009 and April 2011, 11 
patients (3 women and 8 men) with a total of 13 liver tumors 
were treated with open (n = 7) or laparoscopic (n = 4) 
US-guided MW ablation. Clinicopathological data and out-
comes were prospectively collected in order to determine 
effi cacy and safety.
Results: The primary tumors were colorectal cancer (n = 5), 
hepatocellular carcinoma (n = 5) and neuroendocrine/
carcinoid (n = 3). The median size (maximum diameter) of 
the 13 metastases was 25 mm (range, 8–52 mm). The median 
number of ablation cycles was 2 (range, 1–3 cycles) and 
median ablation time per patient 6 min (range, 3–12 min). 
The technical success rate was 100%. The clinical effective-
ness was 100% with complete coverage of the metastasis by 
an avascular coagulation zone evaluated on computer tomog-
raphy 4 weeks post-ablation. The length of stay in the lapa-
roscopic group was 2.5 days (range, 1–8) and 5 days (range, 
3–9) for the open group. There was no 30-day mortality and 
one complication – A peri-operative myocardial infarct. 
During a median follow up of 8 months (range, 2–27 months) 
one patient had died from their disease and local recurrence 
was seen in 1 (7.7%) of the 13 treated metastases.
Conclusion: US-guided MW ablation of liver tumors is an 
effi cient and safe ablation technique.
A-046
COMPLICATIONS OF INTRAOPERATIVE 
ABLATION OF LIVER TUMORS: 
MICROWAVE VERSUS 
RADIOFREQUENCY
M. T. Mirarchi, S. Dokmak, O. Farges, B. Aussilhou and 
J. Belghiti
Beaujon Hospital, Clichy, France – University Paris 7
Objective and Summary Background Data: Intraoperative 
thermal ablation, often associated with surgical resection is 
poorly described. The aim was to compare immediate post-
operative results of intraoperative ablation using microwave 
(MWA) ablation versus radiofrequency (RFA) for liver 
tumors.
Patients: Since 2004, 44 patients underwent intraoperative 
ablation therapy (MWA in 17 and RFA in 27) of 61 malig-
nant liver tumors including colorectal metastases in 21, 
HCC in 13 and others in 10. Age, etiology, associated 
surgical procedures were similar in the two groups with 
similar number of ablated nodules (2.8 ± 1.7 vs 1.8 ± 2.1 
p = ns) and similar mean size (19.8 ± 11.4 vs 18.7 ± 
10.0 mm p = ns).
Results: The duration of the procedure was lower in MWA 
group (4.04 ± 2.20 vs 6.95 ± 3.99 min p = 0.013). Presence 
of post-procedure fever was similar (35.2% vs 25.9% p = 
ns); AST and ALT levels on Day 1 was similar (581 ± 517 
vs 734 ± 565 UI/L and 544 ± 423 vs 789 ± 666 UI/L) respec-
tively. Bilirubin level on Day 5 was lower in the MWA group 
(12 ± 4 vs 19 ± 12 μmoles/L p = 0.0214). Postoperative 
complications included biliary fi stula in one patient in each 
group, pleural effusion in 1 vs 2 patients; ascites in 1 vs 4 in 
the RFA group; portal thrombosis in one after RFA. The rate 
of overall complications was lower in the MWA group (11% 
vs 48% p = 0.021).
Conclusion: This study confi rms the lower duration of 
MWA ablation for liver tumors with a lower rate of complica-
tion when compared to RFA procedure.
A-047
ACTUAL VS ACTUARIAL 10-YEAR 
SURVIVAL FOLLOWING RESECTION OF 
COLORECTAL CARCINOMA LIVER 
METASTASES
N. Cocco1, A. Gluer1, J. Laurence1, E. Johnston1,2, 
M. Hollands1, H. Pleass1,2, A. Richardson1,2 and V. Lam1,2
1Department of Upper Gastrointestinal Surgery, Westmead 
Hospital, Sydney, Australia; 2Discipline of Surgery, Sydney 
Medical School
Introduction: Surgical resection of colorectal liver metas-
tases (CLM) is potentially curative. The reported recurrence 
rate however remains high of up to 75%. Whilst 10-year 
actuarial survival has been reported up to 36%, limited data 
exists on 10-year actual survival.
Methods: Medline, PubMed and Cochrane databases were 
searched for studies from January 1950 to April 2011 
using the keywords “colorectal carcinoma”, “neoplasms”, 
“hepatectomy”, “liver resection” and “survival”. Additional 
papers were identifi ed by a manual search of references 
from the key articles. Only those papers showing an actual 
ten year survival fi gure were included. Case reports were 
excluded.
Results: Ten papers were included with 339 actual 10-year 
survivors identifi ed from a total of 2251 patients. This cor-
responds to 10-year actual survival rate of 15% following 
CLM resection. Among those studies that reported disease-
free survival, 325 actual 10-year survivors (96%) are disease 
free. Negative prognostic factors include male gender, higher 
number of metastases, unclear resection margins and syn-
chronous metastases.
Conclusions: Actual 10-year survival after liver resection 
of CLM remains low. Long-term follow-up rather than actu-
arial data is required to demonstrate long term outcomes 
following CLM resection.
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A-048
TUMOR PROGRESSION AFTER PORTAL 
VEIN EMBOLIZATION
L. T. Hoekstra, K. P. van Lienden, A. Doets, 
J. W. van den Esschert, T. M. van Gulik
Academic Medical Center, Amsterdam, The Netherlands
Introduction: Portal vein embolization (PVE) induces 
atrophy of the embolized liver segments and hypertrophy 
of the contralateral liver, resulting in an increase in liver 
volume and function of the future remnant liver (FRL). 
However, several studies describe potentially tumor growth 
after PVE.
Methods: In our institute, PVE was performed in 47 patients 
with liver tumors between 2004 and 2011. Patients’ demo-
graphics, imaging, surgical fi ndings, resectability, histology 
and complications were analyzed. The tumor volume and 
tumor growth rate (TGR) were measured by CT volumetry. 
31 PVE-patients were compared with a non-PVE control 
group (n = 84); all diagnosed with CRM. Also, patients with 
newly diagnosed tumors in the FRL after PVE were recorded.
Results: Mean tumor volume increased signifi cantly after 
PVE (from 247 ± 81 mL to 293 ± 94 mL) compared to 
non-PVE patients (from 153 ± 55 mL to 118 ± 37 mL). The 
median TGR of PVE patients was 0.53 mL/day (range 
−4.24–8.00) vs 0.09 mL/day (range −5.01–8.74; p = 0.03) 
for non-PVE patients. 7 (22.6%) patients diagnosed with 
CRM showed intrahepatic tumor spread in the FRL after 
PVE, of which 4 (57%) were found to be unresectable. There 
were no differences between the groups regarding preopera-
tive chemotherapy treatment.
Conclusions: Tumor volume and TGR increased after PVE 
in the majority of patients. The current study also showed 
that PVE potentially induces new tumor in the FRL. Short 
intervals between PVE and resection are therefore advised.
A-049
PROSPECTIVE ASSESSMENT OF THE 
INDOCYANINE GREEN’S CAMERA FOR 
THE INTRAOPERATIVE DETECTION OF 
SUBCAPSULAR PRIMITIVE AND 
SECONDARY LIVER TUMOR
E. Vibert, G. Mendes, M. Sebagh, R. Adam, C. Salloum, 
D. Azoulay, C. Guettier and D. Castaing
AP-HP Hôpital Paul Brousse, Centre Hépato-Biliaire, 
Villejuif, France
Introduction: Indocyanine green (ICG) is a vital dye 
excreted in bile that could be trapped around or into liver 
tumor. The presence of the dye at the surface of the liver can 
be detected using an infrared ICG camera. The aim of this 
prospective study was to evaluate the usefulness of this 
camera for the intraoperative detection of superfi cial and/or 
subcapsular hepatocellular carcinoma (HCC) or liver metas-
tasis (MH).
Methods: Between November 2010 and June 2011, 39 
patients (pts) underwent a hepatectomy with diagnosis of 
HCC (n = 8) or MH (n = 31). After the mobilization of the 
liver, intraoperative ultrasound and palpation were routinely 
performed before an exploration of the liver surface with the 
ICG camera. The surgical strategy impact of this method and 
histological analysis of resected areas were assessed.
Results: Among pts with MH (n = 31), the camera had 
identifi ed additional superfi cial “spot” in 4/31 pts (13%). 
Resection of these “spots” had changed surgical strategy in 
all cases and histological analysis diagnosed MH in 3/4 
cases. Among pts with HCC (n = 8), additional spots have 
been demonstrated in 5/8 pts (62%). Resection of these spots 
had changed surgical strategy in 4/5 pts and malignancy were 
found in 2/5 cases at histological analysis.
Conclusions: The ICG fl uorescent imaging is a technologi-
cal innovation that increases the sensitivity of the exploration 
of the liver surface. The diminution of the size of this camera 
will create new perspectives in the evaluation of liver surface 
by laparoscopy.
A-050
PALLIATIVE BILATERAL 
THORACOSCOPIC 
SPLANCHNICECTOMY FOR 
INTRACTABLE PAIN SECONDARY TO 
PANCREAS CANCER
G. C. Vitale, R. M. Galindo, W. B. Jones, C. Scoggins, 
R. C. Martin and L. Fitzpatrick
Department of Surgery, University of Louisville School of 
Medicine, Louisville, USA
Introduction: Pancreas cancer is often incurable. The 
majority of patients are relegated to palliative care. The most 
frequent feature of unresectable disease is pain. One approach 
to palliative pain control, in addition to narcotics and celiac 
block, is splanchnicectomy. Studies have shown splanchni-
cectomy to be safe and effi cacious but are varied in tech-
niques and outcomes. We set out to review our outcomes of 
splanchnicectomy using a bilateral thoracoscopic approach 
in patients with unresectable pancreas cancer.
Methods: We reviewed the records of 25 consecutive 
patients with unresectable pancreas cancer and intractable 
pain who underwent bilateral thoracoscopic splanchnicec-
tomy (BTS) between Oct 2009 and May 2011. All patients 
were prospectively enrolled after failing medical manage-
ment. To assess severity and impact of the pain, all patients 
completed a short form using 0–10 numeric rating scale and 
a 12 question previously validated quality of life survey. Data 
was acquired before and after BTS. All patients were admit-
ted for 23-hour observation after the procedure.
Results: 25 patients underwent BTS between Oct 2009 and 
May 2011. Six patients had incomplete records and were 
omitted from the study. Of the remaining patients, 8 were 
males and 11 females. Three of the patients had recurrence 
of their cancer, the remainder were either unresectable or had 
metastatic disease at the time of diagnosis. There were no 
major complications including death, bleeding or conversion 
to an open procedure. The only minor complication was a 
pneumothorax treated with a thoracostomy tube for 24 hours. 
Survival ranged from 18–403 days with a mean of 229 days 
and median of 240 days. The mean preoperative pain score 
was 8.3 (range 7–10). Pain was signifi cantly decreased post 
procedure. Postoperatively, scores ranged from 0 to 6 with a 
mean of 2 (p-value < .00001). Quality of life survey demon-
strated interference with normal work to be signifi cantly 
improved.
Conclusions: Intractable pain from pancreas cancer is sig-
nifi cantly decreased after undergoing bilateral thoracoscopic 
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splanchnicectomy. BTS is a safe and effective procedure that 
should be adopted for pain control as part of the palliative 
approach for incurable patients.
A-051
TOTALLY LAPAROSCOPIC PANCREAS-
SPARING DUODENECTOMY
H. Yanagibashi, A. Cho, H. Yamamoto, O. Kainuma, 
S. Park, T. Ota and H. Arimitsu
Chiba Cancer Center, Chiba, Japan
Introduction: Pancreaticoduodenectomy, originally per-
formed for malignancy of the duodenum, is also commonly 
used for potentially malignant lesions. Recent advances in 
diagnostic imaging and the surgical anatomy of the pancre-
atoduodenal region permit pancreas-sparing duodenectomy. 
Pancreas-sparing duodenectomy is an attractive surgical pro-
cedure for patients with duodenal adenoma, which is diffi cult 
to resect endoscopically.
Methods: This paper describes a patient that underwent a 
totally laparoscopic pancreas-sparing duodenectomy to 
resect a duodenal adenoma. End-to-side anastomosis between 
the common duct of the bile and pancreatic ducts and the 
jejunal limb was performed intracorporeally following the 
duodenal resection.
Results: The patient developed a biliary leak, that resolved 
spontaneously, and was discharged on the 32th postoperative 
day. The surgical margin was free of neoplastic change.
Conclusions: Although there is limited experience and 
appropriate indications must await future studies, this case 
demonstrates that laparoscopic pancreas-sparing duodenec-
tomy is a feasible, safe, and effective in carefully selected 
patients.
A-052
LAPAROSCOPIC PANCREATICO 
JEJUNOSTOMY FOR CHRONIC 
PANCREATITIS
P. Rao1, P. Rao1, S. Bhagwat2 and P. Rao1
1Mamata Hospital, Mumbai, India; 2BYL Nair Hospital, 
Mumbai, India
Introduction: A 35 year old female presented with history 
of epigastric pain, intermittent exacerbated by meals and 
radiating to the back for many months with worsening sever-
ity. USG and CT scan revealed a dilated pancreatic duct 
greater than 1 cm with ductal calcifi cations.
Methods: Patient was subjected to a laparoscopic lateral 
pancreatico jejunostomy with a laparoscopic assisted Roux 
en Y loop creation. The bowel loop was fashioned through 
a small umbilical incision and pancreatic anastonoses done 
intracorporeally. Great care was taken to visualize the entire 
duct and remove all calculi visualized within. The video 
highlights the salient features of the technique.
Results: Patient had a smooth post-operative recovery and 
the drain was removed on the 3rd day and patient discharged 
on the 5th day. The pain subsided postoperatively and patient 
is fi ne at more than a year of follow up.
Conclusions: Laparocopic lateral pancreatico jejunostomy 
is eminently feasible and ideal for dilated ducts in the pan-
creas greater than 1 cm. In the absence of signifi cant head 
disease, it can give signifi cant relief to the pain of chronic 
pancreatitis.
A-053
VENTRAL LONGITUDINAL PANCREATO-
JEJUNOSTOMY: A NEW TECHNIQUE
C. Kyriakides, A. Frampton, M. Pai and L. Jiao
Hammersmith Hospital, Imperial College London, London, 
UK
Introduction: An alternative method for pancreatic anasto-
mosis following pancreaticoduodenectomy is described for 
cases where mobilization of the pancreatic remnant is not 
possible.
Methods: The patient underwent pancreaticoduodenectomy 
for adenocarcinoma of the head of the pancreas. The pancre-
atic stump could not be mobilized enough to form a pancre-
aticogastrostomy or a pancreaticojejunostomy following a 
standard resection. The surgeon proceeded to create a longi-
tudinal ventral pancreaticojejunostomy (LVPJ). After laying 
open the pancreatic duct along the pancreas, a pancreatico-
jejunostomy with a Roux-en-Y loop was formed using 3/0 
PDS sutures in order to reconstruct the pancreatic drainage.
Results: Reconstruction of the pancreatic anastomosis using 
a LVPJ takes less than 10 minutes on average. A detailed 
description of this novel pancreatic anastomosis is presented 
here.
Conclusions: LVPJ is a quick, easy to perform and safe 
alternative method for pancreatic duct reconstruction after 
pancreaticoduodenectomy in patients with a dilated pancre-
atic duct and either an inadequate length of the pancreatic 
remnant or fi xation of the stump to the surrounding 
vasculature.
A-054
SINGLE INCISION LAPAROSCOPIC 
DISTAL PANCREATECTOMY WITH 
SPLENECTOMY FOR 
NEUROENDOCRINE TUMOR OF THE 
TAIL OF PANCREAS
G. Srikanth and N. Shetty
BGS Global Hospitals, Institute of Gastroenterology, 
Bangalore, India
Introduction: Laparoscopic resection is becoming the stan-
dard of care for tumors located in the body and tail of pan-
creas. A literature search did not reveal any reports on single 
incision laparoscopic surgery for distal pancreatic and splenic 
resection (SILDPS). We herein present an operative video of 
a patient with neuroendocrine tumor in the tail of pancreas 
who underwent SILDPS without the use of a commercial 
port device.
Methods: Forty two year old male patient presented with 
pain abdomen. Multidetector computerized tomography 
showed a well circumscribed lesion in the tail region of pan-
creas. Serum chromogranin was elevated at 960 ng/mL. He 
underwent a single incision distal pancreatectomy with sple-
nectomy. Operative video is presented with technical details.
Results: The operative time was 280 minutes and patient 
was discharged on normal diet on the fourth postoperative 
day. He was readmitted ten days later with a small collection 
in relation to the transacted end of pancreas which was 
managed by percutaneous catheter drainage and appropriate 
antibiotics. At one year follow-up he is asymptomatic with 
no discernable scar at the umbilicus.
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Conclusions: SILDPS is feasible and safe. Simple innova-
tions facilitated the procedure. Complication seen in our 
patient was managed appropriately and was related to the 
nature of procedure rather than the single incision laparo-
scopic approach.
A-055
LAPAROSCOPIC LIGATION OF 
COMMON HEPATIC ARTERY (CHA) TO 
PRECONDITION LIVER AND STOMACH 
PRIOR TO RADICAL DISTAL 
PANCREATECTOMY AND 
SPLENECTOMY WITH ENBLOC 
RESECTION OF THE CELIAC AXIS FOR 
LOCALLY ADVANCED PANCREATIC 
BODY/TAIL TUMORS
N. Houli1 and M. Nikfarjam2
1Northern Hospital, Epping, Australia; 2Department of 
Surgery, Austin Hospital, Heidelberg, Australia
Introduction: In the last decade, several publications in 
literature have discussed the details of radical distal pancre-
atectomy and splenectomy with enbloc resection of the celiac 
axis for locally advanced pancreatic tumors. There has been 
recent interest in the use of preop coil embolization of the 
common hepatic artery prior to major resection in order to 
precondition the liver and stomach and reduce complications 
and avoid arterial reconstructions.
Methods: In this case presentation and video, we will 
briefl y describe the case history of a 77 year old woman with 
locally advanced pancreatic body tumor involving the distal 
celiac axis and proximal CHA.
Patient underwent laparoscopy to stage disease. At laparos-
copy, we ligated the CHA proximal to the hepatic artery 
proper (HAP) and GDA and away from tumor. This was used 
to facilitate the collaterals between the Inferior pancreatico-
duodenal artery from SMA and GDA/HAP axis.
Results: Two weeks later the patient underwent laparotomy 
with radical distal pancreatectomy with splenectomy with 
enbloc resection of the celiac axis, the proximal CHA/Left 
gastric artery/Splenic artery and surrounding celiac nerve 
plexus and ganglion The patient did not require any arterial 
reconstruction. The histology was moderately differentiated 
adenocarcinoma of the pancreatic body with involvement of 
the celiac nerve plexus. Nine out of 45 nodes were positive. 
All margins were negative.
The patient had no signifi cant alteration in LFT post liga-
tion and tolerated the procedure well.
The patient made an uneventful recovery and is well and 
alive at 3 months review.
Conclusions: We believe this is the fi rst ever description of 
laparoscopic ligation of the CHA prior to the radical distal 
pancreatectomy and splenectomy and enbloc resection of the 
celiac axis. This could be used instead of the previously 
described technique of angiographic coil embolization. The 
technique discussed could be applied to other malignancies 
such as cases of hilar cholngiocarcinoma requiring possible 
arterial resections.
A-056
GONADAL VEIN PATCH FOR PORTAL 
VEIN RECONSTRUCTION DURING 
PANCREATODUODENECTOMY
R. C. Shah, D. G. Chhabra and P. Jagannath
Lilavati Hospital and Research Centre, Mumbai, India
Background: Frequently the Superior mesenteric vein or 
the portal vein is involved in head pancreas malignancy and 
involves technical expertise for resection and reconstruction 
of the vein. Various methods have been used for reconstruct-
ing the portal vein.
Aim: To highlight the use of a gonadal vein patch for the 
reconstruction of partially excised portal vein.
Case: A 52 yr old male was diagnosed with head pancreas 
malignancy. A Triphasic CT scan showed a lateral involve-
ment of the spleno-portal junction on a CT scan. A Whipple’s 
resection was done with resection of lateral part of the 
spleno-portal junction. The reconstruction was done using a 
segment of the right gonadal vein that was slit opened to 
patch the cut lateral edge of the portal vein.
Discussion: A direct suturing of the portal vein often leads 
to narrowing and a venous patch would be necessary to avoid 
a narrowed lumen of the portal vein. Different veins have 
been used to repair the portal vein defect and in this video 
we describe a lateral patch repair of portal vein using the 
right gonadal vein which is a fairly large vein in the fi eld of 
dissection.
Conclusion: The right gonadal vein can be comfortably har-
vested and slit open to give an adequate patch to reconstruct 
a partially resected portal vein during pancreatoduodenec-
tomy. This video describes the fi rst such repair in the pub-
lished literature.
A-057
SINGLE STAGE MANAGEMENT OF 
COMMON DUCT STONES WITH TWO 
APPROACHES: LAPAROSCOPIC 
TRANS-CYSTIC DUCT AND 
TRANSCHOLEDOCHAL EXPLORATION
A. Umezawa, Y. Seki, K. Kasama, T. Yamaguchi, Y. Negishi 
and Y. Kurokawa
Yotsuya Medical Cube, Tokyo, Japan
Introduction: Single stage management is the exact word 
for the advantage of laparoscopic common bile duct explora-
tion (CBDE). The aim of this study was to determine the 
feasibility of two kinds of laparoscopic CBDE approaches, 
trans-cystic duct exploration (LTCE) and transcholedochal 
exploration (LCHE).
Methods: All patients who undergoing laparoscopic chole-
cystectomy had routinely intra-operative cholangiograms 
(IOC). Once confi rming the diagnosis of common bile duct 
stones (CBDs), laparoscopic CBDE was carried out accord-
ing to the number and size of stones. The number less than 
four and the size under 8 mm was the indication for LTCE. 
Others were indicated for LCHE.
Results: Out of 544 patients of laparoscopic surgery for 
gallstone disease, 19 patients (3.5%) had received CBDE. 
Incidentally diagnosed CBDs by IOC were 6 patients (1%). 
LTCE was performed 11 patients which include incidentally 
diagnosed 5, while LCHE was performed 8 patients. Mean 
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operative time was 161.9 min (LTCE: 157.1, LCHE: 168.6). 
Both procedures were performed successfully. There was no 
conversion to open surgery, no major complication, and no 
retained stone. Mean number of CBDs was 1.6 (LTCE was 
1.4, LCHE was 2.0) and its mean size was 7.5 mm (5.0 mm, 
10.3 mm). The length of postoperative hospitalization for 
LTCE was 2.3 days, and for LCHE was 2.8.
Conclusions: LTCE shows uncomplicated post operative 
course like simple laparoscopic cholecystectomy. Although 
there are limitations to the indication, LTCE is feasible and 
should be the fi rst line of treatment for CBDs. With LCHE 
as redeeming approach, these approaches can lead feasible 
clinical outcomes for CBDE.
A-058
MANAGEMENT OF SYMPTOMATIC 
CHOLELITHIASIS IN PATIENTS WITH 
HIGH RISK OF CHOLEDOCHOLITHIASIS
A. Y-C. Tsai, E. Gomm, 
S. Higgs and D. Mahon
Musgrove Park Hospital, Taunton, UK
Introduction: 15% of the UK population has gallstones, in 
which 15–26% becomes symptomatic. The American Society 
for Gastrointestinal Endoscopy (ASGE) guideline for risk 
stratifi cation of common bile duct (CBD) stones and man-
agement algorithm suggests that Magnetic resonance chol-
angiography (MRCP) is indicated in the intermediate risk 
group to identify CBD stones. Endoscopic retrograde chol-
angiopancreatography (ERCP) is fi rst-line for the high risk 
and laparoscopic cholecystectomy for the low risk group. 
This study evaluates the MRCP requesting in the high risk 
group in a district general hospital.
Methods: All patients who had symptomatic gallstones con-
fi rmed on ultrasound scan and underwent MRCP for the fi rst 
time between January and December 2010 were included and 
assigned to low, intermediate, or high risk group according 
to ASGE guideline. Patients who had had previous ERCP 
and/or suspected biliary/pancreatic malignancy were 
excluded. The fi nding of ductal stones in MRCP and ERCP 
were compared; the clinical justifi cation for MRCP in the 
high risk group were reviewed.
Results: 84 patients were included: 3 (3.5%) low risk, 66 
(78.6%) intermediate and 15 (17.9%) high. 14 (21%) inter-
mediate risk patients had CBD stones on MRCP. In the high 
risk group, CBD stones were identifi ed in only 4 patients 
(26.7%), of which 2 had stones extracted with ERCP; 6 had 
MRCP due to decreasing bilirubin level within the fi rst 24 
hours.
Conclusions: ERCP carries signifi cant mortality and mor-
bidity and was avoided in 73.3% of high risk patients with 
negative MRCP fi ndings. Monitoring bilirubin level was 
integrated to ASGE guideline as the local protocol.
A-059
CLINICAL AND EPIDEMIOLOGICAL 
CHANGE OF GALLSTONE DISEASE: 
30-YEAR SINGLE CENTER EXPERIENCE
Y. R. Chang1, J-Y. Jang1, I. W. Han1, M. J. Kang1, 
J. K. Ryu2, Y. T. Kim2, Y-B. Yun2 and S-W. Kim1
1Department of Surgery, Seoul National University College 
of Medicine, Seoul, Korea; 2Department of Internal 
Medicine, Seoul National University College of medicine, 
Seoul, Korea
Introduction: The aim of this study is to investigate the 
clinical and epidemiological change of gallstone disease in 
Korea based on single center’s 30-year experience.
Methods: A total of 7,949 gallstone patients who underwent 
surgery during 1981–2010 were analyzed. The patients were 
divided into 6 periods: period I (1981–1985, n = 831), period 
II (1986–1990, n = 888), period III (1991–1995, n = 1,040), 
period IV (1996–2000, n = 1,261), period V (2001–2005, 
n = 1,651) and period VI (2006–2010, n = 2,278).
Results: Total number and mean age gradually increased. 
Female predominance was not observed (male/female ratio, 
1.02–1.37). The relative proportion of GB stone cases was 
increased from 53.0% to 92.6%, while that of CBD stone 
cases was decreased from 68.0% to 5.0%. The number of 
patients with IHD stone had been stationary until period V, 
but changed to decrease. Geographical difference between 
the rural and urban area seemed to be decreasing that chang-
ing patterns of all 3 stone groups were similar. The body 
mass indexes of the GB stone group and IHD stone group 
has been increased (p = 0.013, p = 0.049), while CBD stone 
group did not show specifi c pattern of change (p = 0.146). 
For the relationship between the change in frequency of 
gallstone and socioeconomic status, the prevalence of CBD 
stone showed a strong correlation with Engel’s coeffi cient 
(p < 0.001).
Conclusions: In gallstone disease, total number of cases and 
mean age are continuously increased. The increasing ten-
dency of GB stone and decreasing tendency of CBD stone 
was observed, but IHD group pattern changed from station-
ary to decreasing in this 30-year analysis.
A-060
MORTALITY AFTER 
CHOLECYSTECTOMY DUE TO 
GALLSTONE DISEASE – A POPULATION-
BASED STUDY
A. Svenner1, G. Sandblom1, P. Videhult2 
and O. Sadr Azodi1
1Karolinska Institute, CLINTEC, Sweden; 2Västerås 
Hospital, Dept of Surgery, Sweden
Background: Very few population-based studies have elab-
orated on the mortality after cholecystectomy in patients with 
gallstone disease.
Method: The Swedish Register of Gallstone Surgery and 
ERCP (GallRiks) started in May 2005 and reached 75% 
national coverage in 2007. Between 2006 and 2009, opera-
tions on 18,354 individuals older than 17 years were regis-
tered in GallRiks. By linkage to the Swedish All Cause of 
Death Register, mortality within 30-days after surgery was 
identifi ed. Multivariable logistic regression analysis was 
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performed to study the effect of age, sex, ASA-classifi cation, 
operation planning (acute/elective), indication of surgery, 
operative approach, operative time, thrombosis prophylaxis 
and the occurrence of peroperative complications on the risk 
of 30-day mortality after cholecystectomy.
Results: Within 30 days after surgery, 26 (0.1%) patients 
died. The resulting age- and sex standardized mortality was 
19.7 (95% CI: 11.2–28.2) events per 10,000 individuals and 
month of follow-up, compared to 11.3 (95% CI: 11.0–11.6) 
expected events in the general Swedish population. In mul-
tivariable analysis, there was statistically signifi cant associa-
tion between several factors and the risk of 30-day mortality 
after cholecystectomy. Among other things, being >80 years 
was the strongest factor, increasing the risk of mortality by 
more than 11 fold (OR = 11.26; 95 CI: 2.68–47.35) as com-
pared to those ≤60 years. Those with an ASA-score >3 had 
6 times (OR = 6.13; 95% CI: 1.54–24.41) higher probability 
of lethality compared to those with an ASA-score of 1–2. In 
comparison to laparoscopic surgery, open surgical approach 
increased the risk of mortality by more than 5 times (OR = 
5.43; 95% CI: 1.56–18.89).
Conclusion: Using high-qualitative Swedish register, the 
safety of cholecystectomy due to gallstone disease was 
proven to be high. Paying attention to the presented risk 
factors such as whenever possible performing laparoscopic 
surgical approach could improve the safety of cholecystec-
tomy due to gallstone disease even further.
A-061
THE LONG-TERM EFFECT OF BILE 
DUCT INJURIES ON PHYSICAL AND 
MENTAL HEALTH-RELATED QUALITY 
OF LIFE
M. P. Landman1, I. D. Feurer1,2, D. E. Moore1, 
V. Zaydfudim1 and C. Wright Pinson1
Department of 1Surgery & 2Biostatistics, Vanderbilt 
University Medical Center, Nashville, TN, USA
Introduction: Iatrogenic bile duct injury (BDI) is a serious 
complication of cholecystectomy. Reported long-term effects 
of biliary injury on health-related quality of life (HRQOL) 
have varied among published studies. We applied meta-anal-
ysis methodology to examine the collective fi ndings of the 
long-term effect of BDI on HRQOL.
Methods: A literature search for relevant publications was 
conducted in January, 2011. Because HRQOL surveys dif-
fered among reports, BDI and uncomplicated laparoscopic 
cholecystectomy (LC) groups’ HRQOL scores were fi rst ref-
erenced to general population standards rather than compar-
ing BDI and LC scores directly to each other. Effect sizes 
(ES) were computed as standardized differences between 
HRQOL scores and the general population. Negative ESs 
indicated diminished HRQOL, with substantive clinical 
impairment defi ned as an ES ≤ −0.50. Follow-up time from 
cholecystectomy to HRQOL determination was treated as an 
ordinal covariate. Weighted logistic regression tested the 
effects of cholecystectomy group (BDI vs. LC) and follow-
up time on whether physical and mental HRQOL were sub-
stantively impaired.
Results: Data were abstracted from six publications, which 
encompass all reports of HRQOL after BDI in the current, 
peer-reviewed literature. The analytic database comprised 90 
ES computations representing 831 patients and 11 unique 
study groups (6 BDI, 5 LC). After controlling for follow-up 
time, BDI patients had impaired physical (OR = 6.78, 95%CI 
= 3.54–12.98) and mental (OR = 11.72, 95%CI = 7.29–
18.86) HRQOL (both p < 0.001) compared to LC patients.
Conclusions: In comparison to LC, there is a long-term 
detrimental effect of BDI on physical and mental HRQOL 
that is most pronounced in the mental domain.
A-062
SINGLE-INCISION LAPAROSCOPIC 
CHOLECYSTECTOMY WITH ROUTINE 
INTRAOPERATIVE 
CHOLANGIOGRAPHY AND COMMON 
BILE DUCT EXPLORATION VIA THE 
UMBILICAL PORT
D. A. Yeo1, S. Mackay3,4 and D. Martin1,2
1Royal Prince Alfred Hospital, Sydney, Australia; 2Concord 
Hospital, Sydney, Australia; 3Monash University, 
Melbourne, Australia; 4Box Hill Hospital, Melbourne, 
Australia
Introduction: Laparoscopic cholecystectomy is now the 
gold standard technique for gallbladder removal. The use of 
routine intraoperative cholangiography (IOC) is widely prac-
tised during conventional four-port laparoscopic cholecys-
tectomy (4PLC) to confi rm biliary anatomy and allow for 
immediate management of unexpected choledocholithiasis. 
Single-incision laparoscopic surgery (SILS) offers a more 
aesthetic technique for gallbladder removal however no 
series to date have included routine intraoperative cholangi-
ography without a separate incision. The aim of this study 
was to demonstrate the feasibility of the SILS technique for 
cholecystectomy with routine intraoperative cholangiogra-
phy (LCIOC) and common bile duct (CBD) exploration as 
needed via the umbilical port.
Methods: A database was prospectively completed for a 
series of 60 consecutive patients undergoing single-incision 
LCIOC via the umbilical port. Details of patients, operations, 
indications, outcomes and follow-up were included.
Results: Of the 60 patients included 55 (91.7%) success-
fully underwent single-incision laparoscopic cholecystec-
tomy (SILC) while 5 patients required conversion to 4PLC. 
Of the 55 successful SILC patients, 53 (88.3%) successfully 
received intraoperative cholangiograms, 48 of which were 
normal. The remaining fi ve IOCs demonstrated choledocho-
lithiasis, four of which were able to be managed laparoscopi-
cally via the single port. One patient required post-op ERCP 
after deployment of a transcystic stent. Complications 
included four wound infections (7.8%), one incisional hernia 
(2.0%) and one bile leak (3.2%).
Conclusions: This study represents the largest series to date 
of single-incision laparoscopic cholecystectomies with 
routine intraoperative cholangiography via the umbilical port 
and the fi rst study to demonstrate that the laparoscopic man-
agement of choledocholithiasis during SILC is feasible.
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A-064
PREOPERATIVE INFLAMMATION HAS A 
NEGATIVE IMPACT ON SURVIVAL 
AFTER RESECTION OF EXTRAHEPATIC 
BILE DUCT CANCER
J. Y. Cho, H-S. Han, Y-S. Yoon, K. S. Ahn, J. H. Kim 
and Y. Kwon
Department of Surgery, Seoul National University Bundang 
Hospital, Seoul National University College of Medicine, 
Seoul, Korea
Introduction: The signifi cance of the presence of preopera-
tive infl ammation on the prognosis of patients with extrahe-
patic bile duct cancer (BDCA) was evaluated.
Methods: The clinical data of 84 patients who underwent 
surgery for BDCA from August 2003 and May 2009 were 
reviewed and survival analysis was performed. The patients 
were classifi ed into two groups according to the presence of 
preoperative cholangitis: Group C− showed the absence 
of cholangitis (n = 59) and Group C+ showed the presence 
of cholangitis (n = 25).
Results: There was no difference in gender, the mean age, 
the TNM stage, biliary drainage, the type of resection and 
radicality between the two groups (P > 0.05). The 3-year 
disease-specifi c and disease-free survival rates of the Group 
C+ patients (21.5% and 11.9%) were signifi cantly lower than 
those of the Group C− patients (66.1% and 57.3%; P = 0.013 
and 0.001, respectively). The multivariate analysis showed 
that preoperative infl ammation and lymph node metastasis 
were the independent prognostic factors for both overall sur-
vival (P = 0.021; RR = 2.224 and P = 0.015; RR = 2.367, 
respectively) and disease-free survival (P = 0.014; RR = 
2.192 and P = 0.013; RR = 2.240, respectively). In Group 
C+, the rates of angiolymphatic and perineural invasion were 
higher than those in Group C− (P = 0.016 and 0.030, 
respectively).
Conclusions: The presence of preoperative infl ammation is 
an independent poor prognostic factor for overall and dis-
ease-free survival for the patients with BDCA.
A-065
INTEGRAL LAPAROSCOPIC 
TREATMENT FOR CHOLE-
CHOLEDOCHOLITHIASIS. TECHNICAL 
ASPECTS AND INSTRUMENTATION
D. Fernandez Luengas, I. Pascual Miguelañez, 
R, Fernandez Sanchez, M. A. Vaquero Perez 
and J. Torres Jimenez
Department of General and Digestive Surgery, HPB Unit, 
Hospital Infanta Sofi a, Complutense University, Madrid, 
Spain
Introduction: Video is presented for demonstrate fully 
laparoscopic bile duct exploration with extraction of cho-
ledocholithiasis plus cholecystectomy, after ERCP failure.
Methods: Patient female 55 years old, with previous 
Pfannestiel for hysterectomy, with acute right upper cuadrant 
pain since 3 days before admission, associated to ictericia, 
coluria and hipocolia. Laboratory tests show moderate 
colestasis with 3.8 mg/dl bilirrubine. Abdomen echo shows 
cholelithiasis with bile duct dilatation (11 mm) and two 
distal choledocolithiasis. On MRI the diagnosis is confi rmed, 
showing 5 choledocolithiasis. ERCP is done, not resolving 
the problem. Operation: Laparoscopic access with 30-degree 
laparoscope. Cholecystectomy is done fi rst. Bile duct is dis-
sected and open longitudinally. Exploration with choledo-
choscope is done. Choledocholithiasis extraction with 
Fogarty balloon (5 Fr) is performed. New choledochoscope 
exploration asuring bile duct patency. Primary choledochor-
raphy. Extraction of the specimen and choledocholithiasis is 
done and closed suction drain is left in place.
Results: Postop aneventful, discharged on day 4.
Conclusions: Laparoscopic bile duct exploration is feasible 
and safe. We have performed 14 cases after ERCP failure. 
After good initial experience (results are shown), we are 
encouraging laparoscopic bile duct exploration as initial 
treatment for choledocholiasis in selected cases.
A-066
MANAGEMENTS OF SIMPLE LIVER 
CYSTS: CYST UNROOFING OR 
ABLATION THERAPY
I-Y. Park, Y-K. Lee, D-Y. Hwang, H-S. Seo and 
H-J. Choi
Dept. of Surgery, Bucheon St. Mary Hospital, The Catholic 
University of Korea, Republic of Korea
Introduction: Simple liver cysts were frequently recog-
nized due to advanced imaging procedures such as ultra-
sound and CT scan. A large cyst or signifi cant symptoms 
were indications for the treatments. Ablation therapy with 
sclerotic agents underwent effectively but there were several 
complications such as severe pain. Laparoscopic cyst unroof-
ing method had been introduced. We tried to compare cyst 
unroofi ng method and ablation therapy retrospectively.
Methods: Between March 1997 and May 2011, we per-
formed treatments in simple liver cysts of 27 patients. There 
are 23 women and 4 man (Age range: 42–84 years; mean 
age, 64 years). Cyst unroofi ng was performed with laparo-
scopic (13) and open technique (1). We performed ablation 
therapy with ethanol (13) and acetic acid (1).
Results: Frequent symptoms of the large liver cysts were 
abdominal mass (7), Indigestion (4), abdominal discomfort 
(3) and increasing size of the cyst (4). Mean diameter of 
Cysts was 10.9 cm. Cyst unroofi ng method had underwent 
effectively in 14 patients but one patient had bleeding during 
operation and then we converted to open method and one 
patient had a bile leak from the cyst but it was successfully 
closed with laparoscopic technique. Among 15 ablation 
therapy, there were 4 complications; hematoma (1), cyst 
leaking during aspiration (2), acute renal failure (1) and 
patient’s death due to acetic acid intoxication (1).
Conclusions: Laparoscopic cyst unroofi ng was more effec-
tive and safe management than ethanol ablation therapy in 
large simple liver cysts.
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A-067
ASSESSMENT OF A NEW 
PREOPERATIVE STAGING SYSTEM FOR 
HILAR CHOLANGIOCARCINOMA
A. T. Ruys1, O. R. Busch1, E. A. Rauws2, D. J. Gouma1 
and T. M. van Gulik1
1Department of Surgery, Academic Medical Centre, 
Amsterdam, The Netherlands; 2Department of 
Gastroenterology and Hepatology, Academic Medical 
Center, The Netherlands
Objectives: To devise a new preoperative staging system 
for hilar cholangiocarcinoma (HCCA) based on preoperative 
prognostic factors.
Methods: 289 Consecutive patients with HCCA presenting 
in our center from January 2003 through August 2010 were 
evaluated. Suspicion on lymph node metastasis, portal vein 
and hepatic artery involvement, lobar atrophy, and proximal 
extent of ductal invasion were scored. The prognostic value 
of these parameters for predicting resectability, yield of 
diagnostic laparoscopy, likelihood of metastatic disease, 
R0-resection and survival was assessed.
Results: Of all 289 evaluated patients, 158 Patients (55%) 
had unresectable disease based on cross-sectional imaging 
studies or diagnostic laparoscopy; 131 Patients (45%) under-
went exploration. 83 patients (64%) underwent resection of 
whom 67 (87%) had a radical (R0) resection. Based on the 
predictive value of the various factors we developed a staging 
system taking into account vascular involvement, suspicion 
on lymph node metastasis and bilateral segmental ductal 
involvement as follows; Stage I: absence of vascular, lymph 
node, or bilateral segmental ductal involvement. Stage II: 
vascular involvement of portal vein or hepatic artery. Stage 
III: lymph node involvement, or bilateral segmental ductal 
involvement. Stage IV: unresectable disease (locally 
advanced tumor, distant metastases). Patients with stage IV 
had a median survival of 10 months, which was signifi cantly 
shorter than stages I-III (20 months, p < 0.01).). Stage I 
patients as compared to stage III patients, had a higher resect-
ability rate (85% vs 36%, p < 0.01), lower yield of laparos-
copy (8% vs 17%, p = 0.12), lower likelihood of metastasis 
(9% vs 30%, p < 0.01), higher R0-resection (90% vs 80%, 
p = 0.31) and longer median survival (33 vs 18 months, p = 
0.03).
Conclusions: By taking into account not only segmental 
tumor extension but also vascular and lymph node involve-
ment, the proposed new staging system for HCCA accurately 
correlates with resectability and predicts survival.
A-068
SINGLE INCISION LAPAROSCOPIC 
CHOLECYSTECTOMY FOR THE 
DIFFICULT GALL BLADDER
G. Shenoy, G. Srikanth and N. Shetty
BGS Global Hospitals, Institute of Gastroenterology, 
Bangalore, India
Introduction: Single incision laparoscopic cholecystec-
tomy (SIL Cholecystectomy) is a relatively new approach in 
management of gall stone disease. We present our experience 
with SIL cholecyetectomy for the diffi cult gall bladder.
Methods: Clinical details of patients who underwent SIL 
cholecystectomy during the period July 2009 to 1st September 
2010 were studied from a prospective database. Patients with 
a ‘diffi cult gall bladder’ for the purpose of this study included 
those with acute cholecystitis, mucocele, common bile duct 
(CBD) stones, biliary pancreatitis, cirrhosis of liver and wide 
cystic duct at surgery. Operative techniques employed were 
studied.
Results: Twenty eight patients, 24 female and four male, 
with age ranging between 23 to 70 years underwent SIL 
cholecystectomy for diffi cult gall bladder during the study 
period. Diffi culty was secondary to acute cholecystitis (6), 
mucocele (4), CBD stone (14), biliary pancreatitis (2), cir-
rhosis of liver (1) and wide cystic duct (5). Operative tech-
niques tailored to overcome the diffi culties included fundal 
traction suture (28), transaction of gall bladder neck and 
disimpaction of stone (3), subtotal cholecystectomy with 
endosuturing (1), hemo-lock clipping of the wide cystic duct 
(6). There were no conversions. One patient had wound 
infection. There was no bile duct injury or mortality. Median 
postoperative stay was 1 day (range 0 to 2 days). Cosmetic 
result was excellent with no visible scar at one month.
Conclusions: SIL cholecystectomy is feasible for the diffi -
cult gall bladder without the use of single port device. 
Innovative techniques are required to perform SILS for the 
diffi cult gall bladder.
A-069
DISTINGUISHING AUTOIMMUNE 
 PANCREATITIS FROM PANCREATICO-
BILIARY CANCERS: CURRENT 
STRATEGY
S. Agrawal, C. Daruwala and J. Khurana
Temple University School of Medicine, Philadelphia, USA
Introduction: Pancreatic and biliary manifestations of AIP 
mimic pancreatico-biliary cancers. Misdiagnosis of AIP can 
result in major surgery for a steroid-responsive disease. An 
evidence-based review to identify current modalities for the 
diagnosis of autoimmune pancreatitis (AIP) with the objec-
tive of establishing a strategy to distinguish it from pancre-
atico-biliary cancers.
Methods: A review of the literature to identify recent 
advances in the diagnosis of AIP and evaluate outcomes with 
various diagnostic strategies to minimize operative interven-
tion for an autoimmune disease.
Results: Diagnostic criteria for AIP are based on histology, 
imaging, serology, extrapancreatic organ involvement and 
response to steroid therapy (HISORt). The most commonly 
involved extrapancreatic sites are bile duct, kidney and ret-
roperitoneum. The Mayo Clinic diagnostic strategy utilizes 
core biopsy of the pancreas and the Japanese strategy depends 
on a characteristic pancreatogram. The rate of operative 
intervention was similar with both strategies and none of the 
patients with cancer received steroid therapy. IgG4-associated 
cholangitis mimics cholangiocarcinoma and presence of >10 
IgG4-positive plasma cells/HPF on endoscopic biopsy of the 
bile duct was diagnostic for AIP in 88% patients. Biliary 
complications and early relapse are common after surgical 
resection and immunomodulatory drugs can maintain long-
term remission.
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Conclusions: Criteria based on histology, imaging, endos-
copy, serology, extrapancreatic organ involvement and 
response to steroid therapy improve the diagnostic yield for 
AIP. Application of diagnostic and therapeutic protocols by 
a multidisciplinary team will optimize outcomes with a 
decline in the rate of operative intervention for AIP a steroid-
responsive disease with propensity for relapse.
A-070
EXTENDED RIGHT 
HEPATOPANCREATODUODENECTOMY 
FOR DIFFUSE EXTRAHEPATIC 
CHOLANGIOCARCINOMA
A. Chotirosniramit
Department of Surgery, Faculty of Medicine, Chiang Mai 
University, Thailand
Introduction: Hepatopancreatoduodenectomy is the most 
extensive curative operation for advance biliary tract cancer 
such as diffuse cholangiocarcinoma or locally advance gall-
bladder cancer. Morbidity and mortality rate were still high 
in most reports. The aim of this study was to demonstrate 
this procedure by DVD presentation.
Methods: From May 2001 to May 2011, 413 patients with 
hepatobiliary tract malignancy underwent hepatectomy by 
the author. Of these, 5 hepatopancreatoduodenectomies were 
performed. In the case demonstration, a 72 year-old man 
presented with jaundice with epigastric pain for one month. 
MDCT scan revealed a lobulated arterial enhancing intralu-
minal mass within the dilated extrahepatic bile duct extend-
ing from the hepatic duct confl uence to the distal common 
bile duct. Extended right hepatopancreatoduodenectomy was 
planned.
Results: Extended right hepatopancreatoduodenectomy was 
performed successfully with 2400 ml of blood loss, and 3 
units of pack red cell were transfused. Post-operative chol-
angiography demonstrated the patent anastomotic sites 
without evidence of leakage. Histopathology revealed well 
differentiated intraductal papillary adenocarcinoma without 
stromal invasion and lymph node metastasis. All surgical 
microscopic margins were free of malignancy. The patient 
still survives without recurrence in two years.
Conclusions: To obtain free surgical margins in locally 
advance biliary tract cancer, hepatopancreatoduodenectomy 
may be required for curative intent. With the progress and 
experience in hepatobiliary-pancreatic surgery, this extensive 
procedure can be performed safely in selected patients.
A-071
HEALTHCARE DATA COMPARISON: 
CLINICAL UNIT DATABASE V/S 
ADMINISTRATIVE HOSPITAL DATABASE
K. Mori1, V. Surendran2, M. Fink1,2, M. Nikfarjam1,2, 
G. Starkey1,2, R. M. Jones1,2, C. Christophi1,2 
and V. Muralidharan1,2
1HPB & Transplant Unit, Austin Hospital, Melbourne, 
Australia; 2The University of Melbourne Department of 
Surgery, Austin Hospital, Melbourne, Australia
Introduction: This study compares the quality and reliabil-
ity of the data available from the administrative hospital 
database (HD) in comparison to the prospectively main-
tained and clinician validated unit database (UD).
Methods: The comparison of the two data sources was done 
of the Hepato-biliary unit over fi ve years. A standardized 
‘Data Request Form’ was used to request data from the two 
sources. As the data from the UD is prospectively main-
tained, we have hypothesized it to be ideal and compared it 
to the HD.
Results: The HD recorded 13.3% fewer total admissions, 
77%, 9% and 28% fewer admissions with chronic cholecys-
titis, pancreatic cancer and hepato-cellular cancer respec-
tively and 71%, 8% and 18% more admissions with chronic 
pancreatitis, cholangitis and cholangio-carcinoma compare 
to UD respectively. With procedures, it (HD) recorded 5%, 
5% and 25% fewer liver resections, groin hernia and inci-
sional hernia repairs while it incorrectly recorded 25%, 
9.5%, 15%, and 9% more open cholecystectomies, emer-
gency cholecystectomies, bile duct explorations and laparo-
scopic appendicectomies respectively. No data was available 
from HD in relation to in-hospital referrals, specifi c proce-
dure related complications and specifi c key performance 
indicators. UD was weekly validated by the unit clinicians 
and changes made accordingly.
Conclusions: There is appreciable difference between the 
two sources. The quality, clinical relevance and reliability of 
the UD with clinician validated data are superior compared 
to HD.
A-072
THREE-DIMENSIONAL FUSION IMAGES 
OF HEPATIC VASCULATURE AND BILE 
DUCT FOR THE PREOPERATIVE 
SIMULATION FOR HEPATECTOMY
A. Nanashima, T. Abo, T. Sawai and T. Nagayasu
Division of Surgical Oncology, Nagasaki, Japan
Introduction: Recent radiological technology has been 
developed and provided images with high spatial resolution 
that facilitate effective 3D information. We applied fusion 
images of 3D cholangiography and angiography using 
MDCT, DIC-CT or C-arm CT, which provide useful infor-
mation regarding the precisely operative simulations in the 
hepato-biliary surgery.
Methods: 3D-fusion images were evaluated in 42 patients 
with hepatobiliary malignancies who underwent surgical 
resections.
Results: In one of 17 patients with intrahepatic liver tumors, 
the direct 3D cholangiography shows the aberrant branch 
over umbilical portal vein was observed. In a large hepa-
toma locating the central liver which compressed hilar 
vasculatures, 3D fusion image showed no remarkable 
obstruction. In a case of metastatic liver tumor with right-
side umbilical portal vein, the aberrant branch of caudate 
lobe was failed to diagnose and uncontrolled biliary leakage 
was observed. In 24 patient with extrahepatic biliary car-
cinomas, extent of tumor invasion by the 3D fusion images 
equivalent to the conventional cholangiography could be 
diagnosed. In 2 patients who underwent hepatectomy, more 
extended cancer invasion was observed than that by 3D 
fusion images. Fusion image with 99mTc-GSA liver scin-
tigraphy was useful to evaluate functional liver area before 
hepatectomy.
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Conclusions: 3D-fusion images were very useful for preop-
erative simulations to understand relationship between tumor 
extent and adjacent vasculatures.
A-073
‘PIGGYBACK SYNDROME’ IN 
ORTHOTOPIC LIVER 
TRANSPLANTATION: 10 YEAR SINGLE 
CENTRE EXPERIENCE
A. Takhar, N. Battula, B. Gunson, D. Mayer, P. Muiesan, 
H. Mergental, J. Isaac, T. Parera, D. Mirza, J. Buckels 
and S. Bramhall
The Liver Unit, Queen Elizabeth Hospital, Birmingham, 
United Kingdom
Introduction: Graft venous outfl ow obstruction after ortho-
topic liver transplantation is a rare but recognized complica-
tion of the piggyback technique of implantation. This study 
aimed to evaluate the causative factors in cases of confi rmed 
‘piggyback syndrome (PBS)’ in our centre.
Methods: We carried out a retrospective analysis of a pro-
spectively maintained database of all orthotopic liver trans-
plants carried out at our unit between January 2000 and 
December 2010. Statistical analysis was carried out using 
SPSS (version 13) software with p < 0.05 considered a sig-
nifi cant result.
Results: Over a 10 year period, 1025 liver transplants were 
carried out using the piggyback technique at our unit (587 
male, 438 female, median age 53 years (range 6.5–73.3 
years)). Of these, 2% (n = 21) were found to have radiologi-
cally confi rmed ‘piggyback syndrome (PBS)’. The PBS 
group included 17 whole and 4 split grafts with a median age 
of 55 years. A univariate analysis of risk factors for develop-
ing PBS did not show any signifi cant results including no 
increased risk of PBS in split livers (p = 0.23). No difference 
was demonstrated in graft (p = 0.73) and patient survival (p 
= 79) between the PBS and no PBS groups. All PBS patients 
were treated by endoluminal stenting.
Conclusions: The risk factors for developing PBS are mul-
tifactorial. There is no difference in graft and patient survival 
in those treated for PBS and patients with an uncomplicated 
post operative course.
A-074
LAPAROSCOPIC TRANSUMBLICAL 
PERCUTANEOUS CHOLECYSTECTOMY
A. Aldohayan, H. Alqahtani and F. Bamihrz
College of Medicine, King Saud University, Saudi Arabia
Background: Laparoscopic cholecyetomy in the best 
method for symptomatic cholelithiasis. The use of single port 
for the patient will expopos them to hernia due the big 
midline incision. We describe cosmetic technique using 
periumbilical incisions and needle right hyponchordial 
incision.
Method: The technique was applied to 13 patients and the 
technique used 2 priumbilical 5 mms and 8 mm incision tow 
2 mm incisions are applied in right hypochondrium.
The procedure was donr for 11 patients, tow patient had acute 
cholecystitis Patient were happy from cosmetic appearance.
Conclusion: The procedure is safe, cosmetic, less coast and 
has less postoperative hernia risk.
A-075
SEVERITY STRATIFICATION OF ACUTE 
PANCREATITIS: VALIDATION OF A NEW 
FOUR TIER CLASSIFICATION
R. B. Thandassery2, V. Gupta1, T. D. Yadav1, U. Dutta2, 
K. Singh2 and R. Kochhar2
1Department of Surgery, Postgraduate Institute of Medical 
Education & Research, Chandigarh, India; 2Dept of 
Gastroenterology, Postgraduate Institute of Medical 
Education & Research, Chandigarh, India
Introduction: Atlanta classifi cation divided patients of 
acute pancreatitis (AP) into mild and severe, however this 
classifi cation cannot stratify patients accurately. The aim of 
the present study was to characterize the severity of AP based 
on the presence of two key determinants i.e., organ failure 
(OF) and infected necrosis (IN) into mild, moderate, severe 
and critical AP, and correlate hospital course and outcome 
with these four grades of severity.
Methods: From January 2009 to December 2010, 151 
patients presenting with AP were studied; development of 
necrosis, IN and OF was observed. Patients were classifi ed 
as mild (no necrosis or OF), moderate (sterile necrosis or 
transient OF), severe (infected necrosis or persistent OF) and 
critical (infected necrosis and persistent OF). The four groups 
were compared regarding the hospital course and mortality.
Results: 21 (13.9%) patients had mild, 63 (41.7%) moder-
ate, 59 (39.1%), severe and 8 (5.3%) critical AP. Duration of 
hospital stay, occurrence of blood stream infection, IN, CT 
severity index (CTSI), need for percutaneous catheter drain 
insertion, surgery and mortality were higher in groups with 
higher grades of severity. On univariate analysis, predictors 
of mortality were serum CRP levels (at 24 hours), APACHE 
II (at 24 hours), BMI, CTSI, modifi ed organ failure score 
(day 1), IN and OF. Multivariate analysis showed IN (odds 
ratio 20.60, CI = 3.31–128.26) and APACHE II (odds ratio 
0.69, CI = 0.60–0.79) as the independent predictors of 
mortality.
Conclusions: Classifi cation of severity of AP helps in strati-
fi cation of patients into appropriate clinical groups that 
refl ect the outcome.
A-076
THE RELATIONSHIP BETWEEN 
HOSPITAL VOLUME AND SHORT-TERM 
OUTCOME OF 
PANCREATODUODENECTOMY IN 
KOREA
S. Jo, H-J. Lee and S-H. Oh
Department of Surgery, Dankook University College of 
Medicine, Cheonan, Rep of Korea
Introduction: To utilize hospital volume as a quality indica-
tor of care providers in Korea, it is necessary to assess the 
relationship between hospital volume and short-term surgical 
outcome of pancreatoduodenectomy (PD) for periampullary 
cancers.
Methods: Using the database of the Health Insurance 
Review and Assessment Service, we identifi ed 4,975 patients 
who underwent PD during the period of Jan. 2005–Dec. 
2008. Participating hospitals were divided into fi ve groups 
according to their surgical volume. The primary outcome 
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was postoperative mortality, defi ned as death before dis-
charge or within 30 days after surgery.
Results: The mean age of the patients was 61.5 years and 
male patients were much more (60.1%). Total 126 hospitals 
were enrolled in this study. Pylorus-preserving PD (PPPD) 
was performed in 2,964 (59.6%) patients and high-volume 
hospitals more frequently performed PPPD than low-volume 
hospitals (p < 0.000). Overall postoperative mortality rate 
after PD was 2.1%. Postoperative mortality rates were sig-
nifi cantly lower in high-volume than those in low-volume 
hospitals after adjusting for patient characteristics (p < 
0.000), ranging from 0.5% to 4.5%. In addition, mortality 
rate after classical PD was twice higher than that after PPPD 
(3.0% vs 1.5%, p < 0.000).
Conclusions: High-volume hospitals had better short-term 
surgical outcome than low-volume hospitals. We confi rmed 
the volume-outcome relationship for PD in Korea.
A-077
LAPAROSCOPIC FOLYES 
CHOLANGIOGRAPHY (LFC) KSU 
TECHNIQUE
A. Aldohayan
King Saud University, Riyadh, Saudi Arabia
Method: Performing cholangiogriam in acute cholecystits, 
which is very important may impossible to perform. 
Cholangiography is viatale to avoid biliary injury. Here we 
innovate a technique using folye’s catheter passing through 
the gall bladder.
Method: The FCC (KSU) technique in done through stab 
wound through gall bladder fundus and balloon is infl ated 
and catheter is pulled with purse suture is tied around 
the tube distal to the balloon and cholangiographu is 
performed.
Result: The FCC (KSU) technique is done for 7 patients 
with visualization of the biliary tree. Common hepatic and 
common bile duct are matted with cystic duct and Hartman 
pouch.
Conclusion: The technique is useful and allows the surgeon 
to perform laparoscopic cholecystectomy safely.
A-079
PLANNED MANAGEMENT STRATEGIES 
FOR REDUCING MORTALITY IN ACUTE 
SEVERE PANCREATITIS
D. S. White, R. Ramaiah and A. Patel
ICU, Royal Surrey County Hospital, UK
Introduction: Acute severe pancreatitis [ASP] is associated 
with high mortality and morbidity. The British Society of 
Gastroenterologists has published guidelines for manage-
ment of ASP. The intention of the study was to compare 
management strategies and mortality against national 
standards.
Methods: A retrospective study of patients admitted with 
ASP to our tertiary referral centre was conducted. We 
assessed the overall hospital mortality, radiological/surgical 
intervention, use of antibiotics and enteral feeding in these 
patients.
Results: We had 51 patients admitted to our ICU with ASP 
[Apache II ≥ 8, Ranson Score >3] during 2008–2011. The 
3-year mortality was 25.4%, well below the national standard 
of 30%. The yearly mortality has reduced from 38.1% 
[2008/9] to 10.5% [2010/11]. This was associated with a 
planned management strategy including levels of patient 
care, antibiotic therapy and enteral feeding. An increase in 
use of minimally invasive percutaneous necrosectomy was 
also noted [42.9% in 2008/9 to 63.2% in 2010/11]. There was 
an overall trend toward improved patient outcome and mor-
tality from 2008–2011, however, this was not statistically 
signifi cant, due to small numbers [Fishers test 0.07].
Conclusions: A planned management strategy in our ICU 
was associated with reduced mortality. This may be due to 
1)Aggressive early detection and management including 
radiological imaging ± intervention, 2)Minimally invasive 
surgical intervention, 3)Early diagnosis and treatment of 
infection, with avoidance of inappropriate antibiotics, 
4)Preference for enteral over parenteral nutrition.
A-080
MINOR COMPLICATIONS WITH MAJOR 
IMPLICATIONS
M. Wilhelmsen, H. C. Rolff, P. N. Larsen and A. Wettergren
Department of Surgical Gastroenterology and 
Transplantation, Rigshospitalet, University of Copenhagen, 
Copenhagen
Introduction: Surgery per se will lead to complications. 
The liver often harbors metastases from colorectal cancer. 
We conducted this study to asses if complications after 
surgery for colorectal liver metastases (CRLM) would have 
any impact on long-term survival in liver resection for 
CRLM in patients with co morbidities ahead of surgery.
Methods: From our database we found 78 patients with co 
morbidity before liver-resection for CRLM between 1998 
and 2010. The co morbidity were medical conditions such 
as: Diabetes, COPD, Hypertension and Atrial-fi billation. 
Patients were stratifi ed in two groups with either no-compli-
cations or complications. Patients were excluded if they did 
not survive 90 days after surgery. Duke’s classifi cation was 
recorded as well as uni- or bilobar disease, R0 resection, 
hepatic recurrence and distant recurrence. SPSS was used for 
statistics. P = 0.05 was considered signifi cant.
Results: There were no signifi cant differences with regards 
to age (P = 0.521), number of liver metastases (P = 0.253), 
Dukes score, uni- or bilobar disease (P = 0.723), hepatic 
recurrence (0.318) and distant recurrence (0.392).
A total 31 of complications were encountered such as pneu-
monia, atrial-fi brillation, acute toxin intestinal nephropathies 
(ATIN), septicaemia, bile leakage, wound infections, perfo-
rated ulcus, bleeding, intraperitoneal abscess, ruptures of the 
fascia and hematomas. 52 patients had no complications.
A signifi cant increase in mortality was found with regards to 
the 5-years survival in patients suffering from even minor 
complications provided they had any co-morbidities at the 
time of liver resection (P = 0.008).
Conclusions: More attention should be given to the preven-
tion of minor complications in patients with co morbidities 
undergoing surgery for CRLM.
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A-080a
MAGNIFICATION ASSISTED 
PANCREATICO-JEJUNOSTOMY (MAP-J) 
IN PANCREATICODUODENECTOMY
D. G. Chhabra, K. Sutariya, R. C. Shah and P. Jagannath
Lilavati Hospital and Research Centre, Mumbai, India
Background: Pancreatic fi stula (PF) is the most signifi cant 
cause of morbidity and mortality following pancreaticoduo-
denectomy. A precisely performed anastomosis is the key to 
reduce PF.
Study Design: A prospective database of 64 pancreatoduo-
denectomies performed in a single unit from 2008 through 
2010 was analyzed. An end to side duct-to-mucosal pancre-
aticojejunostomy (PJ) (without stent) was performed in all 
cases with fi ne polydiaxone interrupted sutures. PJ was com-
pleted with surgical loupes of 3.5 × magnifi cation in 32 
patients (MAP-J group) and without in 32 patients (Control 
group). Drain fl uid amylase was measured on postoperative 
day 3 and 7. Incidence of clinically relevant pancreaticoje-
junostomy leak (Grade B/C) was determined using the 
International Study Group of Pancreatic Surgery (ISGPF) 
classifi cation. Pancreas related complications: collections, 
delayed gastric emptying (DGE) and hemorrhage were also 
analyzed.
Results: The characteristics of patients with respect to age, 
sex, pre-operative biliary drainage, type of resection, intra-
operative texture of pancreas and the mean pancreatic duct 
diameter were similar in both groups. Clinically relevant PJ 
leak occurred in 14% cases (n = 9). The leak rate was 3% (n 
= 1; grade B) in MAP-J group, compared to 25% (n = 8; 4 
grade B & 4 grade C) in control group (p < 0.001). Pancreas 
related complications included 7 pancreatic collections, 2 
hemorrhage and 3 DGE in control group compared to single 
case of DGE in MAP-J group.
Conclusions: Magnifi cation assisted pancreaticojejunos-
tomy (MAP-J) with increased visual acuity with surgical 
loupes signifi cantly improves technical performance of PJ 
and reduces clinically relevant PF and related complications. 
We strongly advocate the routine use of surgical 
loupes with 3.5 × magnifi cation for a duct-to-mucosa 
pancreaticojejunos tomy.
A-081
LAPAROSCOPIC OR OPEN LIVER 
RESECTION? LET SYSTEMATIC 
REVIEW DECIDE IT
A. Rao, G. Rao and I. Ahmed
University of Aberdeen, Aberdeen, UK; Aberdeen Royal 
Infi rmary, Aberdeen, UK
Introduction: Laparoscopic liver resection is increasing 
being used for excision of benign and malignant hepatic 
lesions. Data from case series and observational studies is 
available on the safety and effi ciency of laparoscopic resec-
tion. The aim of the study is to perform meta-analysis on the 
compiled data from available studies.
Method: All the studies comparing laparoscopic vs. open 
liver resections were searched on the available databases. 
Data was analyzed using Review Manager software version 
5.0.
Results: There were total of 2466 patients in the included 
studies: 1161 (47.1%) in the laparoscopic group and 1305 
(52.9%) patients in the open group. Laparoscopic group was 
associated with reduced overall complication rate (Odds 
ratio 0.35 CI [0.28, 0.45] P < 0.001, HG P 0.51), fewer 
number of positive resection margins for malignant tumor 
resections (Odds ratio 0.38 CI [0.20, 0.76] P 0.006, HG P 
0.52) and decrease in the patients requiring blood transfusion 
by (Odds ratio 0.36 CI [0.23, 0.74] P < 0.001, HG P 0.30).
Conclusion: Laparoscopic group showed reduced overall 
complication rate for all resection types and fewer positive 
resection margins for malignant resection. For most out-
comes, results of laparoscopic resections were comparable 
to open resection There is still need for randomized con-
trolled trials to compare laparoscopic versus open hepatic 
resection in benign and malignant lesions.
Key words: open hepatic resection, laparoscopic, mortality, 
complication rate, left lateral liver resection, hepatocellular 
carcinoma, hepatic malignancy
A-082
SAFETY AND ONCOLOGICAL 
EFFICIENCY IN LAPAROSCOPIC LIVER 
SURGERY: THE SOUTHAMPTON 
EXPERIENCE
M. A. Hilal1, F. Di Fabio1, A. Takhar2 and N. Pearce1
1University Surgical Unit, Southampton General Hospital, 
Southampton, United Kingdom; 2The Liver Unit, Queen 
Elizabeth Hospital, Birmingham, United Kingdom
Introduction: Use of the laparoscopic approach to complex 
liver malignancies and its impact on safety and oncological 
effi ciency is the subject of ongoing debate.
Aims and Methods: We reviewed our prospectively main-
tained database of patients undergoing laparoscopic liver 
resections for malignant disease. Main outcome measures 
were: tumor-free resection margins, and mid-term survival.
Results: 128 patients underwent 133 laparoscopic liver 
resections. Surgical indications were: colorectal carcinoma 
liver metastasis (CRCLM) (n = 83), hepatocellular carci-
noma (HCC) (n = 18), neuroendocrine tumor (NET) metas-
tasis (n = 17), non-colorectal carcinoma liver metastasis (n 
= 11), lymphoma (n = 2) and intrahepatic cholangiocarci-
noma (n = 2). Forty major hepatectomies (30%) were per-
formed. Median operative time was 210 min (30–480 min). 
Median postoperative length of stay was 4 days (1–15 days). 
Seven patients required conversion to formal open surgery 
and 4 patients required conversion to a laparoscopic-assisted 
procedure. Sixteen patients (13%) developed signifi cant 
postoperative complications. One patient died in-hospital 
(0.8%). In the NET group 6/17 patients (35%) had R1 resec-
tion. R0 resection was obtained in the remaining 112/116 
resections (97%). At multivariate analysis (logistic regres-
sion), intra-operative blood loss >2000 ml was the only sig-
nifi cant variable independently associated with R1 resection 
(odds ratio 21). We recorded an 80%, 77% and 92% 2-year 
overall survival in the CRCLM, HCC, and NET groups, 
respectively.
Conclusions: Our data support the safety and oncological 
effi ciency of laparoscopic resection for liver malignancies.
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A-083
LAPAROSCOPIC VERSUS OPEN 
RESECTION OF HEPATIC COLORECTAL 
METASTASES
R. C. G. Martin, R. Cannon, G. Callender, 
K. M. McMaster and C. R. Scoggins
Division of Surgical Oncology, University of Louisville, 
Louisville, Ky, USA
Introduction: Laparoscopic liver resection is beginning to 
gain widespread acceptance, particularly for benign indica-
tions. More controversy exists over the role of laparoscopic 
resection of malignant disease. This study was undertaken to 
compare outcomes between laparoscopic and open resection 
of hepatic colorectal metastases (CRM).
Methods: A prospective review of all patients undergoing 
fi rst resection of hepatic CRM from 2000–2010. Comparisons 
were made between patients undergoing laparoscopic versus 
open resection in terms of demographics, tumor characteris-
tics, and outcomes.
Results: 35 patients underwent laparoscopic resection vs 
244 patients who received an open operation. There were no 
signifi cant differences in age (62 vs 61 years; p = 0.67), BMI 
(28 vs 27; p = 0.25), number of lesions (1.8 vs. 2.6; p = 0.11), 
size of largest lesion (4.2 vs. 4.6 cm; p = 0.22), or Fong score 
(1.9 vs. 2.1; p = 0.33) in the laparoscopic and open groups, 
respectively. Patients undergoing laparoscopic resection had 
signifi cantly less blood loss (202 vs. 401 ml; p < 0.001), 
shorter length of stay (4.9 vs 8.7 days; p < 0.001), and fewer 
complications (22.9% vs 52.9%; p = 0.001). There were no 
signifi cant differences in rate of major hepatectomy (54.3% 
vs 52.9%; p = 1.0), R0 resection (97.1% vs 85.7%; p = 0.06), 
or signifi cant abdominal adhesions (20.0% vs 15.7%; p = 
0.62) in the laparoscopic and open groups. Median overall 
(47.5 vs 40.7 months; p = 0.51) and disease free survival 
(25.9 vs 26.5 months; p = 0.99) were also similar between 
the laparoscopic and open group.
Conclusions: Laparoscopic resection of hepatic CRM 
results in signifi cantly less blood loss and a shorter length of 
stay than an open procedure, with comparable oncologic 
effi cacy.
A-084
RE-DO LIVER RESECTION FOR 
RECURRENT COLORECTAL LIVER 
METASTASIS: A SINGLE CENTRE 
13-YEAR EXPERIENCE
N. Battula, A. Takhar, D. Tsapralis, D. Mayer, J. Isaac, 
P. Muiesan, S. R. Bramhall, R. P. Sutcliffe, D. F. Mirza 
and R. Marudanayagam
Liver unit, Queen Elizabeth Hospital, Birmingham, United 
Kingdom
Introduction: Isolated intra-hepatic recurrence is noted in 
upto 40% of the patients after a potentially curative resec-
tion for colorectal liver metastasis (CLM). The aim of 
this study was to analyze the outcomes of re-do hepa-
tectomy for recurrent CLM and identify factors predicting 
survival.
Methods: All liver resections for CLM between 1998 and 
2011 were included. Parameters analyzed included demo-
graphic data, clinico-pathological features, operative data, 
morbidity and mortality. Post operative complications were 
graded using clavien-dindo classifi cation.
Results: A total of 1027 liver resections were performed for 
CLM. 58 repeat liver resections were performed in 53 
patients. There were 29 male and the median age was 63 
years. Time interval between the primary and fi rst hepatec-
tomy was 10.5 months and between 1st and re-do hepatec-
tomy was 15.4. The median tumor size was 3 cm and median 
number of lesions was 1. Six (11%) had an R1 resection 
following fi rst hepatectomy. There were no peri-operative 
deaths, signifi cant complications included transient liver 
dysfunction in 1 (2%) and bile leak in 2 (4%). The overall 
1, 3 and 5 year survival following re-do liver resection was 
85%, 61% and 52% at a median follow up of 23 months. R1 
resection at fi rst hepatectomy (P = 0.002), time interval 
between 1st and 2nd hepatectomy (P = 0.02) and presence 
of extra hepatic disease (P = 0.02) were associated with 
signifi cantly poor survival.
Conclusions: Re-do liver resection for recurrent colorectal 
metastasis is safe and has good long term survival in selected 
group of patients.
A-085
OUTCOME AFTER RESECTION OF 
LIVER METASTASES FROM 
COLORECTAL CANCER IN PATIENTS 
WITH PREOPERATIVE PORTAL VEIN 
EMBOLIZATION
S. Yamashita, K. Hasegawa, M. Takahashi, Y. Inoue, 
M. Ikeda, J. Kaneko, Y. Sakamoto, T. Aoki, Y. Sugawara 
and N. Kokudo
Hepato-biliary-pancreatic Surgery Division, Department of 
Surgery Graduate School of Medicine, University of Tokyo, 
Tokyo, Japan
Introduction: Portal vein embolization (PVE), which was 
fi rstly introduced for KLatskin tumor to guarantee the safety 
of major hepatectomy, can also increase the resectability of 
initially unresectable colorectal liver metastases (CLM). The 
aim of the present study is to evaluate the clinical signifi -
cance of PVE in patients undergoing major hepatectomy for 
CLM.
Methods: We have performed one-stage hepatectomy, com-
bined with preoperative PVE, for patients with multiple and 
bilobar CLM who required major hemihepatectomy and 
wedge resections of the opposite lobe. Between September 
1996 and December 2009, 397 patients underwent hepatec-
tomy for CLM in our institution, among whom 51 patients 
had PVE beforehand (PVE group) and 346 did not. Among 
the 346 patients, 66 underwent major hepatectomy (Non-PVE 
group). In this retrospective analysis, the short- and long-term 
outcomes between the two groups were compared.
Results: While there was no mortality in the two groups, 
the postoperative morbidity after hepatectomy in the PVE 
and Non-PVE groups were 33.3% and 25%, respectively (P 
= 0.32). The overall 3-year survival rates were 55% and 
64.4%, respectively (P = 0.93).
Conclusions: One-stage hepatectomy following PVE is 
safe. The long-term results after hepatectomy with PVE were 
comparable with those without PVE, although the former 
had more advanced tumor status. PVE is useful in the treat-
ment for CLM to provide good long-term outcomes.
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A-086
LAPAROSCOPIC LIVER RESECTION 
FOR MALIGNANT LIVER TUMORS. 
WHY NOT MORE?
S. S. Yun, I. S. Kwun, D. H. Lee, D. S. Lee and H. J. Kim
Yeungnam University Hospital, Daegu, Korea
Introduction: Laparoscopic resection of liver malignancies 
remains controversial because of its oncologic safety. The 
purpose of the present study was to analyze the feasibility, 
safety, and outcome of 61 patients undergoing laparoscopic 
resection for liver malignancies.
Methods: From January 2004 to March 2011, 111 patients 
were performed with laparoscopic liver resection. Among the 
111 patients, 61 patients with malignant liver tumors were 
included in this study. Variables analyzed included operating 
time, surgical margin, blood transfusion, conversion to lapa-
rotomy, postoperative hospital stay, postoperative complica-
tion, operation related death, mean follow up period, overall 
survival and disease free survival. Survival curves were cal-
culated according to the Kaplan-Meier method. P < 0.050 
was considered statistically signifi cant.
Results: Mean operating time was 209.7 ± 108.9 minutes 
and mean surgical margin was 1.3 ± 1.2 cm. Blood transfu-
sion needed in 11 patients (18%). There were 2 conversion 
to laparotomy (3%) because of tumor rupture and bleeding. 
Mean postoperative hospital stay was 9.0 ± 4.4 days. 
Postoperative complication occurred in 9 patients (14%) 
including acute renal failure, wound infection, pleural effu-
sion, etc. At mean follow-up period of 18.9 ± 11.7 in HCC 
and 16.6 ± 7.5 in metastasis, 3-year overall survival rates 
were 87% in HCC and 95% in metastasis, and 3-year disease 
free survival rates were 57% in HCC and 90% in 
metastasis.
Conclusion: Even though laparoscopic liver resection needs 
learning curve and we have a limited number of patients, it 
is feasible with minimal surgical trauma even in patients who 
had malignant liver tumor especially in HCC and liver 
metastasis from colorectal cancer.
A-087
LAPAROSCOPIC CYSTOGASTROSTOMY 
(TRANSGASTROCOLIC APPROACH), 
FOR PEUDOPANCREATIC CYST, A 
NOVEL APPROACH
K. Sutariya, T. Bankim, N. G. L., J. R. S., S. Raju and 
Y. Mehta
Laparosurge Hospital, Rajkot, India
Introduction: Laparoscopic internal drainage of large, per-
sistent and symptomatic pancreatic pseudo cyst is appropriate 
for most patients and achieves adequate drainage, facilitates 
debridement and brings predictable benefi ts over open 
surgery and endoscopic approaches. Due to location and size 
of the cyst, transgastric approach may not be feasible.
Methods: 14 year female had acute pancreatitis before 4 
months. She presented with persistant pain in abdomen since 
2 months due to pseudocyst. In view of persistant pain and 
loss of school attendance she was planned for cystogastros-
tomy. CT Scan was suggestive of 10 * 3.2 cm cyst in body 
and tail with minimal contact between stomach and cyst wall.
Laparoscopic transgastrocolic cystogastrostomy was as per-
formed under GA. Four ports inserted. There was minimal 
bulging on the stomach wall and mesocolon. Gastrocolic 
omentum opened. Posterior wall of stomach and anterior 
wall of cyst exposed. Cyst confi rmation done by needle aspi-
ration. Cyst opened. Cyst fl uid drained along with necrotic 
material. Posterior stomach wall opened. Cystogastrostomy 
done using 60 mm blue stapler (Ehicon Endosurgery). The 
defect in cyst wall and stomach sutured with 2–0 Vicryl 
(Jhonson & Jhonson). Port closed after drain placement.
Results: Post operative period was uneventful. There was 
no leak. Patient was discharged on third day. After 6 months 
of follow up she is pain free.
Conclusion: Laparoscopic transgastrocolic approach for 
peudocyst can useful for patient with small to moderate size 
of cyst. It avoids the morbidity of gastrotomy (transgastric), 
and cystojejunostomy. It is technically easier also.
A-088
MINIMAL INVASIVE PANCREATIC 
SURGERY: LAPAROSCOPIC 
TRANSGASTRIC PANCREATIC 
NECROSECTOMY
P. Bhavin
Astha Hospital, Ahmedabad, India
Introduction: Techniques for minimal invasive necrosec-
tomy have largely evolved in last decade. The approaches 
are Laparoscopic, Endoscopic and Percutaneous- retroperi-
toneal. The indications for laparoscopic transgastric approach 
include: infected pancreatic necrosis with a mature well cir-
cumscribed pseudo capsule lies in retrogastric location and 
>6 cm size pancreatic pseudocyst. In his approach, large 
stoma created which allow complete necrosectomy and inter-
nal drainage.
Methods: Operative video : a case of necrotizing pancreati-
tis, 6 weeks after conservative treatment hemodynamically 
stable but having infected pancreatic necrosis with mature 
pseudo capsule. Laparoscopic transgastric necrosectomy 
operation was performed. 2.5 cm stoma was created in pos-
terior stomach wall with harmonic scalpel. About 350 cc pus 
and infected necrosis was removed from lasser sac. Suturing 
of stoma margin was done with 2–0 vicryl.
Results: Total 10 patients were operated by laparoscopic 
transgastric approach from 2001–2010. 6 patients had pan-
creatic pseudocyst after acute necrotizing pancreatitis and 4 
patients had infected walled off necrosis. Post operative com-
plication seen in one patient – bleeding from stoma margin 
require reexploration. Most patients discharge from hospital 
after 5–7 post operative day.
Conclusions: Laparoscopic transgastric approach to pan-
creatic necrosectomy is feasible in selected cases and offers 
potential advantage and fasten post operative recovery as 
compare to open surgery. Laparoscopic approach requires 
careful patient selection as well as expertise in both pancre-
atic and advanced laparoscopic surgery.
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A-089
LAPAROSCOPIC CHOLEDOCHAL CYST 
EXCISION AND HEPATICO 
JEJUNOSTOMY: BEWARE OF 
ABERRANT DUCTAL ANATOMY
P. Rao1, P. Rao1, S. Bhagwat2 and P. Rao1
1Mamata Hospital, Mumbai, India; 2BYL Nair Hospital, 
Mumbai, India
Introduction: A 25 year old female presented with history 
of RHC pain, intermittent jaundice and fever for many 
months. USG and MRCP revealed a fusiform choledochal 
cyst Alonso Lej type 1. Bilirubin was marginally raised as 
were the liver enzymes. MRC also revealed a low entering 
sectoral duct on the right side.
Methods: Patient was subjected to a laparoscopic chole-
dochal cyst excision with a laparoscopic assisted Roux en Y 
hepatico jejunostomy. The bowel loop was fashioned through 
a small umbilical incision and anastonoses done intracorpo-
really. Great care was taken to visualize the aberrant entering 
sectoral duct and preserve it during the anastomoses. The 
video highlights the salient features of the technique.
Results: Patient had a smooth post-operative recovery and 
the drain was removed on the 3rd day and patient discharged. 
The Liver function tests were normal at discharge.
Conclusions: Laparocopic choledochal cyst excision and 
roux en y hepaticoejunostomy is eminently feasible even in 
aberrant ductal anatomy. Preoperative MRC gives indica-
tions of aberrant ductal anatomy and the aberrant openings 
can be meticulously preserved during anastomoses.
A-090
NO-TOUCH EN-BLOC RADICAL 
OPERATION FOR UNRESECTABLE 
HILAR CHOLANGIOCARCINOMA, 
INCLUDING TOTAL HEPATECTOMY, 
PANCREATODUODENECTOY, PORTAL 
VEIN AND HEPATIC ARTERY 
RESECTION, AND RIGHT LOBE LIVING 
DONOR LIVER TRANSPLANTATION
D-B. Moon, S-G. Lee, K-H. Kim, T-Y. Ha, H. Shin, 
C-S. Ahn, K-W. Song, D-H. Jung, G-C. Park and
J-M. Namkoong
Division of Hepatobiliary Surgery and Liver 
Transplantation, Asan Medical Center, University of Ulsan 
College of Medicine, Seoul, Korea
Introduction: Hilar cholangiocarcinoma is a devastating 
disease, and therapy remains a formidable challenge. In par-
ticular, extensive hilar invasion, bilateral liver involvement, 
and vascular encasement often preclude potentially curative 
resection. Recently Mayo group reported combining the ben-
efi ts of radiotherapy, chemosensitization, liver transplanta-
tion for unresectable hilar cholangiocarcinoma could achieve 
favorable outcomes. Here, we report unresectable hilar chol-
angiocarcinoma patient as a video clip, who underwent no-
touch en-bloc radical operation for unresectable hilar 
cholangiocarcinoma, including total hepatectomy, pancre-
atoduodenectomy, portal vein and hepatic artery resection, 
and right lobe living donor liver transplantation, after con-
current chemoradiotherapy (CCRT).
Methods: The patient was 59 year-old female and diag-
nosed unresectable Klatskin’s tumor Bismuth type IV with 
right hepatic artery and left portal vein invasion but no sus-
pected lymph node metastasis on pre-operative CT, MR chol-
angiography and endoscopic biopsy. Preoperative CCRT 
using capecitabine and 5040 cGy was performed and levels 
of CA 19–9 (U/mL) changed 85.7, 984, 36.1 serially. Before 
performing intended major operation, lymph node metastasis 
was not found on the laparoscopic exploration. Hilar infl am-
mation related to pre-operative CCRT preclude reconstruc-
tion using radiation affected common hepatic artery, main 
portal vein, common bile duct in order to avoid vascular 
complications and biliary complications. Also for the purpose 
of no-touch en-bloc radical operation, she underwent en-bloc 
total hepatectomy and pancreatoduodenectomy, and then 
living donor liver transplantation using right liver from her 
daughter was performed. For reconstruction of portal vein 
and hepatic artery, spiral vascular tube with bisected autog-
enous great saphenous vein and gastroduodenal artery were 
used respectively. Pancreatic duct and bile duct were 
reconstructed with duct-to-mucosa anastomosis and 
hepaticojejunostomy.
Results: Explanted liver and pancreatoduodenectomy spec-
imen on pathology revealed moderately differentiated peri-
ductal infi lterating type adenocarcinoma involving both 
intrahepatic and extrahepatic duct with clear resection 
margins, but one metastasis among 5 lymph nodes was 
found. The patient recovered without particular event and 
discharged on postoperative 57 days. The recurrence was not 
found until post-operative 6 months.
Conclusions: En-bloc total hepatectomy and pancreatoduo-
denectomy, and then living donor liver transplantation for the 
treatment of unresectable hilar cholangiocarcinoma might be 
a complicated operation, but a novel technique for this 
patient.
A-091
LAPAROSCOPIC EXTENDED LEFT 
PANCREATECTOMY WITH SPLEEN AND 
SPLENIC VESSELS PRESERVATION. 
TECHNICAL ASPECTS
D. Fernandez Luengas, I. Pascual Miguelañez, R. Fernandez 
Sanchez, M. A. Vaquero Perez and J. Torres Jimenez
Department of General and Digestive Surgery, HPB Unit, 
Hospital Infanta Sofi a, Complutense University, Madrid. 
Spain
Introduction: Video of a left laparoscopic pancreatectomy 
with splenic vessels and spleen preservation is presented. 
The steps or the operation are performed secuentialy and 
cues for learning are explained properly.
Methods: Patient female 56 years old, no previous illnesses, 
consulting for abdominal pain. Abdominal echo demon-
strated a mixed solid-cystic lesion in pancreas body, 3 cm in 
diameter. Laboratory serum tests were normal, including 
CEA and CA 19.9. CT showed a cystic tumor, 3 cm in diam-
eter, in the body of pancreas. MRI showed same pancreas 
lesion, without Wirsung dilatation, without splenic-portal 
vascular axis compromise, consistent with serous cystoade-
noma of the pancreas. Tumor punction was not performed. 
Operation: Laparoscopic access with visual trocar. 30-degree 
laparoscope is used. Lesser sac is opened. Dissection of the 
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anterior surface of the pancreas and tumor localization is 
done. Inferior attachments of the pancreas are divided. The 
splenic and portal vein are disected down of the pancreas 
neck, and then the pancreas is laced right to the tumor. 
Pancreas is sectioned with stapler. Retrograde pancreas dis-
ection from neck to tail, preserving splenic vessels. Specimen 
extraction through a 4 cm Pfannestiel protected incision. 
Closed suction drain left in place.
Results: Postop: Aneventful, discharged on day 5. A year 
later, the patient has normal exo and endocrine pancreas 
function. Pathology: Serous microcystic cystoadenoma 3 cm 
in diameter.
Conclusions: Spleen and splenic vessels preservation is fea-
sible and safe during distal pancreatectomy.
A-092
MINIMALLY INVASIVE SURGERY FOR 
PANCREATIC DISEASE
C. Kyriakides, A. Frampton and L. Jiao
Hammersmith Hospital, Imperial College London, London, 
UK
Introduction: The role of laparoscopy in pancreatic surgery 
was previously limited to staging and palliation for pancre-
atic tumors. With the continuing evolution of technology as 
well as surgical experience procedures that were once con-
sidered impossible to perform laparoscopically, are now 
feasible.
Methods: Three cases are presented. The fi rst case was a 67 
year old female with a low attenuation lesion in the neck of 
the pancreas immediately posterior to segment 3 of the left 
lobe of liver (CT). The tumor was excised using an Endo-
GIA stapler. There were no post-operative complications and 
the patient was discharged on post-operative day 4.
The second case is a 63 year old man with lobulated cystic 
mass adherent to the wall of the duodenum and pancreas. 
The tumor was encapsulated and completely removed 
without damaging the duodenal wall or pancreatic tissue. 
There was minimal bleeding and no post-operative compli-
cations. The patient was discharged on post-operative day 2.
The third case is a 58 year old man with a ampullary 
lesion. He underwent laparoscopic whipple’s resection with 
pancreato-gastric reconstruction. His post operative course 
was uneventful and was discharge on the 9th day.
Results: No major complications were encountered, average 
blood loss was 400 ml and the duration of the procedure 
ranged from 130–360 minutes.
Conclusions: Laparoscopic resection of pancreatic tumors 
is a safe and effective procedure with minimal morbidity and 
reduced hospital stay.
A-093
CHOLEDOCHAL CYST WITH 
MALIGNANCY: A SINGLE CENTRE 
EXPERIENCE
N. Yanger, G. R. Bora, A. Saxena, A. Javed, S. Shivendra, 
A. S. Puri, R. Gondal and A. K. Agarwal
Department of GI Surgery, GB Pant Hospital & MAM 
College, Delhi University, New Delhi
Background and Aim: Malignancy is a recognized compli-
cation of long standing choledochal cyst (CDC). Although it 
commonly occurs in the cyst wall itself, the entire hepato-
pancreatic-biliary region is at risk. We herein report our 
experience of the spectrum of malignancies associated with 
CDC.
Methods: Of the 436 patients admitted with the diagnosis 
of CDC between January 2001 to May 2011, there were 34 
cases (7.79%) of malignancy. Clinical presentation, type of 
cysts (as per Todani’s modifi cation of Alonso Lej classifi ca-
tion), site of the tumor, management and follow up of these 
patients were analyzed.
Result: A total of 34 patients of CDC with malignancy were 
diagnosed during the period form a prospective database. 
Twenty patients (58.8%) were found to have gall bladder 
cancer (GBC) and 14 patients (41.1%) had cholangiocarci-
noma arising from the cyst wall. The majority of the patients 
were females (n = 25) and the mean age was 47 years (range 
20–74). Twenty three had Type I, 9 had type IVa CDC and 
2 had Type V cysts. There were no cases of malignancy in 
the patients between 0–15 years, 19 (55.8%) cases between 
16–49 years and 15 (44.1%) in >50 years. Six of the 20 
patients with GBC had metastatic disease on preoperative 
workup and 2 were found unresectable (metastasis-1, locally 
advanced-1) on surgical exploration. Radical cholecystec-
tomy with excision of choledochal cyst was performed in 9 
and additional resection of adjacent organs was required in 
3 patients. Of the 14 patients with malignancy in the cyst 
wall, 7 had metastatic disease on preoperative workup and 
another 2 at the time of surgical exploration. One patient 
underwent Whipples pancreato duodenectomy with cyst 
excision. Four others underwent excision of the extrahepatic 
biliary tree with the tumor. GBC had a resectability rate of 
60% while cholangiocarcinoma had 35.7%. Overall resect-
ability rate was 50%.
Conclusion: Choledochal cyst has a defi nite risk of malig-
nancy in the cyst wall and the gall bladder, which was 7.79% 
in the current series. All CDC should thus be excised upon 
diagnosis.
A-094
COMPLICATED LIVER HYDATID CYST: 
A COMPARATIVE STUDY OF SURGICAL 
MANAGEMENT AND LONG-TERM 
OUTCOME
J. Lendoire, L. Gil, G. Raffi n, F. Duek, C. Quarin, 
V. Garay, A. Oks and O. Imventarza
Hospital Dr Cosme Argerich – Buenos Aires – Argentina
Introduction: Echinococcosis is a health problem in certain 
endemic areas of Argentina. The appropriate management of 
complicated liver hydatid cyst is still a matter of discussion. 
The aim of this study is to analyze the impact of complica-
tions in the surgical management and outcome of patients 
treated with liver hydatid cysts (LHC).
Methods: Between 1996–2011 61 patients underwent 
radical surgical treatment for LHC at our unit. Diagnosis was 
performed by US, CT and hydatid serolgy. A comparative 
analysis with non-complicated LHC was performed.
Results: 57.4% female, age 46.7. Symptomatic 100%. 
Localization: right lobe (65.6%), left (27.9%) bilateral 
(6.6%). Mean size 8.9 cm (r: 4–25), 37.7% >10 cm. 
Serological analysis positive in 44.3%. Fifteen patients pre-
sented with complicated cysts (24.6%): jaundice (8.2%), 
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abscess (8.2%), cholangitis (6.6%). Four (6.6%) had multiple 
cysts. Intrabiliary rupture was verifi ed in 10 (16.3%). Surgical 
approach was conventional in 98.4%. All patients were 
treated by radical surgery: total pericystectomy 44.3%, sub-
total pericystectomy (>85%) 44.3% and liver resection 
11.4%. Morbidity 31.1% Clavien I 9 (47.3%), II 6 (31.5%), 
IIIa 3 (15.7%) grade IIIb 1 (5.2%). In univariate comparative 
analysis ICU stay (p = 0.04), length of hospital stay (p = 
0.03), biliary fi stula (p < 0.001), bile duct drainage (p < 
0.001) and po complications (p = 0.03) were statistically 
signifi cant.
Conclusions: One fourth of patients with liver hydatid cysts 
develop complications. Radical surgical treatment is the best 
approach, with a higher rate of hospital stay and morbidity in 
the complicated cyst. The most relevant parameter is the pres-
ence of a biliary fi stula and its therapeutic management.
A-095
BILIARY BYPASS SURGERY 
INDICATIONS AND OUTCOME OF 
DIFFERENT SURGICAL PROCEDURES
K. Altaf Hussain Talpur, A. Mehmood Malik and A. Khan 
Sangrasi
Liaquat University of Medical & Health Sciences, 
Jamshoro, Pakistan
Introduction: This is a prospective observational study 
which assesses the utility of biliary bypass surgical proce-
dures in various pancreatico biliary pathologies. It was 
carried out in the department of surgery, LUMHS, Jamshoro, 
Pakistan from Jan 2001 to Dec 2010.
Methods: 1500 patients of cholelithiasis were operated for 
open as well as laparoscopic cholecystectomy in duration of 
10 years. This study includes patients with common bile duct 
stones, congenital anomalies of biliary tree, un-operable 
pancreatico-biliary malignancies, common bile duct stric-
tures & patients who developed iatrogenic biliary injuries 
during cholecystectomy.
Results: Out of 1500 patients, 75 (5.0%) cases required 
different biliary bypass surgical procedures due to one or 
other reason. The main indications for these procedures were 
CBD stones (22.7%), CBD injuries (open 12% & laparo-
scopic 16%), carcinoma head of pancreas (10.67%) & CBD 
obstruction (16%) either due to CBD strictures or unknown 
distal obstruction. The commonly utilized surgical proce-
dures for these pathologies were choledochoduodenostomy 
(22.66%), Roux-en-Y Choledochojejunostomy (13.33%) 
and Roux-en-Y Hepatico-Jejunostomy (26.67%).
Conclusions: Biliary bypass surgical procedures are best 
options for patients with iatrogenic biliary tree injuries & 
un-operable pancreatico biliary malignancies. Roux-en-Y 
biliary bypass is best among all surgical options.
A-096
PREVIOUS SURGERY DOES NOT 
AFFECT THE OUTCOME OF DEFINITIVE 
SURGERY FOR GALLBLADDER CANCER 
– A REVIEW OF THE 10 YEAR 
EXPERIENCE OF A SINGLE 
INSTITUTION
D. J. Cavallucci, A. M. Fox, K. Leung, T. W. Reichman, 
S. Johal, K. Elgadi, S. Gallinger, I. D. McGilvray 
and S. P. Cleary
Department of Hepatobiliary Surgical Oncology, 
University Health Network, University of Toronto, Toronto, 
Ontario
Introduction: Controversy exists whether previous surgical 
intervention prior to defi nitive surgical therapy for gallblad-
der cancer has an impact on overall survival. Intuitively, a 
poorer outcome might be expected; however, recent litera-
ture suggests that there is no impact on overall survival.
Methods: We conducted a retrospective review of all 
patients with gallbladder cancer submitted to operation with 
curative intent during the past 10 years.
Results: 92 patients were identifi ed. 54 patients had previ-
ous surgical intervention with 49 cholecystectomies. There 
was no signifi cant difference in survival for patients who had 
undergone previous surgery, including cholecystectomy (HR 
0.77, p < 0.39) when stratifi ed for stage. Presenting with, or 
requiring intervention for jaundice pre-operatively was con-
fi rmed as a poor prognostic sign (HR 2.23, p < 0.05). The 
extent of liver resection had no signifi cant impact on overall 
survival as long as an R0 resection was obtained. En bloc 
resection of the bile duct or adjacent directly involved organs 
(colon, duodenum, pancreas) when required did not signifi -
cantly impact overall survival.
Conclusions: Our results suggest having undergone previ-
ous surgery, regardless of whether an attempt at cholecystec-
tomy was made, has no signifi cant impact on overall 
survival.
A-097
PORTAL VEIN RESECTION FOR HILAR 
CHOLANGIOCARCINOMA
H. J. Park, D. W. Choi, S. H. Choi, J. S. Heo, M. J. Kim 
and K. K. Choi
Department of Surgery, Samsung Medical Center, 
Sungkyunkwan University School of Medicine, Seoul, 
Korea
Introduction: It is controversial whether portal vein (PV) 
resection leads to survival benefi t in hilar cholangiocarci-
noma patients. The aim of this study is to investigate the 
impact on prognosis of PV resection and liver resection with 
a curative intent in type III and IV hilar cholangiocarcinoma 
patients with PV invasion.
Methods: 230 patients received surgery for hilar cholangi-
carcinoma in Samsung Medical Center from 1995 to 2010. 
Retrospective analysis was done for 162 patients who had 
surgery for type III and IV hilar cholangiocarcinoma. 
Nineteen patients were excluded leaving 143 patients who 
received curative surgery (13 palliative bile duct segmental 
resections, 3 living donor liver transplantations and 3 R2 
resections). 124 patients had R0 resection and 19 patients 
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had R1 resection. PV resection was done in 19 cases, 2 of 
which were R2 resection cases.
Results: 143 patients received radical surgery. There were 
3 cases of in-hospital mortality. There were no signifi cant 
differences in 1-, 3-, 5-year survival between PV resection 
group (n = 17) and PV non-resection group (n = 123, 91.9%, 
60.6%, 47.6% versus 88.2%, 64.2%, 64.2%). There were no 
signifi cant differences in 1-, 3-, 5-year disease-free survival 
between PV resection group and PV non-resection group 
(80.0%, 42.1%, 30.3% versus 70.1%, 57.4%, 57.4%).
Conclusions: There was no difference in survival between 
hilar cholangiocarcinoma patients who had PV resection and 
those who did not. PV resection with a curative intent should 
be carried out for resection of advanced hilar cholangiocar-
cinoma with PV invasion.
A-098
ROLE OF STAGING LAPAROSCOPY IN 
GALL BLADDER CANCER: ANALYSIS OF 
406 PATIENTS
R. Kalayarasan, A. Javed and A. K. Agarwal
Department of GI Surgery, GB Pant Hospital & MAM 
College, New Delhi
Introduction: Gall bladder cancer (GBC) is associated with 
high incidence of metastatic disease detected at the time of 
exploration resulting in non-therapeutic laparotomy. The 
present study was undertaken to ascertain the role of staging 
laparoscopy in GBC.
Methods: Between May 2006 and March 2011, GBC 
patients without evidence of metastatic disease on preopera-
tive imaging (ultrasound and CT/MRI abdomen) underwent 
staging laparoscopy using a single umbilical port with 30 
degree laparoscope. Previously undetected liver metastasis 
and peritoneal deposits were defi ned as ‘detectable lesions’ 
(DL) on staging laparoscopy (SL).
Results: Of the 406 patients of GBC taken up for surgery, 
80 had disseminated disease on SL [(liver metastasis (n = 22) 
or peritoneal deposits (n = 58)]. Overall yield of SL in GBC 
and in patients with primary GBC was 19.70% (80/406) and 
22.91% (74/323) respectively. Of the 326 patients who 
underwent laparotomy, 83 had unresectable disease. Reasons 
for unresectability were liver metastasis (n = 9), peritoneal 
deposits (n = 15), metastatic lymph nodes (n = 41) and 
locally advanced disease (n = 18). Overall, accuracy of SL 
for unresectable disease and DL were 49.07% (80/163) and 
76.92% (80/104) respectively. Patients with incidental GBC 
[IGBC, (n = 83)] had a higher failure rate of SL compared 
to primary GBC (n = 323) due to intra-abdominal adhesions. 
Accuracy of SL for unresectable disease [22.22%, (6/27)] 
and DL [30%, (6/20)] in IGBC was signifi cantly low com-
pared to primary GBC [53.68% (74/138) & 88.09% (74/84, 
p ≤ 0.0001 & 0.003]. In primary GBC yield of SL was sig-
nifi cantly higher in locally advanced GBC (patients with 
jaundice or gastric outlet obstruction, n = 96) compared to 
those who did not. [37.50% (36/96) vs. 16.74% (38/227), 
p = 0.003].
Conclusions: Staging laparoscopy avoids non-therapeutic 
laparotomy and related morbidity in patients with GBC 
(22.91% of Primary GBC patients) and especially in those 
with locally advanced GBC (37.50%). However in subgroup 
of IGBC patients following open cholecystectomy accuracy 
of staging laparoscopy is low.
A-099
DYNAMICS OF INTRAHEPATIC NITRIC 
OXIDE DURING HEPATIC ISCHEMIA-
REPERFUSION IN RAT LIVER
A. Nakagawa, Y. Yokoyama, H. Suzuki, K. Shoji, 
Y. Watanabe, T. Kokuryo and M. Nagino
1Nagoya University Graduate School of Medicine, Japan; 
2Section of Biochemistry, University of Verona, Verona, 
Italy; 3Faculty of Human Arts and Science, University of 
Human Arts and Science, Japan; 4High Technology 
Research Center, Pharmacology, Showa Pharmaceutical 
University, Japan
Introduction: During major hepatic surgery, repetitive 
clamping of the hepatoduodenal ligament is necessary to 
reduce blood loss at the expense of hepatic ischemia-reper-
fusion (IR) damage. Despite its important role, the dynamics 
of intrahepatic nitric oxide (NO) levels during hepatic IR has 
never been shown. We investigated the change of intrahe-
patic NO levels during IR using selective NO sensor.
Methods: Wistar rats were exposed to 15 min hepatic isch-
emia followed by reperfusion and the concentration of NO 
were measured using selective NO sensor.
Results: After starting ischemia, the intrahepatic NO levels 
steeply increased and reached to plateau at around 10 min. 
On reperfusion, the levels quickly decreased and approached 
to the baseline levels. By repeating 15 min ischemia fol-
lowed by 5 min reperfusion, the maximum amount of NO 
produced during ischemia gradually decreased and almost no 
NO production was observed at 5th time ischemia. However, 
the NO production was signifi cantly greater with 15 min 
reperfusion than that of 5 min reperfusion. The potential of 
NO production during ischemia was inversely correlated to 
the levels of hepatic damage evaluated by liver enzymes and 
tissue examination.
Conclusions: We fi rstly showed the real-time dynamics of 
intrahepatic NO levels during hepatic IR using selective NO 
sensor. This sensor can be a useful tool in predicting hepatic 
IR injury during liver surgery.
A-100
AUDIT OF 
PANCREATICODUODENECTOMIES FOR 
PANCREATIC TUMOURS AT TATA 
MEMORIAL CENTRE
Y. D. Bodhankar, V. Borgaonkar, P. J. Shukla, M. Goel and 
S. V. Shrikhande
Department of GI and HPB Surgical Oncology, Tata 
Memorial Centre, Mumbai, India
Introduction: Surgery is the only option in operable pan-
creatic tumours which offers an optimum chance of cure and 
long term survival. Our aim was to audit the experience of 
pancreaticoduodenectomies at a tertiary referral centre and 
to assess the perioperative outcomes in this major surgical 
procedure.
Materials and Methods: We prospectively maintained the 
database of Pancreaticoduodenectomy performed at the Tata 
Memorial Centre from the year 2003 to April 2011. A retro-
spective analysis of the morbidity and mortality in the peri-
operative period was performed.
Results: A total of 356 pancreaticoduodenectomies were 
performed from 2003 till April 2011 and for comparison, 
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divided the data into three time frames, from 2003 to 2007 
(n = 123), 2007 to 2009 (n = 98), and from June 2009 to 
April; 2011 (n = 135). The major postoperative complica-
tions included 23 (6.4%) postoperative pancreatic fi stulas 
(POPF–Grades A: 5, B: 12, C: 6), 15 (4.2%) postoperative 
haemorrhages and 9 (2.5%) biliary leaks. The overall post-
operative mortality was 17 (4.8%) of which 8 were not 
directly related to the procedure (2.2%). Pancreatic fi stula 
related mortality was 4 (1.13%). The reoperation rate for 
complications of pancreatoduodenectomy was 23 (6.4%).
Conclusion: Tata Memorial Centre is now fi rmly estab-
lished as a high volume centre in India for Pancrea-
ticoduodenectomy. The results continue to evolve in terms 
of perioperative outcomes. Our results are in keeping with 
published data from other high volume centres worldwide. 
Despite increasing case load per year, the unit has been suc-
cessfully maintaining acceptable morbidity and mortality 
rates.
A-101
PERCUTANEOUS TRANSHEPATIC 
GALLBLADDER DRAINAGE (PTGBD) 
CHANGES EMERGENCY 
LAPAROSCOPIC CHOLECYSTECTOMY 
TO AN ELECTIVE OPERATION IN 
PATIENTS WITH ACUTE 
CHOLECYSTITIS
I-G. Kim, J-R. Cho, B. S. Kim, S. Ahn, J. Y. Jeon 
and J. S. Kim
Department of Surgery, Hallym University Medical Center, 
Hallym University College of Medicine, Anyang City, South 
Korea
Introduction: Many surgeons have found it diffi cult to 
decide whether to apply percutaneous transhepatic gallblad-
der drainage (PTGBD) in patients with acute cholecystitis 
that is not responsive to initial medical management (IMMx) 
because the indications of PTGBD are ambiguous. The aim 
of this study was to evaluate the appropriate treatment for 
acute cholecystitis that is not responsive to IMMx. 
Specifi cally, we focused on differences in surgical outcomes 
between elective and emergency laparoscopic surgeries.
Methods: Between March 2006 and February 2009, 738 
patients with acute cholecystitis who had undergone laparo-
scopic cholecystectomy (LC) at our institution were studied 
retrospectively. We divided them into 3 groups. Group I 
included 494 patients who underwent elective LC without 
pre-operative PTGBD, group II included 97 patients who 
intended to undergo elective LC after preoperative PTGBD, 
and group III included 147 patients who underwent emer-
gency LC without preoperative PTGBD. We compared age, 
sex, symptom duration, body temperature, leukocyte counts, 
and American Society of Anesthesiologists (ASA) class upon 
admission as clinical characteristics. We compared the time 
interval from symptom development and admission to 
surgery, operative time, the conversion rate to open surgery, 
postoperative complications, the total length of stay, and the 
postoperative length of stay as perioperative surgical 
outcomes.
Results: For ASA 2 and 3 patients, the conversion rate to 
open surgery in group II was signifi cantly less than that in 
group III (p < 0.05, p < 0.01, respectively).
Conclusions: We recommend PTGBD as the fi rst choice for 
acute cholecystitis in patients who show no improvement 
after IMMx, to allow the patient to undergo an elective LC 
rather than emergency surgery for ASA 2 and 3 patients.
A-102
SINGLE INCISION CHOLECYSTECTOMY 
WITH NEEDLESCOPIC INFUNDIBULAR 
RETRACTION
K-H. Kim1, Y-K. You2, C-H. An1, J-S. Kim1, I-Y. Park3 and 
D-G. Kim2
1Uijeongbu St. Mary’s Hospital, Uijeongbu, Korea; 2Seoul 
St. Mary’s Hospital, Seoul, Korea; 3Bucheon St. Mary’s 
Hospital, Bucheon, Korea
Introduction: Single incision LC has been reported to be 
safe and feasible in various clinical experiences. But limited 
retraction has been an obstacle in the advancement of pure 
single incision cholecystectomy. Adequate retraction is nec-
essary to perform a safe cholecystectomy. We reviewed the 
results of a single instituition with respect of single incision 
cholecystectomy with a single 2 mm needlescopic instru-
ment for retraction of gallbladder infundibulum to aid in 
obtaining a critical view of safety.
Methods: From October 2010 to May 2011, 50 patients 
with a mean age 48.3 years (range 14 to 76) were identifi ed. 
Single port device was placed through umbilicus. A (2 mm) 
needlescopic retractor was placed in the right fl ank region 
directly through the abdominal wall for retraction of the 
gallbladder infundibulum in an anterior and cephalad 
direction.
Results: Patient all had a pathologic diagnosis of acute and 
chronic cholecystitis. ASA class averaged 1.46 (range 1 to 
2). Operative times averaged 47.5 minutes (range 28 to 86 
minutes). Postoperative hospital stays averaged 2.9 days.
Conclusions: Operative times and incidence of complica-
tions for Single incision cholecystectomy with a single 
needlescopic instrument are within acceptable range and safe 
for both acute and chronic gallbladder disease. Thus, it can 
be recommended as a safe alternative procedure in elective 
LC.
A-105
THE RECURRENT TUMOR IN THE 
ANASTOMOTIC SITE ORIGINATED 
FROM BILE DUCT CANCER WITH 
EXTENSIVE INTRAEPITHELIAL SPREAD 
MIGHT SHOW PARTIALLY 
SARCOMATOUS CHANGE AND POOR 
OUTCOME
K. Teramura, E. Tanaka, K. Kato, J. Matsumoto, 
T. Tsuchikawa, T. Shichinohe and S. Hirano
Hokkaido University Graduate School of Medicine, 
Sapporo, Japan
Introduction: We report a case of recurrent cancer of the 
extrahepatic bile duct, with intraepitherial cancer spread.
Methods and Results: A 72-year-old male underwent hilar 
bile duct resection for upper bile duct cancer with extensive 
superfi cial spread. Pathological examination revealed posi-
tive surgical margins in the cut ends of both hilar and 
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duodenal side because of the extensive intraepitherial cancer 
spread. Postoperative chemotherapy was performed by 
Gemcitabine. Three years after the fi rst operation, follow-up 
CT scan pointed out a huge mass extended from liver 
segment 7 to inside of the jejunum through the anastomotic 
site. It was diagnosed with anastomotic recurrence of the bile 
duct cancer may be caused by residual intraepithelial cancer 
cells. The second operation, right hemihepatectomy with 
caudate lobectomy and resection of hilar anastomotic site 
were performed three years after fi rst surgery. The tumor in 
the surgical specimen looked like dumbbell shape, and path-
ological examination showed undifferentiated carcinoma 
with sarcomatous change, so-called “carcinosarcoma”. 
Multiple liver and lung recurrent tumors appeared rapidly 
after second surgery. It was generally considered that the 
latent period to the tumor recurrence should be long after 
surgery with positive bile duct margin(s) because of intraepi-
therial cancer spread as we previously reported. In this case, 
it was quite unusual that the recurrent tumor had a sarcoma-
tous change and an aggressive nature and was detected in a 
relatively short interval after surgery.
Conclusions: A close follow-up after surgery may be needed 
in the case of positive ductal margins even caused by intra-
ductal cancer spread.
A-106
PERCUTANEOUS CHOLECYSTOSTOMY 
(PCT) – INDICATIONS AND SHORT AND 
LONG TERM OUTCOMES
A. Marioud, S. Pandanaboyana, S. Barker and R. Ram
HPB Unit, Auckland City Hospital, Auckland, NewZealand
Introduction: This study aimed to review a series of con-
secutive PCT’s to analyze the long term outcomes.
Methods: All consecutive patients who underwent PCT 
between 2000–2010 were reviewed retrospectively for indi-
cations, complications, and short and long term outcomes.
Results: 53 underwent PCT. 58% of patients were ASA III 
and 34% ASA 1V. The median duration of symptoms was 1 
day (range 1–35). 63% (33/53) had caluculous cholecystitis, 
whilst 37% (20/53) had acaluculous cholecystitis. 7% (4/53) 
had gallbladder perforation. 82% (43/53) had USS guided 
drainage while 18% had CT guided drainage. The median 
time to PCT from admission was 3 days.
The median hospital stay was 15.5 days (range 7–120). 13% 
(7/53) patients developed complications including bile leaks 
(n = 5), 1 hemorrhage and 1 duodenal fi stula. The inhospital 
mortality was 18%. 34% (18/53) of patients eventually had 
a cholecystectomy. 4/18 were done on the index admission 
with the majority undergoing a interval cholecystectomy. 
6/18 (33%) had a laparoscopic cholecystectomy and a major-
ity of patients required conversion to open cholecystectomy 
(77%). 22% (13/53) patients were readmitted with recurrent 
cholecystitis during follow-up. 13/53 (24%) had repeated 
PCT. The median time to representation was 151 days 
(2–510).
Conclusions: Only a small fraction of patients undergoing 
PCT proceed to a cholecystectomy. The risk of conversion 
to an open procedure is high and should be emphasized 
during the consent. A quarter of patients present with recur-
rent cholecystitis requiring a repeat PCT during follow up.
A-107
AMOEBIC LIVER ABSCESS: OUR 
EXPERIENCE
H. Hunaid, S. Rajinder, A. Devbrata, J. Saurabh 
and J. Rajeeev
T.N Medical College & B.Y.L. Nair Charitable Hospital, 
Mumbai, India
Introduction: Intestinal protozoa have gained importance 
due to increasing world travel. Entamoeba histolytica is the 
most prevalent protozoa in India and tropical countries that 
causes Amoebiasis. It invades the intestinal mucosa and may 
spread to other organs, mainly the liver and manifests as 
Amoebic liver abscess (ALA).
Aim: To analyze cases of ALA with respect to age and 
gender distribution, risk factors, clinical features, role of CT 
scan, optimal treatment options and mortality.
Material and Methods: Prospective analysis of 421 con-
secutive cases over a 6 year period from 2004 to 2010.
Results: Commonly affected age group 31 to 40 years 
(42%); youngest patient 16 years, oldest 70 years; common 
in males (98.3%) and in those with alcohol abuse and HIV 
infection. Pain (92.6%) and Fever (85.5%) were the com-
monest symptoms. Right hypochondrium (RHC) tenderness 
(85.5%) and tender hepatomegaly (82.2%) were commonest 
signs. On Ultrasonography assessment, solitary liver abscess 
was seen in 75.5% cases. In 24.5% multiple liver abscesses 
CT scan was done in case of equivocal diagnosis. All patients 
were treated by a combined pharmacological and radiologi-
cal approach which involved aspiration or percutaneous 
catheter drainage (PCD). Study highlighted the effi cacious 
role of therapeutic intervention when combined with phar-
macotherapy. 2 patients expired due to ruptured abscess in 
peritoneal and pericardial cavity respectively.
Conclusion: Radiological intervention, along with pharma-
cotherapy, when routinely used helps in expediting recovery.
A-109
SALVAGE LIVER TRANSPLANT 
STRATEGY FOR CIRRHOTIC PATIENTS 
WITH RESECTABLE HCC TREATED 
WITH PRIMARY RESECTION IN THE 
ERA OF SEVERE ORGAN SHORTAGE
M. Bhandari, M. Brooke-Smith, P. Dolan, R. Padbury 
and J. Chen
HPB Unit, Flinders Medical Centre, South Australian 
Liver Transplant Unit, Adelaide, Australia
Introduction: Recurrence is the most frequent cause of 
treatment failure after hepatocellular carcinoma (HCC) 
resection. Salvage liver transplantation (SLT) is an alterna-
tive treatment for recurrent HCC. With the current shortage 
of liver grafts, advocating primary liver transplantation for 
patients with early HCC associated with compensated cir-
rhosis will increase waiting time of transplantation and 
further increases the chance of dropout.
Methods: Due to organ shortage and long waiting time, a 
SLT strategy was adopted for all resectable HCC cases since 
2004. This study was undertaken to evaluate the implications 
of such strategy.
Results: From July 2004 to January 2011, 14 patients 
(age range 42–63 y & M:F 12:2) were eligible for liver 
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transplantation according to the Milan criteria underwent 
liver resection of small HCC. At median follow up of 20 (3 
to 54) months, four patients developed recurrent HCC. Two 
patients with microvascular invasion (MVI) had early recur-
rent metastatic HCC were excluded from salvage transplan-
tation. The other two were placed on SLT waiting list. One 
had a successful liver transplantation and the other under-
went further resection and declined SLT. The remaining 10 
patients are under surveillance have no evidence of recur-
rence disease. These patients had a median follow-up of 39 
months of post resection follow-up without recurrence.
Conclusion: Resection and followed by SLT for recurrent 
HCC appeared to be a good selection strategy in the era of 
severe organ shortage. This result demonstrated that those 
with recurrence were in either the poor prognostic group 
(early recurrence with MVI) for transplantation or were suc-
cessfully transplanted or resected.
A-110
CLINICOPATHOLOGICAL PROFILE OF 
PANCREATIC NEUROENDOCRINE 
TUMORS: AN INSTITUTIONAL 
EXPERIENCE
K. S. Bhushan, N. Murali, B. Vijay kumar, N. bheerappa 
and R. A. Sastry
Nizam’s Institute of Medical Sciences, Hyderabad, India
Introduction: Pancreatic Neuroendocrine tumors are 
uncommon with reported incidence of <1 per 100000/Year. 
Non-functioning tumors comprise a substantial proportion 
(25–100%) with majority (65–80%) being advanced at the 
time of diagnosis.
Aim: To analyze the Clinico-Pathological Profi le of 
Pancreatic Neuroendocrine tumors.
Methods: During the Study period, January 2005–January 
2011, case records from a prospectively maintained database 
of the Department of Surgical Gastroenterology, NIMS were 
reviewed. From the 33 Gastro-entero-pancreatic NET’s 
17 Pancreatic NET’s were listed for analysis. Clinico-
pathological and imaging features, surgical options and com-
plications of these patients were analyzed. All categorical 
variables are described in absolute numbers and results were 
expressed as mean, median, range and percentages.
Results: Pancreatic NET’s constituted 51.5% of GEP-
NET’S. Mean age of incidence is 44.93 yrs (19 yrs–78 yrs). 
Male to female ratio is 3 : 2.3. Pain was the predominant 
symptom (41%). Giddiness (23%), jaundice (15%), syncope 
(15%) were less common. All underwent a CT-scan with 
EUS in 4 patients. Imaging could not localize the lesion in 
3 patients. Majority are non-functioning (76.47%) with all 
functional tumors being Insulinoma (4pts). Well differenti-
ated tumors were common (GradeII-8pts). Enucleation in 4, 
distal pancreatectomy in 3 and pancreatico-duodenectomy in 
6 patients was performed. Post-op complications occurred 
only in 3 patients (23%), PF in 2, PPH in 2 and SSSI in 1 
patient.
Conclusions: Pancreatic NET’s constitute most of GEP-
NET’S with majority (76%) being non-functional. Most 
NET’s are well differentiated with 29% malignancy rate. 
Combined CT and EUS have an accuracy of nearly 82%. 
Morbidity and mortality rates remain low following resec-
tional procedures and hence should be considered.
A-111
A RETROSPECTIVE STUDY OF SINGLE 
INCISION LAPAROSCOPIC AND 
NEEDLESCOPIC CHOLECYSTECTOMY 
– WHICH PROCEDURE IS LESS PAIN 
AND LESS INVASIVENESS?
A. Umezawa, T. Yamaguchi, Y. Seki, T. Shiraishi, 
Y. Negishi, K. Kasama and Y. Kurokawa
Yotsuya Medical Cube, Tokyo, Japan
Introduction: Both needlescopic cholecystectomy (NSCL) 
and single incision laparoscopic cholecystectomy (TANKO) 
have been reported to be safe and feasible. This study com-
pared clinical outcomes in order to determine if there is an 
advantage of any of these procedures.
Methods: 30 patients with gallstone disease underwent 
TANKO. Of them, consecutive 24 patients (b-TAN) had 
received transversus abdominis plane block (TAP) by anes-
thetist at the end of procedure. Other 6 patients had not 
received TAP (nb-TAN). Another 34 patients who received 
NSCL in the same period were divided into two groups, 23 
with TAP (b-NS) and 11 without TAP (nb-NS). We retrospec-
tively reviewed the data including operative time, usages of 
analgesic drugs, CRP, WBC, and the length of the hospital 
stay.
Results: Operative time showed signifi cantly longer (p < 
0.01) in nb-TAN (116.3 min) than NSCL (nb-NS: 56.7, 
b-NS: 54.0). Also b-TAN showed longer operative time 
(84.7 min) than b-NS (p < 0.01). Though the usages of anal-
gesic drugs showed no signifi cant differences, the interval of 
time between the end of the operation and usage of analgesic 
drugs was signifi cant shorter in nb-NS (107 min) than in 
b-TAN (244) and b-NS (279) (p = 0.01, p < 0.01). CRP 
showed a signifi cant difference (p < 0.01) between b-TAN 
(1.1) and b-NS (0.5). The length of the hospital stay showed 
no difference.
Conclusion: Both TANKO and NSCL with TAP showed 
good pain control, and there was no difference in the usages 
of analgesic drugs. Although TANKO required longer opera-
tive time, invasiveness and the length of hospital stay were 
same in both procedures.
A-112
SINGLE INCISION LAPAROSCOPIC 
SURGERY (SILS) FOR HEPATIC 
HYDATID DISEASE
I. Karabicak, S. Yuruker, D. Seren, T. Kesicioglu and 
N. Ozen
Ondokuz Mayis University, Samsun, Turkey
Introduction: Surgical treatment is the gold standard for 
management of hepatic hydatid disease. Laparoscopic peri-
cystectomy combines the advantages of radical surgical 
resection with those of minimally invasive surgery. For better 
cosmetic appearance efforts aiming to reduce incision of lap-
aroscopic surgery has been thought recently. For this purpose 
single-incision laparoscopic surgery (SILS) has gained sig-
nifi cant momentum in different fi elds of surgical practice.
We report the fi rst closed total pericystectomy for hepatic 
hydatid disease managed by SILS.
Material and Method: A 76 year-old female presented with 
a long-time history of nonspecifi c abdominal pain. An USG 
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and MRI demonstrated a 5 cm hydatid cyst in between 
segment 2 and 3.
Result: A 2.5 cm umbilical incision was used for the place-
ment of a special port, specifi cally designed for SILS. Three 
(One 10, and two 5 mm) trocars were used. The operating 
fi eld was isolated with gauzes to prevent any contamination 
in cases of rupture. Pericystectomy was performed using 
ultrasonic shears (Harmonic Scalpel, Ethicon) with the resec-
tion made through healthy live parenchyma adjacent to the 
pericyst. The specimen was delivered in a plastic bag by 
enlarging the incision. A single drain was placed. The proce-
dure lasted 70 minutes. No perioperative complications 
occurred.
Conclusion: This is the fi rst reported SILS hydatid disease 
case, demonstrating that even advanced surgical procedures 
can be performed using the SILS technique in well-experi-
enced centers. Transumbilical single incision laparoscopic 
pericystectomy is feasible and can be performed safely in 
experienced centers.
A-113
BENEFICIAL EFFECTS OF INCHINKOTO, 
A HERBAL MEDICINE, AGAINST THE 
STRESS OF MAJOR LIVER SURGERY
Y. Yokoyama, K. Kawai, T. Kokuryo, K. Watanabe, 
T. Kitagawa and M. Nagino
Nagoya University Graduate School of Medicine, 
Department of Surgery, Division of Surgical Oncology, 
Nagoya, Japan
Introduction: Inchinkoto (ICKT), a herbal medicine, has 
been empirically used as a hepatoprotective agent. We sought 
to determine whether this agent has a benefi cial effect on the 
outcome of major liver surgery through human and animal 
studies.
Methods: In human study, ICKT was preoperatively admin-
istered for the patients who were planned to undergo major 
hepatectomy due to biliary malignancy. The liver samples 
were harvested during hepatectomy and the expression of 
antioxidant genes were investigated by PCR array. In animal 
study, Wistar rats were divided into three groups: simple 
laparotomy and 70% hepatectomy (Hx), ischemia/reperfu-
sion (IR; clamp of hepatoduodenal ligament for 15 min) 
and subsequent 70% Hx with vehicle treatment (IRHxV), 
IR and subsequent 70% Hx with ICKT treatment. Vehicle 
or ICKT was administered for 3 days preoperatively. Rats 
were sacrifi ced 1 h after Hx. Serum transaminase levels 
and the gene expression of infl ammatory cytokines, and 
inducible nitric oxide synthase (iNOS) in the remnant liver 
were determined.
Results: In human study, ICKT pretreatment increased the 
expression of antioxidant genes in the liver. In rat study, the 
elevation of serum transaminase levels, the upregulation of 
infl ammatory cytokines and iNOS in the remnant livers of 
the IRHxV group were all signifi cantly attenuated by preop-
erative administration of ICKT in the IRHxK group. The 
expression of antioxidant genes was also higher in the 
IRHxK group compared with that of the IRHxV group.
Conclusions: Preoperative administration of ICKT pro-
vides benefi cial effects through attenuating infl ammatory 
responses and oxidative stress in the liver following IR and 
subsequent Hx.
A-114
REDO-LAPAROSCOPIC LONGITUDINAL 
PANCREATICOJEJUNOSTOMY IN A 
PATIENT WITH PREVIOUSLY FAILED 
OPEN MODIFIED PEUSTOW’S 
PROCEDURE
G. Srikanth, N. Shetty, S. Kumar and G. Shenoy
BGS Global Hospitals, Institute of Gastroenterology, 
Bangalore, India
Introduction: Single incision laparoscopic cholecystec-
tomy (SIL Cholecystectomy) is a relatively new approach in 
management of gall stone disease. We present our experience 
with SIL cholecyetectomy for the diffi cult gall bladder.
Methods: A 20 year old lady with recurrent episodes of 
upper abdominal pain since 4 years with history of undergo-
ing open pancreaticojejunostomy 2 years before. There was 
recurrence of pain from the immediate post-operative period. 
CECT abdomen showed features of chronic pancreatitis with 
dense stone load in the head, distal body and tail. The main 
pancreatic duct was 1.5 cms and there was no evidence of 
local complications. Peroperatively a Roux limb was noted 
in the lesser sac with short segment PJ in the tail region, 
extensive fatty replacement of pancreas, dense stone load in 
the head and tail region and main pancreatic duct of 1.5 cms. 
Operative video of the redo laparoscopic longitudinal pan-
creaticojejunostomy is presented.
Results: The post operative period was uneventful except 
for low output pancreatic fi stula which settled and she was 
discharged on 7th postoperative day. At one month followup 
she remains asymptomatic.
Conclusions: Redo-laparoscopic pancreaticojejunostomy is 
feasible and safe in a carefully selected patient with chronic 
calcifi c pancreatitis following previous failed attempt at open 
surgery.
A-115
LIVER METASTASIS FROM 
ADRENOCORTICAL CANCER – 
SURGERY CAN HELP
B. M. Patel, R. Bryant and N. A. O’Rourke
Royal Brisbane and Women’s Hospital, Brisbane, Australia
Introduction: Adrenocortical carcinoma is a rare tumor 
with variable survival statistics. Long term survival after 
resection of liver metastases is occasionally reported. We 
would like to report on 4 liver resections in 3 patients with 
good medium term outcomes and one important histologic 
misdiagnosis.
Methods: We reviewed three patients from our liver resec-
tion database. All had undergone resection of liver tumors in 
the setting of a previously resected primary tumor of the 
adrenal cortex. Case 1. A 48 yo male underwent an R0 resec-
tion of an 8 cm left adrenal primary. 8 years later a 3 cm 
lesion in segment 4B was detected and resected in a non 
anatomic fashion with clear margins. Histology suggested 
Focal Nodular Hyperplasia (FNH). 10 years later, he repre-
sented with a 12 cm tumor in the right lobe. This was posi-
tive on PET scan and solitary. Laparoscopic trans hepatic 
biopsy suggested metastasis from well differentiated adreno-
cortical carcinoma. This was confi rmed after uneventful right 
hepatectomy, although immune-phenotyping was needed to 
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exclude a primary hepatic lesion. Histologic review of the 
previous “FNH”, showed identical features! He is alive 
without disease 3 months later.
Case 2. A 37 yo female underwent R0 resection of a 10 cm 
left adrenal primary. 18 months later 3 large liver metastases, 
5–9 cms in size were detected on follow up and she under-
went an uneventful extended R0 right hepatectomy. She 
remains well and disease free at 12 months follow up.
Case 3. A 52 yo female presented with an 18 cm primary 
left adrenocortical carcinoma, which was resected. A syn-
chronous 3 cm secondary tumor in segment 6 was observed 
for 3 months and then resected with a posterior sectionec-
tomy. She is alive with nodal and lung mets at 30 months 
despite adjuvant Mitotane chemotherapy.
Conclusion: Long term survival is possible in some patients, 
following resection of liver metastases from adrenocortical 
cancers. The histology can be confusing and immunohisto-
chemistry is recommended.
A-117
EXTENDING THE BOUNDARIES OF 
LAPAROSCOPIC AND OPEN LIVER 
RESECTION FOR HEPATOCELLULAR 
CARCINOMA
M. Basedow, R. Bryant and N. O’Rourke
Royal Brisbane and Women’s Hospital, Brisbane, Australia
Introduction: Liver resection is the best available treatment 
for hepatocellular carcinoma in patients not suitable for 
transplantation. However options for resection are limited by 
the regenerative capacity of the remnant liver, particularly 
where extended or bilateral resections are required. Strategies 
to improve the remnant volume include portal vein emboliza-
tion and staged resections.
Methods: We review a series of three patients undergoing 
extended and staged resections for hepatocellular carcinoma. 
Analysis of the suffi ciency of the expected liver remnant 
included the degree of fi brosis or presence of cirrhosis, 
Child-Pugh score, volumetric measurement of the remnant 
liver, indocyanine green clearance and response to portal 
vein embolization.
Results: Patient1. 58 male with cirrhosis secondary to 
alcohol. HCC segment 6 (3 cm) and segment 2 (2.5 cm). 
The patient underwent a laparoscopic segmentectomy 6 
and two months later underwent a second stage laparo-
scopic left lateral sectionectomy (home day 3 both 
admissions).
Patient2. 29 male with chronic hepatitis B and F2 
fi brosis. HCC right liver (15 cm, multifocal) and segment 
4 (6 cm). The patient underwent right portal vein embo-
lization followed by trans-arterial chemo-embolization to 
segment 4 with a subsequent extended right hepatectomy. 
(home day 7).
Patient3. 50 male with chronic hepatitis B. Large and 
multifocal HCC right liver and segment 4. Volumetric analy-
sis and surgical planning enabled an extended right hepatec-
tomy with suffi cient liver remnant (home day 9).
No patients developed postoperative hepatic insuffi ciency.
Conclusion: Extended and staged liver resections are an 
option for the surgical management of hepatocellular carci-
noma. Patients must be carefully selected by assessment of 
the regenerative capacity of the remnant liver.
A-118
MESENCHYMAL STEM CELLS RESTORE 
CCL4-INDUCED LIVER INJURY BY AN 
ANTIOXIDATIVE PROCESS
K-A. Cho1, S-Y. Woo1, J-Y. Seoh1, H-S. Han3 
and K-H. Ryu2
Departments of 1Microbiology and 2Pediatrics, Ewha 
Womans University School of Medicine, Ewha Medical 
Research Center, Seoul, Korea; Department of 3Surgery, 
Seoul National University College of Medicine, Seoul, 
Korea
BM-derived mesenchymal stem cells (MSCs) have been 
studied in the treatment of liver injury. We hypothesized that 
MSC-mediated resolution of liver injury could be caused 
through an antioxidative process. After being injected with 
carbon tetrachloride (CCl4), mice were injected with syn-
genic bone marrow (BM)-derived MSCs or normal saline. 
Oxidative stress activity of the MSCs was determined by 
analysis of reactive oxygen species (ROS) and superoxide 
dismutase (SOD) activity. In addition, cytoprotective genes 
of liver tissue were assessed by real time PCR and an anti-
oxidant response element (ARE) reporter assay. Upregulated 
ROS of CCl4 treated liver cells were attenuated by cocultur-
ing of MSCs. Blockage of SOD by adding an SOD inhibitor 
decreased the effect of MSCs on injured liver cells. MSCs 
caused a signifi cant increase in SOD activity and inhibited 
ROS production in injured liver. The gene expression levels 
of heme oxygenase-1, BI-1, hepato growth factor, glutathi-
one S-transferases, and nuclear factor erythroid 2-related 
factor 2, attenuated by CCl4, were increased up to basal 
levels after MSC transplantation in real time PCR. Also, 
MSCs were able to induce an antioxidant response element, 
luciferase activity, which represented a cytoprotective 
response in injured liver.
Our results give evidence of a new cytoprotective effect, 
in which MSCs promote an antioxidant response, and support 
the potential of using MSC transplantation as an effective 
treatment modality in liver disease.
A-119
CHANGE OF NUTRITIONAL INDEX, 
PANCREAS FUNCTION AND QUALITY 
OF LIFE AFTER PANCREATECTOMY: 
PROSPECTIVE STUDY
J. W. Park, J-Y. Jang, E-J. Kim, M. J. Kang, I. W. Han 
and S-W. Kim
Departments of Surgery, Seoul National University College 
of Medicine, Seoul, Korea
Introduction: Pancreatectomy is major treatment modality 
for various pancreas and periampullary diseases. But still 
there are a few studies concerning with change of nutritional 
index, pancreas function and quality of life after pancreatec-
tomy with regular interval follow up.
Methods: From 2007 to 2011, we analyzed 158 consecutive 
pancreatectomy patients. Relative body weight (RBW), 
Triceps skinfold thickness (TSFT), Serum protein/albumin, 
transferrin, fasting blood sugar (FBS), Oral glucose tolerance 
test (oGTT), HbA1c, EORTC QLQ-C30 questionnaire were 
collected serially (preoperative, postoperative, 3 month, 6 
month, 12 month).
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Results: RBW (107.7, 102.0, 101.0, 102.8, 103.6; respec-
tively preoperative, postoperative, 3-month, 6-month, 
12-month) TSFT (13.3, 13.0, 12.0, 12.5, 12.3) recover at 
6-month, whereas transferrin, albumin, protein recover at 3 
month. DM or impaired fasting glucose (IFG)/impaired 
glucose tolerance (IGT) recover slowly to 12-month (34.8, 
69.4, 63.7, 50.8, 53.9; % of total numbers). Also steatorrhea 
decrease slowly (31.5, 37.5, 35.2, 31.9, 27.8%). Global 
health status/QoL and functional scales recover to preopera-
tive score at 3 month and improve to higher than preoperative 
score (61.7, 41.2, 63.4, 67.4, 71.3). Multivariate analysis 
reveals extensive operation, adjuvant therapy have signifi -
cant impact on nutritional index, pancreas function and 
quality of life (p < 0.05)
Conclusions: Nutritional index, pancreas function and 
quality of life recover at 3 month and 6 month after pancre-
atectomy. Patients with extensive operation, adjuvant therapy 
need more careful follow-up and supportive management.
A-121
CLINICAL VALIDATION OF ISGPF FOR 
POSTOPERATIVE PANCREATIC FISTULA
D. G. Chhabra, K. Sutariya, R. C. Shah and P. Jagannath
Lilavati Hospital and Research Centre, Mumbai, India
Objective: To validate the clinical signifi cance of Pancreatic 
Fistula (PF) defi ned by ISGPF (International Study Group 
for Pancreatic Fistula) and Strasberg’s classifi cation of 
Pancreatic Anastomotic failure and its impact on manage-
ment after pancreaticoduodenectomy (PD) in a HPB spe-
cialty surgical unit.
Background: Both, the ISGPF and Strasberg et al have 
proposed a retrospective classifi cation for postoperative PF 
based on clinical parameters; however both have not been 
rigorously validated.
Methods: Between March 2006 and October 2010, 90 
patients underwent PD with a duct-to-mucosal pancreatico-
jejunostomy with an abdominal drain. Drain fl uid amylase 
(DFA) was measured on postoperative day (POD) 3 and 7 in 
all patients and on POD 10 in patients with elevated levels 
(>thrice serum value) on POD 7. PF was defi ned by ISGPF 
and Strasberg’s criteria. The outcomes including pancreas 
related complications were analyzed.
Results: POD 3 DFA diagnosed 31% patients with 
ISGPF-PF (n = 28) as against 15.5% (n = 14) on POD 7 DFA. 
14/28 patients showed normal DFA values within 4 days 
without any change in management and outcome. Strasberg’s 
criteria identifi ed 14 (15.5%) patients with PF similar to 
latter group of ISGPF. These 14 patients labeled as ISGPF 
Grade B (n = 12) and C (n = 2) were better categorized by 
Strasberg’s grades (3 Grade 1, 9 Grade 2, 1 Grade 3b, 1 
Grade 4a). ISGPF Grade A especially if defi ned by POD 3 
DFA (n = 14) had no clinical relevance and misleading.
Conclusions: DFA estimation on POD 7 is clinically more 
relevant and avoids unnecessary diagnosis of PF by ISGPF 
(biochemical/transient/Grade A) for patients with no change 
in clinical course. Our study validates that the Strasberg’s 
grading system better than the ISGPF classifi cation for 
management.
A-122
EARLY VS LATE MORTALITY IN ACUTE 
PANCREATITIS: ANALYSIS OF 180 
PATIENTS
M. K. Hinduja, T. D. Yadav, R. Kochhar, R. Singh 
and K. Mahesh
PGIMER, Chandigarh, India
Introduction: Despite all efforts to make an early diagnosis 
and timely intervention, mortality is still high in patients with 
severe acute pancreatitis.
Methods: All patients dying of AP between 2004 and 2008 
were retrospectively analyzed for demographics, duration of 
AP, lab parameters, APACHE II score, pancreatic necrosis 
and need for surgery/ postoperative complication.
Results: In 180 patients (12–80 yr, 122 males), etiology of 
AP was alcohol (52.8%), gallstones (31%) and trauma 
(10%). 33% of deaths occurred early and 67% late. The 
primary cause of death was organ failure in 102 patients and 
sepsis in 73 patients. Comorbidities (p = 0.001), elevated 
serum creatinine (p = 0.001), blood glucose (p = 0.003), low 
pH (p = 0.001) and high base defi cit at admission were sig-
nifi cantly associated with early death. Number of organ 
failure at admission and presence of any organ failure were 
associated with early death (p = 0.001). Only 16.6% of 
patients had been operated in the early death group as com-
pared to 64.2% in the late death group. Multiorgan failure 
was the commonest cause of death in early death group and 
sepsis in the late death group. Of the 102 deaths due to sepsis 
19 (18.6%) were early deaths and 83 (81.3%) were late 
deaths. Of the 73 patients who died of organ failure 40 (59%) 
had early death and 32 (41%) had late death. On multivariate 
analysis, the only predictor of early death was the number of 
organ failure at admission.
Conclusions: Number of organ failures at admission pre-
dicts early mortality in patients with AP. Sepsis is responsible 
for most late deaths.
A-123
CLINICAL OUTCOMES IN DISTAL 
PANCREATECTOMY. ASSOCIATION OF 
DRAIN USAGE AND FISTULA 
FORMATION
A. M. Fox1, K. Pitzul2, F. D. Bhojani2, M. Kaplan2, 
A. C. Wei2, C. A. Moulton2, P. Greig2, B. Taylor2, 
S. P. Cleary2 and A. Okrainec2
1Department of Hepatobiliary Surgery, St Vincent’s 
Hospital Melbourne, Australia; 2Department Department 
of General Surgery, University Health Network, Toronto, 
Canada
Introduction: The purpose of this study is to compare 
short-term clinical outcomes including pancreatic fi stula rate 
associated with laparoscopic or open distal pancreatectomy 
with and without use of an operative drain.
Methods: We evaluated all distal pancreatic resections per-
formed at our center between January 2004 and March 2010. 
Non-parametric statistical analysis was used to compare 
oncologic and surgical outcomes.
Results: A total of 133 cases were identifi ed, 50 laparo-
scopic (including 10 converted cases), and 83 open resec-
tions. Operative drains were placed laparoscopically in 84% 
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(n = 42) and open 69% (n = 57) (P = 0.09) Post operative 
pancreatic fi stulae occurred in 26 (20%) patients. Pancreatic 
fi stula by group: laparoscopic 28.57% (n = 14) and open 
14.46% (n = 12) (P = 0.049). Pancreatic fi stulae by Grade A, 
B or C: 13, 1 and 0 laparoscopic. 4, 7 and 1 for open group. 
(P = 0.004) Pancreatic fi stula by use of drain: Used 26% (n 
= 26) not used 0% (n = 0). (P < 0.001) Of the patients who 
did not have a drain placed at the initial operation (n = 34) 
there were no fi stulae or collections that required drainage 
or signifi cantly extended hospital stay.
Conclusions: This series has shown a trend towards lower 
rates of clinically signifi cant pancreatic leak in cases where 
drains were not placed at the time of surgery. This series 
provides early preliminary data which may infl uence future 
study into technical aspects of laparoscopic pancreatic tran-
section techniques and the use of drains.
A-124
BILIARY FISTULA FOLLOWING LIVER 
RESECTION: CAUSATIVE FACTORS AND 
OUTCOMES
S. Mahesh, B. Venugopal, A. Venugopal, M. A. Wani, 
S. A. Rather, B. Abraham, K. P. Manjuraj and H. Ramesh
Lakeshore Hospital & Research Center, Cochin, Kerala, 
India
Introduction: Bile leaks occur after liver resection in 
2–15% of cases and add considerably to postoperative 
morbidity.
Patients and Methods: 112 consecutive patients, 72 males, 
40 females, with ages ranging from 1 to 77 years (median 
55 years) underwent liver resection during a 5 year period. 
56 underwent major resections (>3 segments) and 56 minor 
resections. 22 underwent additional bile duct resection with 
reconstruction by hepaticojejunostomy. Patients were divided 
into two groups: a) those that had bile leak, and b) those 
without bile leak. Analysis of factors correlating with biliary 
leak was made by univariate and multivariate techniques 
using chi square, or Mann Whitney test and by binomial 
logistic regression (SPSS version 17).
Results: 8 patients had postoperative bile leak (7.14%). 2 
patients in this group were cirrhotic. Univariate analysis 
revealed bilirubin levels, biliary reconstruction and blood 
loss to be signifi cant factors. On multivariate analysis biliary 
reconstruction was alone signifi cant. 4/8 patients with bile 
leak were managed with percutaneous drainage, two required 
endoscopic biliary stenting, and one patient underwent lapa-
rotomy and drainage of bile collection. 2 patients required 
prolonged retention of intraoperatively placed drains. 
Majority of leaks settled within 3 months. 3/8 patients are 
alive and are on follow up and one of these patients has been 
diagnosed to have a recurrent HCC.
Conclusions: Incidence of bile leaks in the post liver resec-
tion setting in our group is 7.14%. Biliary reconstruction 
signifi cantly increased leak rates. Majority of the bile leaks 
following liver resections can be managed non operatively.
A-125
THE ROLE OF FAT AND FIBROSIS IN 
PANCREATIC TEXTURE AND IN THE 
INCIDENCE OF POSTOPERATIVE 
PANCREATIC FISTULA
R. A. Sastry, T. Venumadhav, N. Bheerappa 
and S. G. Uppin
Nizam’s Institute of Medical Sciences, Hyderabad, India
Introduction: Although soft pancreas is traditionally asso-
ciated with increased risk of pancreatic fi stula, the histologi-
cal features of soft and hard pancreas have not been clearly 
defi ned. The aim of the study was to analyze the role of fat 
and fi brosis in pancreatic texture with particular reference to 
soft pancreas and in the incidence of postoperative pancreatic 
fi stula.
Methods: 59 patients underwent Whipples procedure of 
whom 13 (22%) developed pancreatic fi stula. The pancreatic 
texture was graded by the operating surgeon as soft (20) or 
hard (39). Histological sections from the pancreatic neck 
were graded (0–4) for intralobular fat, interlobular fat, total 
fat and fi brosis. The amount of pancreatic fat and fi brosis 
was correlated with the softness of pancreas identifi ed at 
surgery. The infl uence of fat and fi brosis on postoperative 
pancreatic fi stula was analyzed. The infl uence of other 
factors on the amount of fat and fi brosis was also studied.
Results: Soft pancreas was identifi ed as a signifi cant risk 
factor (OR 10.8; CI 2.55–45.8; p = 0.001) for pancreatic 
fi stula. Soft pancreas had more fat (p = 0.08) and less fi brosis 
(p = 0.09) when compared with hard pancreas. Negative 
correlation existed between fat and fi brosis (R = −0.148; p = 
0.19). Intralobular fat (p = 0.001), interlobular fat (p = 0.13), 
total fat (p = 0.03) and fi brosis (p = 0.017) were found to be 
signifi cant in development of pancreatic fi stula. Incidence of 
pancreatic fi stula in patients with total fat score >1 was 40% 
whereas in patients with score ≤1 it was 12.8% (p = 0.02). 
No patient developed pancreatic fi stula with fi brosis score 
>1. Fatty pancreas was more common with advanced age. 
Fibrosis was more common in smokers (p = 0.09) and 
chronic pancreatitis (p = 0.01). Undilated pancreatic duct 
(PD < 3 mm) was more common in fatty pancreas (p = 0.04).
Conclusions: Soft pancreas was associated with increased 
amount of fat and less amount of fi brosis. Pancreatic fat and 
fi brosis play a signifi cant role in development of pancreatic 
fi stula.
A-126
DUODENAL INVOLVEMENT ON 
IMAGING IN GALLBLADDER CANCER: 
HOW ACCURATE? HOW SIGNIFICANT?
R. Kalayarasan1, A. Javed1, S. Puri2, A. S. Puri3, P. Sakhuja4 
and A. K. Agarwal1
1Department of GI Surgery, GB Pant Hospital & MAM 
College, New Delhi; 2Department of Radiology, GB Pant 
Hospital & MAM College, New Delhi; 3Department of 
Gastroenterology, GB Pant Hospital & MAM College, New 
Delhi; 4Department of Pathology, GB Pant Hospital & 
MAM College, New Delhi
Introduction: Duodenal involvement on imaging is often 
taken as sign of inoperability in patients with gall bladder 
cancer (GBC). This study was undertaken to assess the 
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accuracy of duodenal involvement on imaging and to ascer-
tain its surgical implications.
Methods: Study group included patients with evidence of 
duodenal involvement on contrast enhanced computed 
tomography (CECT) abdomen from a prospectively col-
lected database of operated GBC patients between August 
2009 and March 2011. The accuracy of CT scan for detecting 
duodenal involvement and resectability was assessed in these 
patients.
Results: One hundred and seventy six of 318 patients 
assessed during the period were considered operable. Of 
these, 74 had duodenal involvement on imaging. Thirty three 
of these had symptoms suggestive of duodenal involvement. 
Upper gastrointestinal endoscopy (UGIE) revealed duodenal 
infi ltration in 16 patients, extrinsic compression in 35 & 
normal endoscopy in 23 patients respectively.
Thirteen patients underwent staging laparoscopy alone. Of 
the 61 patients who underwent laparotomy 31 had actual 
duodenal involvement [Positive predictive value of CECT 
abdomen = 50.82% (31/61)]. Thirty three patients underwent 
a curative resection [resectability rate – 44.59% (33/74)]. 
Resectability rate in symptomatic and asymptomatic (for 
duodenal obstruction) patients were 36.36% (12/33) and 
51.21% (21/41) respectively (p = 0.24). Resectability rate in 
patients with evidence of duodenal infi ltration on UGIE 
[18.75% (3/16)] was signifi cantly less compared to patients 
either extrinsic compression [54.28% (18/35)] or normal 
endoscopic fi nding [52.17% (12/23), p < 0.001]. A signifi -
cantly higher number of patients with endoscopic evidence 
of duodenal infi ltration had a metastatic disease [68.75%, 
(11/16)] compared to those with an extrinsic bulge or a 
normal endoscopy (36.20% (21/58); p = 0.02).
Conclusion: CECT abdomen had an accuracy of 50.82% in 
detecting duodenal involvement in the study. Infi ltration of 
the duodenal mucosa on UGIE and symptoms of duodenal 
obstruction in these patients signifi cantly decrease the resect-
ability in these patients, however does not preclude 
resection.
A-127
ROBOTIC 
PANCREATICODUODENECTOMY – 
PRELIMINARY RESULTS
K-H. Chen, Y-D. Chen, S-D. Chen, K-H. Cheng, 
S-H. Huang and S-H. Chu
General Surgery, Department of Surgery, Far-Eastern 
Memorial Hospital
Introduction: Minimally invasive pancreatic surgery is an 
evolving fi eld in HPB surgery. Although technique demand-
ing, some series of laparoscopic pancreatoduodenectomy had 
been published. In da Vinci robotic surgical system, more 
freedom of working angle has been observed and may 
improve surgical dissection. However, robotic pancreatoduo-
denectomy has been reported only until recently.
Materials and Methods: From July 2010 to June 2011, we 
used the da Vinci robotic surgical system to perform pancre-
aticoduodenectomy for 7 patients with benign or malignant 
pancreatic head lesions. The patients included 4 male and 3 
female. Age ranged from 48 y/o to 67 y/o. Surgical indica-
tions included pancreatic head cancer in 4, periampulary 
cancer in 2 and head serous cystadenoma with obstructive 
jaundice in 1. Four robotic arm technique was used in all 
patients. Another one to two assistant ports were also needed 
to assist the procedure.
Results: All procedures were completed under the da Vinci 
robotic surgical system except in one patient with pancreatic 
head cancer which invading the portal vein. Open conversion 
with portal vein resection was necessary in that patient. The 
operation time ranged from 630 min to 870 min. Estimated 
blood loss ranged from 50 to 300 c.c. The postoperative 
hospital stay ranged from 13 to 33 days. The wound pain was 
typically minimal especially after days 5. Postoperative 
evaluation of the amylase/lipase level revealed pancreatico-
jejunostomy leakage in 3. One of the three patients needed 
percutaneous drainage of intraabdominal abscess.
Conclusion: Our preliminary experience of robotic pancre-
aticoduodenectomy using da Vinci robotic surgical system 
showed possible clinical benefi t regarding wound size, 
wound pain and wound complications. The physical activity 
recovery seemed also fastened. However, larger control 
studies are necessary to demonstrate the true benefi ts.
A-128
LAPAROSCOPIC RESECTION OF GIANT 
LIVER HEMANGIOMA USING 
LAPAROSCOPIC 4× HABIB PROBE FOR 
PARENCHYMAL TRANSECTION
G. Srikanth and N. Shetty
BGS Global Hospitals, Institute of Gastroenterology, 
Bangalore, India
Introduction: Experience with laparoscopic liver resections 
is limited. Laparoscopic resection of a variety of liver lesions 
has been reported and is considered appropriate for lesions 
in the left lateral segment and inferior segments of right lobe. 
Herein, we present an operative video of a 52-year-old male 
patient who underwent a laparoscopic resection of giant right 
lobe liver hemangioma.
Methods: A 45 years old male patient with no known 
medical risk factors presented to the out patient department 
with complaints of right upper quadrant pain restricting his 
regular activity. A multi-detector Computerized tomography 
(MDCT) of the abdomen showed a giant hemangioma (18 
cm in greatest diameter) arising from the segment 5 and 6 of 
liver. The feeding vessel to the hemangioma was from the 
anterior branch of right hepatic artery. Operative video dem-
onstrates the resection performed in fi ve distinct steps. Liver 
parenchymal transection was aided with the use of laparo-
scopic 4 × Habib probe.
Results: The operative time was 220 minutes and blood loss 
was around 50 cc. Patient was started orally the same evening 
and discharged from hospital on the third postoperative day. 
He had no postoperative complications. At three months 
follow-up he was asymptomatic.
Conclusions: Laparoscopic resection is feasible in giant 
liver hemangiomas located in the inferior segments of right 
lobe of liver. Careful preoperative planning with MD CT 
imaging facilitated intraoperative dissection. Laparoscopic 4 
× Habeeb probe is an important tool in the armamentarium 
of liver transection methods.
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A-129
SAFE AND FEASIBLE EXTRAHEPATIC 
GLISSONEAN ACCESS IN 
LAPAROSCOPIC ANATOMICAL LIVER 
RESECTION
H. Arimitsu, A. Cho, H. Yamamoto, O. Kainuma, T. Ota, 
S. Park and H. Yanagibashi
Chiba Cancer Center, Chiba, Japan
Introduction: Recent rapid developments in technological 
innovations, improved surgical techniques and the accumula-
tion of extensive experience by surgeons have improved the 
feasibility and safety of laparoscopic liver surgery. However, 
laparoscopic anatomical liver resection remains a highly spe-
cialized fi eld, as major technical diffi culties remain, such as 
hilar dissection and pedicle control.
Methods: During open anatomical liver resections, each 
Glissonean pedicle is often ligated and divided en bloc extra-
hepatically before parenchymal dissection. We describe 
herein a novel technique by which each Glissonean pedicle 
can be easily and safely encircled and divided en bloc extra-
hepatically during laparoscopic anatomical liver resection.
Results: A total of 115 Glissonean pedicles could be encir-
cled en bloc extrahepatically, as planned. No serious compli-
cations, including major bleeding or injury of the portal triad, 
were encountered during procedures.
Conclusion: Extrahepatic Glissonean access appears feasi-
ble and safe for laparoscopic anatomical resection of the 
liver.
A-130
SINGLE PORT ASSISTED ANTERIOR 
RESECTION AND LEFT LATERAL 
SECTIONECTOMY FOR SIGMOID 
COLON CANCER WITH LARGE LIVER 
TUMOR
S. Iyer, T. W. V. Lee and K. Madhavan
National University Health System, Singapore
Introduction: This case illustrates feasibility of single port 
surgery for sigmoid colectomy and left lateral sectionectomy. 
A 72-year old man was diagnosed to have locally advanced 
Sigmoid CA with bladder invasion and single 8 cm metasta-
sis to liver.
Methods: Three 5 mm ports were inserted directly through 
the rectus sheath at the umbilicus under direct vision. 
Laparoscopy showed locally advanced sigmoid tumor invad-
ing bladder. Intraoperative ultrasound was done replacing 
5 mm port with 10 mm which showed 8 cm tumor in left 
lateral segment. Pre-curved laparoscopic instruments and 
5 mm Ligasure were used for dissection. Left colon was 
mobilized and Inferior mesenteric vessels were secured with 
ties and divided. The tumor was dissected with cuff of 
bladder. The falciform ligament and left triangular ligaments 
were taken down; liver transection line was marked with 
ultrasound guidance. Liver transection done with ligasure 
and infl ow pedicle and outfl ow pedicles were divided with 
vascular staplers. The liver specimen was placed in endobag. 
A 7 cm Pfannensteil incision was made; bladder cuff was 
closed in 2 layers. Distal rectal transection and proximal 
colon transections were done using staplers. End to end anas-
tomosis was done using intraluminal stapler.
Results: The operative time was 315 minutes and the blood 
loss was 330 mls. Hospital stay was 1 week and patient made 
uneventful recovery. Histology showed moderately differen-
tiated adenocarcinoma with clear margins. Liver specimen 
showed 8 cm hepatocellular carcinoma and a small focus of 
metastasis.
Conclusion: This video illustrates feasibility of single port 
combined colon and liver resection.
A-131
TOTAL LAPAROSCOPIC LEFT 
HEPATECTOMY USING HILAR 
GLISSONEAN PEDICLE TRANSACTION
T. Ota, A. Cho, H. Yamamoto, O. Kainuma, 
S. Paku, H. Yanagibashi and H. Arimitsu
Division of Gastroenterological Surgery, Chiba Cancer 
Center
Introduction: Recently, laparoscopic liver resection has 
surprisingly developed and become widely accepted as a 
superior alternative to conventional open hepatectomy.
Methods: We describe herein a total laparoscopic left hepa-
tectomy using hilar Glissonean pedicle transaction.
Surgical procedure
1) Encircling the hepatoduodenal ligament to be used as a 
tourniquet for complete interruption of blood infl ow to 
the liver if necessary.
2) Mobilization of the left lateral section.
3) Dividing the ligamentum venosum.
4) Encircling the left Glissonean pedicle left to the left 
caudate branch using an Endo Retract Maxi retracting the 
round ligament upwards. Clamping the left pedicle makes 
a demarcation line apparent on the liver surface.
5) Parenchymal transaction along the middle hepatic vein.
6) Left Glissonean pedicle transaction using laparoscopic 
stapler.
7) Dividing the left hepatic vein using laparoscopic stapler.
Results: A total laparoscopic left hepatectomy using hilar 
Glissonean pedicle transaction could be performed, as 
planned. No serious complications, including major bleeding 
or injury of the portal triad, were encountered during 
procedures.
Conclusion: Although our experience is limited and ran-
domized study to elucidate appropriate indications and 
effects of the present procedure is necessary, we believe that 
total laparoscopic left hepatectomy using hilar Glissonean 
pedicle transaction can be feasible, safe, and effective in 
highly selected patients.
A-132
LAPAROSCOPIC LIVER RESECTION 
ASSISTED BY A BIPOLAR 
RADIOFREQUENCY DEVICE
C. Kyriakides, M. Pai, A. Frampton, N. A. Habib 
and L. R. Jiao
HPB Surgery Hammersmith Hospital, Imperial College 
London, London, UK
Introduction: In recent years the progress of laparoscopic 
procedures and the development of new and dedicated 
technologies have made laparoscopic hepatic surgery fea-
sible and safe. In spite of this laparoscopic liver resection 
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remains a surgical procedure of great challenge because of 
the risk of massive bleeding during liver transection and 
the complicated biliary and vascular anatomy in the liver. 
We present our technique of laparoscopic liver resection 
using this device in a patient with colorectal liver metastases 
(CLM).
Methods: A patient with CLM in the left lobe underwent 
laparoscopic left lateral segmentectomy assisted the laparo-
scopic HabibTM 4× . This is a bipolar radiofrequency device 
consisting of a 2 × 2 array of needles arranged in a rectangle. 
It is introduced perpendicularly into the liver, along the 
intended transection line. It produces coagulative necrosis of 
the liver parenchyma sealing biliary radicals and blood 
vessels and enables bloodless transection of the liver 
parenchyma.
Results: The length of procedure was 125 minutes whilst 
the resection time was 50 minutes. Blood loss was minimal 
and patient did not receive blood transfusion. Patient was not 
admitted to intensive care unit following surgery. He was 
discharged on the 4th post-operative day and had no post-
operative complications.
Conclusions: Laparoscopic liver resection can be safely 
performed with laparoscopic HabibTM 4 × with a signifi -
cantly low risk of intra-operative bleeding or postoperative 
complications.
A-133
RIGHT HEPATECTOMY WITH PORTAL 
VEIN TUMOR THROMBECTOMY FOR 
HEPATOCELLULAR CARCINOMA
K. H. Kim, D. B. Moon, T. Y. Ha, D. H. Jung, S. W. Jung, 
Y. H. Park and H. W. Park
Asan Medical Center, Ulsan University, Seoul, Republic of 
Korea
Recent progress in imaging techniques has allowed the diag-
nosis of HCC at an early stage. However, portal venous 
invasion is still found in 12.5–39.7% of patients with HCC. 
A median survival is only 9.7 weeks for untreated patients 
with HCC and main portal vein tumor thrombus. According 
to our data, a hepatectomy with portal vein tumor thrombec-
tomy gave help to increase the survival rate in selected 
patients with acceptable hepatic functional reserve. In here I 
report my case by a video clip. 51 year-old male patient with 
HBV and HCC was admitted for surgery. The patient’s 3D 
CT scan showed about 10 sized mass involving right poste-
rior section and right portal vein tumor thrombus reached the 
bifurcation area. The important thing of this surgery was to 
remove the portal vein tumor thrombus safely and prevent 
going into the left portal vein of tumor thrombus during 
hepatectomy. The left glissonean pedicle and hepatoduode-
nal ligament were identifi ed and taped and the right portal 
vein was dissected and taped selectively. The exposed right 
portal vein was incised in order to remove tumor thrombus 
around the bifurcation area after tightening of the left glis-
sonean pedicle and hepatoduodenal ligament. The opened 
right portal vein was closed on both sides using Prolene 6–0 
and the hepatic parenchyma were transected using a Pringle’s 
maneuver, exposing middle hepatic vein. The operative time 
was 225 mins and estimated blood loss was less than 800 ml. 
There was no complication and the patient was discharged 
on postoperative day 12.
A-134
LONG TERM SURVIVAL ANALYSIS OF 
PURE LAPAROSCOPIC VERSUS OPEN 
HEPATECTOMY FOR LIVER CANCER
T. T. Cheung, T. R. Poon, W. K. Yuen, S. H. Chok, C. Y. 
Chan, C. M. Lo and S. T. Fan
Department of Surgery, The University of Hong Kong, 
Queen Mary Hospital, Hong Kong, China
Introduction: Laparoscopic liver resection is a safe and 
effective approach to the management of liver cancer. 
However, long term outcome concerning the tumors recur-
rence and patient survival is still limited. The aim of this 
study is to analyze the survival outcome of laparoscopic liver 
resection.
Method: Between October 2002 and September 2009, total 
46 patients had undergone pure laparoscopic liver resection. 
Case matched control (n = 92) patients who had received 
open liver resection were included for comparison. Patients 
were matched in term of cancer stage, tumor size, location 
of tumor and magnitude of resection. The immediate opera-
tion outcome and survival outcome and long term stage spe-
cifi c survival analysis were compared.
Results: Amongst laparoscopic liver resection (n = 46), 14 
patients had liver resection for liver metatstasis, 32 patients 
had liver resection for hepatocellular carcinoma (HCC). 
Amongst the 92 patients who had matched tumor character-
istic for the laparoscopic counterpart, 28 patients had liver 
resection for liver metastasis, 64 patients had liver resection 
for HCC. Comparing laparoscopic group to open resection 
group, the median operation time was 195 minutes vs 207 
minutes P = 0.597, the median blood loss was 150 ml vs 
300 ml (P = 0.0004). Hospital stay was 4 days vs 7 days 
(P < 0.0001), post operative complication was 3 (6.5%) vs 
12 (13%) (P = 0.246), disease free survival was 53.2 months 
vs 21.9 months (P = 0.074) and the median survival was 92 
months vs 57.9 months (P = 0.179).
Conclusion: Laparoscopic liver resection is associated with 
less blood loss, shorter hospital stay, and shorter operation 
time in selected group of patients with no compromise to 
survival.
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A-135
RECURRENCE AND POOR PROGNOSIS 
FOLLOWING RESECTION OF SMALL 
HEPATITIS B-RELATED 
HEPATOCELLULAR CARCINOMA 
LESIONS ARE ASSOCIATED WITH 
ABERRANT TUMOR EXPRESSION 
PROFILES OF GLYPICAN 3 AND 
OSTEOPONTIN-MICROARRAY ANALYSIS
M. C. Yu1,2, C. W. Lee1, S. E. Lin4, T. C. Chen5, Y. S. Lee3, 
C. N. Tsai2 and M. F. Chen1
1Department of Surgery, Chang Gung Memorial Hospital, 
Linkou, Taoyuan, Taiwan; 2Graduate Institute of Clinical 
Medical Sciences, Chang Gung University, Taoyuan, 
Taiwan; 3Genomic Medicine Research Core Laboratory, 
Chang Gung Memorial Hospital, Taoyuan, Taiwan; 
4Department of Pathology, Taipei Medical University 
Hospital, Taipei, Taiwan; 5Department of Pathology, 
Chang Gung Memorial Hospital, Chang Gung University, 
Taoyuan, Taiwan
Backgrounds: Early detection of hepatocellular carcinoma 
(HCC) is still the gold standard for good outcome for HCC 
patients; nevertheless, a small portion of Hepatitis B virus 
(HBV)-related small HCC (<5 cm) patients got poor prog-
nosis. Therefore, aim of this study was to explore potential 
genetic signature for HBV-related small HCC as novel prog-
nostic factors.
Methods: We examined expression profi les of HBV-related 
small HCC using an Affymetrix U133A GeneChip, evaluated 
differential gene expression by quantitative real-time poly-
merase chain reaction (qRT-PCR) and fi nally validated these 
expression patterns by immunohistochemistry.
Results: Of total 57 genes were differentially expressed 
between tumor and normal parts by using Affymetrix U133A 
chip, and 16 genes were further evaluated by qRT-PCR. The 
result was compatible with the fi nding of oligonulceotide 
microarray (Pearson’s correlation, r = 0.87). Furthermore, the 
expression pattern in HCC tissue by immunohistochemistry 
in another groups of small HBV-HCC (n = 100) showed 
over-expression of either OPN or GPC3 is an independent 
prognostic factor for disease-free survival (DFS) in HBV-
positive small HCC (p < 0.01 and = 0.03; respectively).
Conclusions: Patients with over-expression of OPN or 
GPC3 carried high risks of recurrence and might benefi t from 
more aggressive treatment and more intensive follow-up 
regimens.
A-136
AETIO-PATHOGENESIS AND 
MANAGEMENT OF SPONTANEOUS 
LIVER BLEEDING IN THE WEST: A 16 
YEAR SINGLE CENTER EXPERIENCE
D. Tsapralis, N. Battula, A. Takhar, D. Mayer, J. Isaac, 
P. Muiesan, R. P. Sutcliffe, R. Marudanayagam, 
D. F. Mirza and S. R. Bramhall
Liver unit, Queen Elizabeth Hospital, Birmingham, United 
Kingdom
Introduction: Spontaneous liver bleeding (SLB) is a rare 
but potentially life threatening complication of liver diseases. 
In contrast to the East, various benign pathologies are the 
source of SLB in the West. The clinical signs are usually non 
specifi c but a timely implementation of appropriate treatment 
is crucial, we present our experience with SLB.
Methods: Retrospective analysis of patients presented with 
SLB between Jan 1995 & Jan 2011.
Results: 67 had SLB, the median age at presentation was 
47 years and majority were (66%) female. Upper abdominal 
pain was the main symptom (97%), 8 (12%) presented with 
hypovolemic shock. Contrast-enhanced computed tomogra-
phy of the abdomen was the investigation of choice. The 
etiology for SLB was hepatic adenoma in 27 (40%) and 
hepatocellular carcinoma (HCC) in 17 (25%). Apart from 2 
(3%) cases of metastatic colorectal adenocarcinoma rest 
were a mixture of several benign liver lesions. Emergency 
treatment included conservative approach in 42 (64%), coil 
embolization in 6 (9%), laparotomy and packing in 6 (9%) 
and liver resection in 11 (16%) patients. Following initial 
stabilization and discharge 11 (16%) had further planned 
treatments. Seven (10%) died during the same admission but 
the peri-operative mortality was the highest (75%) in patients 
with HELLP syndrome. At a median follow-up of 54 months 
all with benign disease are alive. The 1, 3 and 5 year survival 
of patients with HCC was 59%, 35% and 17%.
Conclusions: SLB is a life-threatening complication of 
various underlying conditions. The management should 
include initial hemostasis followed by appropriate staging 
investigations to provide a defi nitive treatment for each indi-
vidual case.
A-137
SURVIVAL ANALYSIS OF PATIENTS 
UNDERGOING TRANSARTERIAL 
CHEMOEMBOLIZATION FOR 
HEPATOCELLULAR CARCINOMA. A 
PROSPECTIVE COHORT STUDY
K. M. Eltawil1, R. Berry2, S. De Coutere3, M. Abdolell4 
and M. Molinari1
1Department of Surgery, Queen Elizabeth II Health 
Sciences Center, Dalhousie University, Halifax, Nova 
Scotia, B3H 2Y9, Canada; 2Section of Vascular and 
Interventional Radiology, Department of Diagnostic 
Radiology, Queen Elizabeth II Health Sciences Center, 
Dalhousie University, Halifax, Nova Scotia, B3H 2Y9, 
Canada; 3Canadian Centre for Vaccinology, IWK Health 
Centre, Halifax, Nova Scotia, B3K 6R8, Canada; 
4Department of Diagnostic Radiology and Division of 
Medical Education, Dalhousie University, Halifax, Nova 
Scotia, B3H 2Y9, Canada
Introduction: Despite advancement in the treatment of 
hepatocellular carcinoma (HCC), a great proportion of 
patients are eligible only for palliative therapy due to 
advanced stage or poor hepatic reserve. The use of 
Transarterial chemoembolization (TACE) for palliation of 
unresectable HCC has shown a survival benefi t in European 
and Asian populations. The aim of this study was to assess 
the effi cacy of TACE by analyzing the overall 5-year sur-
vival, tumor size, and serum alpha Feto-protein (AFP) levels 
of a prospective North American cohort.
Methods: From September 2005 to December 2010, 46 
candidates for TACE were enrolled in this study and under-
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went at least one session. Data on their tumor response, AFP 
and survival were prospectively collected every 3–4 months.
Results: For most of the patients, there seemed to be a 
disease-stabilizing effect on the tumor size together with 
non-signifi cant reduction in AFP levels in the fi rst 9 months 
only. The overall survival at 1, 3 and 5 years were 72, 28 and 
12% respectively. Patients affected by a single HCC vs. 
multifocal disease or by involvement of one lobe vs. both 
lobes had signifi cant better survival rates after TACE (P < 
0.05). Multivariate analysis revealed that, AFP levels and 
MELD scores were considered potential predictors of long 
term survival (P = 0.02, P = 0.04 respectively).
Conclusions: TACE is an effective palliative intervention 
for unresectable and non-ablatable HCC that provides 
improved survival in comparison to best supportive care. 
Most patients tolerated TACE well and clinicians need to 
consider survival predictors when planning their manage-
ment strategies.
A-138
IMPACT OF TREATMENT MODALITY 
AND NUMBER OF LESIONS ON 
RECURRENCE AND SURVIVAL 
OUTCOMES AFTER TREATMENT OF 
COLORECTAL CANCER LIVER 
METASTASES
A. Saxena, T. Chua, F. Chu, K. M. Ng, P. Herle, A. Sarkar, 
J. Zhao and D. Morris
University of New South Wales, Sydney, Australia
Background: Ablative strategies have been used to treat 
and facilitate hepatic resection (HR) in patients with other-
wise unresectable colorectal liver metastases (CLM). We 
evaluated the effi cacy of HR, concomitant HR and ablation 
and isolated ablation on recurrence and survival outcomes 
after treatment of CLM in patients with 1–4 and ≥5 lesions, 
respectively.
Methods: A retrospective review of a prospectively col-
lected hepatobiliary surgery database was performed on 
patients who underwent treatment for isolated CLM between 
1990 and 2010. Pre-operative and treatment characteristics 
were compared between patients who underwent HR, con-
comitant HR and ablation and ablation alone. The impact of 
treatment modality on survival and recurrence outcomes was 
determined.
Results: 701 patients met inclusion criteria; 550 patients 
(78%) had 1–4 lesions and 151 patients (22%) had ≥5 lesions. 
Overall median survival for the entire cohort was 35 months 
with 5- and 10- year survival of 33% and 20%, respectively. 
Overall median and 5-year recurrence-free survival (RFS) 
was 13 months and 21%, respectively. For patients with 1–4 
lesions, median survival was 37 months with 5-year survival 
of 36%. Stratifi ed by procedure type, 5-year survival was 
41% in patients who underwent HR, 35% in patients who 
underwent concomitant HR and ablation and 13% in patients 
who underwent ablation alone (p < 0.001). For patients with 
≥5 lesions, median survival was 28 months with 5-year sur-
vival of 23% without difference between treatment groups 
(p = 0.078).
Conclusion: HR appears to be the most effective strategy 
for patients with 1–4 lesions. When ≥5 lesions are present, 
ablative strategies are useful in facilitating hepatic resection 
in otherwise unresectable patients.
A-140
THE ROLE OF CAUDATE LOBECTOMY 
IN TYPE IIIA & IIIB HILAR 
CHOLANGIOCARCINOMA: A 15-YEAR 
EXPERIENCE IN A TERTIARY 
INSTITUTION
A. W. C. Kow1, D. W. Choi2, S. C. Song2, W. S. Kim2, 
M. J. Kim2, J. S. Heo2 and S. H. Choi2
1Department of HPB and Liver Transplantation, University 
Surgical Cluster, National University Health System, 
Singapore; 2Department of Surgery, Samsung Medical 
Center, Sungkyunkwan University School of Medicine, 
Seoul, South Korea
Background: Concomitant liver resection for Type III hilar 
cholangiocarcinoma could improve the R0 resection rate and 
long term outcome. In this study, we examine the specifi c 
role of caudate lobectomy in liver resection for Type IIIA & 
IIIB hilar cholangiocarcinoma and the prognostic factors for 
survival in this group of patients.
Methods: We reviewed all patients with Type IIIA & IIIB 
hilar cholangiocarcinoma who underwent liver resection in 
Samsung Medical Center from January 1995 to July 2010. 
Patients were divided into those with and without caudate 
lobectomy (CL). Logrank test and Cox regression analysis 
was employed to investigate for prognostic factors of 
survival.
Results: There were 127 patients in this cohort, with 57 
patients (44.9%) without CL and 70 patients (55.1%) with 
CL. The demographics and symptoms of presentation were 
comparable. The median preoperative bilirubin level was 
signifi cantly higher in the group with CL performed (p = 
0.017). Patients with CL had a signifi cantly better overall 
survival (OS) (CL: 64.0 months vs Without CL: 34.6 months) 
(p = 0.010) and disease-free survival (DFS) (CL: 40.5 months 
vs Without CL: 27.0 months) (p = 0.031). Multivariate analy-
sis showed that presence of symptoms (p = 0.025) and posi-
tive LN metastasis (p < 0.001) were negative prognostic 
factors for OS. Furthermore, multivariate analysis for DFS 
found that caudate lobectomy (p = 0.016) and positive LN 
metastasis (p = 0.001) were positive and negative prognostic 
factors respectively.
Conclusion: Caudate lobectomy contributed to improve-
ment of DFS and OS in Type III hilar cholangiocarcinoma. 
Other prognostic factors include positive LN metastasis and 
presence of symptoms.
A-141
CLINICOPATHOLOGIC FEATURES AND 
PROGNOSTIC FACTORS OF COMBINED 
HEPATOCELLULAR AND 
CHOLANGIOCARCINOMA: 
COMPARATIVE ANALYSIS WITH 
HEPATOCELLULAR CARCINOMA AND 
CHOLANGIOCARCINOMA
S. D. Lee, S-J. Park, S-S. Han, S. H. Kim, Y. H. Ko 
and E. K. Hong
Center for Liver Cancer, National Cancer Center, 
Goyang-si, Gyeonggi-do, Republic of Korea
Introduction: We evaluated the clinicopathologic features 
and long-term prognosis of HCC-CC and compared those 
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with hepatocellular carcinoma (HCC) and cholangiocarci-
noma (CC).
Methods: The clinicopathologic features, survival rates, 
and prognostic factors of 45 patients who underwent surgery 
for HCC-CC at the National Cancer Center, Republic of 
Korea during 2003–2010 were retrospectively analyzed and 
compared with those of 90 HCC and 45 CC patients who 
were matched with their sex, Child classifi cation, and AJCC 
6th stage.
Results: There were signifi cant differences in clinicopatho-
logic factors among HCC-CC, HCC and CC groups: HBsAg 
(+), normal AFP, normal CA 19–9, capsule formation, bile 
duct invasion, and cirrhosis. The overall survival rates at 1, 
3, and 5 years for HCC-CC group were 74.6%, 56.5%, and 
49.8%, respectively. Disease-free survival rates at 1, 3, and 
5 years for HCC-CC group were 47.9%, 30.3%, and 30.3%, 
respectively. The stage-matched comparison of overall sur-
vival and disease-free survival with HCC-CC group showed 
no signifi cant difference with those of CC group, but signifi -
cant poor outcomes with those of HCC group (overall sur-
vival; HR 1.34, p = 0.3336, and HR 0.53, p = 0.029, 
respectively: disease-free survival; HR 0.70, p = 0.194, and 
HR 0.61, p = 0.032, respectively). In multivariate analysis, 
intrahepatic metastasis was the only signifi cant prognostic 
factor for overall survival and disease-free survival in the 
patients with HCC-CC (HR 3.52, p = 0.017, and HR 7.62, 
p = 0.003, respectively).
Conclusions: Patients with HCC-CC showed similar clini-
copathologic feature with patients with HCC, but poor prog-
nosis similar with patients with CC. Intrahepatic metastasis 
was associated with poor survival and early recurrence.
A-142
COMPARATIVE ANALYSIS OF 
“REVERSE” VERSUS “CONVENTIONAL” 
STRATEGY FOR THE SURGICAL 
MANAGEMENT OF SYNCHRONOUS 
COLORECTAL LIVER METASTASES
M. Auguste, E. Vibert, D. Castaing, D. Azoulay, 
C. Salloum and R. Adam
AP-HP Hopital Paul Brousse, Centre Hepato-Biliaire, 
Villejuif, France
Introduction: Resection of CRLM prior that of colorectal 
tumor (reverse strategy) has been proposed as an alternative 
to the conventional strategy (primary resection then CRLM). 
The objective of this study was to compare the results of both 
strategies.
Methods: From 2006 to 2008, all patients resected from 
synchronous CRLM were included in a prospective database. 
Reversed strategy was mainly considered for advanced 
hepatic tumor disease with asymptomatic primary and con-
ventional one for the other patients. Groups were compared 
for pre- and perioperative fi ndings then outcome after 
surgery.
Results: Among 111 consecutive patients (pts) surgically 
treated for synchronous CRLM in the 2-year period, 93 pts 
(72%) had a Conventional strategy and 18 pts (28%) had a 
Reverse strategy. A higher maximal tumor diameter was 
demonstrated in the Reverse group (62 ± 66 vs 32 ± 25 mm 
– p = 0.0034) as well as a higher rate of severe morbidity: 
33% vs 12% (p = 0.003). Postoperative mortality was nil. A 
R0 resection was achieved in 12/18 (66%) pts of the Reverse 
group. After a similar follow up in the 2 groups (RS vs Conv: 
24 ± 13 vs 25 ± 13 months; p = 0.76), one and 3-year overall 
survival were 82% and 67% in the Reverse group vs 94% 
and 75% in the Conventional one (p = 0.10). After R0 resec-
tion, one and 3-year recurrence-free survival were 78% and 
57% vs 86% and 73% (p = 0.18), respectively. One and 
3-year recurrence rate was 26% and 55% vs 34% and 61% 
respectively (p = 0.58).
Conclusions: The «reverse strategy» provide a similar 
outcome compared to conventional strategy, despite a more 
advanced metastatic disease.
A-143
ENHANCED ANTI-TUMOR EFFECT OF 
COMBINATION THERAPY WITH 
GEMCITABINE AND GUGGULSTERONE 
IN PANCREATIC CANCER
D. W. Ahn1, J. K. Seo2, S. H. Lee3, J-H. Hwang3, 
J. K. Lee4, J. K. Ryu2, Y-T. Kim2 and Y. B. Yoon2
1Department of Internal Medicine, Seoul National 
University Boramae Medical Center, Seoul, Korea; 
2Department of Internal Medicine, Seoul National 
University College of Medicine, Seoul, Korea; 3Department 
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Introduction: Guggulsterone is a dietary plant sterone pos-
sessing therapeutic potential against cancers. However, the 
anti-tumor effect of this natural compound on pancreatic 
cancer has not been determined yet. This study was designed 
to investigate the therapeutic effi cacy of guggulsterone in 
pancreatic cancer.
Methods: In the current study, we examined the effect of 
guggulsterone on cell proliferation and apoptosis in pancre-
atic cancer cell lines, and then we investigated the mecha-
nisms responsible for the effect of guggulsterone. Finally, we 
investigated whether the combination of guggulsterone and 
gemcitabine had an additional therapeutic effect compared 
to gemcitabine single regimen in pancreatic cancer cell lines 
(in vitro) and in xenograft model using nude mice (in vivo).
Results: In vitro, the combination treatment resulted in 
more growth inhibition and apoptosis through the down-
regulation of NF-κB activity with suppression of Akt and 
BcL-2 and through the activation of JNK and Bax in pancre-
atic cancer cell lines. In vivo, the combination therapy aug-
mented tumor growth inhibition through the same mechanisms 
in tumor tissue.
Conclusions: The combination of gemcitabine and gug-
gulsterone enhanced anti-tumor effi cacy through apoptosis 
induction in pancreatic cancer.
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A-144
ACCURATE PREOPERATIVE 
LOCALIZATION OF INSULINOMAS 
AVOIDS THE NEED FOR BLIND 
RESECTION AND REOPERATION
B. K. Goh, L. L. Ooi, P. C. Cheow, Y. M. Tan, H. S. Ong, 
Y. F. Chung, P. K. Chow, W. K. Wong and K. C. Soo
Singapore General Hospital & National Cancer Center, 
Singapore
Introduction: Presently, the need for and choice of preop-
erative localization tests for insulinomas remain controver-
sial. We report the of our experience whereby the management 
policy adopted was that of accurate preoperative localization 
before surgery.
Methods: 17 patients with an insulinoma who underwent 
surgery were retrospectively reviewed.
Results: All tumors were localized preoperatively and an 
average of 2.2 preoperative localization studies including 1.4 
noninvasive studies and 0.8 invasive studies were utilized 
per patient. Invasive localization modalities were more sensi-
tive (92%) than noninvasive modalities in localizing insuli-
nomas (71%). Intra-arterial calcium stimulation with hepatic 
venous sampling was the most sensitive invasive modality 
(100%), whereas magnetic resonance imaging was the most 
sensitive noninvasive modality (63%). Fifteen of 17 tumors 
(88%) were localized intraoperatively via inspection/palpa-
tion and/or intraoperative ultrasonography. Both insulinomas 
which were not localized intraoperatively were localized cor-
rectly to the distal pancreas via preoperative transhepatic 
portal venous sampling. None of the patients required a blind 
resection or surgical reexploration for failed localization. All 
17 patients underwent complete surgical resection which 
included eight enucleations and nine distal pancreatectomies 
with a cure rate of 94% (16/17) at a median follow-up of 35 
(range, 1–217) months. The postoperative morbidity and 
long-term outcome of enucleation was similar to distal pan-
createctomy despite a higher rate of microscopic margin 
involvement.
Conclusions: Accurate preoperative localization of insuli-
nomas is useful as it eliminates the need for blind distal 
pancreatectomy and avoids reoperation.
A-145
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Introduction: Severe acute pancreatitis (AP) is associated 
with multiple organ dysfunction syndrome (MODS). 
Recently, mitochondrial dysfunction (MD) has been 
proposed as a key event in development of MODS in critical 
illness. Treatment to protect mitochondria may prevent or 
reduce early MD, reducing morbidity and mortality. This 
study aimed to evaluate the effi cacy of a novel specifi c mito-
chondrial treatment (MT01) in experimental AP.
Methods: AP was induced in male Wistar rats randomized 
into (I), saline control (II) AP control and (III) AP with MT01 
treatment groups. Animals were euthanized six hours after 
AP induction and their tissues and blood collected for analy-
sis. The primary endpoint was mitochondrial respiration 
(pmol/O2/mg protein/second), determined using high resolu-
tion respirometry (Oroboros Oxygraph, Graz, Austria), in 
tissue homogenates. Secondary endpoints included lipid per-
oxidation and severity of tissue injury by histology.
Results: Mitochondrial respiration was signifi cantly 
depressed in the pancreas, jejunum and lung (but not kidney, 
heart or liver) during untreated AP compared to saline con-
trols. In the jejunum and lung this occurred in absence of 
signifi cant histological changes. Treatment with MT01 
decreased mitochondrial dysfunction of jejunum, and lung, 
and increased mitochondrial respiration capacity in kidney 
during AP. The treatment was also associated with a decrease 
in serum lipid peroxidation markers.
Conclusion: MD occurs in the pancreas, jejunum and lung 
early in the course of AP and before histological evidence of 
tissue injury. In extra-pancreatic organs, mitochondrial dys-
function can be reduced by MT01. These fi ndings highlight 
a new therapeutic target at the organelle level for AP induced 
MODS.
A-146
POSTOPERATIVE PANCREATIC FISTULA 
AND FUNCTIONAL ASSESSMENT 
FOLLOWING TRANSGASTRIC 
PANCREATICOGASTROSTOMY IN 
MANAGING REMNANT SOFT 
PANCREAS; A SINGLE SURGEON 
EXPERIENCES
S. H. Choi, H. K. Hwang, C. M. Kang and W. J. Lee
Division of Hepato-Biliary-pancreas, Department of 
Surgery, Yonsei University College of Medicine, Seoul, 
Korea
Introduction: Pancreaticoenterostomy is an Achilles heel in 
managing remnant pancreas following pancreatic head resec-
tion or central pancreatectomy. As soft pancreas is known to 
be closely related to postoperative pancreatic fi stula, this 
issue must be a great challenge especially to novice young 
pancreatic surgeons.
Methods: Form January 2008 to December 2010, 77 
patients underwent transgastric pancreaticogastrostomy in 
managing soft remnant pancreas. Among them, 49 patients 
with 1-year follow up data were analyzed for nutritional 
and functional status based on clinically detectable 
parameters.
Results: 71 patients underwent pylorus-preserving pancre-
atoduodenectomy, central pancreatectomy in 4, and subtotal 
stomach-preserving pancreatoduodenectomy in 2 patients. 
Only 1 postoperative mortality unrelated to pancreaticogas-
trostomy (pneumonia sepsis) was noted. Postoperative com-
plications were noted in 35 patients (45.5%). Clinical 
relevant postoperative pancreatic fi stula (POPF, grade B) 
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was found in 18 patients (23.4%), and it prolonged postop-
erative hospital stay (17.3 ± 6.6 days vs. 25.4 ± 7.1 days, p 
< 0.001). All complications could be successfully managed 
conservatively without interventional radiologic approach. 
One-year follow-up morphologic assessment showed some 
atrophic change and dilated pancreatic duct in remnant pan-
creas (Δ thickness = −3.7 ± 4.7 mm, Δ pancreatic duct = 1.2 
± 2.9 mm, p < 0.05). There was signifi cant negative correla-
tion between Δ thickness and ratio of Δ pancreatic duct (R2 
= −0.097, p = 0.033), however, nutritional assessments 
including body weight, cholesterol, albumin, and body mass 
index were all acceptable comparing to preoperative values. 
Thirteen patients (13.6%) reported intermittent steatorrhea. 
Postoperative glucose control is solely dependent on preop-
erative reserve function of patients’ endocrine function (p < 
0.05).
Conclusions: Transgastric pancreaticogastrostomy is easy, 
safe and can be alternative surgical technique in managing 
remnant soft pancreas.
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ANALYSIS OF METHODS OF 
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Introduction: Benign liver tumors can be a diagnostic chal-
lenge. Hepatocellular adenomas (HCA) and focal nodular 
hyperplasia (FNH) can share similar radiological and even 
histological appearances. Recent work from Pathologists in 
Bordeaux (France) using Quantitative Reverse Transcriptase 
Polymerase Chain Reaction (RT-PCR) has lead to a reclas-
sifi cation of hepatocellular adenomas into three main sub-
types. Immunohistochemical markers can be applied to 
specimens to stratify risk of malignant transformation into 
Hepatocellular Carcinoma (HCC), which is thought to be 
much less than traditionally believed (about 16%).
Methods: New techniques in the histological diagnosis of 
hepatocellular adenomas will be adopted with retrospective 
histological examination of benign liver tumor biopsied and 
resected over a ten year period at Royal Brisbane & Women’s 
Hospital in collaboration with interested pathologists.
Results: Preliminary results from fi rst twenty patients 
re-classifi ed into subgroups according to Bordeaux 
classifi cation.
Conclusions: Trucut biopsy and subsequent Immuno-
histochemical (IHC) staining can subcategorize patients with 
hepatocellular adenomas into high and low risk of malignant 
transformation based on the presence of a beta-Catenin muta-
tion. We hope to improve outcomes of patients with benign 
liver tumors with the avoidance of surgery when not required 
and the reduction of costly surveillance.
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Introduction: Pancreatic visceral aneurysms and pseudoa-
neurysms are described following surgery, trauma and pan-
creatitis. Spontaneous occurrence is rare and infrequently 
cited, especially in a non-acute manner. Here we present 3 
patients with spontaneous rupture and review the literature.
Case Presentation: Two of the patients were admitted 
with hypovolemic shock secondary to spontaneous intra-
abdominal bleed. The 72 year-old woman required laparot-
omy on two occasions and suture ligation was successfully 
performed. Subsequent mesenteric angiography confi rmed 
cessation of bleeding and showed chronic dissection of the 
coeliac trunk. The 74 year-old man required multiple lapa-
rotomies and urgent pancreaticoduodenectomy, after angiog-
raphy had revealed persistent bleeding (and associated 
coeliac trunk stenosis). The third patient was a 26 year-old 
man presenting electively with a pancreatic head mass and 
history of anabolic steroid use. An ill defi ned solid and cystic 
mass was evident in the uncinate process which also involved 
the transverse colon mesentery. Pancreaticoduodenectomy 
and extended right hemicolectomy were performed. 
Histology revealed the presence of organized hematoma with 
associated false aneurysmal changes.
Conclusions: This report documents a rare series of 3 
patients with spontaneous rupture of pancreatic visceral 
aneurysm. There was confi rmed coeliac trunk pathology in 
two of patients with acute hemorrhage. Management of 
these patients is demanding and presents signifi cant clinical 
challenges to HPB surgeons as part of a multi disciplinary 
team.
A-149
THE ROLE OF CT CHOLANGIOGRAPHY 
IN THE MANAGEMENT AND DIAGNOSIS 
OF SUSPECTED BILE LEAKS POST 
CHOLECYSTECTOMY?
E. Kaplan1a, R. Udayasiri1a, M. Kirk2 and V. Usatoff1
1Department of Surgery, Alfred Hospital, Prahran, 
Australia; 2Monash Medical Centre, Clayton, Australia
aDenotes equal fi rst author
Introduction: To evaluate the diagnostic potential and clini-
cal utility of CT cholangiography in patients post cholecys-
tectomy with a suspected bile leak.
Most bile duct injuries are not recognized at the time of 
initial surgery. Optimal treatment of bile leak requires early 
recognition. CT IVC has become increasingly important in 
identifying bile leaks and their source after cholecystectomy. 
Our study aims to report the outcomes of using CT IVC post 
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operatively and how accurately it can detect bile leaks, duct 
injury, and retained stones prior to open laparotomy.
Methods:
Patients
From 2000–2009 twenty patients were managed for sus-
pected bile leak post cholecystectomy. The study included a 
retrospective evaluation of the initial procedure, presenting 
symptoms of the bile duct lesion, site of ductal injury, diag-
nostic procedures and therapeutic interventions. Information 
concerning the initial procedure was obtained from the 
patients’ medical records.
Data Collection
The prospective database kept by the Upper gastrointestinal 
surgical unit was investigated and all patients admitted with 
suspected bile leak between January 1st, 2000, and April 
2009 were investigated. Additionally we performed a retro-
spective review of all CT IVC completed.
The results of CT Cholangiography were analyzed retro-
spectively to determine technical success rate of the imaging 
procedure and to correlate imaging diagnosis with results of 
other diagnostic procedures and with clinical follow-up.
Results: The study patients included 20 patients who had a 
suspected bile leak. 3 bile leaks were detected at the time of 
surgery.
7 Patients had a CTIVC as their primary investigation. It 
identifi ed a bile leak in 6 patients, and the anatomical site in 
5 of these. 1 patient had a leak excluded by CTIVC and was 
successfully managed conservatively.
Conclusion: CT Cholangiography was used to investigate 
patients with suspected bile leaks post operatively in order 
to localize the leak, defi ne the anatomy and identify ductal 
stones. CT Cholangiography is a feasible tool for imaging of 
the biliary tract and the detection and localization of bile 
leak. It is a valuable non-invasive investigation that may help 
avoid endoscopic retrograde Cholangiography or surgery.
A-151
CLINICAL ANALYSIS OF 
EXTRAHEPATIC RECURRENCES OF 
HEPATOCELLULAR CARCINOMA 
AFTER CURATIVE HEPATIC RESECTION
E. H. Cho1, S. B. Kim1, J. Byeon1 and D. W. Choi2
1Korea Cancer Center Hospital, Seoul, Korea; 2Samsung 
Medical Center, Sungkyunkwan University School of 
Medicine, Seoul, Korea
Introduction: This study is performed to evaluate the 
pattern and clinicopathological features of extrahepatic 
recurrence of hepatocellular carcinoma (HCC) after curative 
hepatic resection.
Patients and Methods: From January 2000 to July 2009, 
307 patients underwent curative hepatectomy for hepatocel-
lular carcinomas in Korea Cancer Center Hospital, Seoul, 
Korea. During the follow-up period, 152 patients suffered 
recurrence of HCC. Recurred patients were divided into 
intrahepatic recurrence group (IHR, n = 111) and extrahe-
patic recurrence group (EHR, n = 41) according to the site 
of initial recurrence of HCC. We analyzed and compared the 
clinicopathological data between the two groups retrospec-
tively using medical records.
Results: Five year overall survival rate of 307 patients was 
65.1%. Five year overall survival rates were 49.9% in IHR 
group and 21.8% in EHR group (p = 0.006). In multivariate 
analysis, high alpha-fetoprotein level (>200 ng/ml) is the 
only independent high risk factor for extrahepatic recurrence 
of HCC. Frequent sites of extrahepatic recurrence of HCC 
are lung (n = 24), lymph nodes (n = 5), and bone (n = 4). 
Among EHR group, patients who received surgical resection 
for metastatic diseases tended to survive longer.
Conclusion: Careful follow up including chest evaluation is 
needed in early postoperative period for the patients who had 
high preoperative AFP level. Aggressive surgical manage-
ment for extrahepatic disease in selected cases can improve 
the survival of the patients.
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PANCREATODUODENECTOMY AND 
SUPERIOR MESENTERIC-PORTAL VEIN 
RESECTION: SAFETY AND EFFICACY
F. Wang1, R. Aranagam1, V. Puttaswamy2, M. Neale2, 
T. J. Hugh1 and J. S. Samra1
1Department of Gastrointestinal Surgery, Royal North 
Shore Hospital, Sydney, Australia; 2Department of Vascular 
Surgery, Royal North Shore Hospital, Sydney, Australia
Introduction: The surgical management of locally advanced 
periampullary malignancy with superior mesenteric-portal 
vein involvement is technically challenging. The aim of this 
study was to investigate the safety and outcomes of pancre-
atoduodenectomy with superior mesenteric-portal vein 
resection.
Methods: Retrospective review of 144 patients with peri-
ampullary tumor who underwent curative pancreatoduode-
nectomy (PD) with or without superior mesenteric-portal 
vein resection (VR) between January 2004 and June 2011 
was performed. Clinical data, operative results, pathological 
fi ndings and post-operative outcomes were analyzed.
Results: Fifty three (36.8%) patients underwent PD with 
VR (PD + VR); majority (96.2%) had pancreatic carcinoma. 
Duration of operation, volume of intraoperative blood loss 
and perioperative blood transfusion requirement were sig-
nifi cantly greater in the PD + VR group compared to patients 
without VR. Furthermore, signifi cantly higher rates of neu-
rovascular invasion (p = 0.009 and 0.01, respectively) and 
positive resection margin (p < 0.001) were noted in the PD 
+ VR group. However, there were no statistical differences 
in the length of hospitalization, postoperative morbidity and 
grades of complications. Multivariate logistic regression 
modeling identifi ed PD + VR, intraoperative blood loss and 
neural invasion as predictors of positive resection margin, 
while ASA score, blood loss and blood transfusion require-
ment were associated with increased postoperative 
morbidity.
Conclusions: Pancreatoduodenectomy with superior mes-
enteric-portal vein resection has comparable postoperative 
morbidity but is associated with increased duration of opera-
tion, intraoperative blood loss and positive resection margin.
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CARCINOMA
A. Gluer1, N. Cocco1, J. Laurence1, E. Johnston1,2, 
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Introduction: The 10-year actuarial survival of people with 
hepatocellular carcinoma (HCC) following liver resection 
ranges from 10.5% to 53.4%. Few papers report actual 
10-year survival. The aim of this systematic review was to 
quantify the 10-year actual survival of these patients.
Methods: The Medline, PubMed and Cochrane databases 
were searched for studies from January 1950 to April 2011 
using the keywords “hepatocellular carcinoma”, “hepatec-
tomy”, “liver resection” and “survival”. Additional papers 
were identifi ed by a manual reference search. Papers which 
stated the absolute number of patients alive after ten years 
were included. Case reports and case series of less than fi ve 
patients were excluded.
Results: Fourteen studies met the inclusion criteria. The 
total number of patients was 4803, 309 of whom survived 
for at least ten years. This corresponded to a 10-year actual 
survival of 6.4%. The mean patient age at study enrolment 
was 52 years and the median 54. Eighty-six percent of the 
patients were male and 79% had cirrhosis.
Conclusions: Actual 10-year survival after liver resection 
for HCC remains low and is lower than the actuarial survival 
reported in most surgical series. Transparent reporting of 
outcomes is required in order to inform both surgical deci-
sions and patient treatment preferences.
A-154
FLEXIBLE USAGE OF GEMCITABINE 
AND S-1 CAN IMPROVE THE OVERALL 
SURVIVAL OF PANCREATIC CANCER
H. Shimamura1, Y. Narushima1, S. Ishiyama1,2 
and K. Takeda1
1Department of Surgery, Sendai Medical Center, Sendai, 
Japan; 2Department of Surgery, Sendai Kosei Hospital, 
Sendai, Japan
Introduction: Here we report our treatment results of inva-
sive pancreatic carcinoma (IPC) by fl exible usage of gem-
citabine (GEM) and S-1.
Patients and Methods: 123 patients with IPC operated in 
our hospital between April 2001 and July 2010 were retro-
spectively reviewed. Among them, 88 cases underwent 
resection, whereas the rest underwent palliative operations. 
GEM was administered as the fi rst line adjuvant to most of 
the patients at the variable dosage according to their condi-
tion, in some cases at reduced doses, or in other cases 
biweekly. S-1 was mostly used as the second line, also with 
fl exibility. Overall survival (OS) was calculated by Kaplan-
Meier comparing between the chemotherapy (Chemo) group 
and non-chemotherapy (Non-chemo) group.
Results: In resection cases, 72 patients were classifi ed into 
Chemo group, and 16 into Non-chemo. OS of Chemo group 
was signifi cantly higher than that of Non-chemo group 
(MST: 20.7 M vs. 13.4 M). When limiting to Stage > 2A 
(UICC), Chemo group also obtained good result. In terms of 
curability, among Stage > 2A Chemo group, OS of R0 (no 
remnant tumor group) was signifi cantly higher than that of 
R1+2 (with micro- or macroscopically remnant tumor). In 
addition, OS of R1+2 was as bad as that of palliation group. 
We have had eleven 5-year survivors of IPC, all of whom 
were R0, and all but one Chemo group.
Conclusion: R0 resection with fl exible usage of GEM and 
S-1 can improve the overall survival of IPC.
A-155
PANCREATIC HEAD LESION: 
DILEMMAS AND SOLUTIONS
H. Hunaid, A. Devbrata, S. Rajinder, J. Saurabh 
and J. Rajeev
Department of Surgery, T.N Medical College & B.Y.L Nair 
Ch Hospital, Mumbai, India
Introduction: Differentiation between chronic pancreatitis 
and pancreatic cancer is a dilemma as 3% of cases with 
chronic pancreatitis harbor an occult malignancy and malig-
nancy can have focal pancreatitis.
Aim: To review nature of lesion to avoid misdiagnosis and 
form a diagnostic and therapeutic algorithm.
Methods: All cases of pancreatic head lesions (1999–2010) 
were analyzed clinically, using Ultrasonography and CT scan 
and treated. Tumor markers, MRI and EUS guided FNAC 
was done in selected cases.
Result: Of 293 cases included. 228 were suspected malig-
nancy while 56 were suspected chronic pancreatitis. Of 
the 228, 40 cases were resectable and underwent pancre-
atico-duodenectomy, 85 underwent palliative bypass, and 
the rest 105 were inoperable. Of the resectable 40 cases 
22 were diagnosed as malignancy pre-operatively, 16 were 
proven malignant on histopathology and 2 turned out to 
be chronic pancreatitis postoperatively. Of the 56 cases 
of chronic pancreatitis 35 patients underwent Frey’s pro-
cedure and histopathology showed chronic pancreatitis in 
all and rest 21 were managed non-surgically. Of the rest 
9, 8 patients had metastatic lesions with known primary 
underwent resection and 1 patient of lymphoma was given 
chemotherapy.
Conclusion: No diagnostic modality can, in isolation or in 
combination, accurately detect or differentiate between 
chronic pancreatitis and cancer. Preoperative tissue diagnosis 
is desirable but not mandatory provided the clinico-radiolog-
ical co-relation is strongly indicative. In our study 18 of 40 
patients underwent resection without a tissue diagnosis and 
only 2 proved negative, justifying our approach based on the 
above concept.
114 Concurrent Sessions: Submitted Abstracts
HPB © 2011 International Hepato-Pancreato-Biliary Association, HPB, 13 (Suppl. 3), 65–159
A-157
OUTCOME IMPROVEMENT THROUGH 
IMPLEMENTATION OF FAST TRACK 
LIVER RESECTION PROGRAM: 
EXPERIENCE SHARING
C. F. Mak, C. C. Cheung and W. M. Wong
Department of Surgery, Tuen Mun Hospital, Hospital 
Authority, HKSAR
Introduction: Evidence is accumulating that signifi cant 
improvement in recovery and outcome can be achieved by 
using multimodal, peri-operative care protocols in various 
surgical procedures. A modifi ed fast-track protocol was 
implemented for patients having liver operations in a regional 
hospital in Hong Kong.
Method: Between June 2009 and December 2010, 152 
patients were enrolled in this program. A multi-disciplinary 
protocol involving different team member was adopted. 
Essential features of the program including pre-operative 
assessment and education, avoidance of excessive intrave-
nous fl uids, avoidance of post-operative drains and naso-
gastric tubes, peri-operatively effective control of pain, early 
reinstitution of oral feeding, immediate mobilization and res-
toration of bowel function following surgery. Outcome mea-
sures were postoperative complications such as bleeding, 
wound infection, biliary leak, intra-abdominal abscess, liver 
failure and blood transfusion rate; 30-day operative mortal-
ity, postoperative hospital stay, postoperative ICU stay and 
readmission rates within one month.
Results: The commonest diagnosis was hepatocellular car-
cinoma (n = 87); 25% received major liver resections. On 
average, patients were discharged on postoperative Day 11, 
with a 30-day readmission rate of 12%. The mean ICU length 
of stay was 0.6 day. 23% of patients with at least one compli-
cation, 15% of patients received blood transfusion with mean 
blood loss of 599 ml and the in-hospital mortality was 2%.
Conclusion: Fast-track programs are feasible; they are 
applicable to patients undergoing major surgeries such as 
liver resections with good coordination between multiple 
team members.
A-158
PLASMA BILE ACID LEVELS IN THE 
PREDICTION OF THE HYPERTROPHY 
RESPONSE AFTER PORTAL VEIN 
EMBOLIZATION IN THE RABBIT
L. T. Hoekstra, K. P. van Lienden, M. Rietkerk, 
J. W. van den Esschert and T. M. van Gulik
Academic Medical Center, Amsterdam, The Netherlands
Introduction: Portal vein embolization (PVE) is a tech-
nique to increase the future remnant liver (FRL). The com-
monly employed method to assess liver hypertrophy in the 
non-embolized lobe following PVE is CT volumetry, per-
formed 3 weeks after PVE. Another method to predict effec-
tive hypertrophy at a relatively early time-point is therefore 
desirable. The aim of the study was to assess plasma bile acid 
levels after PVE to predict the hypertrophy response in a 
rabbit model of PVE.
Methods: Fifteen rabbits were divided into 3 groups: 
Spongostan (short-term occlusion; group I); polyvinylalco-
hol particles with coils (long-term occlusion; group II), and 
NaCl (control, group III). In all rabbits CT-volumetry and 
blood sampling were performed prior to PVE and at day 3 
and 7. Additional blood samples were taking 3 hours and 1 
day after intervention.
Results: Bile acids were increased after PVE in group I and 
II, with a peak concentration after 3 hours and 3 days respec-
tively. These values normalized after 7 days. The degree of 
hypertrophy was signifi cantly higher in the embolization 
groups compared to control on day 3 (p < 0.016), which 
correlated with plasma bile acid levels (p < 0.05). On day 7, 
the hypertrophy response was signifi cantly higher for group 
II compared to group I and III (p < 0.016).
Conclusions: The increase of %FRL on day 3 positively 
correlated with bile acids. In rabbits with a greater hypertro-
phy response after PVE, the increases in bile acids were also 
larger. Plasma bile acids can predict the hypertrophy response 
after PVE.
A-159
LAPAROSCOPIC APPROACH IS GOLD 
STANDARD FOR LEFT LATERAL 
RESECTION FOR BENIGN LIVER 
LESION
D. Safi , R. Vikram, F. Samir, A. Béatrice, F. Olivier, 
S. Alain and B. Jacques.
Department of Hepato-Pancreato-Biliary Surgery, Beaujon 
Hospital, Clichy, France
Introduction: The left lateral segment of the liver is the fi rst 
choice for a laparoscopic anatomic resection because of its 
peripheral location, minimal dissection. In this controlled 
matched study, we analyzed effi cacy of open and laparo-
scopic left lateral resection for benign lesion.
Methods: 31 laparoscopic left lateral resections were 
control matched with 31 open left lateral resections by strict 
selection based on pathology of lesion, size of lesion, ASA 
grade, BMI, age and sex of the patient.
Results: Despite strict matching of age and sex in both 
groups, females constitute 80.6% of study population with 
mean age of 38.9 years as compared 19.4% males with mean 
age of 57.9 years. Duration of operation in open group was 
243.9 ± 104.6 minutes as compared to 181.7 ± 71.5 minutes 
in laparoscopic group (p = 0.048). Blood loss was signifi -
cantly lower in laparoscopic group (455.8 ± 593.1 ml vs. 
223.0 ± 281.2 ml; p = 0.035). Duration of hospital stay was 
signifi cantly lower in laparoscopic group (8.06 ± 4.4 days vs. 
4.1 ± 1.7 days; p ≤ 0.001). Total cost of hospitalization for 
left lateral resection in open group was 11504 ± 7776 Euros 
whereas for laparoscopic group it 7475 ± 2679 Euros (p ≤ 
0.001).
Conclusions: Our strictly control matched study demon-
strated operative safety, excellent post-operative outcomes, 
economic benefi ts of the laparoscopic liver resection. 
Moreover postoperative quality of life was higher in the 
young females after laparoscopic liver resections. Results of 
the liver surgery are improved, when the benefi ts of the lapa-
roscopic surgery combined to it, we recommend the laparo-
scopic left lateral liver resection as a gold standard procedure 
for benign liver lesions.
 Concurrent Sessions: Submitted Abstracts 115
HPB © 2011 International Hepato-Pancreato-Biliary Association, HPB, 13 (Suppl. 3), 65–159
A-160
POSTOPERATIVE AND PREOPERATIVER 
RECURRENCE-PREDICTION MODELS 
FOR THE RESECTED 
HEPATOCELLULAR CARCINOMA
S-J. Park, B. H. Nam*, S. H. Kim, S-S. Han, S. Y. Cho, 
Y-K. Kim, T. S. Yoo, S. D. Lee, Y. H. Ko, H. Y. Kim, 
J-W. Park and C-M. Kim
Center for Liver Cancer and *Cancer Registration and 
Biostatistics Branch, National Cancer Center, Goyang-si, 
Republic of Korea
Introduction: Accurate recurrence-prediction after resec-
tion is most valuable in clinical fi eld. The aim of this study 
is to present the practical postoperative and preoperative 
recurrence-prediction models.
Methods: We enrolled the 533 patients of HCC with follow-
up >2 years. Prognostic factor analysis for recurrence was 
done by Cox Proportional-Hazard-Regression-Model. With 
the signifi cant factors for recurrence, we made the postopera-
tive recurrence-prediction model for probability of recur-
rence within 5-years after resection. Then we did the Test of 
Independency to know the dependency of preoperative 
factors with postoperative pathologic factors. Finally we 
made the preoperative recurrence-prediction model for prob-
ability of recurrence within 5-years after resection with pre-
operatively predictable factors.
Results: One-year/3-year/5-year disease-free survival rates 
were 68%/49%/37% respectively. With the uni- and multi-
variate analysis for recurrence, satellite nodule (+), micro-
vascular invasion (+), resection margin (+), platelet <80 K, 
number ≥3, major vessel invasion (+), tumor necrosis >10%, 
GPT > 40 IU, AFP > 12 ng/ml were independent signifi cant 
factors for recurrence. With these 9 factors, we made the 
postoperative recurrence-prediction model within 5-years 
and the C-performance scale of this model was 0.749. 
Though tumor size >5 cm and presence of viral hepatitis 
were signifi cant in only univariate analysis, since they have 
so strong dependency with signifi cant pathologic factors 
such as satellite nodule (+) and microvascular invasion, we 
made the preoperative recurrence-prediction model with 7 
preoperatively predictable factors (platelet <80 K, number 
≥3, major vessel invasion (+), GPT > 40 IU, AFP > 12 ng/
ml, tumor size >5 cm, presence of viral hepatitis) and the 
C-performance scale of this model was 0.708.
Conclusions: Postoperative and preoperative recurrence-
prediction model are helpful for predicting accurate progno-
sis and selection of the treatment modality for HCC.
A-162
AN EVIDENCE-BASED APPROACH TO 
MANAGEMENT OF HEPATIC ADENOMA 
IN PREGNANCY
T. L. Yong, P. M. Evans, M. Smith and V. Usatoff
The Alfred Hospital, Melbourne, Australia
Introduction: Hepatocellular adenoma (HCA) is a rare 
benign liver disease. It is strongly associated with sex 
hormones. Hence, there is an increased incidence of HCA 
with usage of oral contraceptive pill and growth of tumor 
during pregnancy. However, controversy remains of its 
management during pregnancy. This paper aims to provide 
a guideline of management of this disease in pregnant 
patients.
Methods: A Medline and Pubmed search of articles pub-
lished from 1990 to present was performed.
Results: Fourteen English language articles were indenti-
fi ed and reviewed.
Conclusions: There is a role for conservative management 
of smaller HCAs during pregnancy. Nevertheless a more 
aggressive approach is still warranted in larger, growing or 
symptomatic tumors.
A-163
OPEN HEPATECTOMY WITH OR 
WITHOUT PRINGLE MANEUVER: A 
PROSPECTIVE RANDOMIZED TRIAL
Y. S. Cheung, K. F. Lee, J. Wong, S. W. J. Wong, 
C. N. C. Chong and B. S. P. Lai
Division of Hepatobiliary and Pancreatic Surgery, 
Department of Surgery, Prince of Wales Hospital, The 
Chinese University of Hong Kong, China
Introduction: Pringle maneuver (PM) is commonly used in 
hepatectomy to cut down blood loss and operative time but 
it is associated with ischemic-reperfusion injury to remnant 
liver. With the advances in instruments used for liver transec-
tion, we challenged the routine use of PM in liver 
resection.
Methods: We conducted a prospective randomized trial 
from May 2008 to April 2011. Eligible patients undergoing 
elective open hepatectomy were randomized to PM or 
non-PM group. Techniques and instruments used for liver 
transection were the same in both groups. Outcome measures 
included total blood loss, blood loss during liver transection, 
total operation time, time used for liver transection, operative 
mortality, morbidity, hospital stay and recovery of liver 
function.
Results: Both groups (63 patients each) were comparable in 
patient demographics, pre-operative liver function, histologi-
cal diagnosis, proportion of cirrhosis and types of hepatec-
tomy. There was no difference in total blood loss, blood loss 
during liver transection, total operative time and time for 
liver transection between the two groups. One death occurred 
in each group and there was no difference in hospital stay. 
However, PM group had signifi cantly more post-operative 
complications than non-PM group (44.4% vs. 25.4%, P = 
0.025). PM group also had signifi cantly higher serum alanine 
aminotransferase (ALT) but not serum bilirubin, albumin and 
prothrombin time in early post-operative period.
Conclusion: In open hepatectomy, PM does not reduce 
blood loss or operation time. However, it is associated with 
elevated post-operative ALT and increased incidence of post-
operative complications.
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RADIOFREQUENCY ABLATION 
COMBINED WITH TRANSCATHETER 
ARTERIAL CHEMOEMBOLIZATION 
VERSUS RADIOFREQUENCY ABLATION 
ALONE FOR RECURRENT 
HEPATOCELLULAR CARCINOMA
Z-W. Peng1,2, Y-J. Zhang1,2 and M-S. Chen1,2
1Department of Hepatobiliary Surgery, Cancer Centre of 
Sun Yat-Sen University, 651 Dongfeng Road East, 
Guangzhou 510060, China; 2State Key Laboratory of 
Oncology in Southern China, Guangzhou 510060, China
Introduction: To compare prospectively, the effects of 
combined radiofrequency ablation and transcatheter arterial 
chemoembolization (TACE-RFA) with radiofrequency abla-
tion (RFA) alone for the treatment of recurrent hepatocellular 
carcinoma (HCC).
Methods: From January 2002 to December 2006, 139 
patients with recurrent HCC ≤5 cm were treated with TACE-
RFA (n = 69) or RFA alone (n = 70). The survival curves 
were constructed by Kaplan-Meier method and compared by 
log-rank test.
Results: There were 69 patients who received TACE-RFA, 
and 70 patients who received RFA alone. The 1-, 3-, 5- year 
overall survivals for the groups TACE-RFA and RFA were 
94.2%, 68.6%, 45.6% and 82.5%, 46.8%, 35.9%, respec-
tively. (p = 0.037). The corresponding recurrence-free sur-
vivals for the groups TACE-RFA and RFA were 80.0%, 
45.2%, 40.2% and 64.1%, 18.4%, 18.4%, respectively. (p = 
0.005). On subgroup analyses, the overall survival and recur-
rence-free survival for TACE-RFA group were better than 
those for RFA group for patients. The interval of tumor recur-
rence from the initial treatment was ≤1 year (p = 0.004, p = 
0.020, respectively) and tumors 3.1–5.0 cm (p = 0.002, p < 
0.001, respectively), but not for patients with interval of 
tumor recurrence from the initial treatment of >1 year (p = 
0.421, p = 0.111, respectively) and tumors ≤3.0 cm (p = 
0.478, p = 0.204, respectively). A logistic regression analysis 
showed that the interval of tumor recurrence from the initial 
treatment, and treatment allocation were signifi cant prognos-
tic factors for overall survival, while the interval of tumor 
recurrence from the initial treatment, treatment allocation 
and tumor size were signifi cant prognostic factors for recur-
rence-free survival.
Conclusion: TACE-RFA has better effi cacy than RFA for 
recurrent HCC.
A-165
DNA MISMATCH REPAIR DEFICIENCY 
IN HILAR CHOLANGIOCARCINOMA
A. T. Ruys1, F. J. ten Kate2, M. Broekgaarden1, 
O. R. Busch1, D. J. Gouma1 and T. M. van Gulik1
1Department of Surgery, Academic Medical Centre, 
Amsterdam, The Netherlands; 2Department of Pathology, 
Academic Medical Center, Amsterdam and University 
Medical Center Utrecht, Utrecht, The Netherlands
Introduction: As a result of dysfunctional DNA mismatch 
repair (MMR), tumor cells with microsatellite instability 
(MSI) respond poorly to several chemotherapeutic agents 
that specifi cally modify DNA at the nucleotide level (e.g. 
5-fl uorouracil and cisplatin). In patients with colon carci-
noma, MMR status directs chemotherapeutic treatment. 
Palliative therapy for hilar cholangiocarcinoma has recently 
changed dramatically, since the results of the ABC-02-trial 
have shown a survival benefi t of chemotherapy in patients 
with unresectable cholangiocarcinoma. Since MMR status 
could also tailor chemotherapy in patients with hilar cholan-
giocarcinoma, we aimed to asses the incidence of MMR 
defi ciency in these patients.
Methods: We assessed the incidence of MSI in 75 resected 
hilar cholangiocarcinoma specimens by staining tissue 
microarrays immunohistochemically for MLH-1, MSH-2, 
MSH-6, and PMS-2. In addition, the effect of MSI on sur-
vival after resection was analyzed.
Results: Loss of MMR protein by immunohistochemical 
analysis was identifi ed in thirteen patients (17%), six lost 
MLH-1, seven lost MSH-6, and six lost PMS2. Median sur-
vival was similar in patients with and without MSI (37 
months vs 45 months, log rank p = 0.48).
Conclusion: In this series of patients with hilar cholangio-
carcinoma, the incidence of MMR defi ciency was 17%, 
which is comparable to the incidence of MMR defi ciency in 
colon carcinoma. These data support MMR status assess-
ment in hilar cholangiocarcinoma patients considered for 
chemotherapy.
A-166
CYSTIC NEOPLASMS OF THE 
PANCREAS: THE TATA MEMORIAL 
CENTRE EXPERIENCE
V. Borgaonkar, Y. D. Bodhankar, P. J. Shukla, M. Goel, 
S. V. Shrikhande
Department of GI and HPB Surgical Oncology, Tata 
Memorial Centre, Mumbai, India
Introduction: Cystic neoplasms of pancreas, though 
uncommon, are increasingly diagnosed due to increased 
awareness and modern imaging. Number of diverse pan-
creatic cystic neoplasms has been identifi ed and the prog-
nosis depends upon the type of the cystic neoplasm and 
the treatment offered. This study assessed the clinico-path-
ological characteristics of the disease and to audit the effect 
of surgical intervention by examining a referral centre 
experience.
Materials and Methods: The pancreatic surgery database 
of the Tata Memorial Centre from 2006 to 2010 was reviewed. 
Patients with cystic neoplasm of pancreas were identifi ed. 
Assessment of the clinic-pathological characteristics of the 
disease, operative intervention and survival data was done.
Results: 26 patients with the median age 38 years (range 
15–70 years) were treated at Tata Memorial Hospital. 18 
(69.2%) were females and 8 (30.8%) were males. Pain in the 
abdomen was the most common presenting symptom (in 15 
cases) and 6 cases presented with a lump in abdomen and 5 
were incidentally diagnosed. 14 (53.8%) were Solid Papillary 
Epithelial Neoplasms (SPEN), 3 (11.5%) were mucinous 
cystadenoma and 5 (19.2%) were serous cystadenomas. 
Intraductal Papillary Mucinous Neoplasm (IPMN) was diag-
nosed in 3 (11.5%) cases and 1 (3.8%) was diagnosed as 
mucinous cystic neoplasm of border line malignant variety. 
14 (53.8%) were located in tail of pancreas, 6 (23.1%) in 
head of pancreas and in 6 (23.1%) cases the tumor was 
involving body of pancreas.
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16 distal pancreatecotmies were done of which 9 were 
spleen-preserving. Splenectomy was required in 7 and 1 
patient each required nephrectomy and portal vein resection 
additionally. 6 Pylorus Preserving Pancreaticoduodenectomies 
(PPPD) were done. Total pancreatectomy was required in 2 
cases with extensive disease and a median pancreatectomy 
for localized disease. One case was unresectable. Mean 
blood loss in distal pancreatectomy was 728.8 ml (range 
100–2800 ml), in PPPD was 600 ml (range 500–750 ml) 
while 450 ml blood loss was noted in total pancreatectomy 
and 300 ml in median pancreatectomy.
18 (69.23%) patients had an uneventful recovery. 5 
(19.23%) patients developed postoperative pancreatic fi stula 
(POPF). 2 patients had grade B POPF and 3 had grade A 
POPF (ISGPF classifi cation). One patient developed left 
sided pleural effusion and there was single post-operative 
mortality. Average hospital stay in patients undergoing distal 
pancreatectomy was 12.3 days (range 9–27 days), in PPPD 
it was 12.5 days (range 7–16 days) and 16 days for the total 
pancreatectomy while median pancreatectomy patient had a 
hospital stay of 18 days.
Kaplan Meier method was used to calculate the overall 
survival. The study revealed overall survival of 88% with 
follow-up ranging from 6 months to 10 years.
Conclusion: Pancreatic cystic neoplasms are rare and pre-
dominant in females of second and third decade. Solid pseu-
dopapillary neoplasm (SPEN) was the most common 
pathological variety detected in our study with tail of pan-
creas as the commonest site. Looking at the overall survival 
benefi t, even major pancreatic resections including multivis-
ceral resections should be considered as a treatment option 
in cystic tumors of pancreas with acceptable morbidity and 
mortality.
A-167
THE ELEVEN YEARS SURGICAL 
OUTCOME OF LAPAROSCOPIC 
COMMON BILE DUCT EXPLORATION 
(LCBDE) IN SINGLE INSTITUTE
K. Y. Paik1, I. Y. Park2 and E. K. Kim1
1The Catholic University, Yeouido St. Mary's Hospital, 
Korea; 2The Catholic University, Bucheon St. Mary's 
Hospital, Korea
Introduction: Laparoscopic common bile duct exploration 
(LCBDE) for choledocholithiasis is feasible and has become 
increasingly popular. Several methods of biliary drainage 
following LCBDE have been advocated to prevent bile 
leakage. We report herein a surgical outcome of LCBDE in 
single institution during eleven years.
Methods: Between 2000 and 2010, the retrospective review 
of 136 consecutive patients underwent LCBDE via choledo-
chotomy utilizing fl exible choledochoscopy were performed.
Results: The median age was 63 years (range 23–93). Sixty-
four patients (53.3%) had undergone failed preoperative 
endoscopic retrograde cholangiopancreatography (ERCP) 
due to duodenal diverticulum or large size stone. 68 patients 
(57.7%) were applied with internal stent in common bile duct 
during surgery, T-tube were inserted 12 patients (13.3%), the 
remainder having primary closure with endoscopic nasobili-
ary drainage. There was no failure of lithotripsy by LCBDE. 
There was no bile leakage which was required additional 
intervention. Thirteen patients (10.8%) were relapsed CBD 
stone, six patients were re-explored with LCBDE, and seven 
patients were removed stones by ERCP. The mean relapse 
period was 4.5 years (6 month ~ 10 years) All patients having 
relapsed stones were performed stone removal successfully.
Conclusions: LCBDE is safe and effective treatment for 
CBD stones which has diffi culty for endoscopic approach. 
The short and long term results of LCBDE is good in terms 
of complication and stone relapse.
A-168
EXPRESSION OF EXTRACELLULAR 
MATRIX PROTEIN 1 AND MATRIX 
METALLOPROTEASE-9 IN 
HEPATOCELLULAR CARCINOMA AND 
THEIR PROGNOSTIC SIGNIFICANCE
H. Chen, J-S. Li, W-D. Jia and G-L. Xu
Center for the Study of Liver Cancer and Department of 
Hepatic Surgery, Anhui Provincial Hospital, Anhui Medical 
University, No. 17 Lujiang Road, Hefei 230001, Anhui, 
China
Introduction: To investigate the expression of extracellular 
matrix protein 1 (ECM1) and matrix metalloproteinase-9 
(MMP-9) in hepatocellular carcinoma (HCC) and to eluci-
date its correlation and prognostic signifi cance.
Methods: Immunohistochemisty was employed to deter-
mine the expression of ECM1 and MMP-9 in 120 HCC and 
17 normal liver tissues.
Results: The positive rates of ECM1 and MMP-9 expres-
sion in HCC tissues were 73.3% (88/120) and 65.0% 
(78/120), signifi cantly higher than that in normal liver 
tissues, only 23.5% (4/17) and 11.8% (2/17), respectively. 
Both of the expression of ECM1 and MMP-9 were signifi -
cantly associated with TNM stage (P = 0.049, P < 0.001) and 
venous invasion (P = 0.030, P = 0.001). In addition, the 
expression of MMP-9 was signifi cantly associated with 
tumor size, number of tumor nodules, tumor differentiation 
and the stage of liver cirrhosis. Neither was found has sig-
nifi cant correlation with gender, age, HBsAg status, Child-
Pugh class, tumor capsule and AFP level. The patients with 
ECM1 and MMP-9 positive have signifi cantly poorer overall 
and disease-free survival rate. According to the conjoined 
expression of ECM1/MMP-9, the patients were categorized 
into four groups: ECM1-/MMP-9-, ECM1-/MMP-9+, 
ECM1+/MMP-9-, and ECM1+/MMP-9+. In all four groups, 
ECM1-/MMP-9- patients had the best prognosis, there was 
no signifi cant difference among the latter three groups. There 
was a signifi cant positive correlation between ECM1 and 
MMP-9 (r = 0.585, P < 0.001).
Conclusions: Both ECM1 and MMP-9 are signifi cantly 
related to the invasion and metastasis. ECM1 and MMP-9 
has a predictive value for prognosis and recurrence of HCC 
after surgery.
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CHANGING PATTERNS IN THE 
MANAGEMENT OF EMERGENCY 
PRESENTATIONS WITH ACUTE BILIARY 
PAIN IN A TERTIARY INSTITUTE
J. Fong1, C. Illing1, M. Yeoh2, V. Surendran3, M. Fink1,3, 
M. Nikfarjam1,3, G. Starkey1, R. Jones1, C. Christophi1,3 
and V. Muralidharan1,3
1HPB & Transplant Unit, Austin Hospital, Melbourne, 
Australia; 2Emergency Department, Austin Hospital, 
Melbourne, Australia; 3The University of Melbourne 
Department of Surgery, Austin Hospital, Melbourne, 
Australia
Introduction: Biliary pain is one of the commonest diagno-
ses in patients presenting with abdominal pain to the emer-
gency department. Although early treatment is advocated, 
demand on acute surgical beds leads to delayed treatment in 
many hospitals. A strict policy of treating patients with defi n-
itive surgery on the same admission was instituted in our 
tertiary referral centre in 2007. This study reviews the impact 
of this policy over a fi ve year period.
Methods: A retrospective review of all patients presenting 
with biliary colic as documented in an emergency depart-
ment database in two specifi c periods were chosen for the 
study. The fi rst was between 1st October 2004 to 30th 
September 2005 prior to the new policy and the second 1st 
October 2009 and 30th September 2010 two years after the 
institution of the policy.
Results: Between October 2004 and September 2005, 158 
patients with biliary colic presented to the ED. Ninety seven 
(61%) were discharged home, 23 (14%) were admitted 
without having surgery, whilst 38 (24%) were admitted for 
a cholecystectomy. Fifty six percent of patients discharged 
home represented with complications including recurrent 
biliary pain, acute cholecystitis, pancreatitis and obstructive 
jaundice. In the second period, 282 patients presented with 
biliary colic. Sixty three percent of these patients underwent 
surgery on the same admission. Of those discharged home, 
fewer than 10% represented to ED before their surgical OP 
review.
Conclusions: A strict policy of admission and treatment on 
presentation to ED has demonstrably reduced patient mor-
bidity, representations and overall hospital stay.
A-170
PALLIATIVE ENTERAL STENTING OF 
MALIGNANT GASTRODUODENAL 
OBSTRUCTION: SHORT-TERM 
OUTCOMES, PATIENT SELECTION AND 
DESCRIPTION OF TECHNIQUE
A. M. Fox1, E. Morrison1, M. Hatzifotis1, 
D. Thiruchelvam1, S. Hassen2, S. Banting1, R. Cade1
1St Vincent’s Public Hospital, Melbourne, Australia; 2Box 
Hill Public Hospital, Melbourne, Australia
Introduction: We present our experience with Self-
expanding metallic stents (SEMs), to relieve Gastroduodenal 
obstruction (GDO) from irresectable malignant disease of 
the upper gastrointestinal tract.
Methods: All patients submitted to palliative endoscopic 
stenting for malignant GDO between January 2008 and 
January 2011 were prospectively entered into a purpose-
specifi c database. Criteria for patient selection included (i) 
established, symptomatic GDO (ii) a diagnosis of irresect-
able malignant GDO on the basis of tumor factors or the 
patient being medically unfi t for surgery.
Results: Thirty patients underwent stenting for malignant 
GDO, the majority were either unable to tolerate any oral 
intake (13/30) or a liquid diet only (13/30). No patient prior 
to stenting could tolerate solids. The most common cause of 
GDO was pancreatic cancer (67%) and the most common 
site of obstruction was the duodenum in its second part 
(52%). Stent insertion was successful in 28/30 cases. Early 
complications occurred in 6 patients. Following stenting oral 
intake improved quickly with 16/28 patients tolerating a soft 
diet within 24 hours. The median hospital stay was two days 
(range 0–10 days) Recurrent GDO affected 3 patients at 4, 6 
and 6 months, all of whom were successfully re-stented.
Conclusions: Palliative enteral stenting for malignant GDO 
is a safe, reliable means of providing fast, effective and 
lasting relief of symptoms in patients not suitable for pallia-
tive surgery. Stent occlusion can be overcome with restenting 
and stent migration was not seen in this series.
A-171
ROLE OF ENDOSCOPIC 
ULTRASONOGRAPHY IN THE 
DIAGNOSIS OF 
CHOLANGIOCARCINOMA IN PATIENTS 
WITH AN UNDERLYING PRIMARY 
SCLEROSING CHOLANGITIS
N. Battula, D. Tsapralis, D. Croagh, A. Takhar, D. Mayer, 
J. Isaac, P. Muiesan, D. F. Mirza, B. S. Mahon 
and S. R. Bramhall
Liver unit, Queen Elizabeth Hospital, Birmingham, United 
Kingdom
Introduction: Primary sclerosing cholangitis (PSC) is an 
idiopathic cholestatic liver disease that predisposes to the 
development of cholangiocarcinoma (CCA). Detection of 
CCA in PSC patients still remains diffi cult and many cases 
are only diagnosed incidentally at histology after surgery. 
The aim of this study was to evaluate the effi cacy of endo-
scopic ultrasonography (EUS) in the diagnosis of CCA with 
underlying PSC.
Methods: PSC patients submitted to EUS for the evaluation 
of suspected CCA by cross-sectional imaging and/or 
endoscopic retrograde cholangiopancreatography (ERCP) 
between Jan 2007 & June 2010 were included. FNAC was 
only performed in those with suspicious morphology. 
Reference standard for fi nal diagnosis included either surgery 
or clinical and/or imaging follow-up.
Results: 34 had EUS during the study period, thirteen 
(38%) were female and the median age was 63 years. FNA 
cytology was performed in 26 (77%). A diagnosis of CCA 
was confi rmed in 7 (21%) and excluded in 26 (76%). One 
patient had EUS morphology in favor of CCA but negative 
FNA, he subsequently underwent a liver transplantation (LT) 
and histology confi rmed CCA. EUS results were confi rmed 
by histology after LT in 4, two died awaiting LT with sepsis 
at 13 and 14 months. All patients with a presumed benign 
PSC after EUS had a minimum follow up period of 
12 months (Range 12–43) with no clinical or radiological 
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evidence of CCA. The sensitivity, specifi city, positive and 
negative predictive values for EUS were 88%, 100%, 100% 
and 96%.
Conclusions: EUS is a useful tool to evaluate suspicious 
lesions diagnosed on cross-sectional imaging or ERCP in 
patients with PSC.
A-172
PREDICTORS FOR FAILURE OF NON 
OPERATIVE MANAGEMENT IN BLUNT 
LIVER INJURY
K. Sai, T. D. Yadav, M. Kang, M. Hinduja, A. Maurya, 
V. G. Gupta and R. Sigh
Postgraduate Institute of Medical Education and Research, 
Chandigarh, India
Introduction: Non-operative management has been vali-
dated as a standard of care for patients with blunt hepatic 
trauma. We studied the predictors for failure of non-operative 
management in blunt liver injuries to avoid morbidities and 
mortalities associated with delayed diagnosis & intervention 
in patients who were being managed on conservative line in 
surgical emergency ward (EW).
Methods: The study was conducted on patients admitted to 
EW from January 2009 to April 2010 & who had liver injuries 
on contrast enhanced computed tomography of abdomen. 
Patients were hemodynamically stable on presentation or after 
resuscitation. Patients with intra-abdominal injuries which 
necessitated immediate surgical intervention were excluded. 
Patients who required surgery after receiving treatment under 
non-operative management for 24 hours were taken as failure. 
Factors which were found signifi cant on univariate analysis 
were entered into multivariate logistic regression analysis.
Results: Total patients studied were 60 of which eight 
(13.3%) failed conservative management. Causes of the 
failure were missed bowel/mesenteric injury 37.4%, 
Hemodynamic instability due to liver injury (25%), biliary 
peritonitis 12.5% and liver & associated solid organ injury 
(12.5%). Liver related failure was seen in grade 5 injuries 
only. Base defi cit (BD) at admission (p = 0.001), blood 
transfusion (p = 0.027) have been found to be signifi cant 
predictor of failure in the study.
Conclusions: On admission BD levels are important vari-
able & patient having deranged BD values should be moni-
tored more closely. Overall physiological and clinical status 
should guide the management as there is nothing better than 
repeated clinical assessment.
A-174
DEFINITIVE SURGERY IN CHRONIC 
PANCREATITIS DURING A PHASE OF 
ACUTE EXACERBATION: IS IT SAFE?
S. Mahesh, H. Ramesh, B. Abraham, B. Venugopal, 
A. Venugopal, V. Lekha and G. Singh
Lakeshore Hospital, Cochin, India
Introduction: Chronic pancreatitis, is a disease character-
ized by remissions and exacerbations. Surgery during acute 
exacerbation may be required if the symptom free intervals 
are short. The aim of the study was to compare outcomes 
after surgery during an acute episode with those during inter-
val phase.
Methods: Out of 201 patients operated for chronic pancre-
atitis during the period 2005–2009, 53 patients were in group 
1 (operated during the same admission of an acute episode), 
and 152 patients were in Group 2 (during the interval between 
episodes). Outcomes such as mortality, morbidity, complica-
tions, hospital stay and early results such as pain relief were 
assessed.
Results: Of 52 patients, 7 cases were abandoned after peri-
pancreatic lavage and placement of drains, as there were 
dense adhesions, severe infl ammation. In 4 cases, drainage 
of infected collection was alone performed. 41 cases under-
went the Frey procedure. There was no mortality. 
Complications occurred in 14 patients. Univariate analysis 
revealed that peripancreatic necrotic material, raised C 
Reactive protein above 40, and systemic sepsis predisposed 
to increased complications. In multivariate analysis, CRP 
levels above 40 correlated with complications. Hospital and 
ICU stay was prolonged in Group 1.
Conclusions: Defi nitive Surgery can be performed safely in 
patients with chronic pancreatitis during the acute attack. 
Patients with sepsis, peripancreatic necrosis, and high CRP 
over 40 may benefi t from conservative approaches.
A-175
A 10-YEAR EXPERIENCE OF 
LAPAROSCOPIC CYST-GASTROSTOMY 
FOR PANCREATIC PSEUDOCYST IN A 
TERTIARY REFERRAL CENTRE
S. C. Gibson, B. Robertson, E. Dickson, C. McKay 
and R. Carter
Glasgow Royal Infi rmary, Glasgow, UK
Introduction: Laparoscopic cyst-gastrostomy (LCG) is 
rarely utilized in the management of pancreatic pseudocyst 
with endoscopic and open surgical approaches preferred 
despite potential advantages of the laparoscopic approach.
Methods: Data was abstracted from a prospectively popu-
lated database. Decision for drainage of pseudocyst was 
made at multi-disciplinary team meeting. Expertise for lapa-
roscopic, endoscopic (with EUS guidance) and percutaneous 
drainage were available during the 10-year study period.
Results: 44 patients underwent surgical intervention. 37 
(82%) patients underwent planned LCG with 16 (43%) 
undergoing concomitant laparoscopic cholecystectomy. 6 
(20%) LCGs were converted due to poor access and failure 
to progress; however, the latter 17 cases in the series were 
all completed laparoscopically. The median length of stay 
in those patients completed laparoscopically was 6 days 
(2–10) vs. 15.5 days (8–19) in those patients who were 
converted (p-0.0351). 8 patients (18%) underwent planned 
open cyst gastrostomy. Median length of stay was 22 days 
(20–65.5).
There were no deaths. One patient had a self-limiting 
upper GI bleed following LCG requiring no intervention or 
transfusion. After a median follow-up of 397 days (161–
1854) no intervention has been required for a recurrent cyst. 
One patient underwent a laparoscopic cyst-jejunostomy for 
a residual collection following LCG.
Conclusions: LCG is a safe and effective technique for 
drainage of pancreatic pseudocyst allowing defi nitive man-
agement of gallstones. With evolution in technique and 
improved patient selection, conversion rates are low.
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A-176
SHORT-TERM AND LONG-TERM 
OUTCOME OF SEVERE PANCREATIC 
NECROSIS MANAGED BY DRAINAGE 
WITH OR WITHOUT NECROSECTOMY
M. T. Cheung and M. Cheng
Department of Surgery, Queen Elizabeth Hospital, Hong 
Kong
Introduction: Many reports have confi rmed the success of 
percutaneous drainage for infected necrosis and the removal 
of the necrotic tissue by less invasive maneuvers. This paper 
aims to determine the overall success and survival rate of 
drainage with or without necrosectomy in the management 
of pancreatic necrosis. The long-term outcome with respect 
to re-collection or fi stula was also examined.
Methods: All patient suffered from pancreatic necrosis in a 
single institution from 2001 to 2011, was retrospectively 
reviewed.
Results: A total of 36 patients with severe pancreatic necro-
sis were studied. 22 patients had Ransons’ score 5 or above; 
27 had been in intensive care unit, 21 patients required posi-
tive ventilation. 16 patients had open surgery, among which 
6 required subsequent percutaneous necrosectomy. Rest 20 
patients had percutaneous drainage while 13 patients had 
subsequent necrosectomy. Open surgery was rarely required 
in the last 4 years despite positive culture during the fi rst 
aspirate. The overall mortality rate was 22.2% and was sig-
nifi cantly higher in those patients who had earlier interven-
tion (before 6 weeks; 55.5% vs 11.1%) and also signifi cantly 
higher for those before 2007 (31.8% vs 7.1%). Among those 
28 survivors with a median follow-up of 40.3 months, 3 had 
pancreatic recollection requiring intervention and 1 had per-
sistent fi stula lasting for 6 months.
Conclusions: With a multi-disciplinary approach, particu-
larly with a sophisticated intensive care, most patients can 
survive the initial phase. Open surgery would be limited, 
while most necrosis can be removed by minimally-invasive 
maneuvers. The long-term fi stulation or recollection rate was 
low.
A-177
COMPARATIVE STUDY OF 
LAPAROSCOPIC VS OPEN PANCREATIC 
NECROSECTOMY
K. Sutariya1, S. Vaze2, H. Mehta3, P. Wagle3, P. Varty3 and 
J. Zaveri3
1Laparosurge Hospital, Rajkot, India; 2Apollo Jahangir 
Hospital, Pune, India; 3Lilavati Hospital and Research 
Center, Mumbai, India
Introduction: High surgical stress in already critically ill 
patients associated with Open Pancreatic Necrosectomy 
(OPN) led to search of minimal invasive surgery in treatment 
of pancreatic necrosis. This study is an attempt to compare 
laparoscopic pancreatic necrosectomy (LPN) with OPN.
Methods: Retrospective study of prospective database at 
tertiary center from Dec2005 to Mar2009. 32 patients 
(16OPN and 16LPN) of age group 15 to 70 years, operated 
between 3–10 weeks. The principles of surgery similar for 
both. Mean follow-up months OPN 12.92 ± 4.4 and LPN 
17.00 ± 5.77. Demography, pre-operative parameters were 
comparable. Peri-operative outcomes and results in patients 
with CTSI >8/≤8. Organ failure ≥2/ <2 were compared using 
SPSS software.
Results: Details below are written as OPN and LPN 
respectively;
Duration of surgery 148.13 ± 44.15 and 248.46 ± 52.81 min 
(P = 4.80E–05). Operative blood loss 320 ± 184.57 and 
353.85 ± 230.45 ml (P = 0.774). None in OPN and Four 
(25%) in LPN had per-operative complications (P = 0.109). 
Four LPN converted to open. ICU stay was 5.63 ± 15.05 and 
6.77 ± 6.75 days (P = 0.048). Hospital stay was 30.94 ± 19.6 
and 18.62 ± 11.44 days (P = 0.031). Pancreatic fi stula devel-
oped in six (37.5%) and 5 (38.5%) (P = 1.0). Bowel fi stula 
developed in two (12.5%) and one (7.7%) (P = 1.0). Post-
operative hemorrhage occurred in three (18.8%) and two 
(15.4%) (P = 1.00). Residual collection in nine (56.3%) and 
6 (46.2%) (P = 0.867). Wound complications developed in 
Ten (62.5%) and 2 (15.4%) (P = 0.029). Mortality rate was 
25% (Four) and 23% (Three) (P = 1.0). Endocrine insuffi -
ciency developed in three (25%) and four (40%) (P = 0.770). 
Exocrine insuffi ciency in two (16.7%) and one (10%) (P = 
1.0). One (8.3%) and none had incisional hernia (P = 1.0).
Conclusion: Patient Selection is critical as LPN refl ects 
inferior results in extremely ill and those having multiple 
extra pancreatic collections. Laparoscopy is safely performed 
for patients, who are hemodynamically stable, necrosis con-
fi ned to lesser sac and by surgeons with expertise in advanced 
laparoscopy.
A-178
PANCREATIC DEBRIDEMENT: HAVE 
RESULTS IMPROVED?
W. Schraut, B. Boone, S. Downs-Canner, D. Yadav 
and K. Lee
University of Pittsburgh School of Medicine, Pittsburgh, 
PA, USA
Introduction: Pancreatic debridement (PD) procedures 
have been associated with signifi cant mortality and morbid-
ity. We have reviewed a ten year experience with PDs to 
determine contemporary outcomes from such procedures.
Methods: All patients undergoing PDs in a tertiary medical 
center between 1/1/00 and 9/9/09 were identifi ed from an 
electronic database.
Results: 99 patients ranging in age from 21 to 85 years 
(median 57) underwent PDs. The most frequent etiologies of 
the pancreatitis were gallstones (52), alcohol (13), post-
ERCP (6), hypertriglyceridemia (3), and indeterminate (16). 
The most frequent indications for surgery were infected 
necrosis (75), multiorgan system failure (9), and other 
intraabdominal infections or perforated viscus (5). The inter-
val between onset of pancreatitis and the PD ranged from 0 
to 120 days. Debridements for infected necrosis were per-
formed as early as 4 days and as late as 120 days after onset 
of pancreatitis (mean 40 days). Seven patients underwent 
surgical debridement after failing prior treatment with per-
cutaneous drains. 59 patients underwent additional debride-
ment procedures (range 1–10, median 1). Eleven patients 
(11%) died. Sixty seven patients required extended post dis-
charge care (long term acute care, inpatient rehabilitataion, 
or skilled nursing) and 20 patients were discharged to home. 
A shorter interval between onset of pancreatitis and surgery 
was associated with a need for multiple debridement 
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procedures (28 vs. 45 days; p < 0.05) and extended care (31 
vs. 45 days; p < 0.05).
Conclusions: PD procedures are associated with encourag-
ing mortality rates, although morbidity remains substantial 
and postoperative recovery remains lengthy. Initial non-
operative treatment of pancreatitis may prevent or delay the 
timing of such procedures. If surgery then becomes neces-
sary, such delays may facilitate operative management and 
improve patient outcomes.
A-179
EARLY VS. DELAYED LAPAROSCOPIC 
CHOLECYSTECTOMY AFTER 
PERCUTANEOUS TRANSHEPATIC 
GALLBLADDER DRAINAGE
I. W. Han1, J-Y. Jang1, M. J. Kang1, K. B. Lee2, S. E. Lee3 
and S-W. Kim1
1Department of Surgery & Cancer Research Institute, Seoul 
National University College of Medicine, Seoul, South 
Korea; 2Department of Pathology, Seoul National 
University College of Medicine, Seoul, South Korea; 
3Department of Surgery, Chung-Ang University College of 
Medicine, Seoul, South Korea
Introduction: Percutaneous transhepatic gallbladder drain-
age (PTGBD) is a procedure intended to resolve the acute 
cholecystitis mainly in patients with other comorbidities. 
However, the timing of LC after the resolution of an acute 
episode remains controversial.
Methods: From January 2004 to January 2010, cholecystec-
tomy after PTGBD was performed 67 patients with AC. 
Group I members (the early operation group) underwent LC 
within 72 hrs of PTGBD (n = 21), whereas Group II members 
(the delayed operation group) underwent LC at more than 72 
hrs after PTGBD (n = 46).
Results: Mean patient age was 70.8 years (range 32–90) and 
the open conversion rate was similar in the two groups. The 
perioperative complication rate was higher in group I than in 
group II (19.0 vs. 4.3%), but with marginal signifi cance (p = 
0.07). Furthermore, mean operative time was longer in group 
I than in group II (79.3 ± 25.3 vs. 53.7 ± 45.3 (min); p = 
0.02). However, overall hospital stay was non-signifi cantly 
shorter in group I than in group II (10.8 ± 4.5 vs. 14.7 ± 9.3 
(days); p = 0.08).
Conclusions: Open conversion rate and the perioperative 
complication rate were comparable in the two study groups, 
and pros and cons were well balanced between the two 
groups. The fi ndings of the present study indicate that deci-
sions on the timing of cholecystectomy after PTGBD should 
be made based on considerations of patient condition, hos-
pital facilities, and surgical experience.
A-180
LIVER RESECTION ASSISTED BY A 
BIPOLAR RADIOFREQUENCY DEVICE
C. Kyriakides, M. Pai, N. A. Habib and L. R. Jiao
HPB Surgery Hammersmith Hospital, Imperial College 
London, London, UK
Introduction: The only curative procedure to date for liver 
tumors is surgical resection and it still remains a major 
procedure with signifi cant morbidity and mortality. 
Radiofrequency (RF) has been used increasingly for ablation 
and also resection in recent times. Based on this technique a 
new device, “Habib sealer” has recently been developed and 
used clinically. We present our technique of major liver 
resection using this device.
Methods: “Habib sealer” has recently developed and used 
clinically. This is a four electrode bi-polar resection device 
which uses RF energy for tissue necrosis. Following lapa-
rotomy and intraoperative ultrasound, the plane of resection 
was marked 1 cm away from the edge of the lesion. 
Coagulative desiccation was performed along this plane 
using this sealer connected to a RF generator. A zone of 
coagulated liver parenchyma was then divided using a 
scalpel.
Results: Major liver resection has been performed with this 
technique: right or extended left hepatectomy. The median 
length of resection was 120 min with a median blood loss of 
200 mL. No blood transfusions were required and there were 
no intensive care admissions following surgery. There was 
no mortality. None of patients developed postoperative liver 
failure or bile leakage.
Conclusions: Major liver resection using this new device is 
safe and effective. It is much quicker than the conventional 
resection device with a minimum blood loss.
A-181
TOTAL LAPAROSCOPIC RIGHT 
HEPATECTOMY USING EXTRAGLISSON 
APPROACH
K. H. Kim, D. B. Moon, T. Y. Ha, D. H. Jung, S. W. Jung, 
Y. H. Park and H. W. Park
Asan Medical Center, Ulsan University, Seoul, Republic of 
Korea
Laparoscopic major hepatectomy has been performed in 
limited numbers and is not widely used because of safety 
concerns and the signifi cant technical challenge. Here we 
introduce a total laparoscopic right hepatectomy while 
middle hepatic vein was fully exposed for anatomical resec-
tion as a video presentation. 50-year old male patient with 
HBV-LC who underwent 1st time TACE 6 months ago was 
admitted for hepatic resection because of uncontrolled HCC. 
Preoperative CT scan showed about 4 cm sized residual 
viable HCC with lipiodol uptake which was located in right 
anterior segment. Patient had the liver function of Child A 
classifi cation and 132,000/mm3 of platelet count. There was 
no portal hypertension. We planned to perform laparoscopic 
right hepatectomy for which major resection appeared low 
recurrence rate of tumor while remnant liver volume esti-
mated 37% on preoperative volumetric CT scan. After 5 
trocars were inserted along the inverted-L incision, consider-
ing conversion to open surgery, the right glisson was isolated 
and taped using golden fi nger. Right hepatic parenchyma 
were dissected with CUSA and Harmonic scalpel along the 
exposed middle hepatic vein for anatomical resection and 
Pringle’s maneuver was not used. The specimen was removed 
through a 10 cm suprapubic skin incision site. The operative 
time was 380 mins excluding waiting time and blood loss 
was about 400 ml. The patient was discharged on postopera-
tive day 7 without any problem.
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A-182
ROBOT ASSISTED LEFT HEPATECTOMY 
FOR HEPATOCELLULAR CARCINOMA 
IN A CIRRHOTIC PATIENT
K. F. Lee, J. Wong, C. Chong, Y. S. Cheung, J. Wong and 
P. Lai
Department of Surgery, Prince of Wales Hospital, CUHK, 
Hong Kong
Introduction: Robot assisted operation represents the latest 
development in the fi eld of minimally invasive surgery. The 
use of robot allows 3-dimensional image with magnifi cation, 
advanced instruments with 7 degrees of freedom and better 
ergonomics for operating surgeon. We started to apply the da 
Vinci robot system in hepatobiliary and pancreatic surgery 
in September 2010. Here we report our fi rst case of robot 
assisted left hepatectomy.
Methods: A 50-year-old man underwent left hepatectomy 
for a hepatocellular carcinoma located in segment 4b just 
next to left portal vein. Operation started with division of the 
falciform ligament and left triangular ligament. Hilar dissec-
tion was performed and the left hepatic artery and left portal 
vein were freed, ligated and divided. Gallbladder was then 
removed. The liver was transected with a robotic harmonic 
shear and a TissueLink dissecting sealer through assistant 
port. No Pringle maneuver was applied. The left hepatic duct 
and left hepatic vein was divided with endovascular stapler. 
Specimen was retrieved through a Pfanneinstel incision 
within plastic bag.
Result: Operation lasted for 6 hours with blood loss 50 ml. 
Patient was discharged on post-operative day 5. However, 
patient was readmitted for a wound hematoma over the 
Pfanneinstel wound which was treated successfully with con-
servative treatment. Pathology confi rmed a 2.5 cm hepatocel-
lular carcinoma with 2 cm resection margin in a cirrhotic liver.
Conclusion: Robot assisted left hepatectomy was safe and 
feasible. It conveys the same benefi ts of minimally invasive 
surgery like decreased blood loss, shortened hospital stay and 
better cosmesis.
A-183
TOTALLY LAPAROSCOPIC LIVING 
DONOR HEPATECTOMY
N. Jarufe1, F. Moisan1, J. Varas1, J. Martanez1, J. C. Pattillo2 
and M. Sanhueza1
1Digestive Surgery, Pontifi cia Universidad Católica de 
Chile, Santiago, Chile; 2Pediatric Surgery, Pontifi cia 
Universidad Católica de Chile, Santiago, Chile
Introduction: This video reviews our fi rst experience in 
living donor hepatectomy for liver transplantation using a 
totally laparoscopic technique.
Case: A 14 months old child who had a large hepatoblas-
toma (13 × 11 cm) involving both liver lobes. No possibili-
ties for a negative margin resection. Liver transplant was 
determined after systematic chemotherapy with partial tumor 
regression. The donor was his 36 year old father.
Surgical Technique: Five laparoscopic ports were used. 
Pedicle dissection began by identifying the left hepatic artery 
(LHA). Three segment 1 branches arising from the left portal 
vein (LPV) were cut, allowing the isolation of the LPV. The 
hilum plate was dissected until the left bile duct (LBD) was 
identifi ed. Parenchymal transection started in segment 4, 
2 cm to the right of the falciform ligament using harmonic 
scalpel and bipolar. LBD was cut with scissors and the 
remnant LBD was closed with intracorporeal interrupted 4/0 
vicryl stitches. Hem-o-locks® were placed to the LHA and 
LPV near the bifurcation. A long LPV and artery were 
obtained with the graft. LHV was controlled using a non 
cutting ETHICON® ENDO-SURGERY ETS 45 mm stapler. 
The graft was removed using an endobag® through a 
Pfannenstiel incision. The operative time was of 4 hours and 
the estimated bleeding was 150 cc. Post operatory course 
was uneventful and the donor was discharged at the fourth 
postoperative day. There was no liver dysfunction after 
transplant.
Conclusion: Under an experienced laparoscopic hepatobili-
ary surgery team, living donor hepatectomy can be per-
formed safely by a totally laparoscopic approach.
A-185
ISOLATED LAPAROSCOPIC CAUDATE 
LOBE RESECTION: A MODIFIED 
TECHNIQUE
C. Kyriakides, N. Panagiotopoulos, L. Jiao
Hammersmith Hospital, Imperial College London, London, 
UK
Introduction: The local anatomy of the caudate lobe of the 
liver, between the hepatic hilum and the inferior vena cava 
(IVC), presents a surgical challenge when an isolated resec-
tion is attempted. A modifi ed technique is presented in a 20 
year old woman with a 60 × 40 mm lesion.
Methods: The patient presented with epigastric fullness and 
occasional pain. On CT tomography and MRI a 60 × 40 mm 
lesion in the caudate lobe was identifi ed.
Results: Under general anesthesia and the patient in the 
dorsal modifi ed lithotomy position, pneumoperitoneum was 
established through an infraumbilical incision using a Hasson 
trocar. The surgeon was standing between the patient’s legs 
and four trocars were placed, two in the right and two in the 
left upper quadrant (10 mm ports). The falciform ligament 
was divided and the left liver mobilized and retracted to the 
right, exposing the caudate lobe. After opening the gastrohe-
patic ligament, the caudate lobe was carefully dissected off 
the IVC and along the umbilical fi ssure. This was performed 
using a combination of diathermy and Ligasure (LigaSure 
Atlas™) as well as clipping of the small vessels. Pringle 
maneuver was not performed. Once the dissection is com-
plete and full mobilization of the caudate lobe was achieved, 
the parenchyma was divided using a Ligasure device. Total 
operative time was 120 minutes with a blood loss of 100 ml.
Conclusions: Isolated laparoscopic resection of the caudate 
lobe without applying the Pringle maneuver is a safe and 
effi cient technique, with signifi cantly shorter operating time 
and hospital stay.
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CONVERSION OF UNRESECTABLE TO 
RESECTABLE HEPATOCELLULAR 
CARCINOMA BY TRANSARTERIAL 
THERAPY WITH OR WITHOUT PORTAL 
VEIN EMBOLIZATION
P. B. S. Lai, J. Wong, Y. S. Cheung, J. S. W. Wong, 
C. N. Chong and K. F. Lee
Department of Surgery, The Chinese University of Hong 
Kong, HKSAR, China
Introduction: Transarterial therapy notably transarterial 
chemoembolization (TACE) is a form of useful palliative 
treatment for unresectable hepatocellular carcinoma (HCC). 
Successful down-staging of advanced HCC has been 
reported. Portal vein embolization (PVE) may further 
enhance resectability by compensatory hypertrophy of the 
remnant liver. We aimed to analyze the outcome of patients 
who received hepatectomy after these treatments for initially 
unresectable HCC.
Methods: From May 2004 to March 2011, 17 patients with 
unresectable HCC received transarterial therapy with/without 
sequential PVE underwent hepatectomies. Retrospective 
analysis on the outcome of these patients was performed.
Results: Patients’ median age was 51.5 years (range 39–68). 
On initial presentation, reasons for being unresectable were 
large single tumor extending to central lobe (n = 12), and 
multifocal tumors (n = 5). Pre-operatively, fourteen patients 
received TACE with cisplatin, lipiodol and gelfoam. One 
patient received lipiodol-ethanol mixture. Two patients had 
transarterial embolization only. Portal vein embolization was 
performed as an additional procedure in 9 patients (52.9%). 
The mean duration from diagnosis to operation was 9.1 
months. According to the location of the lesions, extended 
right hepatectomy (n = 3), right hepatectomy (n = 10), 
extended left hepatectomy (n = 1), left hepatectomy (n = 1) 
and non-anatomical resection (n = 2) were performed. 
Resection with clear margin was achieved in all but 1 case. 
There was no operation-related mortality. The median fol-
low-up period from diagnosis was 45.6 months (range 5.4–
85.3). The mean survival was 71.3 months.
Conclusions: In selected group of patients with unresect-
able HCC, transarterial therapy with/without PVE can effec-
tively down-stage the disease, such that hepatectomy of 
curative-intent can be safely performed.
A-187
SURGICAL ABLATION OF 
HEPATOCELLULAR CARCINOMA WITH 
2.45-GHZ MICROWAVE: A CRITICAL 
APPRAISAL OF TREATMENT 
OUTCOMES
K. F. Lee, Y. S. Cheung, C. N. Chong, J. Wong and P. Lai
Department of Surgery, Prince of Wales Hospital, CUHK, 
Hong Kong
Introduction: Local ablation therapy now plays a curative 
role in management of hepatocellular carcinoma (HCC). A 
new generation of 2.45-GHz microwave has been used for 
local ablation of HCC by surgical approach in our institute 
since 2009.
Methods: This is a prospective cohort study conducted in a 
university hospital. From March 2009 to January 2011, 26 
consecutive patients with HCC were recruited. Main outcome 
measures were operative mortality and morbidity, rate of 
incomplete ablation, recurrence rate, and survival rate.
Results: Nineteen male and seven female patients of median 
age 62.5 years (range, 49–79 years) underwent microwave 
ablation for HCC (1 tumor, n = 24; 2 tumors, n = 2) using a 
laparoscopic (61.5%) or open approach (38.5%). Five 
patients (19.2%) had recurrent HCC after previous treat-
ments. Median tumor size was 3.75 cm (range, 2–6 cm). 
Complications occurred in fi ve patients (19.2%); only one 
complication was ablation-related. There was no operative 
mortality. One patient experienced incomplete ablation 
(3.8%). Recurrent tumors were noted in 11 patients (42.3%; 
local, n = 5; remote, n = 2; multifocal, n = 4) with a median 
follow-up of 13.6 months (range, 4–26.1 months). The 
failure rate for local disease control was 23.1% and was 
14.3% if patients with initially recurrent HCC were excluded. 
All but one patient survived until the time of censor. Mean 
survival was 25.2 ± 0.89 months.
Conclusion: This new generation microwave technique is 
safe and effective for local ablation of HCC. It is a valuable 
treatment option for patients who are not candidates for 
hepatectomy.
A-188
IMPACT OF SEVERE 
GASTROESOPHAGEAL VARICES ON 
LIVER RESECTION FOR 
HEPATOCELLULAR CARCINOMA IN 
CIRRHOTIC PATIENTS
C-C. Wu1, S-B. Cheng1, H-Z. Yeh2 and C-S. Chang2
1Department of Surgery, Taichung Veterans General 
Hospital, Taichung, Taiwan; 2Department of 
Gastroenterology, Taichung Veterans General Hospital, 
Taichung, Taiwan
Introduction: Liver resection for hepatocellular carcinoma 
(HCC) in cirrhotic patients with portal hypertension is 
usually not advocated. Presence of gastroesophageal varices 
(GEV) is a optical condition of portal hypertension. The 
impact of severe GEV on liver resection for HCC in cirrhotic 
patients remains unclear.
Methods: A retrospective review of 1073 cirrhotic patients 
who underwent liver resection for newly-diagnosed HCC 
between 1994 and 2010 was conducted. According to preop-
erative gastroendoscopic examination, these patients were 
divided into 3 groups; group A (n = 861) no evidence of GEV, 
group B (n = 184) presence of mild GEV (grade F1 or F2); 
group C (n = 32) presence of severe GEV (grade F3 or pres-
ence of red-colored sign (RCS)). The clinicopathological 
characteristics, early and long-term results of the patients 
among the three groups were compared. Preoperative endo-
scopic ligation or sclerotherapy were performed on all group 
C patients. Periodic endoscopic surveillance was performed 
in group B and C patients postoperatively.
Results: The group B and C patients had higher incidence 
of thrombocytopenia and poorer liver function (higher ICG 
R15 level) than group A patients. The ICG R15 was also 
higher in group C than group B. There were no differences 
in postoperative morbidity and mortality among the three 
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groups. The disease-free and overall survival rates among the 
three groups were also not signifi cant.
Conclusions: With preoperative endoscopic ligation or 
sclerotherapy for severe GEV, liver resection for HCC 
remains justifi ed in cirrhotic patients with severe GEV.
A-189
LONG-TERM OUTCOMES OF REPEAT 
HEPATIC RESECTION IN PATIENTS 
WITH RECURRENT HEPATOCELLULAR 
CARCINOMA AND ANALYSIS OF 
PROGNOSTIC FACTORS
Z. Huang1, B.Y. Liang1, M. Xiong2 and X. P. Chen1
1Hepatic Surgical Center, Tongji Hospital; 2Department of 
Gynecology, Tongji Hospital
Objective: The purpose of this study was to investigate the 
outcomes of repeat hepatic resection and prognostic factors 
in patients with different types of recurrent hepatocellular 
carcinoma (HCC).
Summary Background Data: Recurrent HCC after cura-
tive resection usually originates from intrahepatic metastasis 
(IM) or multicentric occurrence (MO). The long-term out-
comes of repeat hepatic resection in patients with different 
types of recurrence have not been evaluated in a large number 
of patients. The surgical indications for recurrent HCC 
remain controversial.
Methods: Eighty-one patients undergoing repeat hepatic 
resection for recurrent HCC were retrospectively studied. 
The recurrent type was evaluated by histopathologic analysis 
of primary and recurrent HCC. The survival rates and prog-
nostic factors of the patients with different types of recur-
rence were analyzed.
Results: Forty-four patients (54.3%) had confi rmed IM, and 
37 patients (45.7%) had MO. Both the recurrence-free and 
overall survival rates in the MO patients after initial or repeat 
resection were signifi cantly higher than those in the IM 
patients (p < 0.001). Recurrence-free time was identifi ed as 
the most signifi cant differentiating factor between MO and 
IM. A recurrence-free time of greater than 18 months after 
initial resection was a signifi cant cutoff time-point for dif-
ferentiating between MO and IM.
Conclusions: Repeat hepatic resection resulted in much 
higher survival rates in the MO patients than in the IM 
patients. Repeat hepatic resection should be recommended 
for those patients in whom the recurrent HCC occurs greater 
than 18 months after initial resection.
A-190
RADIOFREQUENCY ABLATION VERSUS 
HEPATIC RESECTION FOR THE 
TREATMENT OF HEPATOCELLULAR 
CARCINOMA SMALL THAN 2 CM
Z.-W. Peng1,2, Y.-J. Zhang1,2 and M.-S. Chen1,2
1Department of Hepatobiliary Surgery, Cancer Centre of 
Sun Yat-Sen University, 651 Dongfeng Road East, 
Guangzhou 510060, China; 2State Key Laboratory of 
Oncology in Southern China, Guangzhou 510060, China
Introduction: To compare retrospectively, the effects of 
radiofrequency ablation (RFA) with hepatic resection (HR) 
for the treatment of hepatocellular carcinoma (HCC) ≤2 cm.
Methods: From December 2003 to December 2008, 145 
patients with single resectable HCC ≤2 cm were studied. 
“Central HCC” was defi ned as tumor located 3 cm or more 
away from liver capsule. As an initial treatment, 71 patients 
were treated by PRFA and 74 patients by SR. There were 37 
patients and 29 patients with central HCC receiving PRFA 
or SR, respectively.
Results: Major complications occurred signifi cantly more 
often in SR group (38/74) than that in PRFA group (n = 
14/74) (p = 0.009). The 1-, 3-, 5- year overall survival after 
PRFA and SR were 98.5%, 87.7%, 71.9% and 90.5%, 70.9%, 
62.1%, respectively. (p = 0.048), and the corresponding 
recurrence-free survival after PRFA and SR were 76.4%, 
65.2%, 59.8% and 75.6%, 56.1%, 51.3%, respectively. (p = 
0.548). On subgroup analyses, for patients with central HCC, 
the 1-, 3-, 5- year overall survival after PRFA and SR were 
96.6%, 93.0%, 79.9% and 92.0%, 71.6%, 61.5%, respec-
tively. (p = 0.020). The corresponding recurrence-free sur-
vival after PRFA and SR were 86.5%, 74.0%, 67.0% and 
68.0%, 40.0%, 40.0%, respectively. (p = 0.033). For patients 
with peripheral HCC, 1-, 3-, 5- year overall survival after 
PRFA and SR were 97.3%, 83.3%, 65.1% and 87.8%, 68.4%, 
62.9%, respectively. (p = 0.464) The corresponding recur-
rence-free survival after PRFA and SR were 68.7%, 59.2%, 
54.9% and 82.9%, 66.6%, 52.9%, respectively. (p = 0.351).
Conclusion: PRFA had better effi cacy and safety than that 
for SR for HCC ≤2 cm, especial for patients with central 
HCC.
A-191
18F-FLUOROCHOLINE PET/CT FOR 
DETECTION OF HEPATOCELLULAR 
CARCINOMA AND EVALUATION OF THE 
EXTEND OF DISEASE
M. Bieze1, Y. El Massoudi1, T. M. van Gulik1, 
S. S. K. S. Phoa2 and R. J. Bennink3
1Department of Surgery, Academic Medical Center, 
Amsterdam, the Netherlands; 2Department of Radiology, 
Academic Medical Center, Amsterdam, the Netherlands; 
3Department of Nuclear Medicine, Academic Medical 
Center, Amsterdam, the Netherlands
Abstract: Positron emission tomography (PET) using a 
glucose-tracer has shown no accuracy in diagnosis of (meta-
static) hepatocellular carcinoma (HCC). The aim of this 
study was to assess the accuracy of the 18F-fl uorocholine 
tracer in detection of HCC.
Methods: Fourteen consecutive patients with HCC and one 
with hepatoblastoma were included. Fifteen minutes after 
intravenous injection of FCh, a whole-body PET and CTscan 
were performed. All patients underwent a baseline-PET, 3 
patients a treatment-control-PET, and 2 a follow-up-PET. 
Standard of reference was two imaging studies (MR, CT, or 
ultrasound) if histopathological diagnosis was not obtained. 
The standardized uptake values (SUV) of the lesion and sur-
rounding tissue were assessed, and the SUV-ratio calculated 
(SUV-ratio >1.15 was found positive).
Results: Diagnostic work-up revealed 33 hepatic lesions. 
Histopathological diagnosis (n = 15) showed 5 well-
differentiated HCC (5/5 uptake), 6 moderately/poorly-
differentiated (2/6 uptake), and 1 post-RFA lesion without 
signs of active tumor (no uptake). Five lesions were detected 
 Concurrent Sessions: Submitted Abstracts 125
HPB © 2011 International Hepato-Pancreato-Biliary Association, HPB, 13 (Suppl. 3), 65–159
on FCh-PET, additional MR showed HCC. Six abdominal 
lesions; 3 proved HCC (2/3 uptake), 3 detected on FCh-PET 
(additional imaging proved metastases). Three lung lesions 
were detected on FCh-PET; One proved tuberculosis, 2 are 
followed-up. Three patients underwent follow-up PET and 
progressive/metastatic disease was detected by FCh-PET in 
lung and abdomen of 2 patients, corroborated by additional 
imaging.
Conclusions: These preliminary results show that FCh-PET/
CT potentially detects well-differentiated HCC and some 
moderately-differentiated HCC. FCh-PET/CT may be of 
value in addition to conventional imaging, providing a means 
for non-invasive evaluation and follow-up of HCC and 
hepatoblastoma.
A-192
MIRIZZI SYNDROME: A 
RETROSPECTIVE REVIEW OF A TEN 
YEAR EXPERIENCE AT A NATIONAL 
HPB REFERRAL CENTER
H. Thamutaram, K. Raman and H. Singh
Department of Hepato-Pancreato-Biliary Surgery and 
Liver Transplantation, Hospital Selayang, Selayang, 
Malaysia
Introduction: Mirizzi Syndrome is a rare clinical entity, the 
surgical management of which is associated with high mor-
bidity and has implications in the laparoscopic era of chole-
cystectomy. This is a retrospective case series of 30 
consecutive cases managed at our centre over a ten year 
period. The aim of this study is to analyze the clinical pre-
sentation, management and clinical outcome with a special 
reference to pre-operative diagnosis and safe, complete 
cholecystectomy.
Methods: Clinical notes of patients managed in our center 
from January 2000 to August 2010 were analyzed.
Results: Total number of cases was 30. 26 cases were diag-
nosed pre operatively. 23 patients were classifi ed type 1 and 
7 patients were deemed type 2. Patients with type 1 disease 
underwent open cholecystectomy. Among the type 2 patients, 
three patients underwent open cholecystectomy and choled-
ochoplasty. Four patients were treated with hepaticojejunos-
tomy. Mean follow up period was 16.5 months.
Conclusions: Pre-operative diagnosis of Mirizzi Syndrome 
requires a high degree of suspicion and prudent use of appro-
priate adjuncts. Open, complete cholecystectomy in patients 
with Type 1 disease is a safe procedure in experienced hands.
Keywords: Mirizzi Syndrome, Open cholecystectomy, 
Cholelithiasis
A-193
MODIFIED SINGLE PORT 
LAPAROSCOPIC SURGERY USING 
“HOLD PORT”–APPENDECTOMY, 
CHOLECYSTECTOMY
S. H. Bae and C. H. Kim
Soonchunhyang University, Cheonan, Korea
Introduction: Currently the laparoscopic surgery has been 
active in the full range of surgical procedures and single port 
laparoscopic surgery is gradually being expanded in this situ-
ations; appendectomy, cholecystectomy. However, according 
to the surgeon’s expertise and accumulated experience, the 
operative time and its complications has been reported vari-
ably. To overcome these problems, we will introduce the 
surgical methods using the auxiliary device (2 mm, Hold 
port, NELISR) in appendectomy and cholecystectomy.
Methods: Patients who underwent appendectomy were 
focal or suppurative types and who underwent cholecystec-
tomy were non-infl ammatory gallbladder stones or gallblad-
der polyps. Enrolled patients were judged on the basis of 
computed tomography. First, after insertion of single port 
through umbilical incision, we inserted aids in RUQ abdomen 
and dissected mesoappendix by traction and rotation in 
appendectomy. And we inserted hold port in RUQ area in 
cholecystectomy, and if needed, inserted another port.
Results: We could proceed to surgery without diffi culty and 
extension of operative time, even if less experienced surgeon.
Conclusions: On single port laparoscopic surgery, the oper-
ation using hold port is a technically feasible and it might be 
thought that will reduce the operative time and learning 
curve.
A-194
A NEW SURGICAL APPROACH FOR THE 
GALLBLADDER TUMOR – AIM FOR 
APPROPRIATE OPERATION
S. Sawada, S. Sekine, I. Yoshioka, K. Matsui, R. Hori, 
T. Okumura, T. Yoshida, T. Nagata, H. Uotani, Y. Shimada 
and K. Tsukada
Department of Surgery and Science, University of Toyama, 
Toyama, Japan
Introduction: Despite recent advances in imaging tech-
niques, we sometimes experience the patient who we could 
not perfectly exclude gallbladder cancer preoperatively. For 
such patients, we propose a new surgical approach by per-
forming a simple but adequate operation.
Methods: In the fi rst operation we perform whole layer 
cholecystectomy and then replace with the great omentum in 
order to cover the liver bed and surgical fi eld. If the resected 
specimen showed the subserosa invasion gallbladder cancer, 
we performed a second operation. In the second operation, 
we resected the extrahepatic bile duct for lymph node 
dissection and we also resected the liver bed concomitant 
with the resection of the great omentum which was used to 
pack the surgical area. If there is no malignancy or early 
gallbladder cancer, we would then just follow up the patient. 
Between October 1997 and December 2010 we performed 
whole layer cholecystectomy with this procedure for 31 
patients.
Results: Thirteen patients (41.9%) were pathologically 
diagnosed as having gallbladder carcinoma. Among them, 
eight patients (61.5%) were diagnosed with subserosa inva-
sion and we performed a second operation for seven of the 
eight patients. Five of seven patients are still alive without 
recurrence. The other two patients had recurrence to the 
lymph nodes, however there were no patients with peritoneal 
dissemination.
Conclusion: Great omentum covering method enables us to 
perform the second operation more safely with few adhe-
sions and helps protect tumor dissemination. Our two-step 
surgical approach is reasonable for the patients who we could 
not perfectly exclude gallbladder cancer preoperatively.
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A-196
ANALYSIS FOR ENHANCEMENT 
PATTERN OF DIFFUSE GALLBLADDER 
WALL THICKENING: IS IT HELPFUL TO 
DIFFERENTIATE BETWEEN TUMORS 
AND OTHER BENIGN DISEASES OF GB?
K. H. Ko and S. P. Yun
CHA Bundang Medical Center, CHA University, 
Seongnam, Korea
Introduction: Gallbladder (GB) wall thickening on CT scan 
is challenging to physicians. Some studies suggested that 
analyzing the pattern of gallbladder wall enhancement is 
helpful to characterize a diffuse gallbladder wall thickening 
as benign or malignant. The objective of our study is to 
defi ne the pattern of GB wall thickening for classifying the 
diagnosis.
Methods: Abdominal computed tomography images and 
pathologic results were obtained from 60 patients who under-
went cholecystectomy due to diffuse gallbladder wall thick-
ening were reviewed retrospectively. Enhancement patterns 
were divided into 5 types. We compared CT fi ndings with 
the pathologic results and categorized pathologic fi ndings as 
benign infl ammatory diseases and tumors. Tumors include 
adenomyoma, adenomyomatosis, and adenocarcinoma.
Results: Enhancement was classifi ed as one of the follow-
ing fi ve patterns. Type 1 pattern was a heterogeneously 
enhancing one-layer gallbladder wall; type 2, strongly 
enhancing thick inner layer and weakly enhancing outer 
layer; type 3, borderline enhancement and thickness of the 
inner layer with small cystic spaces and non-enhancing outer 
layer; type 4, weakly enhancing thin inner layer and non-
enhancing thin outer layer; type 5, weakly enhancing thin 
inner layer and non-enhancing thick outer layer. Type 1 and 
3 showed tendency for tumorous condition but no statistical 
signifi cance between gallbladder wall enhancement patterns 
and pathologic causes of diffuse gallbladder wall thickening 
was found (Table 1).
Conclusion: Analyzing the enhancement pattern of a diffuse 
gallbladder wall thickening on CT may be helpful in distin-
guishing gallbladder tumor from benign lesion. The study 
with more patients and scoring system of GB wall thickening 
on CT scan to simplify the patterns is needed to apply this 
result for clinical use.
A-197
EFFECT OF TRANSARTERIAL 
CHEMOEMBOLIZATION ON EARLY 
RECURRENCE OF HEPATOCELLULAR 
CARCINOMA AFTER SURGICAL 
RESECTION IN A SINGLE CENTRE
L. Kwek, J. K. Low and W. Woon (Presented by: T. Huey)
General Surgery, Tan Tock Seng Hospital, Singapore, 
Singapore
Introduction: Hepatocellular carcinoma (HCC) is the third 
most common cause of cancer related death worldwide. 
Although surgical resection and liver transplantation are 
known to prolong survival, recurrence is common.
We aim to evaluate the effect of transarterial chemoemboli-
zation (TACE) on early recurrent HCC after curative 
resection.
Methods: Between January 2007 to December 2010, 51 
patients with HCC who had undergone radical resection with 
curative intent, were identifi ed from a prospectively col-
lected database in a single centre. Out of these patients, 30 
patients (59%) have early (<6 months) local recurrence and 
25 (16.7%) underwent TACE. The effi cacy of TACE on this 
group of patients was evaluated.
Results: 7 (13.7%) patients presented initially with multifo-
cal HCC and 1 (2%) had both HCC and rectal carcinoma. 
The mean tumor size was 5.8 cm ± 3.7 cm. 66.7% of the 30 
patients had a single nodule. The mean size of the recurrence 
HCC was 3.2 cm ± 2.5 cm. Out of these 25 patients who had 
undergone TACE, 15 (60%) of them had multiple attempts 
at TACE for repeated recurrences. Out of these 15 patients, 
7 (28%) had 2 attempts at TACE, 6 (24%) 3 attempts and 2 
(8%) had ≥4 attempts. The overall survival after TACE was 
92%, 88% and 85% at 1, 1.5 and 2 years. Although there 
were 4 (16%) patients treated for sepsis, there was no mortal-
ity associated with the procedure.
Conclusions: TACE is a safe and effective procedure with 
minimal mortality and morbidity for treatment of recurrent 
HCC post curative resection. It can be used repeatedly in 
patients with multiple recurrences.
A-198
ENCAPSULATION IS A SIGNIFICANT 
PROGNOSTIC FACTOR FOR BETTER 
OUTCOME IN LARGER 
HEPATOCELLULAR CARCINOMA
C. W. Lee1, M. C. Yu1,2, T. H. Wu1, C. F. Lee1, K. M. Chan1, 
T. C. Chen3, H. S. Chou1, W. C. Lee1 and M. F. Chen1
1Department of General Surgery, Division of 
Transplantation and Liver Surgery, Ch; 2Graduate Institute 
of Clinical Medical Sciences, Chang Gung University, 
Taoyuan, Taiwan; 3Department of Pathology, Chang Gung 
Memorial Hospital, Chang Gung University College of 
Medicine, Taipei, Taiwan 
Background: The aim of this study was to determine the 
effect of tumor encapsulation of hepatocellular carcinoma 
(HCC) on long-term survival.
Methods: A retrospective review of 1240 patients who 
underwent hepatectomy from January 1993 to June 2005 was 
conducted. There were 891 patients with tumor encapsula-
tion (EC type) and 349 patients without tumor encapsulation 
(NC type). Clinicopathological factors, surgical outcome, 
and long-term survival were analyzed.
Results: Disease-free survival (DFS) was affected by surgi-
cal margin involvement, the presence of surgical complica-
tions, vascular invasion, liver cirrhosis, tumor encapsulation, 
tumor size >5 cm, tumor rupture, and the presence of satellite 
lesions (all, p < 0.05). Overall survival (OS) was also affected 
by the same parameters, except for satellite lesions. When 
the patients were grouped by tumor size >5 cm or ≤5 cm, the 
protective effect of encapsulation was only observed when 
the tumor size was >5 cm (odds ratio [OR] for DFS = 0.75, 
p = 0.02; OR for OS = 0.68, p < 0.01)
Conclusions: Tumor encapsulation is a signifi cant prognos-
tic factor for HCC >5 cm.
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A-199
IDEAL SURGICAL STRATEGY OF SMALL 
SIZED NONFUNCTIONING PANCREATIC 
NEURENDOCRINE TUMORS
M. J. Kim, D. W. Choi, S. H. Choi, J. S. Heo, H. J. Park 
and K. K. Choi
Samsung Medical Center, Seoul, Korea
Introduction: Although small sized pancreatic neuroendo-
crine tumors (PNETs) are known to have low risk of recur-
rence after complete resection, the prognostic factors and 
management guidelines are not well known. The aim of this 
study is to identify the ideal surgical strategy of small 
sized nonfunctioning pancreatic neuroendocrine tumors 
(NFPNETs)
Methods: The medical records of all patients who under-
went pancreatic resection for NFPNETs between 1994 and 
2010 were reviewed. The survival and clinical outcomes 
were analyzed.
Results: Of 168 consecutive patients surgically treated for 
proven primary PNET, 51 patients underwent complete 
removal of NFPNET with the greatest dimension of the 
resected specimen was 2 cm or less. Thirty-nine tumors 
(75%) were classifi ed as benign, 12 (25%) as malignant. Of 
the malignant, 3 (12%) patients who underwent standard 
pancreatoduodenectomy showed recurrence at a median 
follow-up time of 26 months. Two recurrent patients under-
went adjuvant chemotherapy. The patient who did not 
received adjuvant therapy died 8 months after operation. A 
high mitotic index was a predictor of recurrence (p < 0.001), 
but that tumor size, method of resection were not.
Conclusions: NFPNETs can display aggressive behavior. 
Therefore we recommend performing standard surgical 
resection rather than limited resection and careful postopera-
tive surveillance even in small sized NFPNETs. Further, 
active systemic adjuvant therapy is necessary if the patients’ 
pathologic stage shows malignant features with high mitotic 
(> or =2/10 HPF) count.
Keywords: Pancreatic neuroendocrine tumor, 
Nonfunctioning tumor, Small nonfunctioning pancreatic 
neuroendocrine tumor
A-200
WHAT ARE THE RISK FACTORS FOR 
NAFLD AFTER 
PANCREATODUODENECTOMY?
S. Takayuki, S. Mitsugi, K. Takayuki, K. Masato, 
S. Tokihiko and K. Kubota
Second Department of Surgery, Dokkyo Medical University
Aim: Pancreatoduodenectomy (PD) is the operation with 
big damage for patient. After operation, we often encoun-
tered patients who showed poor intake or weight loss and 
some patients had sever fatty liver. In this study, we exam-
ined what was the cause of NAFLD after PD.
Materials and Methods: Eighty-Three patients who had 
undergone PD between January 2008 and Dec. 2010 were 
included in this study. We divided patients into two groups 
in NAFLD group (N-G) and non-NAFLD group (non N-G). 
We compared the risk factors between the two groups in 
below risk factors, BMI, Labo data (GOT, GPT, ALT, γ-GTP, 
total protein, albumin, Na, K, Cl, glucose), blood cell count 
and trace elements (Fe, Zn, Cu, pre-albumin) were evaluated 
preoperatively, 1-week, 3-week, and 3 months after surgery. 
NAFLD was defi ned as the condition that neither HU value 
was less than 40 HU nor spleen/liver HU ratio was more than 
1.5 using abdominal CT three months after operation. One 
of the two reconstruction methods, R-Y or modifi ed 
Traverso’s method (B-II) was selected. After operation, all 
patients received TPN with 2 ml of trace element drug.
Result: There was no postoperative death. Twenty-four of 
the 83 patients had NAFLD within three months after opera-
tion. In NG, pre operative AST, ALT, γ-GTP, Fe and Zn were 
signifi cantly higher than in non N-G (p < 0.05). Fe and Zn 
were signifi cantly higher than in non N-G one week after PD 
(p < 0.05).
Conclusion: Preoperative liver function, elevated Fe and Zn 
levels were high risk factors for NAFLD after PD.
A-201
PERI-OPERATIVE OUTCOMES AND 
FACTORS INFLUENCING 
CONVALESCENCE AFTER 
LAPAROSCOPIC CHOLECYSTECTOMY
S. Lokman, M. R. S. Siddiqui, J. Barry, K. Lodha 
and F. Hasan
Benenden Hospital
Introduction: Laparoscopic cholecystectomy is a common 
surgical procedure yet little is known about convalescence 
after surgery. We conduct a database review to analyze peri-
operative outcomes and factors infl uencing return to normal 
daily activities and work.
Methods: 658 patients had a laparoscopic cholecystectomy 
for proven gallstones between 9/4/2001 and 15/2/2006.
Results: 431 patients replied at a mean follow up of 22.4 
months. Mean operating time was 75.1 minutes. Patients 
stayed in hospital for an average 2.96 days. 1.3% required 
blood transfusions. In the immediate post-operative period 
infection occurred in 9.3%. Overall we experienced a 97.2% 
satisfaction rate. Blood transfusions (Beta = 0.180, p < 
0.004), hospital stay (Beta = 0.185, p < 0.003) and conver-
sion to open (Beta = 0.253, p < 0.001) were signifi cant 
predictors of return to normal daily activities Operation time 
was a non signifi cant predictor (Beta = 0.088, p < 0.162) of 
return to normal activity. There was a signifi cant correlation 
with number of complications (r = 0.29, p < 0.001) and return 
to normal activity. Number of days to return to normal activi-
ties was a signifi cant predictor (Beta = −0.486, p < 0.001) of 
return to work and there was a signifi cant correlation with 
the number of complications (r = 0.205, p < 0.001).
Conclusions: Blood transfusions, hospital stay and conver-
sion to open may impact on patient convalescence after lapa-
roscopic cholecystectomy. Return to employment may be 
infl uenced by return to normal activities and number of post-
operative complications.
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A-202
AUDIT OF THE MANAGEMENT OF 
MAJOR POST 
PANCREATICODUODENECTOMY 
BLEEDING (EARLY AND DELAYED) AT 
QUEEN ELIZABETH HOSPITAL, 
BIRMINGHAM
N. Houli and D. Mirza
HPB and Liver Transplant Unit, Queen Elizabeth Hospital, 
Birmingham
Introduction: Management of post pancreaticoduodenec-
tomy (PD) major bleeding is very challenging. It requires 
careful coordination between the surgeon, the interventional 
radiologist, endoscopist and intensive care unit. There is little 
in literature regarding the best approach.
Methods: We present on retrospective analysis of clinical 
presentation, risk factors and management of post pancreati-
coduodenectomy major bleeding in a major HPB unit over a 
5 year period.
We analyzed age, gender, postop interval between pancreati-
coduodenectomy and bleeding, sentinel bleed, cause and 
source of bleeding, risk factors for bleeding, clinical grading 
of severity and management.
Results: 452 pancreaticoduodenectomy were done in this 
period. 22 patients had post PD major bleeding. Severe bleed 
was defi ned as bleed from drain or GIT requiring transfusion 
of at least 4 units of RBC within 24 hours, fall of HB level 
by 3 g/L and need for more invasive treatment.
10 patients had early bleeding (<24 hrs) and 12 had late 
bleeding (>24 hours). The most common site of bleeding was 
from pancreatic parenchyma. In early group, 8 out of 10 had 
pancreatic anastomosis bleeding that required early return to 
theatre.
In late group, 7 out of 12 had grade C pancreatic leak and 
sepsis and were associated with 50% mortality regardless of 
management undertaken. The favored management was 
angiographic embolization, but this was associated with high 
mortality and high morbidity.
Conclusions: Management of early post PD bleeding needs 
immediate surgery. Late post PD bleeding is associated with 
pancreatic leak and sepsis and is associated with high mortal-
ity. Angiography is still the gold standard modality of inves-
tigation and therapy, but perhaps we need to consider the use 
of covered stents and avoid embolization of major hepatic 
arteries.
A-204
ENDOSCOPIC MANAGEMENT OF POST 
CHOLECYSTECTOMY BILIARY FISTULA
M. Hii, S. Banting, R. Cade, D. Gyorki and K. Sakata
St Vincents Hospital, Fitzroy, Australia
Background: Bile duct injury is an uncommon but poten-
tially serious complication of cholecystectomy. A recognized 
treatment of minor biliary injury is internal biliary decom-
pression by endoscopic retrograde cholangio-pancreatogra-
phy (ERCP) and stent insertion. A retrospective review was 
performed to assess the effectiveness of this intervention.
Methods: A retrospective medical record review at a ter-
tiary referral centre identifi ed 36 patients treated for postop-
erative minor biliary injuries between 2006 and 2010. 
Management involved establishing a controlled biliary fi stula 
followed by ERCP to confi rm the nature of the injury and 
decompress the bile duct with stent insertion.
Results: Controlled biliary fi stulae were established in all 
36 patients. Seven patients had resolution of bile leak prior 
to ERCP. ERCP with stent insertion was successful in 27 of 
the remaining 29 patients. All patients achieved resolution of 
bile leak without further intervention. After successful ERCP 
median time to resolution was four days. Two patients had 
ERCP complicated by mild pancreatitis. No other complica-
tions were seen.
Conclusions: This review confi rms that postoperative minor 
biliary injuries can be managed by sepsis control and semi-
urgent endoscopic biliary decompression.
A-205
THE EFFECTS OF GEMCITABINE IN 
HUMAN GALLBLADDER CARCINOMA 
CELL LINES
S. Sekine, S. Sawada, M. Moriyama, T. Omura, S. Hojo, 
R. Hori, K. Matsui, I. Yoshioka, T. Okumura, T. Yoshida 
and T. Nagata
Department of Surgery and Science, Unversity of Toyama, 
Toyama, Japan
Introduction: Gemcitabine (GEM) is frequently adminis-
tered chemotherapeutic agents for gallbladder carcinoma 
patients. On the other hand, deoxycytidine kinase (DCK) 
mediates the rate-limiting catabolic step in the activation of 
GEM. Using new GBC cell line (TYGBK-1), we searched 
for the GEM sensitivity in GBC.
Methods: We analyzed the sensitivity of three human GBC 
cell lines (TYGBK-1, NOZ, TGBC2TKB and G-415) to 
gemcitabine by MTT assays. We also examined the associa-
tion between expression levels of dCK and GEM sensitivity. 
The effects of GEM on cell cycle were analyzed by fl ow 
cytometry.
Results: TYGBK-1 cell showed high sensitivity to gem-
citabine. We were able to classify these cell lines into two 
groups: a gemcitabine-sensitive group (TYGBK-1, NOZ) 
cells and a gemcitabine-resistant (TGBC2TKB, G-415) cells, 
whose IC50 values were beyond the range of our measure-
ment (>100 μM). Furthermore, expression of DCK was asso-
ciated with GEM sensitivity of GBC cell lines. In the cell 
cycle effects, of TYGBK-1, the percentage of cells in S phase 
increased.
Conclusions: We established GEM sensitive GBC cell line. 
DCK gene expression was associated with GEM sensitivity 
of GBC cell lines. Our results suggested that DCK gene 
expression of the tumor may predict GEM sensitivity.
A-206
PERFORMANCE OF GLASGOW’S AND 
RANSON’S SCORING SYSTEMS IN 
PREDICTED SEVERE ACUTE 
PANCREATITIS IN AN ASIAN 
POPULATION
K. Teh, S. Iyer, T. W. V. Lee, K. Y. S. Chang 
and K. Madhavan K
National University Health System, Singapore
Introduction: The aim of this paper is to evaluate perfor-
mance of Glasgow’s and Ranson’s scoring in predicted 
severe acute pancreatitis in an Asian population.
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Methods: Patients between 18–99 years with severe acute 
pancreatitis from January 2007 to December 2009 were 
included. Inclusion criteria were: Ranson score ≥3, Glasgow 
score ≥3 or CT scan fi ndings indicating local complications. 
Patients were considered to have truly severe episodes if they 
required intensive care unit management, had hospital stays 
>7 days or died. Charlson’s comorbidity index was added in 
Logistic regression model for mortality prediction.
Results: Of the 261 patients admitted with acute pancreati-
tis, 100 were included in the study. Ranson’s score ≥3 had 
sensitivity of 88.64%, specifi city of 7.14% and PPV of 
42.87% for severe pancreatitis. The Glasgow score ≥3 had 
sensitivity 88.64% and specifi city 17.86% and PPV of 
45.88%. The mortality for Ranson’s criteria was 11–15% 
with score ≥3, 40% with score ≥6, for Glasgow’s criteria 
4.0% with score 3–5, 33.3% with ≥6. The AUC for mortality 
prediction for Ranson’s was 0.88 (p = 0.002, 95% CI 0.77 to 
0.99) which improved to 0.94 (p = 0.00, 95% CI 0.88 to 0.99) 
with addition of Charlson’s comorbidity index. The AUC for 
mortality prediction for Glasgow’s was 0.85 (p = 0.004, 95% 
CI 0.72 to 0.98) which improved to 0.93 (p = 0.00, 95% CI 
0.87 to 0.99) with addition of Charlson index.
Conclusions: Both scoring systems have a high sensitivity 
but low specifi city. Adding Charlson’s comorbidity index 
improves mortality prediction.
A-207
THE SOLID-PSEUDOPAPILLARY 
TUMORS OF THE PANCREAS: CLINICAL 
ANALYSIS OF 17 CASES
X-T. Zhi, Z-L. Li and T. Li
Department of General Surgery, Qilu Hospital of Shandong 
University, Jinan, P.R. China
Introduction: The solid-pseudopapillary tumor of the pan-
creas (PSPT) was a rare and easily misdiagnosed tumor. We 
ever treated 17 patients with PSPT and analyzed 
retrospectively.
Methods: The clinical data of the seventeen patients with 
PSPT treated at our hospital from January 2006 to December 
2009 were reviewed retrospectively.
Results: Of the 17 patients (ranged 15~43 years with 
median age 24.3 years), one was male, the others were 
female (the ratio was 1:16). Clinical presentations included 
palpable abdominal mass in fi ve patients and abdominal dis-
tention and pain in eight, and four patients were asymptom-
atic. Ultrasonography revealed solid and solid-cystic masses 
of low echo in pancreas. CT scan found masses with low 
density in pancreas, while irregular enhancement appeared 
in the circumference or parenchyma of all tumors in enhanced 
CT scan sequences. The serum tumor markers were all nega-
tive. Only four patients were diagnosed as PSPT preopera-
tively by ultrasound guided fi ne-needle aspiration biopsy. 
The locations of the tumors were: 7 in the head and 10 in the 
body and tail of the pancreas. All the cases were treated 
surgically, including pancreaticoduodenectomy (5 cases), 
distal pancreatectomy (4 cases), distal pancreatectomy plus 
spleen resection (6 cases), and simple tumor resection (2 
cases). The average diameter of the tumors was 8.2 cm 
(ranged 3~20 cm). The pathological results verifi ed the 
PSPT with no or low malignant potential. No major morbid-
ity and mortality occurred. All the patients were followed up 
ranging from 3 to 47 months (average 21.6 months). No 
evidence of recurrence and metastasis was found during the 
follow-up period.
Conclusions: The PSPT is a rare tumor with no or low 
malignant potential, and more preferred to young female. CT 
and MRI have comparative characteristics and are extremely 
important for the diagnosis. B ultrasound or CT guided pre-
operative abdominal fi ne-needle aspiration biopsy could 
confi rm the diagnosis. Surgical resection is generally cura-
tive and the prognosis is excellent. Postoperative patients 
should be closely followed, especially for those with the 
pathological invasion potential.
Keywords: Solid-pseudopapillarytumors; Pancreatic neo-
plasms; Pancreaticoduodenectomy; Distal pancreatectomy
A-208
OUTCOME ANALYSIS OF 
PANCREATICODUODENECTOMY AT A 
LOW VOLUME GOVERNMENT FUNDED 
TERTIARY CARE PUBLIC HOSPITAL IN 
INDIA
U. C. Biswal, R. A. K. Singh, N. Saxena and D. Poddar
GGSIP University, New Delhi, India
Background: Pancreaticoduodenectomy (PD) is a high-
risk, technically demanding operation associated with sub-
stantial perioperative morbidity and mortality. There is an 
abundance of evidence in literature regarding the positive 
impact of hospital volume on the outcome of pancreatico-
duodenectomy. The purpose of our study is to demonstrate 
that good outcomes can be achieved in a well managed low 
volume government funded tertiary care public hospital.
Patients and Methods: We retrospectively analyzed patho-
logic fi ndings, morbidity, mortality and one year survival in 
31 patients who underwent pancreaticoduodenectomy in a 
single General Surgery unit at Dr. Ram Manohar Lohia 
Hospital, New Delhi, India over a 7 year period and com-
pared these results with recently published reports for cases 
of pancreaticoduodenectomy.
Results: The morbidity was 52% and the 30-day mortality 
rate was zero. The anstomotic leak rate was 9.2%, which is 
not statistically different from that reported in literature. The 
average operating time was 470 mins and the length of hos-
pital stay was 16.2 days, which is marginally more than that 
in high volume centers. One year survival rate at Dr. Ram 
Manohar Lohia Hospital (82%) is higher than that reported 
from high volume centers (upto 79%). The postoperative 
complication rate was 12%, the most common complication 
was delayed early gastric emptying. These results of PD, 
though a small series, are comparable to international stan-
dards. A statistical difference in morbidity exists between the 
results at Dr. Ram Manohar Lohia Hospital and that from 
high volume centers.
Conclusions: Therefore, in low volume government funded 
public hospitals in developing countries, pancreaticodude-
nectomies can be performed safely in centers where a dedi-
cated team with special interest in pancreatic surgery is in 
place and the expertise and care pathways necessary for 
improved results are available.
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A-209
PANCREAS-PRESERVING DUODENAL 
RESECTION, “CONVENTIONAL” 
SURGERY OR MEDICATION FOR 
DUODENAL DYSTROPHY TREATMENT?
V. I. Egorov1, A. C. Vankovich1, N. I. Yashina1, R. V. 
Petrov1, T. L. Silina2, V. K. Lyadov2 and V. Sinitsin V2
1Vishnevsky Institute of Surgery, Moscow, Russia; 2Medical 
and Rehabilitation Centre, Moscow, Russia
Introduction: Duodenal dystrophy (DD) is a chronic pan-
creatitis (CP) in the aberrant gland located in the duodenal 
wall. Proposals for its management vary between pancreati-
coduodenectomy (PD) and conservative treatment.
Objective: To assess clinical features and results of medica-
tion and surgery for DD treatment.
Methods: Retrospective analysis of 45 case reports of the 
DD cystic forms treatment (2005–2011).
Results: Constant or relapsing abdominal pain was revealed 
in 100%, weight loss in 29 (64.4%), vomiting in 14 (31%) 
and jaundice in 11 (24.5%) of cases. The most precise diag-
nostic methods were CT, MRI and endoUS. Twenty six 
patients were operated on by pancreatico – and cystoenter-
ostomy (4), PD (16), total pancreatic head resection with the 
resection of the second part of the duodenum (2), duodenum-
preserving pancreatic head resection (3) and partial gastrec-
tomy (1). In fi ve cases pancreas-preserving technique was 
used: resection of the second part of the duodenum (RSPD) 
with direct duodeno-duodenoanastomosis (2), RSPD with 
jejunal interposition (2) and subtotal dudenectomy (1). 
Postoperative lethality was zero. Full pain control and symp-
toms disappearance were achieved after conservative treat-
ment (2 cases), after all pancreas-preserving procedures, PDs 
(13 (81%)) and after the pancreatic head resections and 
draining procedures (2 (28.6) 16%). In two cases of severe 
“orthotopic” CP development of diabetes mellitus was 
observed after PD.
Conclusions: Surgery is preferable option for DD treat-
ment. Effectiveness of pancreas-preserving procedures for 
DD is a real proof of the existence of DD as a separate 
entity. Pancreas-preserving surgery could be optimal for 
DD treatment in cases of mildly unaffected orthotopic 
gland.
A-210
ANALYSIS ON THE EFFECTS OF 
ADJUVANT CHEMORADIATION 
THERAPY FOLLOWING SURGICAL 
RESECTION FOR LYMPH NODE-
NEGATIVE ADVANCED GALLBLADDER 
CANCERS
Y. Park, S. Hwang, G. H. Kim, C. S. Ahn and S. G. Lee
Department of Surgery, Division of Hepatobiliary Surgery 
and Liver Transplantation
Background: To analyze the effect of radical resection and 
adjuvant chemoradiation therapy on T2N0M0 and T3N0M0 
gallbladder (GB) carcinoma.
Methods: Retrospectively reviewed the records from con-
secutive patients who underwent surgical resection of gall-
bladder carcinoma between January 2000 to December 2007. 
Patient had either Stage Ib (T2N0M0) or stage IIa (T3N0M0) 
disease. The clinicopathologic factors, recurrence and sur-
vival were retrospectively analyzed.
Results: Patient who underwent extended surgery (hepatic 
wedge resection, segment 4a,5 hepatectomy and/or bile duct 
resection) in T2N0M0 and T3N0M0 group showed lower 
recurrence rate and survival gain. (p = 0.01, p = 0.02)
The two lymph node negative stages (T2N0M0 and T3N0M0) 
did not show any gain in survival by adding adjuvant chemo-
radiation therapy. (p = 0.1, p = 0.67) In addition, no survival 
gain was showed in R1 resection group of T2N0M0 and 
T3N0M0 patients (p = 0.23, p = 0.63). In patients with lymph 
node-negative T2/T3 gallbladder cancers, adjuvant chemo-
radiation therapy was an independent prognostic factor for 
survival.
Conclusion: Generally used adjuvant chemoradiation 
therapy (5-fl uorouracil based chemotherapy and external 
beam radiation) is not recommended for lymph node-nega-
tive T2/T3 gallbladder cancer following surgical resection.
Key words: gallbladder cancer, lymph-node metastasis, 
adjuvant chemoradiation
A-211
MANAGEMENT OF DELAYED 
POSTOPERATIVE HEMORRHAGE DUE 
TO THE RUPTURE OF 
PSEUDOANEURYSMS AFTER 
PANCREATICODUODENECTOMY
Y. Toyoki, K. Ishido, D. Kudo, N. Kimura, S. Narumi and 
K. Hakamada
Department of Gastroenterological Surgery, Hirosaki 
University Graduate School of Medicine, Hirosaki City, 
Japan
Introduction: Delayed postoperative hemorrhage due to 
rupture of pseudoaneurysms caused by pancreatic fi stula 
after pancreaticoduodenectomy is a rare but serious compli-
cation associated with high mortality. This study aimed to 
determine the management in delayed postoperative 
hemorrhage.
Methods: From January 1996 to December 2010, 377 
patients underwent pancreaticoduodenectomy at our insti-
tute. We reviewed, retrospectively, medical charts of all 
patients who had experienced postoperative hemorrhage.
Results: Six patients presented with delayed postoperative 
hemorrhage (1.9%). All patients had rupture of pseudoaneu-
rysm associated with pancreatic fi stula. Median onset was 23 
days postoperative day. Four patients had sentinel bleeding. 
In initial management, two patients underwent emergency 
laparotomy, covered stent were placed on 2 patients, one 
patient underwent transarterial embolization, one patient 
occurred sudden death due to hemorrhage shock. Re-bleeding 
occurred 2 patients performed laparotomy and these patients 
underwent transarterial embolization. Finally, fi ve patients 
survived.
Conclusions: The patients with delayed postoperative hem-
orrhage due to rupture of pseudoaneurysms should perform 
transarterial embolization or placement of covered stent. 
Laparotomy should avoid because of re-bleeding.
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OUTCOME OF LAPAROSCOPIC LIVER 
RESECTION FOR LIVER TUMORS IN 
HIGH-RISK PATIENTS
Y. Otsuka, J. Ishii, Y. Kubota, T. Maeda, M. Tsuchiya, A. 
Tamura, T. Katagiri, S. Kagami, K. Kimura, S. Imamura, 
Y. Nagashima, H. Shimada and H. Kaneko
Department of Surgery, Toho University Faculty of 
Medicine, Tokyo, Japan
Introduction: We have been introducing Laparoscopic liver 
resection (LLR) as an option of minimally invasive surgical 
treatments for liver tumor since 1993. The aim of this retro-
spective study is to examine the feasibility and safety of LLR 
in high-risk patients.
Methods: Favorable indications of LLR are partial resec-
tion or left lateral sectionectomy for tumor located in left-
lateral segment or lower segments (S4b, S5, and S6). With 
the accumulation of our experience, major LLR has been 
introduced for tumors beyond these indications, occasionally 
using hand assisted or laparoscopy assisted techniques. 
Patients who have been pre-operatively evaluated to have 
insuffi cient organ functions other than liver, including 
chronic cardiac disease above NYHA class II, chronic 
obstructive pulmonary disease above stage III, chronic 
kidney disease above stage III, Insulin dependent diabetes 
mellitus, cerebral vascular accident with residual neurologi-
cal defi cit, were classifi ed into the “high-risk” group. Peri-
operative data of LLR in high-risk patients were compared 
to the common-risk patients who showed no signs of other 
organ dysfunctions.
Results: Out of 146 LLRs, 43 patients were classifi ed into 
high-risk group with a mean age of 65.8. There were no sig-
nifi cantly differences between the high-risk and the common 
risk groups in operative blood loss (272.8 cc vs. 277.7 cc), 
operative duration (299.1 min. vs. 314.6 min.), post-operative 
hospital stay (10.8 days vs. 10.6 days) and morbidity (14.0% 
vs. 9.7%). No carbon-dioxide gas embolism, post-operative 
liver failure or mortality was found in both groups.
Conclusions: With stringent patient selection and peri-oper-
ative management, LLR can be safely performed and is fea-
sible in high risk patients.
A-213
TO COMPARE THE ANALGESIC 
EFFICACY OF INTRAPERITONEAL 
LIGNOCAINE VS BUPIVACAINE AFTER 
ELECTIVE LAPAROSCOPIC 
CHOLECYSTECTOMY (LC)
M. S. Effendi, M. R. Khan, R. Raza, S. N. Zafar, 
F. Shamim*, S. A. Raza, K. M. I. Pal, H. Zafar, A. R. Alvi, 
T. Chawla and R. Azami
Departments of Surgery and Anesthesiology*, Aga Khan 
University, Karachi, Pakistan
Introduction: LC is associated with signifi cant pain. 
Intraperitoneal local anesthetics have shown to reduce post-
operative pain. However, the choice of local anesthetic agent 
is still debated.
Methods: We conducted a double blind randomized 
controlled trial. Consecutive patients undergoing LC were 
randomized into two groups. Group L received 10 ml of 2% 
lignocaine while group B received 10 ml of 0.5% bupiva-
caine, each diluted in 10 ml of normal saline. All patients 
underwent standard peri-operative anesthesia and analgesia 
protocol. Post-operative pain was assessed by the visual ana-
logue scale (VAS), verbal rating scale (VRS) and the need 
for additional analgesic medications at 0, 4, 8, 12 and 24 
hours postoperatively.
Results: A total of 206 patients were analyzed: 106 in group 
L and 100 in group B. Demographic details were similar 
between the two groups (p > 0.05). Abdominal pain decreased 
signifi cantly with time in both the groups with a similar mean 
response profi le (p < 0.001). There was no statistically sig-
nifi cant difference between the groups with regards to abdom-
inal or shoulder pain (p > 0.05). There was also no signifi cant 
difference in the side effect profi le of both drugs (p > 0.05).
Conclusions: Bupivacaine and Lignocaine are both safe and 
equally effective at decreasing post-operative pain after LC.
A-214
ESTABLISHING HPB SURGERY IN THE 
PACIFIC ISLAND. A PERSPECTIVE 
FROM PAPUA NEW GUINEA
K. Ikau1 and W. Arnold2
1Surgery Department, University of Papua New Guinea & 
2Port Moresby General Hospital. Port Moresby, Papua 
New Guinea
Introduction: Hepato Pancreatic Biliary (HPB) surgery 
was introduced as a specialist surgical entity over the last 
fi ve (5) years in Papua New Guinea. The surgical department 
of the University of Papua New Guinea and the Health 
Department have accepted as a specialist service. It was only 
after they noted an increased incidence of cancers in the 
upper GI including the Liver, Gall Bladder, Pancreas and 
Esophagus in the country and the already increasing work-
load on the General Surgeons that they recommend for a 
specialist pathway to be established.
Methodology/Results: Post Graduate Higher Diploma 
(PGHD) in HPB surgery is awarded after three (3) years of 
course work and clinical work in HPB surgery in the country. 
The training is undertaken only after completing the Masters 
of Surgery (MMED). A further one (1) year is spent overseas 
for accreditation from established fi rms. Assessment is done 
by log Book (HPB cases), written assignments, written 
examinations including practical and the Supervisors’ rec-
ommendations. Only then the University of Papua New 
Guinea awarded the candidate(s) with PGHD in HPB surgery.
Conclusion: This model can be tailored to some Pacifi c 
Island countries where there is limited number of surgeons 
per population and especially when the disease is becoming 
prevalent.
A-215
APACHE O: THE ROLE OF ‘O’ FACTOR 
IN AN ASIA PACIFIC PERSPECTIVE
V. Gupta, R. Thandassery, T. Yadav, K. Singh and 
R. Kochhar
Postgraduate Institute of Medical Education & Research, 
Chandigarh, India
Introduction: APACHE II score is a valid predictor of 
severity of pancreatitis, but the role of obesity and APACHE 
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O score in predicting outcome has been variably 
reported.
Methods: Between January 2009 and June 2011, 280 
patients of acute pancreatitis were managed as per a standard 
protocol. APACHE O score was calculated by adding 
APACHE II score (24 hours) and obesity score [Asia pacifi c 
consensus; normal, score 0 (BMI, 18.5 kg/m2–22.9 kg/m2); 
overweight, score 1 (BMI, 23 kg/m2–24.9 kg/m2) and obese 
score 2 (BMI, 25 kg/m2–29.9 kg/m2)]. Computed tomogra-
phy severity index (CTSI), organ failure, infected necrosis 
and requirement of intervention and mortality were noted 
and correlated with APACHE and APACHE O scores.
Results: Mean age 40.67 ± 13.12, male: female of 2.4:1, 
46.8% patients were normal weight, 29.6% overweight and 
23.6% obese. 23 (8.2%) patients underwent surgery and 61 
(21.8%) patients died. The occurrence of infected necrosis 
(p < 0.001), requirement for percutaneous drain insertion (p 
= 0.04), surgery (p = 0.008) and mortality (p < 0.001) were 
signifi cantly higher in patients with higher BMI. The area 
under the curve (AUC) for predicting mortality was 0.879 
for APACHE (95% CI = 0.819–0.938), 0.886 for APACHE 
O (CI = 0.827–0.944), and 0.740 for CTSI (CI = 0.651–
0.828). At a cut off of 8.5 APACHE score had sensitivity of 
88.2% and specifi city of 68.7% and APACHE O 90.2% and 
64.0% respectively.
Conclusions: Obesity is an important predictor of outcome 
in patients with acute pancreatitis. Predictive accuracy of 
APACHE O is similar to APACHE II, but higher than CTSI.
A-216
OUTCOME OF LIVING DONOR LIVER 
TRANSPLANTATION FOR 
HEPATOCELLULAR CARCINOMA WITH 
PORTAL VEIN INVASION. IS IT 
CONTRAINDICATION FOR LIVER 
TRANSPLANTATION?
D-B. Moon, S-G. Lee, S. Hwang, K-H. Kim, C-S. Ahn, 
T-Y. Ha, G-W. Song, D-H. Jung, G-C. Park, S-W. Jung, 
S. Yun and J-M. Namkung
Hepatobiliary Surgery and Liver Transplantation, Asan 
Medical Center, University of Ulsan College of Medicine, 
Seoul, Korea
Purpose: Even though liver transplantation (LT) for HCC 
with portal vein (PV) invasion has been contraindicated 
because of poor prognosis after LT, living-donor liver trans-
plantation (LDLT) for those patients is performed infre-
quently after informed consent because of strong request of 
donor & recipient. Our experiences of LDLT for HCC with 
PV invasion hinted that some patients could survived unex-
pectedly long. Hence, we are aim to fi nd favorable prognos-
tic factors by reviewing LDLT patients for HCC with PV 
invasion.
Methods: From October 1993 to December 2009, LDLT for 
HCC with PV invasion was performed in 28 patients (3.7%) 
among total 737 LDLT patients for HCC. The patients were 
subdivided into less than 24 months Short-survival group 
(SSG, 13), and more than 24 months Long-survival group 
(LSG, 11). Four patients were excluded due to short follow 
up time (1) and tumor unrelated death (3). Variables between 
two groups were compared and then signifi cant variables 
were evaluated how much affected on survivals.
Results: The overall and disease free 5-year survival rate 
after LDLT for HCC with PV invasion were 29.8% respec-
tively. Mean age, AFP level, PET scan, pre-LT treatment or 
not, graft-versus-recipient weight ratio, maximum tumor size 
on pre-LT CT, and Edmonson-Steiner grade were not differ-
ent between SSG and LSG. On pre-LT CT scan, however, 
LSG had signifi cantly higher frequency of lipiodol uptake of 
portal vein tumor thrombus (36% vs 0%), less tumor number 
(2.8 vs 7.4), smaller sum of tumors diameter (6.9 cm vs 
15.7 cm), single lobe tumor location (81.8% vs 30.8%), and 
higher frequency of subsegmental PV tumor invasion 
(Vp1/2/3/4, 3/4/4/2 vs 0/6/5/2) than SSG. When HCCs were 
localized at single lobe, the 5-year overall survival was 
62.9%, almost comparable to HCC patients without PV inva-
sion. In addition, sum of tumor diameter (≤11 cm) and tumor 
numbers (≤5) had signifi cantly better overall survival 48%, 
40.6% respectively.
Conclusions: Among HCC patients with PV invasion, 
selected patients having lipiodol uptake of PV tumor throm-
bus, less than 5 tumor number, less than 11 cm sum of tumor 
diameter, single lobe localization, and Vp1 might not be any 
more absolute contraindication for LDLT.
A-217
EXPERIENCE OF LIVER 
TRANSPLANTATION FOR HEPATITIS A 
VIRUS INDUCED ACUTE LIVER 
FAILURE IN ADULTS AT A SINGLE 
CENTER
D. H. Jung, S. G. Lee, S. Hwang, C. S. Ahn, D. B. Moon, 
T. Y. Ha, G. W. Song, G. C. Park, S. Y. Yoon 
and S. W. Jung
Asan Medical Center, University of Ulsan College of 
Medicine, Seoul, Korea
Introduction: The sero-positivity pattern of anti-hepatitis A 
virus antibody has been changing rapidly from the intermedi-
ate to the low during the past 30 years in Korea. Thus adult-
hood acute hepatitis A became widespread in last 10 years 
in Korea due to decreased seroprevalence of anti-HAV in 
adults. The objectives of this study were to evaluate the 
results of liver transplantation (LT) for HAV associated acute 
liver failure (ALF) and to compare the clinical profi les and 
outcomes between the patients with HAV- and HBV-
associated ALF.
Methods: 64 Adult recipients who underwent LT for acute 
liver failure from HAV (n = 37) and HBV (n = 27) between 
January 2005 and May 2011 at a single center were included 
this study.
Results: Liver transplantation for HAV infection was sub-
stantially increased in recent years at our center. There was 
no difference between two groups with regard to age, gender, 
total bilirubin, prothrombin time, platelet count, pressor use, 
MELD score, CTP score, Graft type, GRWR, ICU stay, and 
hospital stay. HAV infection was associated with younger 
recipient age (p = 0.003), higher serum creatinine values (p 
= 0.009), AST and ALT (p ≤ 0.001) compared with HBV 
infection. 1 year patient survival after LT for HAV and HBV 
was 71.4% and 100% respectively (p = 0.013). HAV infec-
tion recurred in 5 patients after LT (13.5%). Patients with 
pancreatitis had a poorer prognosis in recipients with HAV 
infection (p = 0.0114). Causes of death after LT for HAV 
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were sepsis from pancreatitis (n = 3), reinfection of HAV (n 
= 3), sepsis from pneumonia (n = 1), intracranial hemorrhage 
(n = 1), and brain death (n = 1).
Conclusions: Patient survival after LT was much lower for 
HAV than HBV due to pancreatitis and reinfection in HAV 
recipients. Multiple drainage procedures around pancreas 
and dependent portions are needed, if patient has pancreatitis 
in operative fi eld. As the risk of HAV reinfection after LT 
may be higher than expected, routine check of HAV RNA is 
needed.
A-218
PREDICTING GRAFT SURVIVAL AFTER 
LIVER TRANSPLANTATION IN A 
NATIONAL COHORT: EXAMINING THE 
EFFECTS OF RECIPIENT, DONOR AND 
TECHNICAL COVARIATES
M. P. Landman, I. D. Feurer, P. Arbogast, D. E. Moore 
and C. W. Pinson
Vanderbilt University Medical Center, Nashville, TN, USA
Introduction: Liver transplantation is the only curative 
therapy for end-stage liver disease. While numerous reports 
have characterized various clinical covariates’ ability to 
predict post-transplant outcomes, this study entails a com-
prehensive examination of the effects of all previously-
reported recipient, donor and technical covariates on graft 
survival after liver transplantation.
Methods: A January, 2010 PubMed search identifi ed previ-
ously-reported covariates, which were classifi ed as recipient, 
donor or technical. The Scientifi c Registry of Transplant 
Recipients database of July, 2010 included US adult, single 
organ liver transplants. Nested, multivariate Cox propor-
tional hazards regression models evaluated the effects of 
recipient only (REC), recipient plus donor (RECDON) and 
recipient plus technical (RECTECH) covariate sets in rela-
tion to all covariates (ALLCOV). All models controlled for 
transplant year, separate analyses were conducted for hepa-
titis C virus (HCV) -positive and -negative recipients, and 
multiple imputation methods were employed. Somers’ D and 
Harrell’s C concordance statistics were compared between 
models.
Results: Forty-four covariates (23 recipient, 18 donor, 3 
technical) were identifi ed and 35,030 transplantation events 
(16,394, 47% in HCV+ recipients) between March 2002 and 
July 2010 were included. All nested models in the HCV+ and 
HCV− cohorts were statistically signifi cant in comparison to 
ALLCOV (all p < 0.001). Concordance statistics indicated 
that RECDON, RECTECH and ALLCOV models had better 
predictive capacity than REC only models.
Conclusions: The addition of donor and technical covari-
ates to recipient covariates signifi cantly improves the predic-
tive ability of multivariate models of graft survival. These 
fi ndings further support the inclusion of non-recipient 
covariates in models predicting survival after liver 
transplantation.
A-219
FACTORS THAT COULD PREDICT 
ASYSTOLE WITHIN AN HOUR AFTER 
TREATMENT WITHDRAWAL IN 
DONATION AFTER CARDIAC DEATH
N. Battula, D. Tsapralis, A. H. Mohamedbhai, D. Mayer, 
J. Isaac, P. Muiesan, D. F. Mirza, S. R. Bramhall, 
R. P. Sutcliffe, R. Marudanayagam, M. T. Perera 
and H. Mergental
Liver Unit, Queen Elizabeth Hospital, Birmingham, United 
Kingdom
Introduction: Donation after cardiac death (DCD) is an 
emerging source of organs to meet the increasing demands 
of transplantation. The time interval between withdrawal of 
donor life-sustaining treatment (WDLT) to the onset of asys-
tole is a crucial factor that determines a successful donation 
and organ quality. The aim of our study was to identify 
factors that could predict asystole within an hour following 
WDLT.
Methods: DCD donor records between January 2005 and 
March 2011 were reviewed retrospectively. Demographic 
and physiological data recorded prior to WDLD were 
assessed using death within an hour as an outcome. Chi-
square/Fisher exact test was used for categorical data and 
Student t test for continuous variables.
Results: 170 DCD donors formed our study cohort, there 
were 91 male (53%) and the median age was 51 years (Range 
17–70 years). Majority of the donors (69%) had an underly-
ing central nervous system (CNS) pathology. 101 (59%) died 
within an hour after WDLT. Statistical analysis of the entire 
cohort identifi ed stay in intensive care unit <4 days (P = 
0.013), hypothermia [<35°C] (P = 0.01), inotropic support (P 
= 0.001), abnormal arterial pH (P = 0.03), high oxygen 
requirement [FiO2 > 60%] (P = 0.03), renal dysfunction (P = 
0.05), diabetes (P = 0.02) and CNS hemorrhage (P = 0.05) 
as potential variables that could predict death within an hour. 
A subgroup analysis of the patients only with CNS pathology 
(n = 117) identifi ed history of respiratory arrest (P = 0.04) as 
signifi cant factors along with shorter ICU stay and use of 
inotropes.
Conclusions: Our data suggests hypoxia, hypothermia, 
short ICU stay, CNS hemorrhage and inotropic support as 
strong predictors of DCD asystole within an hour after 
WDLT.
A-220
BILE DUCT ANASTOMOTIC STRICTURE 
AFTER PEDIATRIC LIVING DONOR 
LIVER TRANSPLANTATION
K. S. H. Chok1, S. C. Chan1,2, K. L. Chan1, W. W. Sharr1, 
P. K. Tam1, S. T. Fan1,2 and C. M. Lo1,2
1Department of Surgery, The University of Hong Kong, 
Hong Kong, China; 2State Key Laboratory for Liver 
Research, The University of Hong Kong, Hong Kong, 
China
Introduction: Hepaticojejunostomy is a well-accepted 
method while duct-to-duct anastomosis is gaining popularity 
for bile du ct reconstruction in pediatric living donor liver 
transplantation (LDLT). Biliary complications, especially 
biliary anastomotic stricture (BAS), are not clearly defi ned. 
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The aim of the present study is to determine the rate of BAS 
and its associated risk factors.
Methods: The study included 78 pediatric patients (below 
18 years old) who underwent LDLT during the period from 
end of September 1993 to end of November 2010. The diag-
nosis of BAS was based on clinical, biochemical, histologi-
cal and radiological results.
Results: All patients received left-side liver grafts. Thirteen 
patients (16.7%) developed BAS after LDLT. Among them, 
three patients (23.1%) had duct-to-duct anastomosis during 
LDLT. The median follow-up period for the BAS group 
and the non-BAS group was 57.8 and 79.5 months respec-
tively (p = 0.683). Ten of the BAS patients required 
percutaneous transhepatic biliary drainage with or without 
dilatation for treating the stricture. Multivariate analysis 
showed that hepatic artery thrombosis and duct-to-duct 
anastomosis were two risk factors associated with 
BAS.
Conclusions: In pediatric LDLT, hepaticojejunostomy is the 
preferred method for bile duct reconstruction wherever 
possible.
A-221
EXTREMELY MARGINAL GRAFTS 
FROM DECEASED DONORS HAVE 
SIMILAR OUTCOME THAN IDEAL 
GRAFTS USED FOR LIVER 
TRASPLANTATION
L. McCormack, N. Goldaracena, E. Quiñones, 
P. Capitanich, P. Mendez, M. Anders and R. C. Mastai
Liver Surgery & Trasplantation Unit, Hospital Alemán of 
Buenos Aires, Argentina
Background: Although there is a worldwide need to expand 
the donor liver pool, many cadaveric marginal livers are 
usually discarded for liver trasplantation (LT). We report a 
consecutive series of patients receiving marginal grafts and 
we evaluated their outcome.
Methods: All patients that underwent liver transplantation 
in our unit from 2006–2011 (n = 120) were analyzed 
using a prospective database. We selected patients with 
≥3 of the following donor criteria: prolonged hypotensive 
episodes, donor age >55 years, high vasopressor drug 
requirement, hypernatremia, prolonged ICU stay, elevated 
transaminases, steatosis >30%, cold ischemia >12 hours 
and warm ischemia time >40 minutes (Extremely Marginal 
Grafts group) and we compared their outcome with patients 
receiving grafts without any marginal criteria (Ideal graft 
group).
Results: The Extremely Marginal Grafts group (n = 36) had 
higher operative transfusion requirement (66.6% vs 55.6%), 
30-days mortality (11.1% vs 5.5%), and 1 year mortality 
(22.2% vs 5.5%) when compared with Ideal grafts group (n 
= 18) but not signifi cantly different. Other variables such as 
major complications, postoperative hemodylisis, ICU and 
hospital stay and 1–3 year survival were also not statistically 
different.
Conclusions: The liver pool can be safely expanded using 
extremely marginal grafts from deceased donors for liver 
trasplantation. These usually discarded liver grafts had 
similar early and long term outcome when compared with 
ideal organs.
A-222
MEDIAL APPROACH FOR 
LAPAROSCOPIC 
PANCREATICODUODENECTOMY
A. Cho, H. Yamamoto, O. Kainuma, T. Ota, S. J. Park, 
H. Yanagibashi, H. Arimitsu, A. Ikeda, H. Souda, 
Y. Nabeya, N. Takiguchi and M. Nagata
Chiba Cancer Center Hospital, Chiba, Japan
Introduction: Recent rapid developments in technological 
innovations, improvements in surgical skills and the exten-
sive experience of surgeons have proven the feasibility and 
safety of laparoscopic pancreatic resection for properly 
selected patients. However, laparoscopic pancreaticoduode-
nectomy (Lap-PD) is a complicated procedure with a steep 
learning curve for surgeons performing it.
Methods: A standard approach can help to fl atten the learn-
ing curve and improve the outcome. In previous reports, 
Lap-PD was commonly performed using a conventional 
approach, in which the Kocher maneuver was performed at 
the early stage of the operation. In contrast, we have pro-
posed a medial-to-lateral (medial) approach, in which dissec-
tion of the Treitz ligament and the mesentery of the jejunum 
and duodenum is performed before the Kocher maneuver. 
Seventeen patients underwent Lap-PD using medial 
approach. These patients were compared with 17 patients 
who underwent a conventional Lap-PD.
Results: Mean operative time and mean blood loss have 
been improved since medial approach was initiated. There 
were no signifi cant differences in the incidence of complica-
tions or the hospital stay between the two groups. The distal 
margin, the number of lymph nodes found in the resected 
specimen did not differ between the two groups.
Conclusion: Although our experience is limited and ran-
domized study to elucidate appropriate indications and 
effects of the present procedure is necessary, we believe that 
Lap-PD using a medial approach can be feasible, safe, and 
effective in highly selected patients, and will be one of thera-
peutic standard options for carefully selected patients with 
periampullary disease.
A-223
PARTIAL SPLENECTOMY WITH 
BIPOLAR RADIOFREQUENCY DEVICE
C. Kyriakides, M. Pai, A. Zarzavadjian, A. Frampton, 
D. R. C. Spalding, L. R. Jiao and N. A. Habib
HPB Surgery Hammersmith Hospital, Imperial College 
London, London, UK
Introduction: Over the years various resection techniques 
have been used for spleen preservation with unsatisfactory 
results, due to uncontrollable intra-operative bleeding. A 
bipolar Radiofrequency (RF) device has been used routinely 
for liver surgery in our unit with good results over the last 5 
years and its role has been expanded successfully for partial 
splenectomy. We present here a patient undergoing spleen 
preservation surgery with this technique.
Methods: A 40 yr old male patient presented with left upper 
quadrant pain over a period of 4 weeks. Imaging revealed a 
solid lesion in the lower pole of the spleen. It was diffi cult 
characterize this lesion on imaging and we decided to do 
partial splenectomy after discussing with the patient. 
Following mobilization of spleen, ablation of tissue to induce 
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coagulative desiccation was carried out, along an intended 
line of division with the bipolar RF device. Subsequently the 
splenic parenchyma was divided with a scalpel.
Results: The operative time was 90 minutes and blood loss 
was minimal. The postoperative course was uneventful and 
the patient was discharged on the 7th postoperative day. The 
histology confi rmed this to be a hemartoma. A CT scan one 
month postoperatively showed normal enhancement of the 
porto-splenic venous system and the splenic artery.
Conclusions: This technique, with increasing experience, 
may allow surgeons to perform splenic preservation surgery 
with minimal intra-operative bleeding.
A-224
ANTERIOR APPROACH USING THE 
HANGING LIVER MANEUVER FOR 
LARGE HCC
M. V. Perini, F. F. Coelho, R. M. Lupinacci, P. Herman and 
I. Cecconello
Department of Gastroenterology – Hospital das Clinicas 
– University of Sao Paulo – Brazil
Backgroud: Anterior approach has became the standard 
technique for liver resection of hepatocellular carcinoma 
greater than 5 cm. The hanging liver maneuver has gained 
wide acceptance for its feasibility and demarcation of paren-
chyma transection. The association of these two techniques 
can lead to a safe and oncological liver resection.
Material and Methods: A video regarding the treatment of 
a large HCC located in the right lobe pushing the right 
hepatic vein medially using hanging maneuver combined to 
the anterior approach in cirrhotic patient is presented.
Conclusions: Hepatic resection for large HCC in the setting 
of cirrhosis using tactical tips is feasible, safe and can lead 
to oncological resections.
A-225
SIDE-TO-END RENOPORTAL 
ANASTOMOSIS USING AN EXTERNALLY 
STENTED-PTFE 
(POLYTETRAFLUOROETHYLENE) 
VASCULAR GRAFT FOR A PATIENT 
WITH PHLEBOSCLEROTIC PORTAL 
VEIN AND LARGE SPONTANEOUS 
SPLENORENAL SHUNT
D-B. Moon, S-G. Lee, S. Hwang, K-H. Kim, C-S. Ahn, 
T-Y. Ha, G-W. Song, D-H. Jung and G-C. Park
Division of Hepatobiliary Surgery and Liver 
Transplantation, Asan Medical Center, University of Ulsan 
College of Medicine, Seoul, Korea
Purpose: As a novel technique to solve obliterated of PV 
due to phlebosclerosis and large splenorenal shunt (SRS) in 
LT, end-to-end renoportal (R-P) anastomosis using fresh 
cadaveric vessels has been described by Kato et al. However, 
it might have problems in feasibility and safety. Therefore, 
we devised technically side-to-end R-P anastomosis. Here, 
we aim to evaluate feasibility and safety of our technique, 
and also usefulness of artifi cial ringed-PTFE as an alternative 
interposition vessel conduit.
Patient & Method: Since October 2005, we performed R-P 
anastomosis in 6 patients. End-to-end anastomosis was per-
formed only in one patients. Side-to-end R-P anastomosis 
was performed in another 5 patients. As an interposition 
vessel conduit, fresh cadaveric vessels such as iliac vein or 
aorta were used in fi rst 5 patients. However, recipients could 
not undergo R-P anastomosis timely in urgent situation 
because of limited availability of fresh cadaveric vessels. 
Recently we used ringed-PTFE for R-P anastomosis as a new 
solution.
Results: Side-to-end R-P anastomosis were performed 
easily and securely under better and more stable operation 
fi elds, because of left renal vein continuity with vena cava 
was preserved without retraction of anastomosis site. 
However, the patient undergone end-to-end R-P anastomosis 
experienced anstomotic stenosis due to poor operation fi eld. 
Among 6 patients, 5 patients are alive except one patient died 
of brain hemorrhage on 1 month. The interposition grafts are 
all patent. The last patient using ringed-PTFE in semiurgent 
situation is doing well and the patency is good on 8 months 
follow-up CT scan.
Conclusion: Side-to-end R-P anastomosis is technically 
more feasible and easier method than end-to-end R-P anas-
tomosis. In addition, artifi cial ringed-PTFE is an useful 
anternative for fresh cadaveric vessels in R-P anastomosis 
for timely LT.
A-226
SINGLE INCISION 
CYSTOGASTROSTOMY – TECHNICAL 
FEASIBILITY AND SHORT TERM 
RESULTS
C. Palanivelu, P. Senthilnathan, P. S. Rajan, 
S. Rajapandian, P. Praveenraj, V. Vaitheeswaran, 
A. Ramanujam and A. P. Manoj Kumar
GEM Hospital and Research Centre, Coimbatore, India
Background: Single incision laparoscopic surgery is now 
being employed for increasing number of procedures and is 
now envisioned as an alternative to NOTES. The perceived 
advantages are better cosmesis and possible reduced postop-
erative pain.
Materials: We studied the feasibility and short term postop-
erative outcomes in 3 patients who had pseudocyst pancreas 
and underwent single incision laparoscopic cystogastros-
tomy. All cysts were located in the retrogastric region. The 
sizes of the cysts were 9, 12 and 15 cms with wall thickness 
of more than 5 mm. Two of them were males and one female. 
One had biliary pancreatitis and 2 had alcoholic pancreatitis 
with pseudocyst.
Technique: The patient was placed in supine with legs split 
position. A small incision was made in the umbilicus which 
was extended 0.5 mm cranially, fl aps raised on either side 
and 3 trocars – one 10 mm and two 5 mm were placed 
through this incision. Different sizes of trocars were used, 
pointing out in different directions to avoid cluttering of 
instruments. Conventional laparoscopic instruments were 
used for the procedure. Anterior gastrotomy was made in the 
most prominent part of the bulge. After placing everting 
stitches in the anterior wall of stomach, the exact position 
and content of the cyst is confi rmed by aspiration. At the 
summit of the cyst, posterior wall of the stomach and the cyst 
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wall opened, fl uid sucked out and a small portion of stomach 
and cyst wall removed. Cystogastrostomy stoma is formed 
by approximately cyst and posterior wall of stomach using 
20 PDS continuous sutures. Finally, anterior gastrotomy is 
closed. Umbilical wound is closed with 1 prolene.
Results: The mean operating time is 145 mins. Though we 
had diffi culty in getting the triangulation for endo suturing, 
we managed all intra corporeal suturing with trocars angu-
lated away from each other. The mean hospital stay was 3 
days and analgesic requirement was for 1 day. There were 
no complications in the form of collection, delayed gastric 
emptying or wound infection.
Conclusion: Single incision laparoscopic cystogastrostomy 
is technically possible but operating time is slightly more. 
Immediate postoperative outcomes are comparable with 
laparoscopic surgery but require large series to assess 
the exact place of single incision approach for such 
procedures.
A-227
INITIAL CLINICAL EXPERIENCE FOR 
THE TREATMENT OF THE END-STAGE 
OF ALVEOLAR ECHINOCOCCOSIS
H. Wen1, J-H. Dong2, J-H. Zhang1, J-M. Zhao1, 
Y-M. Shao, W-D. Duan2, Y-R. Liang2, X-W. JI1, 
Q-W. Tai1, A. Tuergan1 and T. Li1
1Department of Liver and Laporoscopy Surgery, First 
Affi liated Hospital of Xinjiang Medical University, Xinjiang 
Organ Transplantation Research Institute, Urumqi 830000, 
China; 2Department of Hepatobiliary Surgery, General 
Hospital of Chinese People’s Liberation Army, Beijing 
100853, China
Alveolar echinococcosis (AE) is a rare and crucial parasitic 
disease, which is commonly located in liver as original 
organ. For the advanced AE point of view, liver transplanta-
tion (LT) may be a radical and fi nal approach. In addition, 
immunosuppressive agents must be employed following LT, 
and commonly result in some drug-ralated complications and 
high cost. Ex vivo liver resection and liver autotransplanta-
tion could be considered as an idea choice for advanced AE 
due to not only radical techniques but also without any 
immunosuppressive agents postoperatively. In this case 
report, we present a end-stage of AE patient with located in 
the right lobes and invaded into the adjacent retrohepatic 
inferior vena cava. Fortunately, the left lobes was normal 
over 1,200 g in size. This patient had no any other extrahe-
patic metastasis. So, liver autotransplantation was performed 
as the fi nal choice for socalled radical treatment. The AE 
lesions with more than 4300 g in size, were completely 
removed on the operating bench. The extracorporeal repair 
of the retrohepatic vena cava was suffi ciently radical resec-
tion and the remaining AE-free left lobes were more than 
700 g in size, and the retrohepatic inferior vena cava were 
reimplanted in situ. A temporary intracorporeal end-to-end 
cavo-caval shunt with interposition of a blood vessel pros-
thesis and end-to-side portocaval shunt was established for 
maintenance of the fl ow during the 4-hour anhepatic phase. 
When the patient was discharged on postoperative day 22, 
the major clinical items showed serum aspartate aminotrans-
ferase, alanine aminotransferase, albumin, total bilirubin, 
and direct bilirubin concentrations of 47 U/L, 22 U/L, 
28 g/L, 25 μmol/L, and 8 μmol/L, respectively. Within 
6 months following-up postoperatively, the patient had no 
signs of residual liver disease with reasonably good liver 
function.
Keywords: Liver disease; Autotransplantation; Alveolar 
echinococcosis; Intracorporeal shunt; Ex vivo liver 
resection
A-228
FOCAL INTRAHEPATIC STRICTURES – 
DIAGNOSIS AND MANAGEMENT
D. Yeo1, M. Perini1, V. Muralidharan2 and C. Christophi1,2
1Austin Hospital, Heidelberg, Australia; 2University of 
Melbourne, Melbourne, Australia
Introduction: Focal intrahepatic strictures are becoming 
more common due to more prevalent and accurate cross-
sectional imaging however data relating to their management 
is lacking. The purpose of this systematic review was to 
summarize the current evidence regarding their natural 
history, diagnosis and management.
Methods: A literature search of relevant terms was per-
formed using Medline. References of papers were subse-
quently searched to obtain older literature.
Results: Focal intrahepatic strictures involve segmental 
hepatic ducts and/or left and right main hepatic ducts during 
their intrahepatic course. Most patients are asymptomatic 
while the minority present with vague abdominal pain or 
recurrent sepsis and only rarely with jaundice. The cause 
may be benign however more commonly malignant and can 
be suggested using a various modalities including biochemi-
cal (CEA, Ca19.9), radiological (US, CT, MRCP, FDG-PET) 
and interventional (ERCP, PTC, Cholangioscopy, intraductal 
ultrasound, biliary brushings) technologies. A history of pre-
vious biliary surgery, the presence of calculi or evidence to 
suggest the presence of parasites all can suggest a benign 
etiology, while an associated mass points toward malignancy. 
However in patients without any of the above, the false nega-
tive rate remains at least 7% despite extensive investigation. 
The natural history of untreated asymptomatic benign intra-
hepatic strictures is sparse although data from liver transplant 
patients with unilateral focal strictures post transplant 
demonstrate intervention is almost never required.
Conclusions: In patients without a history of biliary inter-
vention, stones or parasitic disease, focal intrahepatic stric-
tures should be suspected as malignant and surgery pursued 
given the small but signifi cant false negative rate for diag-
nostic investigations.
A-229
CLINICOPATHOLOGIC ANALYSIS OF 
EXTRAHEPATIC BILE DUCT CANCER 
WITH A MICROSCOPIC POSITIVE 
DUCTAL MARGIN
I. W. Han1, J-Y. Jang1, M. J. Kang1, K. B. Lee2 
and S-W. Kim1
1Department of Surgery & Cancer Research Institute, Seoul 
National University College of Medicine, Seoul, South 
Korea; 2Department of Pathology, Seoul National 
University College of Medicine, Seoul, South Korea
Introduction: Although 5-year survival rates of extrahe-
patic bile duct (EHBD) cancer lie between 20–30%, the fate 
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of microscopic positive ductal margin (MPDM) is unclear. 
The objectives of this study were to analyze the clinicopatho-
logic features of EHBD cancer with a MPDM and to identify 
prognostic factors.
Methods: 466 patients from a total 508 patients with EHBD 
cancer underwent curative-intended resection between 1995 
and 2007. Among them, 119 patients (25.5%) had MPDM 
which included invasive carcinoma (n = 83, 69.7%), carci-
noma in situ (n = 16, 13.4%), high grade dysplasia (n = 20, 
16.8%).
Results: EHBD cancer was classifi ed as perihilar and distal 
bile duct cancer (n = 209, n = 246). The type of operation 
included hepatobiliary resection (n = 118, 25.3%), bile duct 
resection (n = 82, 17.6%), pancreatoduodenectomy (n = 225, 
54.7%), and Hepatopancreatoduodenectomy (n = 11, 2.4%). 
Median survival in patients with MPDM and with negative 
margin were 20.0 and 41.0 month (p < 0.001). 5 year survival 
rate in patients with MPDM and with negative margin were 
13.6 and 44.5%, respectively (p < 0.001). Invasive carci-
noma on the resection margin was single prognostic factors 
(median survival 18 vs. 29 month, p = 0.029). But other 
factors, such as, stage, tumor location, tumor differentiation, 
type of operation, presence of adjuvant treatment were not 
statistically signifi cant.
Conclusions: The presence of MPDM is an important prog-
nostic factor in the EHBD cancer. Resection should be con-
sidered and efforts should be made to obtain an ‘invasive 
carcinoma’-free margin.
A-230
EFFECT OF PREOPERATIVE PORTAL 
VEIN EMBOLIZATION IN PATIENTS 
WITH KLATSKIN TUMOR
M. J. Kang, J-Y. Jang, I. W. Han and S-W. Kim
Department of Surgery, Seoul National University College 
of Medicine, Seoul, Korea
Introduction: PVE has been widely used to reduce the 
operative morbidity or mortality after major hepatectomy for 
various disease. However, indicated liver volume criteria or 
its clinical usefulness of portal vein embolization (PVE) are 
not well established in Klatskin tumor.
Methods: From 2005 to 2010, 33 patients who underwent 
right sided hepatectomy for Klatskin tumor with preopera-
tive future liver remnant (FLR) of less than 30% were 
included. Liver volumetry and liver function tests were eval-
uated at times of pre-PVE, preoperative, postoperative day 
1, 7, and 30.
Results: The study subjects included 11 PVE. Eight patients 
underwent right trisectionectomy. Preoperative total liver 
volume (1394 vs. 1425 ml, p = 0.750) or FLR (21 vs. 22%, 
p = 0.260) were comparable in PVE or non-PVE group. FLR 
increased in 19.3% (288 to 348 ml, p = 0.068) after mean of 
16 days. Postoperative liver function tests, liver hypertrophy 
ratio (234 vs. 204%, p = 0.179), and volume (663 vs. 628 ml, 
p = 0.588) after 1 week of operation were equivalent between 
2 groups. There was no severe PVE related morbidity, and 
postoperative mortality (n = 2 vs. 0, p = 0.104) were com-
parable. Ten patients had initial FLR of less than 20%. 
Postoperative liver hypertrophy ratio correlated with initial 
FLR (R2 = 0.255, p = 0.003). Postoperative liver hypertro-
phy was not affected by PVE in patients with initial FLR of 
less than 20% (258 vs. 219%, p = 0.326) or higher than 20% 
(221 vs. 199%, p = 0.291).
Conclusions: Although preoperative PVE increased FLR of 
19.3% in Klatskin tumor, postoperative liver hypertrophy 
ratio, fi nal liver volume, or liver function tests were not 
affected by PVE even in patients with initial FLR of less than 
20%. Preoperative PVE in Klatskin tumor has minimal clini-
cal effect.
A-231
EFFECT OF SUPRACOLIC VERSUS 
INFRACOLIC GASTROJEJUNOSTOMY 
ON GASTRIC EMPTYING IN PATIENTS 
UNDERGOING WHIPPLES 
PANCREATICODUODENECTOMY – A 
PROSPECTIVE RANDOMIZED CONTROL 
TRIAL
P. Rebala1, G. V. Rao1, S. Patil1, K. Kumaresan2, M. Jayaraj1, 
R. Dama1 and D. N. Reddy1
1Asian Institute of Gastroenterology, Hyderabad, India; 
2KK Nuclear Scan, Hyderabad, India
Introduction: Common cause of increased morbidity and 
prolonged hospitalization in patients undergoing whipples 
pancreaticoduodenectomy (PD) is delayed gastric emptying 
(DGE). Causes attributed for delayed gastric emptying are 
placement of gastrojejunal stoma, pancreatic anastomotic 
leaks.
This randomized study compared two techniques of gas-
trojejunal anastomosis (Infracolic and supracolic) and their 
effect on gastric emptying and correlation of anastomotic 
leaks with DGE.
Materials and Methods: Between Jan 2009 and June 2010, 
patients undergoing Whipples PD were randomized to either 
an Infracolic gastrojejunostomy (Group A) or Supracolic 
gastrojejunostomy (Group B).
Postoperatively Ryle’s tube output, drain fl uid amylase 
levels, tolerance of oral feeds were recorded. Ryle’s tube was 
removed if the output was <200 ml in 24 hrs.
DGE was defi ned according to ISGPF classifi cation. 
Radio isotope gastric emptying studies were done for 
both liquids and solids on postoperative day 7 & 8 
respectively.
Results: Out of 57 patients, 30 were randomized to infra-
colic gastrojejunostomy (Group A), 27 to supracolic gastro-
jejunostomy (Group B).
Clinically DGE was seen in 16/30 patients in Group A and 
24/27 patients in Group B. (P = 0.0041).
Isotope study for gastric emptying could not be done in 5 
patients (Group A-2 & Group B-3). DGE for liquids was seen 
in 11/28 patients in Group A compared to 18/24 patients in 
Group B (P = 0.0129). DGE for solids was seen in 16/28 
patients in Group A compared to 16/24 patients in Group B 
(P = 0.5729). There was no correlation of DGE and pancre-
atic anastomotic leaks in both groups.
Conclusion: Infracolic gastrojejunostomy has a signifi -
cantly low incidence of clinical DGE.
Radioisotope study for liquid emptying was signifi cantly 
better in the infracolic group though solid emptying did not 
reach statistical signifi cance. There is no correlation of pan-
creatic leak with DGE.
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BLUMGART’S TECHNIQUE OF 
PANCREATICOJEJUNOSTOMY: AN 
APPRAISAL
P. K. Mishra, S. S. Saluja, M. Gupta, R. Rajalingam R 
and P. Pattnaik
Department of Gastrointestinal Surgery, Govind Ballabh 
Pant Hospital and Maulana Azad Medical College, New 
Delhi, India
Background: Although mortality of Whipple’s pancreato-
duodenectomy (WPD) is reduced to <5%, morbidity still 
remains between 30–50%. Pancreatojejunal anastomosis 
remains the main cause of morbidity. Blumgart anastomosis 
using transpancreatic U sutures has been proposed to 
decrease the leak rate and its associated morbidity. We ana-
lyzed the results of Blumgart anastomosis applied in con-
secutive cases of WPD.
Methods: Of 189 patients of periampullary or pancreatic 
cancer admitted, 100 patients underwent WPD. Except 2 
patients (no duct identifi ed per-operatively) all patients 
underwent pancreaticojejunostomy by Blumgart anastomotic 
technique. The records of 98 patients were analyzed for pan-
creatic leak and its related complications using defi nitions 
given by International Study Group for Pancreatic surgery.
Results: Of 98 patients, 63 were men. The mean operative 
time was 390 min (270–690 min) and blood loss was 275 ml 
(100–1000 ml). Overall mortality was 3.06%. The clinically 
signifi cant pancreatic anastomotic failure leak was seen in 
only 7 (7.14%) cases (grade B n = 4, grade C n = 3) with 
one patient requiring re-laparotomy due to leak. Only one 
patient died due to leak-related complication.
Conclusion: Blumgart pancreaticojejunal anastomosis can 
be routinely used for reconstruction in Whipple’s pancreati-
coduodenectomy. It is technically simple procedure and is 
associated with low rates of fi stula and its related 
complications.
A-233
AN ANALYSIS OF REVISION 
HEPATICOJEJUNOSTOMY FOR 
RECURRENT BENIGN BILIARY 
STRICTURES
N. Dash, E. Kumaran, V. Mangla, Rajesh, S. Pal, P. Sahni 
and T. K. Chattopadhya
Department of GI Surgery All India Institute of Medical 
Sciences, Delhi, India
Background: For nearly thirty years hepaticojejunostomy 
(HJ) has been the standard surgical procedure for the man-
agement of benign biliary stricture (BBS) following chole-
cystectomy. Long term results from different parts of the 
world shows the emergence of the problem of restructure 
following HJ. We wanted to report our experience of manag-
ing such recurrent biliary strictures.
Materials and Method: Prospectively maintained database 
of all BBS cases managed between 1992 and 2006 in our 
institute was reviewed and analyzed. Cases having at least 5 
year follow up were included.
Results: Thirty-three cases of strictured HJ were managed. 
All underwent revision HJ. The mean age was 36 years with 
a female preponderance. Median duration of symptoms was 
17 months. History of jaundice (100%), cholangitis (92%), 
external biliary fi stula (38%), intra abdominal collection 
(26%), percutaneous drainage and PTBD (7%) were present. 
Uni and multivariate analysis showed anastomosis size, 
intrahepatic stones and atrophy-hypertrophy complex were 
associated with poor outcome. Follow up at 5 years showed 
grade I complications in 70%, grade II in 15% and grade IV 
in 6 (15%) cases. The results are comparable to the outcome 
in 178 historical controls (primary BBS) managed in our 
department.
Conclusion: In a high volume hepatobiliary center the 
results of revision HJ for recurrent BBS can have good long 
term result in the form of amelioration of symptoms and 
recurrence of stricture.
A-234
CHOLEDOCHAL CYST: ANALYSIS OF 436 
PATIENTS FROM AN INDIAN CENTRE
N. Yanger1, G. R. Bora1, A. Javed1, S. Singh1, S. Agarwal1, 
H. H. Nag1, S. Saluja1, P. K. Mishra1, R. Gondal2 and 
A. K. Agarwal1
1Department of GI Surgery, GB Pant Hospital & MAM 
College, New Delhi; 2Department of Pathology, GB Pant 
Hospital & MAM College, New Delhi
Background/Aim: Choledochal Cyst (CDC) or congenital 
bile duct cyst is a rare disorder affecting biliary system. 
Prospective database of choledochal cyst was analyzed to 
ascertain the clinical presentation, cyst morphology & com-
plications of choledochal cysts.
Material and Methods: Study group included patients of 
choledochal cysts presenting to the surgical clinic over a 
period of 11 years (January 2001 to May 2011) at our teach-
ing tertiary referral centre.
Result: A total of 436 cases of choledochal cyst were 
managed between January 2001 to May 2011. There were 63 
(14.44%) pediatric and 373 (85.55%) adult patients. Male to 
female ratio was 1 : 4.1. Pain abdomen was most common 
presenting complaint followed by jaundice, cholangitis, 
abdominal lump and pancreatitis. A history of prior biliary 
surgery was found in 44 (10.09%) patients. Two hundred and 
seventy patients (49.7%) had Type I CDC, 158 had Type IVa 
(36.2%), 3 had Type V, and 2 had Type II. One patient each 
had Type III, IVb and VI (Todani’s modifi cation of Alonso 
Lej classifi cation). Malignancy in form of gallbladder cancer 
& cholangiocarcinoma was present in 7.79% cases and portal 
hypertension in 4.12%. Patients with Type I, II and IV CDC 
underwent excision of the extrahepatic portion of the 
Choledochal cyst with Roux-en-Y Hepaticojejunostomy. 
Two patients of Type V cyst underwent left hepatectomy. 
One patient of Type VI cyst underwent laparoscopic chole-
cystectomy. Thirty day mortality was 0.22%.
Conclusion: Type I was the most common type of CDC. 
Malignancy was present in 7.79% cases and portal hyperten-
sion in 4.12%. Choledochal cyst excision with bilioenteric 
anastomosis is a safe procedure and should be performed 
early.
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IMPACT OF HEPATECTOMY FOR 
SOLITARY HUGE HEPATOCELLULAR 
CARCINOMA
S. Ariizumi, Y. Takahashi, Y. Kotera, S. Katagiri and M. 
Yamamoto
Department of Surgery, Institute of Gastroenterology, 
Tokyo Women’s Medical University, Tokyo, Japan
Introduction: To evaluate the surgical outcome of patients 
with huge solitary hepatocellular carcinoma (HCC, ≥10 cm 
in diameter) without major vascular invasion.
Methods: We retrospectively studied 177 patients with huge 
HCC (≥10 cm in diameter) who underwent hepatectomy 
from 1990 to 2008. Surgical outcomes and clinicopathologi-
cal characteristics were compared among 54 patients with 
solitary HCC without a major portal vein tumor thrombus 
(MPVT), 53 patients with multiple HCCs without MPVT, 
and 70 patients who have HCC with MPVT.
Results: The mean tumor size and indocyanine green reten-
tion rate at 15 minutes showed no signifi cant difference 
among patients groups. The overall 5-year survival rate was 
signifi cantly higher in patients with solitary HCC (79%) than 
in patients with multiple HCCs (31%, p < 0.0001) and MPVT 
(17%, p < 0.0001). In patients who underwent curative 
surgery, the 5-year disease-free survival rate was signifi -
cantly higher in patients with solitary HCC (48%) than in 
patients with multiple HCCs (12%, p = 0.0008) and MPVT 
(12%, p = 0.0003). Multivariate analysis showed solitary 
HCC to be a signifi cant independent prognostic factor for 
overall survival and disease-free survival.
Conclusions: Patients with solitary HCC without MPVT 
show a favorable surgical outcome even for tumor size 
≥10 cm in diameter.
A-236
RESECTION OF HEPATOCELLULAR 
CANCER (HCC) IN AN AUSTRALIAN 
TERTIARY REFERRAL HOSPITAL
S. M. Schlichtemeier1, N. E. Williams1, A. Campain1, R. C. 
Smith1, A. Gill2, J. S. Samra1 and T. J. Hugh1
1Upper GI Surgery Unit and 2Department of Anatomical 
Pathology, Royal North Shore Hospital, University of 
Sydney, St Leonards, NSW, Australia
Introduction: HCC is a common cause of cancer death 
worldwide. Surgery offers the best chance of long-term sur-
vival. Outcomes following resection are heavily infl uenced 
by patient selection criteria and frequency of chronic liver 
disease in the referred population. This study documents our 
experience of treating HCC at an Australian tertiary hospital 
in a referral population with low levels of chronic liver 
disease.
Methods: Between January 1998 and February 2009, 108 
patients with HCC were referred to our institution for surgi-
cal consideration; 34 patients subsequently underwent cura-
tive liver resection. A retrospective analysis of various 
prognostic factors including clinical, pathological, and 
immunohistochemical markers (Ki-67, CK-19 and p53) was 
performed on these patients.
Results: Twenty-two males and 12 females with a median 
age of 65 years (34–87 years) were studied. Ninety four 
percent (32/34) had Childs-Pugh A liver disease and ten 
(29%) had histologically confi rmed cirrhosis. Post-operative 
morbidity and in-hospital mortality was 14.7% and 2.9% 
respectively. Overall actuarial 5-year survival was 42% with 
a median follow up of 17.8 months. During this time, 16 
patients had recurrent HCC and 14 of these received further 
therapy. Overexpression of Ki-67, CK-19 or p53, maximal 
tumor size and tumor multicentricity did not predict poor 
long-term survival. Only histologically confi rmed microvas-
cular invasion by tumor predicted both poor overall and 
disease-free survival (p = 0.012, p = 0.021 respectively).
Conclusion: Resection of HCC in selected patients can 
provide satisfactory long-term survival. Vascular invasion by 
tumor is a marker of early recurrence and poor survival after 
an apparently curative resection.
A-237
CHANGES OF PIVKA-II AND AFP AFTER 
TREATMENT OF HEPATOCELLULAR 
CARCINOMA AS PREDICTORS OF 
PATIENTS SURVIVALS
T. Abo, A. Nanashima, T. Sawai and T. Nagayasu
Division of Surgical Oncology, Nagasaki University 
Hospital
Introduction: AFP is used as a marker for hepatocellular 
carcinoma (HCC), which is infl uenced by hepatitis. Protein 
induced vitamin K absence or antagonist II (PIVKA-II) is a 
sensitive diagnostic marker of HCC. Changes in these 
markers after treatment refl ect curability and predict outcome.
Methods: We conducted an analysis of prognosis in 614 
HCC patients who received various treatments, and exam-
ined relationship between changes in AFP and PIVKA-II 
levels in 236 patients. Subjects were divided into 4 groups 
according to changes in both levels: normal (L) group before 
treatment, normalization (N) or unchanged (DU) group after 
treatment.
Results: High AFP and PIVKA-II levels were signifi cantly 
associated with poor tumor-free and overall survival. 
Multiple tumors, large size and advanced stage were signifi -
cantly associated with DU group. There were no differences 
in tumor relapse between groups. Overall survival in the 
AFP-L group was signifi cantly better than those of other 
groups and overall survival in PIVKA-II-L and N groups 
were signifi cantly better than those of PIVKA-II-DU groups. 
Combination of changes in AFP-DU and PIVKA-II-DU 
group showed the worst tumor-free and overall survivals. 
Multivariate analysis identifi ed high pre-treatment levels of 
AFP and PIVKA-II and combination of AFP-DU and 
PIVKA-II-DU as signifi cant determinants of poor tumor-free 
and overall survival.
Conclusions: Normalization of AFP or PIVKA-II after 
treatment for HCC refl ected effi cacy of treatment and is a 
suitable predictor of prognosis in HCC patients.
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A-238
SPLENIC ARTERY ANEURYSM WITH 
EXTRAHEPATIC PORTAL VEIN 
OBSTRUCTION: MANAGEMENT ISSUES
P. K. Mishra1, S. S. Saluja1, A. K. Sharma2 and P. Pattnaik1
Department of Gastrointestinal Surgery1, Room No 219, 2nd 
fl oor, Academic Block GB Pant Hospital and Department 
of Radiology2, Ground fl oor, G B Pant Hospital, New 
Delhi, India
Background: Splenic artery aneurysm although rare is 
clinically signifi cant in view of their propensity for spontane-
ous rupture and life threatening bleeding. While portal hyper-
tension is an important etiological factor, majority of reported 
cases in literature are secondary to cirrhosis of liver. We 
report three cases of Splenic artery aneurysm secondary to 
extrahepatic portal vein obstruction and discuss their 
management.
Methods: The records of patients with extrahepatic portal 
vein obstruction from 2003 to 2010 were reviewed retrospec-
tively. Three out of 45 patients had associated splenic artery 
aneurysm. The clinical presentation, surgical treatment and 
outcome were analyzed.
Results: Ultrasound Doppler demonstrated aneurysm in all 
patients. The size of aneurysm was >3 cm in all cases. The 
clinical symptoms were secondary to extrahepatic portal vein 
obstruction [hematemesis (n = 2), portal biliopathy (n = 2)] 
while aneurysm was asymptomatic. Proximal splenorenal 
shunt was performed in two patients with excision of aneu-
rysm in one and ligation of aneurysm in other patient. Third 
patient had splenic vein replaced by collaterals hence under-
went splenectomy with aneurysmectomy. All patients had 
uneventful post-operative course.
Conclusions: Splenic artery aneurysms are associated with 
extrahepatic portal vein obstruction. Surgery is the mainstay 
of treatment. Although it is technically diffi cult it can be 
safely performed in an experienced centre with minimal mor-
bidity and good outcome.
A-239
FLUORESCENT IMAGING WITH 
INDOCYANINE GREEN FOR DETECTION 
OF BILE LEAKAGE DURING LIVER 
SURGERY
E. Tadahiko, T. Yoshihiro, H. Eijirou, U. Naomasa and H. 
Kimikazu
Yamaguchi University, Department of Surgery and Clinical 
Science, Ube, Japan
Introduction: Despite an improvement of surgical tech-
nique and perioperative managements, bile leakage remains 
one of clinically signifi cant complications after liver surgery. 
In order to prevent this, a special attention has been paid to 
detection of bile leakage on transected surface of the liver 
during surgery, that is, bile leakage test using saline solution 
or lipid emulsion. Indocyanine green (ICG) is widely used 
for the assessment of liver function, while ICG is known to 
emit lights with peak wavelength of 845 nm once bound to 
proteins, when illuminated with near-infrared light. In this 
study, we demonstrate the method in which ICG is utilized 
for the bile leakage test.
Methods: Six Japanese patients with primary and metastatic 
liver tumor were enrolled. After completion of liver transec-
tion (hemihepatectomy in 2 patients and subsegmentectomy 
in 4), bile leakage test was routinely performed. Initially 5 ml 
of ICG solution (0.5 mg/ml) was administered through the 
transcystic tube, and then transected surface was observed 
by an infrared camera system without the surgical light. Until 
fl uorescence was observed in the duodenum, an additive 
injection of ICG was performed.
Results: In all cases, immediately after administration of 
ICG, fl uorescent image of extrahepatic bile duct was dem-
onstrated. In one case fl uorescence of ICG fl owing out of 
transected surface was detected and leakage was closed by 
sutures. There were no patients who required abdominal 
drainage for postoperative biloma. No adverse reaction to 
ICG was identifi ed.
Conclusions: Fluorescent imaging of ICG was safe and fea-
sible in detecting bile leakage during liver surgery.
A-240
GUIDE STROKE VOLUME VARIATION 
OF LIVER ALVEOLAR HYDATID 
PATIENTS UNDERGOING HALF LIVER 
RESECTION OF THE TREATMENT 
CAPACITY
R. Minawaer, H. Zheng and H. Wen
Department of Anesthesiology, the First Affi liated Hospital 
of Xinjiang Medical University, Urumqi PR China
Introduction: To observe the variability of each blog on 
liver alveolar hydatid patients undergoing hepatectomy 
bleeding and renal function.
Methods: SVV group to maintain the SVV in the 8 ~ 12, 
LCVP group completely from the liver during the central 
venous pressure off (CVP) Control 0 ~ 5 cm H2O. Were 
observed in patients undergoing total blood loss, transfusion 
rate, and blood transfusion, compared preoperative, intraop-
erative completion of renal function.
Results: SVV group and blood loss were LCVP group (527 
± 125) ml and (407 ± 108) ml, P < 0.05. Intraoperative blood 
transfusion was signifi cantly less than the LCVP group SVV 
group, and blood transfusion rates between the 2 groups was 
signifi cant difference (P < 0.01). Two groups of surgery com-
pared with preoperative Hb and HCT decreased, but the SVV 
group decreased more signifi cantly, P < 0.01. Preoperative 
and postoperative had no signifi cant changes in renal 
function.
Conclusions: SVV 8 ~ 12, although the treatment for the 
goal to guide the capacity to maintain stable hemodynamics 
and effective tissue perfusion, but reduced LCVP hepatec-
tomy better perioperative blood transfusion, infusion volume, 
reduce the amount of bleeding; and SVV is more affordable 
compared.
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A-241
IDENTIFICATION OF AUTOANTIBODIES 
AS DIAGNOSTIC MARKERS IN THE 
SERA OF PATIENTS SUFFERING FROM 
CHOLANGIOCARCINOMA BY 
PROTEOMIC APPROACH
M. S. Mustafa1,2, E. Beleoken1,2, D. Samuel1,2,3, E. Ballot 1,2 
and J.-C. Duclos-Vallee1,2,3
1Inserm, Unite 785, Villejuif, France; 2Univ. Paris-Sud, 
UMR-S785, Villejuif, France; 3AP-HP Hôpital Paul 
Brousse, Centre Hepato-Biliaire, Villejuif, France
Introduction: Cholangiocarcinoma (CC) represents the 
second most common primary liver cancer in the World. Due 
to lack of early diagnosis and weak knowledge of patho-
physiological mechanisms, the incidence is rising. No immu-
nological diagnostic or prognostic marker has been correlated 
to the disease. Aim of our study is to develop two-dimen-
sional immunoblots performed with proteins of human CC 
cell lines and normal human liver homogenate in order to 
detect auto-antibodies present in patient’s sera.
Methods: We analyzed cholangiocarcinoma patient’s sera 
(n = 13), and sera from healthy donors (n = 10). Immunoblots 
obtained by testing the sera against protein extracts from two 
human cholangiocarcinoma cell lines (CCSW1 and CCLP1) 
and normal human liver homogenate. Proteins from these 
sources had previously been separated by 2D electrophoresis 
and transferred onto nitrocellulose membranes.
Results: Four common immunoreactive spots stained by six 
among thirteen (46%) patient sera and not by controls were 
observed on immunoblots with CCSW1. Their molecular 
weights (MW) in kDa and isoelectric (pI) point were 55/5; 
55/7; 50/5; 50/7. Using CCLP1 as antigen, fi ve spots were 
stained with all CC sera studied while no control sera stained. 
The MW and pI were 55/4; 55/4.5; 45/4.5; 30/5; 30/7, 
respectively. An additional spot corresponding to 55 kDa and 
pI between 4–5 was identifi ed as reacting with the two cell 
lines.
Conclusions: Sera from patients with tumors are the ideal 
source for studying tumor associated auto-antibodies. We are 
looking forward to identify new diagnostic and prognostic 
markers of cholangiocarcinoma by mass spectrometry.
A-242
LAPAROSCOPIC LIVER RESECTION OF 
MALIGNANT TUMORS: A MELBOURNE 
EXPERIENCE
T. L. Yong, V. Usatoff, M. Smith and P. M. Evans
The Alfred Hospital, Melbourne, Australia
Introduction: Laparoscopic hepatectomy for hepatic malig-
nancy is increasingly reported in the literature to be a safe 
and feasible procedure. Some reports also showed the pres-
ervation of oncological margins with such operative 
approach. This series aims to compare results from 3 centers 
in Melbourne against results published in the literature.
Methods: A review of all laparoscopic hepatectomies, per-
formed between January 2005 and December 2010, was 
undertaken. Data was collected and analyzed retrospectively 
from medical records and prospective databases.
Results: A total of 46 laparoscopic hepatectomies were per-
formed on 45 patients. Of these cases, 34 were for malignant 
tumors. The commonest indication for resection was colorec-
tal metastases (88%). Laparoscopic to open conversion rate 
was 15%. Complications occurred in 18% of cases with no 
inpatient or 30-day mortality recorded. Only 3 cases required 
intra- or post-operative blood transfusion. Resection margins 
were pathologically clear in 94% of cases.
Conclusion: Laparoscopic liver resection for malignancy 
can be performed safely in selected patients. Negative resec-
tion margin of 94% was comparable to reported rates in 
current literature (94–97%).
A-243
RISK FACTORS FOR SPONTANEOUS 
RUPTURE OF PYOGENIC LIVER 
ABSCESS
S. Y. Lee1,2, C. S. Chia1, Y. M. Tan1,2, Y. F. A. Chung1,2, 
P. C. Cheow1,2, K. H. P. Chow1,2, H. N. Koong1,2, 
W. K. Wong1,2, L. L. Ooi1,2 and K. C. Soo1,2
1Department of General Surgery, Singapore General 
Hospital, Singapore; 2Department of Surgical Oncology, 
National Cancer Centre, Singapore
Introduction: Pyogenic liver abscess (PLA) is a potentially 
fatal intra-abdominal infection, despite advancements in 
diagnostics, antibiotics and introduction of minimally inva-
sive techniques for treatment, PLA remains a challenging 
condition. The proportion of PLA that rupture is about 
5–15%. We aim to determine the clinical and radiological 
risk factors that may help us to identify patients at risk of 
rupture so that these patients can be identifi ed early and 
treated more aggressively to minimize complications and 
mortality.
Methods: A multi-centre prospective study was performed 
identify 109 patients with PLA treated between 1999 and 
2005. The clinical data, clinical progress, operative informa-
tion and radiological reports of these patients were reviewed 
to identify risk factors.
Results: 109 patients with pyogenic liver abscesses were 
treated during the study period. 12.8% had spontaneous 
rupture of their liver abscesses. The overall mortality is 
4.6%. There was no signifi cant difference between the 2 
groups in terms of age, sex, incidence of diabetes mellitus 
and hematological investigations. The PLA on the left side 
has a signifi cantly higher chance of rupture (p = 0.033). 
There was no difference in size, number and loculation of 
the abscesses. There was also no difference between the 2 
groups in terms of mortality, intensive care unit stay and 
complications.
Conclusion: The assumption that patients with ruptured 
liver abscesses have a poorer outcome may not be accurate. 
We did not fi nd a signifi cant difference in outcome between 
the 2 groups. The only signifi cant difference is that abscesses 
on the left have a higher incidence of rupture.
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A-244
HEPATIC RESECTION VERSUS 
TRANSCATHETER ARTERIAL 
CHEMOEMBOLIZATION FOR THE 
TREATMENT OF HEPATOCELLULAR 
CARCINOMA WITH PORTAL VEIN 
TUMOR THROMBUS
Z-W. Peng1,2, Y-J. Zhang1,2 and M-S. Chen1,2
1Department of Hepatobiliary Surgery, Cancer Centre of 
Sun Yat-Sen University, 651 Dongfeng Road East, 
Guangzhou, China; 2State Key Laboratory of Oncology in 
Southern China, Guangzhou, China
Introduction: The appropriate treatment for HCC with 
PVTT is still under debate. We wanted to compare the long-
term survival outcomes of treatment with hepatic resection 
(HR) or with transcatheter arterial chemoembolization 
(TACE) for hepatocellular carcinoma (HCC) with portal vein 
tumor thrombus (PVTT).
Methods: Two hundred and one consecutive patients diag-
nosed with HCC with PVTT received HR as an initial treat-
ment. These patients were compared with 402 case-matched 
controls who received TACE as an initial treatment. PVTT 
was classifi ed to 4 types: PVTT involving the segmental 
branches of the portal vein or above (type I), PVTT extending 
to involve the right/left portal vein (type II), the main portal 
vein (type III), or the superior mesenteric vein (type IV).
Results: The 1-, 3-, 5- year overall survivals for the HR and 
TACE groups were 42.0%, 14.1%, 11.1% and 37.8%, 7.3%, 
0.5%, respectively (p < 0.001). On subgroup analyses, 
overall survivals for the HR group were better than the TACE 
group for type I PVTT, type II PVTT, alpha-fetoprotein level 
≤400 ng/ml, single tumor and tumor size >5 cm (p < 0.001, 
p = 0.002, p < 0.001, p < 0.001, p < 0.001, respectively), but 
not for type III PVTT, type IV PVTT, alpha-fetoprotein level 
>400 ng/ml, multiple tumors and tumor size <5 cm (p = 
0.541, p = 0.371, p = 0.323, p = 0.264, p = 0.338, p = 0.125, 
respectively). Multivariate analysis showed type of PVTT, 
tumor number, and treatment allocation were signifi cant 
prognostic factors for overall survival.
Conclusion: Compared with TACE, HR provided survival 
benefi ts for patients with HCC with PVTT, especially for 
those with a type I PVTT, type II PVTT or single tumor.
A-246
THE EFFECT OF IN VITRO 
CO-CULTURE WITH ADIPOSE TISSUE-
DERIVED STEM CELLS AND 
HEPATOCELLULAR CARCINOMA CELL 
LINES
H. J. Han1, T. J. Song1, K. O. Lee2, S. B. Choi1, J. S. Lee1, 
S. H. Park1, W. B. Kim1, S. Y. Choi1, S. O. Suh1 
and C. W. Jung1
1Korea University College of Medicine, Seoul, Korea; 
2Korea University Hepatobiliopancreas Laboratory, Ansan, 
Korea
Introduction: The effects of adipose tissue-derived mesen-
chymal stem cells (AT-MSC) on the growth of human malig-
nancies including hepatocellular carcinoma (HCC) are 
controversial, and the underlying mechanisms are not yet 
understood. The aim of this study was to explore the role and 
interaction of AT-MSC with HCC cell lines in vitro co-cul-
ture environments.
Methods: AT-MSCs were mixed with using human Huh7 
HCC cells in various ratios and for 1, 3, 5 and 7 days in vitro. 
Also, AT-MSCs were cultured using the media of HCC cell 
lines and HCC cell lines were culture using the media of 
AT-MSCs for 1, 2, and 3 days in vitro. The LDH cytotoxic 
assay and MTT assay were used.
Results: Conditioned media of AT-MSCs affected the pro-
liferation of Huh7 HCC cell lines in vitro in MTT assay. 
Reversely, the media of Huh7 cell lines decreased the prolif-
eration of AT-MSCs in vitro using MTT assay. LDH release 
co-culture of AT-MSC and Huh7 HCC cell lines demon-
strated no signifi cant change during 7 days. The levels of 
supernatant TGF-beta1 in vitro co-culture with the Matrix 
gel of AT-MSC and Hep3B HCC cell line increased up to 3 
days then decreased.
Conclusions: The AT-MSC did not affect HCC cell line 
proliferation but slightly decreased the production of TGF-
beta1 in Hep3B cell line. The Huh7 HCC cells and AT-MSCs 
infl uenced the proliferations of each cells in vitro in MTT 
assay.
A-247
PROPOSED PROPER INCISION LENGTH 
OF INFERIOR VENA CAVA FOR SIDE-TO-
SIDE CAVO-CAVAL ANASTOMOSIS OF 
PIGGYBACK TECHNIQUE IN DECEASED 
DONOR LIVER TRANSPLANTATION
I-G. Kim, J-R. Cho, J. Y. Jeon, J. S. Kim, D. J. Kim, 
J. P. Jung, S. E. Chon and H. J. Kim
Department of Surgery, Hallym University Medical Center, 
Hallym University College of Medicine, Korea
Introduction: The advantage of the piggyback technique in 
liver transplantation is to maintain physiologic hemodynam-
ics without the need for extra-corporeal venovenous bypass. 
Despite the widespread acceptance of this method, many 
surgeons have diffi culties deciding what incision length of 
inferior vena cava (ILIVC) is enough for need of the donated 
liver. We report 20 cases of DDLT using the side-to-side 
cavo-caval anastomosis of piggyback technique, focusing 
the ILIVC.
Methods: Between May 2007 and April 2011, 20 patients 
who had undergone DDLT in side-to-side cavo-caval anas-
tomosis method at our institution were studied retrospec-
tively. We analyzed the demographics, clinical progress, and 
ILIVC at operating room. Moreover, we analyzed the diam-
eter of each donated hepatic vein and cavo-caval anastomosis 
through postoperative computed tomography. We hypothe-
sized ILIVC is equal to πr (r2 = [a2 + b2 + c2]/4, a = diameter 
of Rt. hepatic vein, b = diameter of common trunk of Lt.-
middle hepatic vein, c = diameter of other hepatic vein).
Results: In postoperative CT, the areas of reconstructed 
IVC orifi ce decreased by 30% to 70% compared with those 
from ILIVC based on the diameter of each hepatic vein. 
Revised length that we multiplied ‘calculated ILIVC’ by 1.2 
(or the square root 1.5) was applied for 20 cases. Seven cases 
had lesser ILIVC than revised ones. Especially, the one case 
of them underwent interventional stent placement at cavo-
caval anastomosis site on postoperative day 10. The other 
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6 cases recovered fully without any specifi c problem after 
the operation.
Conclusions: We recommend the equation of ‘revised 
ILIVC (=1.2 × calculated ILIVC)’ as proposed ILIVC in 
DDLT using side-to-side cavo-caval anastomosis of piggy-
back technique. We think 25 mm to 45 mm of ILIVC is 
enough for side-to-side cavo-caval anastomosis of piggyback 
technique, to calculate based on that equation.
A-248
THREE DIMENSIONAL IDENTIFICATION 
OF LIVER SEGMENT WITH CONTRAST-
ENHANCED INTRAOPERATIVE 
ULTRASOUND USING SONAZOID
J. Arita, R. Yoshioka, N. Takemura, N. Tsutsui, Y. Ono, 
R. Koga, A. Saiura and T. Yamaguchi
Cancer Institute Hospital, Tokyo, Japan
Introduction: Anatomic hepatic resection improves the 
prognosis of patients with hepatocellular carcinoma. We 
have developed a novel technique for ultrasonic visualization 
of a liver segment using mixture of Sonazaoid which has the 
peculiarity of accumulating in the Kupffer cells and indigo 
carmine.
Methods: Seven patients who underwent liver resection for 
liver cancer (4 hepatocellular carcinoma and 3 liver metas-
tasis) were the participants of this study. After clamping 
hepatic artery using a vascular forceps, the target portal 
branch was punctured with a 23-gauge-sized needle under 
IOUS guidance. A mixture of 1.6 microL of Sonazoid and 
5 ml of indigo carmine was injected through the needle as 
slowly as injected particles were not regurgitated. 
Immediately, ultrasonic observation was done in the har-
monic mode dedicated to visualize Sonazoid microbubbles. 
Both a macroscopic observation of dyed liver surface and an 
ultrasonic observation of the enhanced liver parenchyma 
were assessed by attending surgeons.
Results: Macroscopic identifi cation of a liver segment 
through dyed liver surface was apparent in 2 patients, pos-
sible in 3 patients, and not effective in 2 patients. Whereas, 
ultrasonic identifi cation was apparent in 6 patients and was 
possible in 1 patient. After starting liver parenchymal tran-
section, ultrasonic identifi cation of a liver segment is effec-
tive for 10 to 30 minutes and liver transection could be 
performed following the demarcation line identifi ed through 
an ultrasonic image in the harmonic mode.
Conclusions: Using mixture of Sonazoid and indigo 
carmine, we have established a technique for three-dimen-
sional staining of a liver segment.
A-249
HEPATIC VASCULAR INJURY: CLINICAL 
PROFILE, ENDOVASCULAR 
MANAGEMENT AND OUTCOMES
B. Mohan1, H. Bhoday1, S. Budhiraja2 and J. Singh2
1HDHI, Dayanand Medical College & Hospital, Ludhiana, 
Punjab, India; 2Dayanand Medical College & Hospital, 
Ludhiana, Punjab, India
Introduction: Endovascular management using angio-
graphic embolization (AE) has been widely used with 
success in blunt hepatic trauma in adults and with a limited 
pediatric experience. We assess our use of endovascular 
management in patients of blunt and post operative trauma 
with active hepatic vascular bleeding and unstable hemody-
namics in controlling bleeding for an improved clinical 
outcome.
Methods: A retrospective review of inpatients from January 
2006 to November 2010 requiring transarterial embolization/
stenting for active hepatic vascular bleeding was done. All 
patients had evidence of ongoing hemorrhage as proved by 
clinical, laboratory and radiological fi ndings in emergency 
settings. Angiographic intervention in an interventional suite 
with ongoing resuscitation/intubation was performed follow-
ing which patients were monitored for morbidity and mortal-
ity benefi ts on intermediate follow up.
Results: 7 patients underwent soft metal coil embolization 
for arterial bleeding and 1 patient underwent angioplasty 
with a covered stent. There were 6 adults and 2 children with 
a mean age of 30.5 ± 19.07 years and a mean liver injury 
computed tomography (CT) grade of 3.8 ± 0.83 in blunt 
trauma patients. The mean length of hospital stay was 9.62 ± 
7.83 days and the mean follow up period of the group was 
25.25 ± 21.02 months. All patients showed signifi cant clini-
cal improvement with prompt endovascular management 
resulting in no procedure related complications or mortality.
Conclusion: Prompt endovascular management is highly 
effective in improving clinical outcome in pediatric and adult 
patients with hemodynamically compromised vascular 
hepatic trauma.
A-250
TOTALLY LAPAROSCOPIC LIVER 
RESECTIONS – A SINGLE CENTER 
INITIAL EXPERIENCE
P. Herman, M. V. Perini, F. F. Coelho, R. M. Lupinacci 
and I. Cecconello
Department of Gastroenterology, University of São Paulo 
Medical School, São Paulo, Brazil
Background: Laparoscopy has become the standard 
approach to a variety of benign and malignant liver diseases 
in specialized centers. It’s role, feasibility, and safety have 
been supported by many reports of small series. However, 
most of the reports deal with hand-assisted and pure laparo-
scopic liver resection (PLLR) in the same series. Experience 
regarding totally laparoscopic surgery remains scarce.
Aim: The aim of this study is to assess the feasibility, safety 
and outcomes of pure laparoscopic liver resections in a single 
tertiary center.
Material/Methods: A prospective data collection of laparo-
scopic liver resections was initiated in 2007. A consecutive 
series of 59 patients who underwent pure laparoscopic liver 
resection in a tertiary referral center were evaluated.
Results: Fifty nine patients with mean age of 54 years sub-
mitted to 61 PLLR were evaluated. There were 7 right hepa-
tectomies, 3 left hepatectomies, 22 left lateral segmentectomies, 
5 right lateral bi-segmentectomies (6–7), 14 segmentecto-
mies and 10 nodulectomies. Five (8.1%) patients required 
intra-operative transfusion and conversion rate was 6.5% (4 
patients) due to bleeding. Mortality rate was null. One patient 
developed right pleural effusion complicated with empyema, 
two had benign biliary fi stulas and another had nosocomial 
pneumonia and sepsis (complication rate of 6.5%).
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Conclusions: Totally laparoscopic resection is technically 
feasible and safe, even for major liver resections with low 
morbidity and mortality rates. Laparoscopic liver resection 
should be considered for selected cases in the treatment of 
benign and malignant diseases and should be performed by 
surgeons with experience in both, liver and laparoscopic 
surgery.
A-251
LAPAROSCOPIC CHOLEDOCHOTOMY. 
OUTCOME OF TREATMENT OF 
COMMON BILE DUCT STONES IN A 
COMMUNITY HOSPITAL
D. Bahman
Department Surgery, Enkoping, Sweden
Background: Evidence on optimal management of common 
bile duct stones encountered at laparoscopic cholecystec-
tomy is lacking. Laparoscopic choledochotomy is an 
approach that has not been fully evaluated.
Methods: All cholecystectomies performed at the depart-
ment of surgery, Enkoping Hospital, have been registered 
prospectively in the electronic patient register. Additional 
data, including detailed information about the procedures, 
number of stones found ad the exploration and the postopera-
tive outcome, were obtained in a review of the patient 
records. All data were registered according to a standardized 
protocol. Three months after surgery the patients were 
invited for a clinical follow-up.
Results: During 2000–2008, 92 procedures including lapa-
roscopic choledochotomy were performed by two surgeons. 
Mean operative time was 190 minutes, standard deviation 56 
minutes. The operative time decreased signifi cantly with 
time (p = 0.036). Four procedures were converted to open 
cholecystectomy. Retained stones were found at postopera-
tive cholangiography in two patients. One patient One patient 
died within one year postoperatively from a hepaticobiliary 
cancer. Apart from this, no severe postoperative complica-
tions were recorded. Four patients were found to have patho-
logical ALP or liver enzymes at follow-up, but without 
symptoms of retained stones.
Conclusion: Laparoscopic choledochotomy is a safe and 
effective method for extracting common bile duct stones, 
albeit with a long learning curve. These fi ndings should be 
assessed in randomized controlled trials to test the outcome 
in relation to other strategies of treating common bile duct 
stones.
A-252
UNCOMMON MIXED TYPE I AND II 
CHOLEDOCHAL CYST IN ADULT : AN 
INDONESIAN EXPERIENCE
J. Siahaya Fransisca, J. M. Lalisang Toar, 
B. H. Simandjuntak Arnold, B. Philipi and W. S. Jeo
Cipto Mangunkusumo Hospital – Kencana, Digestive 
Cluster, Jakarta; Digestive Surgery Division, Cipto 
Mangunkusumo Hospital, Faculty of Medicine Universitas, 
Indonesia
Introduction: Bile duct cyst is an uncommon diseases 
worldwide, but its incidence is remarkably high in Asian 
population. Mixed type of choledochal cysts are extremely 
rare especially in adult. We report a mixed type I and II 
choledochal cyst in 20-year-old woman.
Methods: A case report.
Result: A 20-year-old woman with history of abdominal 
pain was diagnosed with cholelithiasis and underwent lapa-
roscopic cholecystectomy. Choledochal malformation was 
found intraoperatively. Common Bile Duct (CBD) cyst with 
stone was suspected post cholecystectomy by ultrasound, 
followed by placement of Y stent to avoid obstruction. Two 
months afterward, the patient came to our hospital with 
abdominal pain. CT-scan revealed extrahepatic fusiform 
dilatation of the CBD and diagnosis of provisional type I 
choledochal cyst was made. Complete resection of the cyst 
was performed and a mixed type I and II choledochal cyst 
was found intraoperatively. Reconstruction was carried out 
with Roux-en-Y hepaticojejunostomy.
Conclusion: We have reported a mixed type I and II chole-
dochal cyst in 20-year-old woman. Mixed type choledochal 
cysts are rare, and may be missed on imaging. Mixed type 
choledochal cyst classifi cation should not be added to the 
existing classifi cation since it may not affect the operative 
techniques signifi cantly.
A-253
SPLENIC ACTINOMYCOSIS IN CHRONIC 
PANCREATITIS: A CASE REPORT AND 
REVIEW
S. H. Choi, N. H. Baek, M. W. Kim, J. H. Kim, B. M. Yoo, 
Y. Kim, J. H. Kim, M. W. Kim and W. H. Kim
Departments of Surgery, School of Medicine, Ajou 
University, Suwon, Korea; Departments of 
Gastroenterology, School of Medicine, Ajou University, 
Suwon, Korea; Departments of Pathology, School of 
Medicine, Ajou University, Suwon, Korea
Introduction: actinomycotic involvement of the spleen is 
extremely rare. We report a case of actinomycosis of the 
spleen in recurrent chronic pancreatitis patient, which pre-
sented as huge splenic abscess.
Case Report: a 30-year-old Korean man with a history of 
acute on chronic pancreatitis and hepatitis B was admitted to 
the emergency unit with continuous epigastric pain and left 
fl ank pain accompanied by fever. He had been admitted to 
our hospital for chronic pancreatitis and ERCP and ESWL 
were performed several times in four years of follow-up 
period. When he was presented to emergency unit, he had 
complication of pancreatitis, such as pancreatic pseudocyst 
and splenic infarction. CT of the abdomen showed multiple 
splenic infarction and abscess. Owing to the abscess being 
symptomatic and of considerable size, the decision to 
undergo splenectomy was made. The operation was com-
pleted successfully without complication. Spleen sections 
showed multiple abscess formation with sulfur granules. 
High power magnifi cation showed fi lamentous bacterial 
organisms consistent with actinomyces species His antibiot-
ics were changed to penicillin and it was continued for 3 
months. He recovered with a good result. This case report 
was fi rst case in splenic actinomycosis associated with 
chronic pancreatitis in otherwise healthy patient. We believe 
that our patient had actinomyces by repeated episodes of 
acute pancreatitis on chronic pancreatitis.
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A-254
SEPTIC COMPLICATIONS FOLLOWING 
SURGERY FOR ACUTE NECROTIZING 
PANCREATITIS
P. K. Sinha, T. D. Yadav, R. Kochhar, M. Kumar 
and M. Hinduja
Postgraduate Institute of Medical Education and Research 
Chandigarh India
Introduction: Acute necrotizing pancreatitis a life threaten-
ing disease. Post operative septic complications signifi cantly 
increase morbidity and mortality.
Methods: The aim of this study was to know incidence, 
bacterial ecology, antibiotic sensitivity of bacterial isolates, 
and impact of septic complications on outcome in patients 
after pancreatic necrosectomy for SAP. : It was a consecutive 
study conducted in a period of one year in a tertiary care 
hospital in India. All patients with severe acute pancreatitis 
who underwent surgery were followed from time of admis-
sion to discharge or death.
Results: Twenty patients underwent pancreatic necrosec-
tomy with post operative closed lesser sac lavage. Overall 
mortality was 40% (8). Twelve developed septic complica-
tions. Intraabdominal abscess in 7, wound infection in 4, 
Enterocutaneous fi stula in 2, pancreatic fi stula in 2, pneumo-
nia in 3, urinary tract infection in 2, and central venous 
catheter related blood stream infection in 2 patients. They 
were associated with higher morbidity but did not increase 
mortality. Bacterial ecology of locoregional complications 
was dominated by gram negative bacteria. Third generation 
cephalosporin and aminoglycosides were effective.
Conclusions: infections account for most of the deaths in 
acute pancreatitis. Patients are especially susceptible to 
infections in the post operative period owing to the progres-
sive nature of disease, major abdominal surgery and inten-
sive care unit stay. This study showed that septic complications 
increase the morbidity but did not increase mortality signifi -
cantly. Nosocomial infections are common and important 
cause of morbidity. It is probably the severity of disease 
which determines the fi nal outcome.
A-255
REASON AND PROGNOSIS ANALYSIS 
FOR THE HILAR BILIARY BENIGN 
STRICTURE (WITH 142 CASES)
Y. Yusufu, W. Hao, S. Paizula and T. Tursun
Digestive and Vascular Department, The First Affi liated 
Hospital Of Xinjiang Medical University, Urumqi, PR 
China
Introduction: To analyze the reason and prognosis for hilar 
biliary benign stricture.
Methods: the clinical history, causes, pathological changes, 
management, re-operation rate and therapeutic effects of 142 
cases with hilar biliary benign stricture during January 2003 
to January 2009 were retrospectively analyzed.
Results: Biliary injury is the main cause for the hilar biliary 
benign stricture (65/142) and stricture occurred in common 
hepatic duct, hepatic duct convergence and right hepatic duct 
respectively in 34, 28 and 3 cases. Biliary infl ammation is 
the second cause (27/142) and stricture occurred in common 
hepatic duct, hepatic duct convergence and left hepatic duct 
respectively in 11, 14 and 2 cases. Liver hydatid Post-
operation is the third cause (22/142) and stricture occurred 
in hepatic duct convergence, right hepatic duct and left 
hepatic duct respectively in 3, 16 and 3 cases. Choledochal 
cyst is the fourth cause (15/142) and stricture occurred in 
right hepatic duct and left hepatic duct respectively in 1 and 
14 cases. Stricture caused by Mirizzi Syndrome observed in 
13 cases and stricture occurred in common hepatic duct, 
hepatic duct convergence respectively in 11 and 2 cases.
Conclusions: Biliary injury and biliary infl ammation are the 
main causes for hilar biliary benign stricture. The stricture in 
liver hydatid postoperative cases are mostly high and with 
heavy pathological alterations, usually diffi cult to treat and 
with poor diagnosis.
A-256
EXPRESSION OF GLYPICAN-3 IN WELL-
DIFFERENTIATED HEPATOCELLULAR 
CARCINOMA
I-P. Chen1, S-I. Ariizumi1, M. Nakano2 and M. Yamamoto1
1Department of Surgery, Institute of Gastroenterology, 
Tokyo Women’s Medical University, Tokyo, Japan; 
2Department of Pathology, Ofuna Chuo Hospital, Ofuna 
Kamakura, Kanagawa, Japan
Introduction: Glypican-3 is a specifi c biomarker for 
advanced hepatocellular carcinoma (HCC). However, the 
role of glypican-3 expression in early HCC or well-
differentiated HCC has not been clarifi ed yet. Therefore, our 
aim is to investigate the role of glypican-3 in early HCC and 
well-differentiated HCC.
Methods: From 1995 to 2010, we studied 97 patients who 
underwent hepatectomy and 102 well-differentiated HCCs 
were diagnosed pathologically. Well-differentiated HCCs 
were classifi ed into the following 3 subtypes according to the 
Japanese Liver Cancer Classifi cation: early HCC, small 
nodular with indistinct margin (n = 53); large well-
differentiated HCC, 3 cm in diameter or larger (n = 14); 
nodule-in-nodule HCC, well-differentiated HCC containing 
a small moderately differentiated area (n = 35). The glypi-
can-3 expression was investigated in relation to the subtypes. 
The immunohistochemical results of glypican-3 expression 
were classifi ed according to the positive cells number as 
follows: negative, 0–9%; weakly positive, 10–29%; positive, 
>30%.
Results: Glypican-3 was positive in 25 nodules of early 
HCC (47%) and 27 nodules (77%) in nodule-in-nodule HCC. 
Only three nodules showed weak glypican-3(22%) in large 
well-differentiated HCCs.
Conclusions: Glypican-3 expression may be an early 
event during multistep progression of human 
hepatocarcinogenesis.
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A-257
THE USE OF 18F-CHOLINE PET/CT IN 
DIFFERENTIATING FOCAL NODULAR 
HYPERPLASIA FROM 
HEPATOCELLULAR ADENOMA: 
A PROSPECTIVE STUDY
M. Bieze1, Y. El Massoudi1, J. W. van den Esschert1, 
S. S. K. S. Phoa2, J. Verheij3, T. M. van Gulik1 and 
R. J. Bennink4
1Department of Surgery, Academic Medical Center, 
Amsterdam, the Netherlands; 2Department of Radiology, 
Academic Medical Center, Amsterdam, the Netherlands; 
3Department of Pathology, Academic Medical Center, 
Amsterdam, the Netherlands; 4Department of Nuclear 
Medicine, Academic Medical Center, Amsterdam, the 
Netherlands
Abstract: Focal nodular hyperplasia (FNH) and hepatocel-
lular adenoma (HCA) are benign focal hepatic lesions. 
Unlike FNH, resection is recommended for HCA > 5 cm, 
because of potential risk of bleeding and malignant transfor-
mation, emphasizing the importance of reliable differentia-
tion between HCA and FNH. Conventional imaging may 
produce inconclusive results. The aim of our study was to 
prospectively evaluate the use of PET/CT with 18F-choline 
in the differentiation between HCA and FNH.
Methods: Consecutive patients with suspicion of one or 
multiple HCA or FNH > 2 cm were included. All patients 
underwent a PET/CT with 18F-fl uorocholine. Standard of 
reference was either Magnetic Resonance (MR) imaging, or 
histopathological diagnosis obtained by liver biopsy or 
surgery. The standardized uptake value (SUV) ratio of the 
lesions compared to normal liver uptake within the same 
patient was calculated and a receiver operating characteristic 
curve analysis was performed.
Results: Seventy patients were included and 104 lesions 
were evaluated. A diagnosis was made of 54 FNH and 50 
HCA on the basis of histological examination or MR imaging. 
The mean SUV ratio for FNH was 1.69 ± .34 SD and for 
HCA 0.83 ± .26 SD (P < .001). The receiver operating char-
acteristic curve analysis suggested that a SUV ratio cut-off 
value of 1.15 predicts patients with FNH versus HCA with 
100% sensitivity and 94% specifi city.
Conclusions: The results of this prospective study show that 
PET/CT with 18F-choline can accurately differentiate FNH 
from HCA. This diagnostic method may be useful when 
conventional imaging is inconclusive.
A-258
A SYSTEMATIC REVIEW OF CLINICAL 
RESPONSE AND SURVIVAL OUTCOMES 
OF DOWNSIZING SYSTEMIC 
CHEMOTHERAPY AND RESCUE LIVER 
SURGERY IN PATIENTS WITH 
INITIALLY UNRESECTABLE 
COLORECTAL LIVER METASTASES
V. W. T. Lam1,2, C. Spiro1, E. Johnston1, M. J. Hollands1, 
H. C. C. Pleass1,2 and A. J. Richardson1,2
1Department of Surgery, Westmead Hospital, University of 
Sydney, Westmead, Sydney, Australia; 2Discipline of 
Surgery, Sydney Medical School, Sydney, Australia
Introduction: Patients with unresectable colorectal liver 
metastases (CLM) may be rendered resectable following sys-
temic chemotherapy. We review the evidence of downsizing 
systemic chemotherapy followed by rescue liver surgery in 
patients with initially unresectable CLM.
Methods: Literature search of databases (Medline and 
PubMed) to identify published studies of neoadjuvant che-
motherapy followed by liver resection in patients with ini-
tially unresectable CLM was undertaken focusing on 
response rate of chemotherapy and survival outcomes.
Results: Ten observational studies were reviewed. A total of 
1886 patients with initially unresectable CLM underwent 
systemic chemotherapy. Objective response was observed in 
64% (range 43–79%) of patients after systemic chemother-
apy. Of these, 22.5% underwent macroscopically curative 
liver resection. Median overall survival was 45 (range: 
36–60) months with 19% of patients were alive and 
recurrence-free.
Conclusions: Current evidence suggests that downsizing 
systematic chemotherapy followed by rescue liver resection 
was safe and effective in selected patients with initially unre-
sectable CLM. Further studies using new targeted molecular 
therapy-based regimens with response rate and secondary 
resectability as main outcomes are required.
A-259
18F-FDG PET FOR COLORECTAL LIVER 
METASTASES: TOTAL GLYCOLYTIC 
VOLUME AND METABOLIC TUMOR 
VOLUME PREDICTS PROGNOSIS
L. Lau1,2, M. Kwok2, S. T. Lee1,3, M. Goodwin1, 
V. Surendran2, M. Fink1, M. Nikfarjam1, G. Starkey1, 
R. Jones1, A. Scott1,3, C. Christophi1,2 
and V. Muralidharan1,2
1Austin Health, Melbourne, Australia; 2University of 
Melbourne, Melbourne, Australia; 3Ludwig Institute for 
Cancer Research, Melbourne, Australia
Introduction: Biological activity of colorectal liver metas-
tases (CRCLM) is a major determinant of patient outcome. 
This study evaluates the predictive value of 18F-FDG PET 
on prognosis in patients undergoing liver resection of 
CRCLM following neoadjuvant chemotherapy.
Methods: The study included all patients (n = 30) who 
underwent liver resection for CRCLM following neoadju-
vant chemotherapy at Austin Health, from 2004–2007. 
Pre-operative PET parameters: standardized uptake vari-
ables, metabolic tumor volume (MTV) and total glycolytic 
 Concurrent Sessions: Submitted Abstracts 147
HPB © 2011 International Hepato-Pancreato-Biliary Association, HPB, 13 (Suppl. 3), 65–159
volume (TGV) were analyzed along with the prognostic 
scoring systems proposed by Fong (MSKCC), Iwatsuki 
(Pittsburgh), Nordlinger, and Rees (Basingstoke). Correlation 
to overall survival (OS) and recurrence-free survival (RFS) 
was assessed using univariate and multivariate regression, 
receiver operating characteristic/area under the curve (AUC) 
and Kaplan Meier survival analysis.
Results: Univariate analysis revealed age, size of largest 
metastasis, TGV, MTV, Pittsburgh and Basingstoke scores to 
be signifi cantly correlated with survival. Multivariate analy-
sis found only TGV to be signifi cantly correlated to OS (p = 
0.002) and RFS (p = 0.001). Each unit of TGV produced 
1.9% and 1.3% increased hazard of death and recurrence 
respectively (HR: 1.019 (OS); 1.013 (RFS)). AUC analysis 
showed signifi cant correlation between MTV to RFS (0.719, 
p = 0.042). High MTV and TGV was signifi cantly predictive 
of poor OS and RFS on Kaplan Meier analysis.
Conclusion: High TGV seen on 18F-FDG PET after neo-
adjuvant chemotherapy is an independent predictor of prog-
nosis in patients undergoing resection of CRCLM. Assessing 
the burden of metabolically active tumor provides unique 
quantifi cation of tumor biology which can augment existing 
prognostic scoring systems in optimizing patient selection 
and treatment.
A-260
SELECTIVE HEPATIC VASCULAR 
EXCLUSION VERSUS PRINGLE 
MANEUVER IN PARTIAL 
HEPATECTOMY FOR TUMORS 
COMPRESSING OR INVOLVING THE 
MAJOR HEPATIC VEINS
W-P. Zhou1, J. Zhang1, E. C. H. Lai2, S-Y. Fu1, Z-Y. Pan1, 
Y. Yang1, W. Y. Lau2 and M-C. Wu1
1The Third Department of Hepatic Surgery, Eastern 
Hepatobiliary Surgery Hospital, Second Military Medical 
University, 225 Changhai Road, Shanghai, China; 2Faculty 
of Medicine, The Chinese University of Hong Kong, Prince 
of Wales Hospital, Shatin, Hong Kong SAR, People’s 
Republic of China
Introduction: In liver resection for tumors compressing or 
involving one or more of the major hepatic veins (right, 
middle or left), intraoperative massive bleeding or air embo-
lism resulting from hepatic vein injury remains as a serious 
threat. Pringle maneuver (infl ow occlusion of the portal 
triad) can only occlude the hepatic vascular infl ow and it has 
no impact on the consequences of hepatic vein injury. 
Although total hepatic vascular exclusion (THVE) can be 
used, it results in signifi cant systemic hemodynamic distur-
bances as a consequence of interruption of venous blood fl ow 
in the inferior vena cava (IVC). THVE should, therefore, 
only be reserved for patients with tumors compressing or 
involving the roots of the major hepatic vein(s) and/or the 
IVC. As selective hepatic vascular exclusion (SHVE) con-
trols both the hepatic vascular infl ow and outfl ow with pres-
ervation of caval fl ow, it has the advantages of preventing 
massive backfl ow hemorrhage or air embolism, and keeping 
the hemodynamics of the patient stable. In this report, we 
retrospectively compared the intraoperative blood loss and 
postoperative morbidity in patients using either SHVE or 
Pringle maneuver in partial hepatectomy carried out for 
tumors compressing or involving the major hepatic veins 
away from their roots with the IVC.
Methods: From January 2003 to December 2010, 3900 con-
secutive patients with liver tumors underwent liver resection 
in our department, and 1320 patients had their tumors com-
pressing or involving at least one of the three major hepatic 
veins (right, middle or left). Either SHVE (n = 550 patients) 
or Pringle maneuver (n = 870 patients) was used to minimize 
blood loss during hepatectomy. Data regarding the intraop-
erative and postoperative courses of these patients were ret-
rospectively analyzed.
Results: There was no signifi cant difference between the 
two groups of patients regarding age, sex, tumor size, Child-
Pugh classifi cation, tumor pathology, types of hepatectomy 
and extent of tumor involvement of the major hepatic veins. 
Intraoperative blood loss, transfusion requirements and 
transfusion volume were signifi cantly less in the SHVE 
group (P < 0.01). In the Pringle group, hepatic vein injury 
resulted in massive bleeding of over 1 liter in 65 patients 
(7.5%), air embolism in 14 (1.6%) and intraoperative death 
in 3 (0.34%). There was no massive bleeding, air embolism 
or intraoperative death in the SHVE group. Postoperative 
liver failure, multiple organ failure and in-hospital mortality 
were signifi cantly higher in the Pringle group (P < 0.05).
Conclusions: Compared with Pringle maneuver, SHVE was 
more effi cacious in minimizing intraoperative bleeding 
during partial hepatectomy for tumors compressing or 
involving the major hepatic veins. It prevented intraoperative 
massive bleeding and air embolism, and signifi cantly 
decreased postoperative liver failure and in-hospital 
mortality.
A-261
SELECTIVE INTERNAL RADIATION 
THERAPY (SIRT) FOR 
NEUROENDOCRINE TUMOR (NET) 
LIVER METASTASES – A NEW AND 
EFFECTIVE MODALITY FOR 
TREATMENT
R. S. Stubbs, H. Rajekar and K. Bogamanna
The Wakefi eld Clinic, Wakefi eld Hospital, Wellington, NZ
Background: Non-resectable carcinoid liver metastases 
respond poorly to most modalities of treatment. Selective 
Internal Radiation Therapy (SIRT) is a promising method for 
treating non-resectable liver cancers, both primary and sec-
ondary. This treatment achieves tumor destruction through 
the relatively selective delivery of high dose radiation to liver 
tumors following hepatic arterial delivery of 90Yttrium 
microspheres. This paper presents an experience of SIRT in 
14 patients with non-resectable carcinoid liver metastases.
Methodology: 14 patients were given 2.0–3.0 GBq of 
90Yttrium microspheres between September 1997 and 
October 2009. Repeat SIRT was undertaken in three patients 
after 16, 27 and 48 months. Responses were assessed clini-
cally, with 24 hour urinary 5-HIAA excretion or serum CgA 
levels and with serial scanning.
Results: All patients had regression or resolution of carci-
noid symptoms. 5HIAA/CgA levels, fell in 6 of 7 in whom 
they were measured, and for a prolonged period. Serial scan-
ning revealed responses in all 14 patients. Repeat treatment 
in three patients was associated with a further good response. 
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Median survival was 25 months with 6 of the patients still 
being alive at 19, 22, 23, 23, 58 and 60 months following 
SIRT and three remaining asymptomatic. One patient under-
went liver resection 18 months after SIRT.
Conclusions: SIRT is a valid and effective treatment option 
for non-resectable carcinoid liver metastases and can achieve 
striking regression in many instances. Repeat treatment is an 
option. Liver resection after downstaging may also be 
possible.
A-262
LONG-TERM OUTCOMES AFTER 
HEPATIC RESECTION FOR 
NONCOROLECTAL NONENDOCRINE 
LIVER METASTASES
N. Takemura1, A. Saiura1, R. Yoshioka1, J. Arita1, R. Koga1, 
M. Seki1, N. Kokudo2 and T. Yamaguchi1
1Cancer Institute Hospital, Japanese Foundation for 
Cancer Research, Tokyo, Japan; 2University of Tokyo, 
Tokyo, Japan
Introduction: Indications of hepatic resection for colorectal 
liver metastasis have already established and it is well known 
that the prognosis of liver metastasis from endocrine tumor 
is relatively better, however the prognosis and indications of 
hepatic resection for non-colorectal non-endocrine liver 
metastases (NCNELM) are still unclear.
Methods: From 1993 to 2009, 179 patients underwent 195 
hepatic resections for NCNELMs in our institution. The 
primary diseases were gastric cancer in 74 patients, breast 
cancer in 35, gynecological cancer in 24, gastrointestinal 
stromal tumor (GIST) in 16, squamous cell carcinoma (SCC) 
of larynx, pharynx and esophagus in 14, sarcoma in 8, other 
adenocarcinoma (including bile duct carcinoma, adrenalcar-
cinoma and pancreas carcinoma) in 14, and other non-ade-
nocarcinoma (including renal cell carcinoma and carcinoid 
tumor) in 9. Fifty fi ve patients underwent simultaneous liver 
and primary site resection. Survivals of each group were 
measured by Kaplan-Mayer method.
Results: The 3- and 5-year overall survival rates after hepa-
tectomy for all patients were 45 and 32%. The survival rates 
according to each primary lesion were 40 and 29% for gastric 
cancer, 51% and 31% for breast cancer, 42 and 28% for 
GIST, 48 and 24% for SCC, 52% and 42% for gynecological 
cancer, 86 and 57% for sarcoma. Thirty one patients survived 
more than 5 years (Among them, 13 patients were gastric 
cancer origin, 9 were breast cancer, 2 were GIST, and another 
2 were SCC). Multiple intrahepatic lesions and noncurative 
resections were signifi cant prognostic factor (p < 0.001). 
Interval between the primary site resection and the metastatic 
lesion appearance was not signifi cant.
Conclusions: Surgical resection of NCNELMs may be ben-
efi cial, if complete resection can be achieved.
A-263
THE USEFULNESS OF CONTRAST 
ENHANCED INTRAOPERATIVE 
ULTRASOUND USING SONAZOID FOR 
COLORECTAL LIVER METASTASES
M. Takahashi, K. Hasegawa, J.-I. Arita, Y. Sugawara 
and N. Kokudo
IHepato-Biliary-Pancreatic Surgery Division, Department 
of Surgery, Graduate School of Medicine, University of 
Tokyo, Tokyo, Japan
Introduction: Intraoperative ultrasound (IOUS) is pres-
ently considered the gold standard for the diagnosis of liver 
metastasis. Recently, a new ultrasound contrast agent, 
Sonazoid, has been developed. But the validity for the diag-
nosis of colorectal liver metastasis has not yet been 
confi rmed.
Methods: Between 2007 and 2010, we performed contrast-
enhanced intraoperative ultrasound (CE-IOUS) using 
Sonazoid during 129 consecutive hepatic resections in 102 
patients with colorectal liver metastasis. All the patients 
underwent preoperative contrast- enhanced CT and/or MRI 
examinations within 6 weeks prior to surgery. After complet-
ing the conventional intraoperative examination, CE-IOUS 
was performed by injecting Sonazoid intravenously at a dose 
of 0.12 μL of microbubbles/kg body weight through the 
peripheral vein. The histopathological fi ndings and 6-month 
follow-up images were used as the reference standard.
Results: CE-IOUS detected 370 lesions and had a better 
diagnostic performance than preoperative imaging and con-
ventional intraoperative examination. CE-IOUS alone cor-
rectly diagnosed 22 lesions in 16 operations (12.4%). The 
CE-IOUS fi ndings altered the surgical plan in 14 operations 
(10.9%) and enabled better visualization of the tumor 
margins in most of the patients.
Conclusions: CE-IOUS using Sonazoid is an essential tool 
for the detection and diagnosis of colorectal liver metastases. 
Moreover, this modality can help to preserve hepatic paren-
chyma or major vessels during hepatectomy by clarifying the 
tumor margins.
A-264
RESECTION OF CONCOMITANT 
EXTRAHEPATIC DISEASE AS THE NEXT 
FRONTIER IN HEPATECTOMY FOR 
COLORECTAL LIVER METASTASES? A 
SYSTEMATIC REVIEW OF CLINICAL 
OUTCOMES
F. Chu1, T. Chua1,2, A. Saxena1, W. Liauw3 and D. Morris1,2
1UNSW Department of Surgery, St George Hospital, 
Sydney, Australia; 2St George Clinical School, University 
of New South Wales, Australia; 3Cancer Care Centre, 
St George Hospital, Sydney, Australia
Background: Increasing data suggests that hepatectomy for 
patients with colorectal liver metastases (CLM) with con-
comitant extrahepatic disease (EHD) achieve encouraging 
survival results. The authors examine the clinical effi cacy of 
this treatment approach through a systematic review of the 
published literature.
Methods: Electronic search of the MEDLINE and PubMed 
databases (January 2000 to January 2011) to identify studies 
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reporting outcomes of hepatectomy for CLM with resection 
of EHD was undertaken. Two reviewers independently 
appraised each study using a predetermined protocol. Clinical 
effi cacy was synthesized through a narrative review with full 
tabulation of results of all included studies.
Results: Twenty-two studies were examined. This com-
prised of 1142 patients. The median disease-free survival 
was 12 (range, 4 to 22) months, median overall survival was 
30 (range, 14 to 44) months and median 5-year survival rate 
was 19% (range, 0 to 42%). Median 5-year survival of 
patients with R0 hepatectomy with resection of EHD was 
25% (range, 19% to 36%). Survival based on site of EHD 
include lung; median survival (M/S) was 41 (range, 32 to 46) 
months, porto-caval lymph node; M/S was 25 (range, 19 to 
48) months, peritoneal metastases; M/S was 25 (range, 18 to 
32) months.
Conclusion: Surgical resection of CLM and concomitant 
EHD in carefully selected patients may achieve survival 
results superior to non-surgically treated patients. This treat-
ment strategy may be considered appropriate especially 
when a R0 hepatectomy and complete resection of EHD may 
be achieved.
A-265
EXPERIMENTAL AND CLINICAL STUDY 
FOR C-MET EXPRESSION IN LIVER 
METASTASIS FROM COLORECTAL 
CANCER
S. Osada, H. Imai, Y. Sasaki and K. Yoshida
Surgical Oncology, Gifu University School of Medicine
Background: Surgery is the curative treatment for patients 
with liver metastasis of colorectal cancer (CRC), but hepa-
tectomy might be principal for proliferation and progression 
of CRC.
Methods: On operated 94 patients, the expression of c-Met 
in the primary and liver metastatic sites was evaluated by 
immunohistochemistry and western blot. Experiments were 
also conducted on a CT26 CRC cell line in mouse liver 
metastasis model.
Results: In the cases with higher c-Met expression in cancer 
tissue, frequent liver metastasis was detected signifi cantly. 
But the c-Met expression in liver metastatic sites was lower 
than in the primary sites in 87% cases, while serum HGF 
level increased signifi cantly. HGF mediated CT26 cell 
growth (135% in 3 days) and signal pathway activation 
(ERK and cyclin B/D), but expression of c-Met decreased 
due to cell density (60% on 7 days and 20% on 11 days). 
HGF induced reduction of E-cadherin with time dependent. 
And the expression of c-Met protein in the liver tumor was 
signifi cantly lower than in culture cells (p = 0.033). The 
CT26 cells with blockade of c-Met expression by siRNA 
were clearly decreased to make liver metastatic tumors. 
Despite an increase in serum HGF after hepatectomy, the 
growth of residual liver tumors was not signifi cantly differ-
ent between 30% hepatectomy group and no liver resected 
group.
Conclusion: The elevation of HGF serum level after hepa-
tectomy might promote the proliferation of residual liver 
tumor, but c-Met in the liver metastatic site was reduced. 
Thus aggressive hepatectomy would be acceptable and 
favorable as a curative therapy.
A-266
INDETEMINATE HEPATIC LESIONS FOR 
COLORECTAL CANCER PATIENTS
J. H. Kim, H.-S. Han, Y.-S. Yoon, J. Y. Cho and Y. Kwon
Seoul National University Bundang Hospital, Department 
of Surgery, Seoul National University College of Medicine, 
Korea
Purpose: The initial abdominal CT scan for patients with 
colorectal cancer may reveal indeterminate hepatic lesions. 
The signifi cance of these lesions is often unknown at the time 
of diagnosis. This study evaluates the indeterminate hepatic 
lesions on abdominal CT scan and the diagnostic accuracy 
of MRI.
Methods: Between 2006 and 2009, data were collected ret-
rospectively. All colorectal cancer patients with hepatic 
lesions less than 2 cm on initial staging CT scan were 
included. These hepatic lesions were formally reported as 
equivocal lesions. MRI was performed in case of the patients 
with equivocal hepatic lesions, after initial CT scan. The 
cyst, hemangioma, and colorectal cancer with liver metasta-
sis were excluded which were defi nitely diagnosed by the 
radiologists.
Results: 102 patients in the enrolled colorectal cancer 
patients had the equivocal hepatic lesions. Total 175 indeter-
minate hepatic lesions were analyzed. Among these lesions 
155 lesions were less than 1 cm, and 20 lesions were within 
the range of 1 cm to 2 cm. 30 lesions (17.1%) were proved 
to be metastasis, and the other 145 lesions (82.9%) were 
benign stable lesions. Sensitivity, specifi city, positive predic-
tive value, negative predictive value and positive likelihood 
ratio for these indeterminate lesions for MRI were 76.6%, 
92.4%, 95.8%, 100% and 10.1, respectively.
Conclusion: Indeterminate hepatic lesions may require 
further evaluation and can be clarifi ed by MRI which is 
useful diagnostic tool.
A-267
LONG TERM RESULTS UTILIZING HIGH 
DOSE INTRA-ARTERIAL MELPHALAN 
DELIVERED VIA PERCUTANEOUS 
HEPATIC PERFUSION (PHP) FOR 
PATIENTS WITH UNRESECTABLE 
HEPATIC METASTASES FROM PRIMARY 
NEUROENDOCRINE TUMORS
J. Pingpank6, M. Hughes1, R. Royal2, R. Alexander3, 
U. Kammula1, I. Avital1, B. Wood4, S. Libutti5 and 
T. Beresneva1
1Surgery Branch, National Cancer Institute, NIH, 
Bethesda, MD, USA; 2Surgical Oncology, MD Anderson 
Cancer Center, Houston, TX, USA; 3Division of Surgical 
Oncology, University of Maryland, Baltimore, MD, USA; 
4Center for Interventional Oncology, NIH, Bethesda, MD, 
USA; 5Department of Surgery, Montefi ore Medical Center, 
Bronx, NY, USA; 6Division of Surgical Oncology, 
University of Pittsburgh, Pittsburgh, PA, USA
Introduction: Patients with hepatic MNET are faced with 
multiple treatment strategies including resection, ablation, 
and a variety of regional therapies which have been success-
fully utilized in this heterogeneous group of patients. 
Treatment options for patients with diffuse hepatic disease 
are more limited. This study examines a minimally invasive 
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PHP with melphalan (MEL) for patients with isolated or 
predominant hepatic metastases from MNET.
Methods: Between December 2001 and October 2009, 30 
MNET patients (mean age: 46 y, range: 13–72 y; M: 16, F: 
14; gastrointestinal neuroendocrine: 23, carcinoid: 7) were 
enrolled on one of two IRB approved PHP protocols. Analysis 
included PHP parameters, complications, toxicities, response, 
progression-free (PFS) and overall survival (OS). PHP con-
sisted of a 30 minute hepatic artery infusion of MEL via a 
percutaneously placed catheter with subsequent hepatic 
venous hemofi ltration using a double balloon catheter 
(Delcath Systems, Inc.) positioned in the retrohepatic infe-
rior vena cava with in-line hemofi ltration. A planned treat-
ment strategy consisted of four PHPs every 28–35 days. 
Survival curves were estimated by the Kaplan-Meier method.
Results: Thirty patients received 83 treatments (median: 3/
pt); 1 patient was not treated due to hepatic arterial anatomic 
limitations. Mean MEL dose was 185 mg (median: 182, 
range: 90–220). Reversible grade III/IV toxicities observed 
were hematologic (77%) and hepatic (23%). Mean hospital 
stay was 3.4 days/PHP (median: 3, range: 1–21). An overall 
radiographic response was seen in 17 of 24 evaluable patients 
(71%; complete n = 2, partial n = 15). There was one treat-
ment-related mortality (3.3%) secondary to complications of 
cholangitis in a patient with previous biliary reconstruction. 
Two patients had disease progression while on active therapy 
(6.7%). Median overall survival was 39 months.
Conclusions: This study shows that PHP with MEL has 
effi cacy in patients with diffuse MNET of the liver too exten-
sive for resection, ablation, or embolization strategies. 
Responses to therapy tend to be durable, with repeat therapy 
effective upon progression.
A-268
ONCOLOGIC RESECTION FOR 
MALIGNANT TUMORS OF THE LIVER
S. Agrawal1 and J. Belghiti2
1Temple University School of Medicine, Philadelphia, USA; 
2Beaujon Hospital, University of Paris, Clichy, France
Introduction: Recommendations for resection of malignant 
tumors of the liver based on traditional considerations of 
locoregional control and survival benefi t are modifi ed by the 
functional reserve of the liver remnant. An evidence-based 
review to ascertain the operative strategy for oncologic 
resection of malignant tumors of the liver and an optimal 
postoperative outcome.
Methods: Recent publications including prospective ran-
domized trials reporting outcomes with various surgical 
approaches were reviewed to establish best current practices.
Results: The goal of hepatectomy for primary or metastatic 
tumors of the liver is complete resection with evidence that 
an anatomic resection in hepatocellular carcinoma and hilar 
cholangiocarcinoma improves survival. For non-anatomic 
resections the optimal width of the resection margin varies 
with the pathological type of tumor. Anterior approach to 
major hepatectomy is a ‘no-touch’ technique which mini-
mizes manipulation of the tumor-bearing liver. Vascular 
invasion is associated with dismal prognosis and limited 
major vascular resection is indicated to achieve a R0 resec-
tion for prolongation of survival. Concomitant regional 
lymphadenectomy is of prognostic value, however it is not 
performed routinely since it’s therapeutic value remain 
unproven. Perioperative blood transfusion and postoperative 
morbidity are independent predictors of survival emphasiz-
ing the importance of measures such as portal vein emboliza-
tion, hepatic pedicle clamping and preservation of venous 
drainage of the liver remnant.
Conclusions: The operative strategy for resection of malig-
nant tumors of the liver should address the key components 
of the extent of hepatectomy including anatomic resection 
and optimal pathologic margins, use of the anterior approach, 
necessity for vascular resection, regional lymphadenectomy 
and measures to minimize blood loss and postoperative mor-
bidity for maximal survival benefi t.
A-269
APPROACH TO COLORECTAL LIVER/
LUNG METASTASES
M. V. Perini, D. Yeo, V. Muralidharan and C. Christophi
Department of Surgery, Austin Hospital, Melbourne 
University, Melbourne, Australia
Background: Over the last decades resection of low-vol-
ume hepatic disease has been recognized as benefi cial in the 
treatment of colorectal metastasis. More recently, resection 
of isolated pulmonary metastases has been shown to offer 
long-term survival in carefully selected patients. In this 
article, we review the current status of resection in liver and 
lung colorectal metastasis.
Aim: The aim of this study is to review the data regarding 
outcome in patients with metastatic colorectal cancer to the 
liver and/or lung treated with surgery (combined or 
separated).
Material and Methods: Medline database was searched 
using a formal search strategy. Articles regarding surgical 
treatment of metastatic colorectal cancer to lung and/or liver 
were included. Only papers regarding survival of simultane-
ous and/or sequential surgical approach were enrolled.
Results: A total of 36 articles regarding lung and liver 
metastasectomy were found. The majority of articles 
described separated approach, being the liver resection per-
formed fi rst, even when metastatic disease appears synchro-
nously. Synchronous disease has a worst prognosis. Data is 
controversial but the majority of the articles agree that pre 
thoracotomy high CEA levels, positive mediastinal lymph 
nodes, synchronous liver and lung metastasis and a short 
period between the fi rst and second metastasectomy are pre-
dictors of poor survival. Best results were achieved in 
patients with low CEA levels, metachronous liver and lung 
metastasis and long interval between metastasectomies.
Conclusions: Data regarding resection of liver and lung 
metastases suggest that surgery may yield long-term survival 
in select patients.
A-270
LINEAR CUTTING STAPLERS IN 
LAPAROSCOPIC LIVER RESECTIONS – 
EFFICACY AND EXPLETIVES . . .
C. B. Kenfi eld1 and N. O’Rourke2
1Royal Brisbane & Women’s Hospital, Brisbane, Australia; 
2Royal Brisbane & Women’s Hospital, Brisbane, Australia
Introduction: The use of linear cutting staplers in open 
liver resections is well described. As laparoscopic resections 
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become more commonplace, the correct choice of stapling 
devices and proper handling becomes imperative. Many of 
the issues are accentuated during division of hepatic 
parenchyma.
Methods: Analysis of problems seen and dealt with during 
an exposure of over 300 laparoscopic liver resections at the 
Royal Brisbane & Women’s Hospital.
Results: Device malfunction can be categorized into User 
issues and Technical issues, and these will both be demon-
strated with the aid of operative photographs and fi lm 
extracts. User issues include misapplication (these are instru-
ments of fi nality and if major vessels are divided, this can 
not be easily reversed), incorrect handling of tissues, “clip 
traffi c” and exceeding tolerances of individual devices will 
be demonstrated. Using clips can have problems because they 
can increase the risk of technical issues causing the stapler 
to break. Technical issues including failure (rare), misfi ring, 
locking, incomplete fi ring with improper staple formation 
and fl aring of the fl ange (common) leading to diffi cult extrac-
tion, will be discussed using case scenarios. Manufacturer 
variances lend certain devices being more suited in specifi c 
situations, such as the presence of cirrhosis.
Conclusions: The use of linear cutting staplers for laparo-
scopic hepatic resection is safe, however increased morbid-
ity/mortality can ensue when used incorrectly. Clips must be 
avoided where possible. This has changed our practice.
A-271
HEPATOPANCREATODUODENECTOMY 
FOR CHOLANGIOCARCINOMA: A 
SINGLE CENTER EXPERIENCE WITH 85 
CONSECUTIVE PATIENTS
T. Ebata1, Y. Yokoyama1, T. Igami1, G. Sugawara1, 
Y. Takahashi1, T. Kokuryo1, M. Fukaya1, K. Itatsu1, 
K. Uehara1, Y. Yoshioka1 and Y. Nimura2
1Nagoya University, Nagoya, Japan; 2Aichi Cancer Center, 
Nagoya, Japan
Objective: Cholangiocarcinoma often exhibits an extensive 
ductal spread invading from the hepatic hilus down to the 
lower bile duct, and such tumor can be resected only by 
hepatopancreatoduodenectomy (HPD). The aim of this study 
is to appraise clinical signifi cance of this challenging 
procedure.
Methods: We reviewed 85 patients with cholangiocarci-
noma who underwent HPD from 1992 to 2011. Major hepa-
tectomy was performed in 79 (92.9%) patients; combined 
vascular resection was performed in 26 (30.6%) patients.
Results: The mean operative time was 762 minutes and 
blood loss was 2696 mL. Liver failure was the most common 
abdominal complications (n = 64), followed by pancreatic 
fi stula (n = 60), wound sepsis (n = 33), intraabdominal 
abscess (n = 22), refractory ascites (n = 17), bacteremia (n = 
16), bile leakage (n = 13), delayed gastric emptying (n = 12). 
Re-laparotomy was necessary in 9 (11.1%). Overall, there 
were 19 (22.4%) patients with Clavien grade 0 to II compli-
cation, 58 (68.2%) with grade III, 6 (7.1%) with grade IV, 
and 2 (2.4%) with grade V (mortality). Overall survival rate 
was 48.5% at 3-year, 37.4% at 5-year, and 32.1% at 10 year; 
nine of whom actually survived more than 5 years. Survival 
for 53 patients with pM0 disease who underwent R0 resec-
tion was the most favorable; 5- and 10-year survival rate was 
54.3% and 46.6%, respectively.
Conclusion: HPD is still a technically demanding with high 
morbidity. However, this surgery can be performed with low 
mortality and offer a better chance of long-term survival in 
selected patients. HPD should be considered as a standard 
procedure for laterally-advanced cholangiocarcinoma other-
wise unresectable.
A-272
MANAGEMENT OF BLUNT AND 
PENETRATING BILIARY TRACT 
TRAUMA
B. N. J. Thomson1, B. Nardino2, K. Gumm1, A. Robertson1, 
B. Knowles1, N. A. Collier1 and R. Judson1
1Trauma Service, Royal Melbourne Hospital, Parkville, 
Victoria, Australia; 2School of Medicine, University of 
Melbourne, Victoria, Australia
Introduction: Injury to the biliary tree is a rare consequence 
of blunt and penetrating trauma. It is often associated with 
liver injury but accounts for only 0.1% of all trauma injuries. 
Gallbladder injury is reported to be the commonest presenta-
tion, most usually secondary to penetrating trauma.
Methods: The trauma audit database at the Royal Melbourne 
Hospital was searched for all biliary, liver and pancreatic 
injuries from the 1st January 1999 – 31st May 2011. Patient 
demographics, length of stay, injury grades, interventions 
and Injury Severity Score (ISS) were recorded.
Results: 30 patients suffered 33 injuries to the biliary tree. 
24 (80%) were associated with hepatic injury and 18 (60%) 
with other abdominal visceral injury. There were 10 injuries 
to the gallbladder of which 8 required cholecystectomy. Six 
patients had injuries to subsegmental intra-hepatic ducts sec-
ondary to hepatic trauma of which 2 where sutured and 4 
managed with drainage. Six patients had injuries to the 
biliary tree which were managed with drainage ± endoscopic 
stenting. Seven patients had injuries to the biliary tree requir-
ing T-tube insertion, roux en Y hepaticojejunostomy or both. 
Three of 5 patients managed with a T-tube required subse-
quent hepaticojejunostomy. A further 3 patients required 
hepatic resection/debridement and one a pancreaticoduode-
nectomy for unreconstructable biliary injuries. Three of the 
30 patients (10%) died but only one was related to the biliary 
injury succumbing to blood loss secondary to injury to the 
portal vein and hepatic artery.
Conclusions: Biliary injury remains a rare consequent of 
trauma. Multimodal treatment is required given the differing 
types of biliary injury as well as associated injuries.
A-273
LIVER TRANSPLANTATION IN 
PATIENTS WITH PORTAL VEIN 
THROMBOSIS GRADES III & IV: 
MANAGEMENT AND OUTCOME
L. Gil, J. Lendoire, G. Raffi n, F. Duek, C. Quarin, 
V. Garay and O. Imventarza
Liver & Transplan Division, Hospital Dr Cosme Argerich, 
Buenos Aires, Argentina
Introduction: Portal vein thrombosis (PVT) is a well rec-
ognized complication in patients with end-stage cirrhosis 
(2–26%). PVT grades (G) III and IV had been associated 
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with more complex transplant procedures and suboptimal 
outcome. The aim was to compare outcome of liver trans-
plants performed in patients with PVT G III & IV vs PVT G 
I & II and no PVT.
Methods: Between 7/1995 and 8/2010, 40 liver transplants 
were performed in patients with PVT (9.8%), 19 G III & IV 
(4.6%). Risk factors, intra-operative and postoperative vari-
ables were analyzed. A comparative analysis between 
patients with PVT G I & II (n = 21) and no PVT (n = 367) 
was performed.
Results: 57.6% males, age 48.4 years. Intraoperative diag-
nosis: 78.9%. Indications for tx: postnecrotic cirrhosis 
84.2%, colestatic disease 15.7%. Surgical technique: throm-
bectomy with endovenectomy in 13 (7 G III, 6 G IV), extra-
anatomical jump-graft in 6 (100%G III). Complication rate 
42%, PVT recurrence 10.5%, mortality 36.8%. Signifi cant 
differences were found in PVT grade G III&IV vs PVT G 
I&II: prolonged operative time (p 0.04) and an-hepatic phase 
(p 0.04), jump grafts procedures (p 0.007) and blood cell 
requirements (p 0.04). One year survival was 57% in PVT 
G III&IV (III = 47%, IV 83%) vs 76% in non-PVT patients 
(p = 0.01).
Conclusions: Prevalence of PVT G III&IV in transplant 
recipients was 4.6%. Thrombectomy was the best therapeutic 
option. PVT G III&IV was associated with longer operative 
time, longer an-hepatic phase, increased blood cell require-
ment and demonstrated similar survival than PVT G I&II but 
lower than patients without PVT.
A-274
PELD SCORE AND AGE AS A 
PROGNOSTIC INDEX OF KASAI 
PORTOENTEROSTOMY IN BILIARY 
ATRESIA
J. Rhu, S-M. Jung, J-M. Seo and S-K. Lee
Division of Pediatric surgery, Department of Surgery, 
Samsung Medical Center, Sungkyunkwan University School 
of Medicine, Seoul, Republic of Korea
Introduction: This study was designed to evaluate the 
validity of the Pediatric End-Stage Liver Disease (PELD) 
scores as a prognostic index of the success of Kasai porto-
enterostomy (KPE).
Methods: The medical records of 63 patients who under-
went KPE at our hospital were reviewed retrospectively. One 
patient was excluded because the patient lacked preoperative 
International normalized ratio of prothrombin time (INR) 
data. Outcome was considered unsuccessful if a patient 
underwent any event, defi ned as liver transplantation (LT) or 
listing for LT, and successful if a patient had no event during 
follow up. The Cox proportional hazard model was used.
Results: KPE was successful in 28 patients (45.2%) and 
unsuccessful in 34 (54.8%). PELD scores of 15 and an age 
at operation of 60 days were found to be signifi cant risk 
factors of failure (p = 0.007, OR = 2.851 and p = 0.010, OR 
= 3.222 respectively). Furthermore, patients with both risk 
factors were found to have a higher risk of failure (p = 0.001, 
OR = 8.809).
Conclusions: Since the failure rate is higher for patients 
with a high PELD score and an older age, these factors 
should be helpful for making decision as to whether KPE or 
LT should be performed initially.
A-275
TEMPORARY PORTOCAVAL SHUNTING 
IN LIVER TRANSPLANT AT QUEEN 
ELIZABETH HOSPITAL, BIRMINGHAM
N. Houli1, D. Mirza2 and S. Bramhall 2
1HPB and Liver Transplant Unit, Austin Hospital, 
Melbourne, Australia; 2HPB and Liver Transplant unit, 
Queen Elizabeth Hospital, Birmingham, United Kingdom
Introduction: A number of studies have shown improve-
ments in hemodynamic parameters and blood products 
required with the use of temporary portocaval Shunt (TPCS) 
in patients undergoing liver transplant.
Methods: Using our transplant database, a retrospective 
analysis of patients having liver transplant with and without 
TPCS since its fi rst use in 2003 (Til June 2010). 329 patients 
had no TPCS, 525 patients had TPCS. We looked at intraop-
erative transfusions of RBC, platelet, Cryo, FFP, cell saver 
volume, time of surgery, postop renal impairment and need 
for dialysis, graft failure, Intensive care stay, hospital stay 
and mortality analysis.
Then sub analysis according to cause of liver failure/cirrho-
sis. Analysis was done using unpaired T test for mean where 
applicable and fi sher exact test for categorical data.
Results: Use of TPCS was associated with less RBC trans-
fusion overall. No difference in operative time and platelet 
transfusion, more Cryo use and longer hospital stay. There 
was similar morbidity and mortality and graft failure rate was 
similar in both groups. In culminant liver failure subanalysis, 
it was associated with more RBC and platelet transfusion and 
longer intensive care stay. There was no harmful effect was 
associated with its use.
Conclusions: Til further randomized studies are done, the 
unit will continue to use it (selective or routine) on basis of 
this analysis and previous systemic analysis. It makes the 
retro hepatic dissection much easier.
A-276
RISK FACTOR ANALYSIS TO PREDICT 
EARLY GRAFT DYSFUNCTION 
FOLLOWING LIVER 
TRANSPLANTATION
N. Battula, A. Takhar, D. Tsapralis, D. Mayer, J. Isaac, 
P. Muiesan, H. Mergental, M. T. Perera, D. F. Mirza 
and S. R. Bramhall
Liver Unit, Queen Elizabeth Hospital, Birmingham, United 
Kingdom
Introduction: Early graft dysfunction (EGF) following 
liver transplantation (LT) has a signifi cant impact on graft 
outcomes, despite the serious implications there is neither a 
standard defi nition nor a scoring system to predict it. In the 
era of extended criteria and DCD donors an accurate predic-
tion of EGF is crucial for effective usage of organs. The aim 
of our study was, to identify factors that could predict EGF 
and assess its impact on longterm outcomes.
Methods: Relevant donor and recipient data from all LT 
between 2001- 2011 were collected retrospectively. EGF was 
defi ned as initial poor function (IPF) or primary non-function 
using (PNF) Nanashima et al and Ploeg et al criteria.
Results: 1107 LT procedures were performed during the 
study period. EGF was noted in 117 (10.4%) and 24 of them 
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(21%) progressed to PNF. Signifi cant factors associated with 
EGF were underlying autoimmune liver disease (P = 0.001), 
recipient BMI > 30 (P = 0.017), in-patients at LT (P = 0.001), 
organ support prior to LT (P = 0.001), MELD score of 30–39 
(P = 0.004), cold ischemic time >12 hrs (P = 0.001). Sub 
group analysis of PNF (n = 24) highlighted donor renal 
dysfunction (P = 0.01), donor on inotropic support (P = 0.05) 
and recipient in-patient (P = 0.001) at LT as risk factors. The 
in-hospital mortality for PNF group was 29% and 71% had 
a re-transplantation. 1, 3 and 5 year graft and patient survival 
of only IPF group (n = 93) was 76%, 69%, 68% and 78%, 
72%, 71% which was signifi cantly lower that good graft 
function group (n = 991).
Conclusions: EGF is associated with poor outcomes. The 
identifi ed potential risk factors could help in better allocation 
of limited organs.
A-277
IMPACT OF STEATOSIS ON HEPATIC 
MITOCHONDRIAL FUNCTION DURING 
COLD LIVER PRESERVATION
M. J. J. Chu1, A. Hickey2, A. Bartlett1,3, A. Dare1, 
M. L. Yeong4 and A. Phillips1,2,3
1Department of Surgery, Faculty of Medical and Health 
Sciences, University of Auckland, Auckland, New Zealand; 
2School of Biological Sciences, Faculty of Science, 
University of Auckland, Auckland, New Zealand; 3New 
Zealand Liver Transplant Unit, Auckland City Hospital, 
Auckland, New Zealand; 4Department of Anatomical 
Pathology, Auckland City Hospital, Auckland, 
New Zealand
Introduction: Severe hepatic steatosis (>60%) is associated 
with poor post-transplant outcome. The impact of steatosis 
on the decline of hepatic mitochondrial function during cold 
ischemia is a possible cause for this dysfunction.
Aim: To determine the impact of steatosis on mitochondrial 
function of livers during cold preservation in University of 
Wisconsin (UW) solution.
Methods: Livers were harvested from 10-week old geneti-
cally obese (ob/ob, n = 9) or lean C57 control mice (n = 9); 
and preserved in ice-cold UW solution. Mitochondrial func-
tion analysis was performed on permeabilized liver samples 
using a substrate and inhibitor titration protocol in conjunc-
tion with a high resolution respirometry oxygraph 
(OROBOROS® Oxygraph 2K) at multiple time-points over 
24 hrs during cold ischemia (CI).
Results: Ob/ob mice livers and control mice livers showed 
either severe (>60%) or no macrovesicular steatosis respec-
tively. Mitochondria from ob/ob mice livers demonstrated a 
faster and greater decrease in the percentage of respiration 
contributing to oxidative phosphorylation over 24 hours of 
cold storage compared to control mice. After 12 hours of CI, 
there was also an increased dependence on Complex II res-
piration relative to Complex I in ob/ob mice livers suggestive 
of Complex I damage and potential loss of key ATP synthesis 
effi ciency.
Conclusion: Steatotic livers demonstrated greater mito-
chondrial dysfunction during cold ischemia compared to 
lean livers. These data confi rm the increased susceptibility 
of steatotic livers to cold preservation and provide a ratio-
nale for shorter cold storage duration for steatotic donor 
livers.
A-278
LIVER TRASPLANTATION WITHOUT 
RED BLOOD CELL TRANSFUSIONS: 
RISK FACTORS AND IMPACT ON 
POSTOPERATIVE OUTCOME
L. McCormack, N. Goldaracena, P. Mendez, P. Capitanich, 
E. Quiñonez, G. Devetach, L. Koo, C. Jeanes, M. Anders 
and R. C. Mastai
Liver Surgery & Trasplantation Unit, Hospital Alemán of 
Buenos Aires, Argentina
Background: Intra-operative red blood cells (IO-RBC) 
transfusion is associated with poor outcome after liver trans-
plantation (LT).
Aim: To evaluate risk factors for the need of IO-RBC and 
to assess its infl uence on postoperative outcome after LT.
Methods: All LT patients from Sept 2006- May 2011 were 
analyzed. We divided the cohort according to the use of 
IO-RBC transfusions: groups “No-Transfusion” and “Yes-
Transfusion”. We compared preoperative status (waiting list 
status, age, gender, diagnosis, biochemical profi le and 
MELD), graft quality, and intra and postoperative variables 
(operative and ischemia time, and dialysis major complica-
tion rate 30-day mortality) to assess IO-RBC transfusion risk 
factors and postoperative outcome.
Results: LT was performed in 120 patients: group “Yes-
Transfusion” = 81; group “No-Transfusion” = 39. While 
median MELD was higher in group “Yes-Transfusion” (22 
vs. 12; p < 0.001); platelet count, prothrombin time and 
hemoglobin were signifi cantly lower. Other variables related 
to recipient status, graft quality and surgery were not differ-
ent. Preoperative hemoglobin (p > 0.001) was the unique 
independent risk factor associated with IO-RBC require-
ment. Although median ICU (3 vs. 2 days; p < 0.01) and 
hospital stay (8 vs. 9 days; p < 0.02) were prolonged in group 
“Yes-Transfusion”, the need of dialysis, 30-day mortality 
rate (14.8 vs. 5.4; p = 0.2) and median survival were not 
statistically different. One (85% vs. 89%) and 3-year survival 
(80% vs. 85%) were equivalent in both groups.
Conclusions: The recipient MELD score is not a predictive 
factor for IO-RBC transfusion during liver transplant. As 
IO-RBC transfusion is associated with longer ICU and hos-
pital stay, maximum efforts must be focus on improving 
hemoglobin levels during waiting list time.
A-279
ARTERIAL CONDUITS IN LIVER 
TRANSPLANTATION: EFFECT ON 
GRAFT AND PATIENT OUTCOMES
A. Takhar, N. Battula, R. Hardstaff, B. Gunson, D. Mayer, 
P. Muiesan, H. Mergental, J. Isaac, T. Parera, J. Buckels, 
D. Mirza and S. Bramhall
The Liver Unit, Queen Elizabeth Hospital, Birmingham, 
United Kingdom
Introduction: The use of arterial conduits (AC) in a liver 
transplant setting is prompted by inadequate length of donor 
or recipient hepatic arteries, unsuitability of the recipient 
hepatic artery or due to previous hepatic artery thrombosis 
or aneurysm in a regraft. This study aimed to evaluate the 
effect of using arterial conduits (AC) on graft and patient 
outcomes at our centre.
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Methods: A retrospective analysis of a prospectively main-
tained database of all orthotopic liver transplants was carried 
out at our unit between January 1999 and December 2008. 
Statistical analysis was carried out using SPSS (version 13) 
software with p < 0.05 considered a signifi cant result.
Results: Over a 10 year period, 1288 orthotopic liver trans-
plants were carried out. Of these, 7.5% (n = 97) patients had 
arterial conduits (AC) with 59 aortic conduits and 38 inter-
position grafts, median age of 50 years (range 16–69 years, 
46 male/51 female). In the AC group, the risk of conduit 
occlusion within 30 days was increased by having multiple 
grafts (p = 0.02). Overall graft survival in the AC group was 
infl uenced by graft number (p < 0.01), use of aortic conduit 
(p = 0.05), type of biliary anastomosis (p = 0.004) and use 
of more than 15 units of fresh frozen plasma during the 
procedure (p = 0.01). 1 year patient survival was infl uenced 
by the presence of multiple donor hepatic arteries (p = 0.03). 
The risk of hepatic artery thrombosis was similar (3.1% AC 
group vs 3.6% No AC group).
Conclusions: The use of AC in liver transplants has 
increased in our centre over the last 10 years with similar 
results reported in terms of hepatic artery thrombosis.
A-280
CLINICAL PRESENTATION, RISK 
FACTORS AND OUTCOME OF LATE 
HEPATIC ARTERY THROMBOSIS AFTER 
LIVER TRANSPLANTATION
O. Ciacio, E. Vibert, C. Salloum, R. Adam, D. Azoulay, 
D. Samuel and D. Castaing
AP-HP Hopital Paul Brousse, Centre Hepato-Biliaire, 
Villejuif, France
Introduction: Hepatic artery thrombosis (HAT) is a life-
threatening complication after orthotopic liver transplanta-
tion (OLT). Early HAT during the fi rst month is often related 
to technical factors. At the opposite, late (>1 month) and very 
late HAT (VLHAT > 1 year) have been poorly studied. Aim: 
to assess the incidence, clinical outcome and risk factors of 
VLHAT.
Methods: 242 OLT realized between 1997 and 1999 were 
retrospectively analyzed. Eleven patients (4.5%) with an 
HAT in the fi rst year were excluded. 4 patients, transplanted 
before 1997 and retransplanted (re-OLT) for a VLHAT in the 
study period, were included for the analyses of clinical 
outcome and risk factors.
Results: The incidence of VLHAT was 3% (median follow-
up: 9.2 years). The median delay of diagnosis was 8.6 ± 3 
years. 4/7 patients (57%) had a VLHAT more than 8 years 
after OLT. The diagnosis was done on routine ultrasound (1 
patient – 9%), modifi cations of liver biological tests (n = 3 
– 27%) or clinical signs of biliary ischemia (n = 7–64%). 
Eight patients (73%) were re-transplanted and 5 (45.5%) 
died of complication after re-OLT (n = 3) or biliary sepsis in 
the waiting list (n = 2). Thus, the mortality of re-OLT for 
VLHAT in intention to treat was 50% (5/10). The indepen-
dent risk factors were recipient-donor ABO mismatch (p = 
0.05), history of cardiovascular events (p = 0.0176) and 
CMV infection post-OLT (p = 0.0011).
Conclusions: VLHAT is a life-threatening complication of 
OLT often diagnosed on clinical signs of biliary ischemia. In 
patients with the mentioned risk factors, a prolonged follow-
up by ultrasound screening could detect earlier VLHAT and 
improve the outcome.
A-281
MICROVASCULAR INVASION IS A 
BETTER PREDICTOR OF TUMOR 
RECURRENCE AND OVERALL 
SURVIVAL FOLLOWING SURGICAL 
RESECTION FOR HEPATOCELLULAR 
CARCINOMA COMPARED TO THE 
MILAN CRITERIA
K. C. Lim, P. K. Chow, B. K. Goh, J. C. Allen, G. S. Chia, 
M. Lim, P. C. Cheow, A. Y. Chung, L. L. Ooi 
and S. B. Tan
Duke-NUS Graduate Medical School, Singapore General 
Hospital & National Cancer Center, Singapore
Introduction: Although the Milan criteria is discriminatory 
for selecting patients with good outcomes in liver transplan-
tation and SR for HCC, it neither adequately predict tumor 
recurrence nor explain differences in survival for patients 
with good liver function. Microvascular invasion (McVI) is 
a strong indicator of intrahepatic metastasis in HCC, but its 
relative signifi cance for predicting clinical outcomes com-
pared to the Milan criteria is unclear. The aim of this study 
is to compare (McVI) with parameters defi ned by the Milan 
criteria in predicting tumor recurrence and overall survival 
(OS) after surgical resection (SR) for hepatocellular carci-
noma (HCC).
Methods: Patients undergoing SR with curative intent were 
stratifi ed fi rst by the Milan criteria and then by the presence 
of McVI and compared relative to OS.
Results: Altogether, 454 of the 515 patients received cura-
tive SR. There were stratifi ed into 4 groups (Milan+, McVI−), 
(Milan+, McVI+), (Milan−, McVI−), and (Milan−, McVI+). 
All pair-wise comparisons between groups relative to OS 
were signifi cant except (Milan+, McVI−) (OS, 90%, 73%, 
and 60% at 1, 3, and 5 years) with (Milan−, McVI−) (OS, 
86%, 71%, and 61% at 1, 3, 5 years) and (Milan+, McVI+) 
with (Milan−, McVI+). Multivariate Cox regression analysis 
showed that McVI was predictive of OS, after which Milan 
status did not add additional discriminative information.
Conclusions: McVI is a better predictor of tumor recur-
rence and OS than the Milan criteria after SR for HCC. 
Assessment of McVI should aid in patient selection for adju-
vant treatments to improve outcomes after SR.
A-282
VALIDATION OF FIVE 
PROGNOSTICATION SYSTEMS FOR 
PRIMARY PANCREATIC ENDOCRINE 
NEOPLASMS
B. K. Goh, P. K. Chow, Y. M. Tan, P. C. Cheow, 
Y. F. Chung, K. C. Soo, W. K. Wong and L. L. Ooi
Singapore General Hospital & National Cancer Center, 
Singapore
Introduction: Presently, several systems for the prognosti-
cation of pancreatic endocrine neoplasms (PENs) exist and 
the most appropriate classifi cation system has not been 
clearly defi ned. This study aims to validate the performance 
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of the 2004 World Health Organization (WHO), European 
Neuroendocrine Tumor Society (ENETS), Memorial Sloan-
Kettering Cancer Center (MSKCC), American Joint 
Committee for Cancer (AJCC) TNM staging and Bilimoria 
criteria in a cohort of 61 patients with PENs who underwent 
surgery at a single institution.
Methods: Actuarial disease-specifi c survival (DSS) of all 
61 patients and recurrence-free survival (RFS) of 53 patients 
who had curative resection were analyzed.
Results: On univariate analyses, tumor size ≥50 mm, non-
curative resection, lymph node involvement, presence of 
distant metastases, presence of necrosis, mitotic count 
≥2/10 hpf and poor differentiation were associated with 
decreased DSS. Tumor size ≥50 mm, lymph node involve-
ment, lymphovascular invasion, presence of necrosis and 
mitotic count ≥2/10 hpf were associated with decreased actu-
arial RFS. All fi ve staging systems were useful in stratifying 
the 61 patients according to actuarial DSS. However, the 
MSKCC grading and ENETS grading systems were not sta-
tistically signifi cant in stratifying DSS in the 61 patients. In 
the 53 patients who underwent curative resection, the WHO, 
ENETS, MSKCC, AJCC staging and the MSKCC grading 
systems were successful in stratifying the patients according 
to actuarial RFS. However, the Bilimoria scoring and ENETS 
grading systems were not useful in prognosticating these 53 
patients.
Conclusions: All fi ve classifi cation systems were useful for 
the prognostication of surgically treated PENs in our patient 
cohort.
A-283
CYSTIC LESIONS OF THE PANCREAS: 
THERAPEUTIC AND DIAGNOSTIC 
DILEMMAS
H. Hunaid, S. Rajinder, A. Devbrata, J. Saurabh 
and J. Rajeev
T. N Medical College and B.Y.L Nair Charitable Hospital, 
Mumbai, India
Introduction: Cystic lesions of the pancreas – pseudocysts 
and true cysts are a challenging clinical situation. While 
pseudocyst are mostly symptomatic, true cysts are asymp-
tomatic and comprise a wide range of differing underlying 
pathologies from being completely benign through premalig-
nant to frankly malignant. The diagnosis and management of 
these cystic lesions remains ambiguous.
Material & Methods: A retrospective analysis of 150 cases 
of cystic lesions of the pancreas operated in a single referral 
unit over past 10 years (2001–2010) was undertaken. Pre-
operative diagnosis was based on blood biochemistry, 
Ultrasonography, CT scan and EUS followed by surgical 
management.
Results & Discussion: Of 150 cases, 122 were pseudocysts 
who presented with pain and lump in epigastrium following 
acute pancreatitis, 88 underwent a cystogastrostomy and rest 
34 underwent cystojejunostomy. Of the 28 patients of true 
cysts, 18 were asymptomatic. All true cysts were surgically 
resected or enucleated. Histopathology showed 6 mucinous 
cystadenoma, 8 mucinous cystadenocarcinoma, 8 Gruber 
Franz tumor and 6 serous cystadenoma.
Conclusion: While the algorithm of management for pseu-
docysts is well established, the same is not true for true cysts. 
However, the diffi culties with pre-operative diagnosis, the 
high incidence of tumors with potential malignancy, and the 
good outcome with resection suggests that all suspected 
cystic tumors of the pancreas should be resected.
A-284
A SYSTEMATIC REVIEW AND META-
ANALYSIS OF SURVIVAL AND SURGICAL 
OUTCOMES FOLLOWING 
NEOADJUVANT CHEMORADIOTHERAPY 
FOR PANCREATIC CANCER
J. M. Laurence1,2,3,*, P. D. Tran4, K. Morarji4, G. D. Eslick5 
and C. Sandroussi1,2,6
1University of Sydney, Australia; 2Royal Prince Alfred 
Hospital, Sydney, Australia.; 3Westmead Hospital, Sydney, 
Australia; 4Liverpool Hospital, Sydney, Australia; 5The 
Whiteley-Martin Research Centre, Discipline of Surgery, 
The University of Sydney, Nepean Hospital, Sydney, 
Australia; 6Surgical Outcomes Resource Centre (SOuRCe), 
The University of Sydney, Australia.
Background: Neoadjuvant chemoradiotherapy (NCRT) 
may be used for both resectable and unresectable, non-met-
astatic pancreatic cancer. The aim of this systematic review 
and meta-analysis was to characterize the surgically impor-
tant benefi ts and complications associated with the use of 
NCRT.
Methods: Studies were identifi ed through a systematic 
search of MEDLINE, EMBASE and reference lists. Two 
independent reviewers extracted data from these studies. The 
outcomes analyzed were survival, peri-operative complica-
tions and death rates, pancreatic fi stula rate and rate of 
involved surgical margins. The odds ratio (OR) was calcu-
lated with a 95% confi dence interval (CI) using the Mantel 
– Haenszel method. ORs and variances for time-to-event 
outcomes were estimated according to Peto’s method.
Results: Nineteen studies involving 2148 patients were 
identifi ed. In order to facilitate metaanalysis, only cohort 
studies were included. Patients with unresectable pancreatic 
cancer who undergo NCRT achieve similar survival out-
comes to patients with resectable disease, even though only 
40% ultimately undergo resection. NCRT was not associated 
with a statistically signifi cant increase in the rate of pancre-
atic fi stula formation (OR 1.59 [0.39, 3.26]), or total compli-
cations (OR 1.33 [0.96, 1.85]). However, patients receiving 
NCRT were less likely to have a positive resection margin 
(OR 0.44 [0.31, 0.63]), and there was an increase in the risk 
of peri-operative death OR 2.34 [1.19, 4.60]).
Conclusion: Approximately 40% of cancers initially desig-
nated unresectable are amenable to surgery after NCRT. 
Initially unresectable pancreatic cancers are less likely to be 
resected with a positive margin after NCRT and the survival 
of these patients two years after treatment is comparable to 
that of patients with cancers that are resectable without 
NCRT.
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A-285
RADICAL RESECTION FOR 
GALLBLADDER CANCER: AN ANALYSIS 
OF SHORT AND LONG-TERM 
OUTCOMES
J. Andrici, J. S. Samra and T. J. Hugh
Upper GI Surgery Unit, Royal North Shore Hospital, 
University of Sydney, St Leonards, NSW, Australia
Introduction: Gallbladder (GB) cancer is a rare condition 
often associated with an aggressive biological behavior and 
poor long-term prognosis. Resection offers the only chance 
of cure. Indications for surgery and the extent of resection 
necessary remain controversial and there are no clear guide-
lines regarding adjuvant treatment.
Aim: To document short and long-term outcomes in patients 
who underwent radical resection for GB cancer.
Methods: A retrospective analysis of prospectively col-
lected data was undertaken on patients who underwent 
radical resection for GB cancer at our institution over a 10 
year period. Peri-operative data and survival outcomes were 
documented and analyzed.
Results: A total of 58 patients were referred for surgical 
consideration between 1999–2010. Of these, 23 patients sub-
sequently underwent a radical GB bed resection including a 
porta-hepatis lymphadenectomy. There were 12 females and 
11 males in this series with a median age of 69 (49–80). 
Postoperative morbidity occurred in 6/23 (26%) patients but 
there was zero mortality. The mean post-operative stay was 
12 days (1–48). The overall 5 year survival in this series was 
35% with a mean follow-up of 20 months. Intra- or extra-
hepatic recurrence occurred in 48% of patients during the 
follow-up period. Although not statistically signifi cant, there 
was a trend for patients with residual tumor found in the 
excised specimen after radical surgery, and those with node 
positive disease or positive resection margins to have a 
higher chance of developing recurrence compared with 
patients without these factors.
Conclusion: Radical resection for patients with T1b or 
greater disease offers a good chance of long term cure. Those 
with T3 or greater disease require an extended hepatectomy 
in order to reduce the risk of intra-hepatic recurrence.
A-286
SURGICAL STRATEGIES IN 
RE-INTERVENTIONS FOLLOWING 
PANCREATIC HEAD RESECTION: WHAT 
TO AVOID?
M. Hamoui and G. F. Calandra
Centre Hospitalier de Perpignan, Perpignan, France
Aim: To defi ne clear indications and technical surgical strat-
egies on what to do and what to avoid in the management 
of surgical complications following pancreatic head 
resections.
Material and Methods: A Pubmed search for surgical 
guidelines, prospective randomized controlled trials, system-
atic metaanalysis, and clinical reports was performed.
Results: Indications of re-interventions following pancre-
atic head resections are: (1) intra-abdominal bleeding; (2) 
abcess and fl uid collections; (3) complications in the site of 
laparotomy; (4) bowel ischemia; (5) bowel obstruction; (6) 
biliary fi stula; (7) pancreatitis; and (8) bleeding from the 
pancreatic anastomosis. In the case of pancreatic fi stula, 
surgery is mandatory in the presence of: (1) uncontrolled 
general sepsis with progressive multi-organ failure; and (2) 
complete disruption of the pancreatic anastomosis. When 
re-operating, redo of the anastomosis should be avoided. 
There are no clear guidelines on what to do, but drainage 
seems to be the safest strategy. Completion of pancreatec-
tomy oftens holds disastrous consequences and should be the 
last resort.
Conclusions: Re-do operations following pancreatic head 
resections are associated with a high rate of mortality (13–
60%). Outcomes are conditionned by the surgeon’s experi-
ence and the timing of intervention. There are no clear 
validated guidelines on what to do technically, but there 
seems to be a consensus that re-do of the anastomosis should 
be avoided, especially in the case of sepsis or peritonitis.
A-287
SURGICAL STRATEGY OF T1 
GALLBLADDER CANCER: A 
NATIONWIDE MULTICENTER SURVEY
S. E. Lee1, J-Y. Jang2, S-W. Kim2, H-S. Han2, 
B-H. Cho3, I-S. Song4, H-J. Kim5, S-H. Cho6, 
S-C. Hong7, I-S. Choi8, Y-H. Kim9, S-M. Lee10, 
S-J. Park11, D. W. Choi12, H-J. Kim13, W. J. Lee14 
and D-S. Yoon14
(Korean Pancreas Surgery Club)
1Department of Surgery, Chung-Ang University School of 
Medicine, Seoul, Korea; 2Department of Surgery, Seoul 
National University College of Medicine, Seoul, Korea; 
3Department of Surgery, Chonbuk National University 
College of Medicine, Jeonju, Korea; 4Department of 
Surgery, Chungnam National University College of 
Medicine, Daejeon, Korea; 5Department of Surgery, 
Chonnam National University College of Medicine, 
Gwangju, Korea; 6Department of Surgery, Dankook 
University College of Medicine, Cheonan, Korea; 
7Department of Surgery, Gyeongsang National University 
College of Medicine, Jinju, Korea; 8Department of Surgery, 
Konyang University College of Medicine, Nonsan, Korea; 
9Department of Surgery, Korea University College of 
Medicine, Seoul, Korea; 10Department of Surgery, 
KyungHee University College of Medicine, Seoul, Korea; 
11Department of Surgery, National Cancer Center, Seoul, 
Korea; 12Department of Surgery, Sungkyunkwan University 
College of Medicine, Seoul, Korea; 13Department of 
Surgery, Yeungnam University College of Medicine, 
Gyeongsan, Korea; 14Department of Surgery College of 
Medicine, Yonsei University, Seoul, Korea
Background: Because T1 Gallbladder (GB) cancer showed 
better prognosis than advanced GB cancer, some authors 
have considered it is amenable to perform only cholecystec-
tomy. However, owing to lack of evidence, there has been 
controversy regarding the optimum management.
Aim: The aim of this study is to investigate clinical feature 
and clinical outcome of T1 GB cancer and to determine 
surgical strategy for T1 GB cancer through a multicenter 
survey.
Methods: A nationwide multicenter study was performed in 
which 16 university hospitals in Korea participated from 
 Concurrent Sessions: Submitted Abstracts 157
HPB © 2011 International Hepato-Pancreato-Biliary Association, HPB, 13 (Suppl. 3), 65–159
1995 to 2004. A total 253 patients including 112 patients with 
T1a and 141 patients with T1b were enrolled. The clinico-
pathologic fi ndings & long-term follow-up results were ana-
lyzed after the consensus meeting of the Korean Pancreas 
Surgery Club.
Results: Mean age of the patients was 63-years-old and 
male to female ratio was 1:1.2. 77 patients (30.4%) were 
diagnosed during routine check-up. Simple cholecystectomy 
was performed in 75 patients (67.0%) with T1a tumor and 
in 67 patients (47.5%) with T1b tumor (p < 0.01). Lymph 
node metastasis was observed in 3% of patients with T1a and 
in 11.8% of patients with T1b (p = NS). There was signifi cant 
difference in 5 year survival rate between T1a and T1b 
(90.4% vs. 47.8%, p = 0.02). There was no signifi cant dif-
ference in 5 year survival rate between simple cholecystec-
tomy and extended cholecystectomy, according to presence 
of lymph node metastasis or not and according to lymph node 
dissection or not. Recurrence occurred in six patients (5.4%) 
with T1a and 20 patients (14.2%) with T1b (p = 0.02).
Conclusion: There was no defi nite evidence of priority of 
extended cholecystectomy to simple cholecystectomy. And 
the effectiveness of regional lymphadenectomy still remained 
questionable for the purpose of the treatment.
A-288
SHOULD ONE RELY ON SHORT 
GASTRICS PERFORMING SPLEEN-
PRESERVING DISTAL 
PANCREATECTOMY WITH SPLENIC 
VESSELS RESECTION?
V. I. Egorov1, N. I. Yashina1, T. V. Zhurenkova1, 
M. V. Petukhova1, N. S. Starostina1, T. V. Shevchenko1, 
R. V. Petrov1, S. A. Zarinskaia2 and K. A. Dmitrieva2
1Vishnevsky Institute of Surgery, Moscow, Russia; 2 Russian 
State Medical University, Chair of Topographical Anatomy, 
Moscow, Russia
Introduction: To know the collaterals is essential for 
spleen-preserving distal pancreatectomy with splenic vessels 
resection (SPDP SVR).
Objective: To ascertain the sources of blood supply to the 
spleen after SPDP SVR.
Methods: Perfusion of the cadaveric left gastric and right 
gastro-epiploic arteries with methylene blue after occlusion 
of all the arteries except the short gastrics (SGA) (n = 20); 
Intraoperative color Doppler US (ICDU) for the evaluation 
of the hilar arterial blood fl ow at distal pancreatectomy (n 
= 23) after a clamping of the splenic artery, a clamping of 
the splenic and left gastro-epiploic arteries and that of the 
splenic and short gastric arteries; CT-angiography (CTA) 
of gastric and splenic vessels before and after SPDP DPSVS 
(n = 10).
Results: Perfusion of cadaveric arteries has revealed no 
effective direct or indirect (through the submucous gastric 
arterial network) communication between the left gastric and 
SGA’s branches; in no case has IDU detected any hilar arte-
rial blood fl ow after the clamping of the splenic and left 
gastro-epiploic arteries; the SGA clamping has not changed 
the fl ow parameters; in none of the cases post-SPDP SVR 
C has delineated the short gastric vessels supplying the 
spleen. In all the cases the gastro-epiploic arcade was the 
main arterial pathway feeding the spleen.
Conclusion: Experimental, intra- and postoperative instru-
mental investigations have not shown the short gastric arter-
ies to be engaged in blood supply to the spleen after SPDP 
SVR. In all the cases the left gastro-epiploic artery was the 
main collateral vessel.
A-289
A COMPARATIVE STUDY BETWEEN PRE 
OPERATIVE C-REACTIVE PROTEIN 
(CRP)/PROCALCITONIN (PCT) LEVELS 
IN STENTED AND NON STENTED 
PATIENTS TO PREDICT INFECTIVE 
COMPLICATIONS POST 
PANCREATODUODENECTOMY
V. Powle, K. Sutariya, R. C. Shah and P. Jagannath
Dept. of Surgical Oncology, Lilavati Hospital and Research 
Centre, Mumbai, India
Background: CRP/PCT levels are the indicators of infec-
tion which are generally raised in patients post stenting and 
which are usually normal in non stented patients. Raised 
preoperative CRP/PCT level usually indicate a positive bile 
culture which is known to increase infective complications 
post pancreatoduodenectomy.
Aim: To compare the preoperative CRP/PCT level in stented 
and non stented patients undergoing pancreatoduodenectomy 
to indicate the infective complications.
Methods: 21 stented and 19 non stented patients undergoing 
pancreatoduodenectomy were part of a prospective study 
from January 2009 to June 2011. Their preoperative CRP/
PCT level, intraoperative bile culture report along with post 
operative infective complications were documented.
Results: 54% of the patients had undergone stenting prior 
to pancreatoduodenectomy and 20% had an elevated preop-
erative CRP > 5 or PCT > 0.5 as opposed to 46% non stented 
patients whom CRP < 5 or PCT < 0.5 except one who had 
raised CRP level with a positive bile culture and postopera-
tive sepsis with multiorgan failure. 96% Stented patients had 
a positive bile culture report intraoperatively and 20% 
showed a higher incidence of infective complications. T –test 
showed signifi cant difference.
Conclusions: A raised preoperative CRP/PCT level seen 
mainly in stented patients is associated with a positive intra-
operative bile culture and increased infective complications 
post pancreatoduodenectomy. It is a simple predictor to insti-
tute appropriate antibiotics prophylactically to prevent pan-
creatoduodenectomy related infective complications.
A-290
ACUTE CARDIOVASCULAR EVENTS 
AFTER CHOLECYSTECTOMY DUE TO 
GALLSTONE DISEASE – A POPULATION-
BASED STUDY
J. Strömberg1, O. Sadr-Azodi2, P. Videhult3 
and G. Sandblom2
1Kalmar Hospital, Dept of Surgery, Sweden; 2Karolinska 
Institute, CLINTEC, Sweden; 3Västerà6s Hospital, Dept of 
Surgery, Sweden
Background: Few studies have elaborated on the risk of 
acute cardiovascular events after cholecystectomy in patients 
with gallstone disease.
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Method: The Swedish Register of Gallstone Surgery and 
ERCP (GallRiks) started in May 2005 and reached 75% 
national coverage in 2007. Between 2006 and 2009, opera-
tions on 18,354 individuals older than 17 years were regis-
tered in GallRiks. By linkage to the Swedish Inpatient 
Register, occurrence of deep venous thrombosis, pulmonary 
thromboembolism and other acute thromboembolic events 
within 30-days after surgery was identifi ed. Multivariable 
logistic regression analysis was performed to study the effect 
of age, sex, ASA-classifi cation, indication of surgery, opera-
tive approach, operative time, thrombosis prophylaxis, previ-
ous history of venous thromboembolism or acute myocardial 
infarction and the occurrence of peroperative complications 
on the risk of acute cardiovascular events within 30-days.
Results: Within 30 days after surgery, 72 (0.14%) patients 
developed acute cardiovascular events. In multivariable 
analysis, previous history cardiovascular events was the 
strongest (OR = 6.59; 95% CI: 3.12–13.95) predictor for the 
development of acute cardiovascular events within 30 days 
after cholecystectomy. Age ≥70 years and open surgical 
approach or conversion also increased the risk of these com-
plications. There was also a positive association between the 
use of thrombosis prophylaxis (OR = 1.80; 95% CI: 1.03–
3.16) and the risk of acute cardiovascular events which also 
represents high-risk individuals.
Conclusion: The incidence of acute cardiovascular events 
after cholecystectomy is low. Yet, thrombosis prophylaxis 
could be offered to all older patients, those undergoing open 
surgery but most importantly those with previous history of 
venous thromboembolism.
A-291
LONG-TERM FUNCTIONAL RESULTS IN 
PATIENTS WITH PANCREATIC/
PERIAMPULLARY CANCER TREATED 
BY WHIPPLE RESECTION WITH 
PANCREATICOGASTROSTOMY
S. Mahesh, M. A. Wani, S. A. Rather, K. P. Manjuraj, 
A. Venugopal and H. Ramesh
Lakeshore Hospital, Cochin, Kerala, India
Introduction: There are concerns that pancreas-stomach 
anastomosis may result in poor exocrine pancreatic function 
and nutritional disturbances.
Aim: Determine functional status among patients with 
greater than 10 year survival after Whipple procedure for 
pancreatic/periampullary carcinoma.
Methods: There were 86 patients (male 49, female 37, age 
range 51–77, median 57.5). All cases underwent reconstruc-
tion after Whipple resection by duct-to-mucosa pancreatico-
gastrostomy. The following parameters were examined: 
(body weight at surgery, and at 10 years; fecal chymotrypsin 
in 29 and fecal elastase in 49 (8 patients had no fecal testing); 
Blood sugar and C peptide levels, and QOL questionnaires.
Results: 36 of the 86 patients had diabetes mellitus prior to 
surgery (3 diet control, 25 on oral drugs, and 8 on insulin) 
and no patient had steatorrhea before surgery. 10 years after 
surgery, 51 patients were diabetic (4 diet control, 32 oral 
drugs, 15 insulin) and 4 patients had symptomatic steator-
rhea. Weight gain occurred in 47 patients, and was main-
tained. In 22 patients, there was gradual loss of weight 
associated with fat intolerance, but no steatorrhea. 17 patients 
lost weight (3 to 17 kg; median 8 kg) which was not cor-
rected by pancreatic enzyme supplementation. Fecal elastase 
levels ranged between 65 and 275 units (median 150). 
Quality of life scores were excellent to good in 67/86 patients, 
fair in 12, and poor in 7 patients.
Conclusion: Over 2/3 of patients developed deterioration in 
pancreatic exocrine and endocrine function, though quality 
of life was preserved.
A-292
SURGICAL MANAGEMENT OF GIANT 
HEPATIC HEMANGIOMAS: 
COMPLICATIONS AND REVIEW OF 
LITERATURE
H-Y. Ho1, T-H. Wu1, M-C. Yu1,2, W-C. Lee1, 
T. C. Chao1 and M-F. Chen1
1Department of Surgery, Chang Gung Memorial Hospital 
at Linko, Chang Gung University College of Medicine, 
Taoyuan, Taiwan; 2Graduate Institute of Clinical Medical 
Sciences, College of Medicine, Chang Gung University, 
Taoyuan, Taiwan
Introduction: Hepatic hemangiomas are the most common 
benign hepatic tumors, and they are usually asymptomatic 
with normal liver function. Treatment options for giant hem-
angiomas are observation, surgical resection, and transcath-
eter arterial embolization (TAE). The aim of this study was 
to identify the risk factors of surgical complications.
Methods: In this series, the records of 61 patients with giant 
hepatic hemangiomas treated with surgical resection were 
retrospectively reviewed, data regarding clinical variables 
including sex, age, symptoms, tumor size, number, and loca-
tion, preoperative liver function tests, operative method, 
operation time, and operative blood loss were collected and 
analyzed.
Results: There were 8 patients (13.1%) with complications 
after resection or enucleation. Postoperative complications 
were associated with larger tumor size and tumors that were 
symptomatic. In addition, complications were associated 
with greater use of intraoperative infl ow control, longer 
operative time, and greater intraoperative blood loss. When 
complications encountered, most patients could be treated 
conservatively, but invasive interventions such as endoscopic 
retrograde cholangiopancreatography (ERCP) and percuta-
neous transhepatic cholangial drainage (PTCD) were 
required for the management of grade III complications.
Conclusions: Most giant hepatic hemangioma can be 
treated with enucleation or resection, and the important 
factors associated with complications were larger tumor size, 
the presence of symptoms, surgical bleeding, and prolonged 
surgery. Most complications were grade I, and could be 
treated conservatively.
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Introduction: Since histologic subtype of intraductal papil-
lary mucinous neoplasm (IPMN) was introduced, divergent 
results concerning its prognostic value have been reported. 
The authors investigated clinicopathologic characteristics 
and prognostic value of histologic subtype of IPMN.
Methods: The study cohort includes 213 consecutive surgi-
cal biopsy proven IPMN at Seoul National University 
Hospital. Pathologic slides including immunohistochemical 
staining were reviewed by a specialized pathologist.
Results: Of 213 IPMN, 38 low grade, 97 intermediate 
grade, 18 high grade dysplasia and 59 IPMN with an associ-
ated invasive carcinoma (invasive IPMN) were identifi ed. 
Histologic subtypes comprised of 135 gastric, 38 intestinal, 
38 pancreatobiliary and 2 oncocytic type IPMN. Histologic 
subtype was related with radiologic type (p < 0.001), main 
pancreatic duct dilataion (p < 0.001), degree of dysplasia (p 
< 0.001), and T stage (p < 0.001). Proportion of invasive 
IPMN was 14.1%, 42.1%, 57.9%, and 100% of gastric, intes-
tinal, pancreatobiliary and oncocytic type IPMN. Of 59 inva-
sive IPMN, cyst size (p = 0.018), perineural invasion (p = 
0.036), recurrence (p = 0.011) and disease related death (p = 
0.002) were related with histologic subtype. Disease specifi c 
survival was not affected by histologic subtype in overall 
IPMN (p = 0.881).
Conclusions: Although histologic subtype is related with 
degree of dysplasia of IPMN, histologic subtype has limited 
prognostic value in disease specifi c survival. However, eval-
uation of histologic subtype plays an important role in inves-
tigating evolution of invasive cancer from its background 
IPMN.
